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AVANT-PROPOS
La science c'est un sérieux divertissement nécessitant du temps, du travail, et
de  la  rigueur.  Elle  procure  beaucoup  de  plaisir  en  cela  que  la  découverte
scientique  c'est  d'abord  des  rencontres,  due  à  un  enchainement  de
circonstances plus ou moins planiées, et même parfois, au hasard... . Etudiant
en biologie cherchant sa voie, je suis entré par hasard dans un laboratoire de
biologie  structurale un après midi  de Juin à Toulouse.  J'y ai découvert  deux
choses : une communauté de chercheurs qui s'attachaient à voir plus loin et au
cœur  même  de  la  matière  an  de  donner  du  sens  aux  expériences  des
biologistes; et surtout la fascinante beauté de la complexité des assemblages
macromoléculaires.  Un  monde  atomique  ordonné  formant  des  « édices »
parfois dynamiques, mais toujours surprenant. Fasciné par l'organisation des
atomes dans l'espace et le temps, je me consacre depuis lors à travailler à la
compréhension de ces architectures. Un peu plus tard une autre rencontre me
t découvrir la virologie et son incroyable diversité stratégique, qui permet aux
virus  de  survivre  et  de  passer  de  génération  en  génération  leur  matériel
génétique. Les implications structurales n'étaient alors pas encore clairement
perçues. L'utilisation des diverses approches expérimentales (de la biochimie à
la biophysique) m'appris qu'il  faut de l'audace, de la détermination et de la
patience dans l'entreprise, mais surtout de l'humilité dans l'interprétation. Si
dans la cellule il y a prévalence de la stabilité des systèmes ; il y a au contraire
dans le monde viral une variété des assemblages qui re@ètent des stratégies
d'adaptation diverses. Ces descriptions structurales ne cessent de remettre en
cause notre perception et notre compréhension des mécanismes du vivant, nul
doute qu'il reste encore beaucoup à décrire. 
Ce mémoire reprend les travaux auxquels j'ai  participé depuis la n de ma
thèse en 2005.
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 I. RESUME DU PARCOURS SCIENTIFIQUE
J'ai commencé mon parcours scientique à l'Université de la Méditerranée à
Marseille dans le laboratoire de B. Canard. J'ai eectué ma thèse sous la co-
direction de S. Longhi et B. Canard, sur l'étude des réplicases virales par bio-
informatique  et  biologie  structurale.  Notre  objectif  était  d'une  part  de
développer une base de données se rapportant aux virus à ARN simple brin, et
qui gèrent les informations structurales et fonctionnelles des protéines virales,
en les classant par module. Le module étant déni comme la fraction (totale ou
partielle)  de  la  protéine  qui  est  cristallisable.  Cette  base  de  données
(VaZyMolO)  a  été  publié  en  2005.  Cette  approche  a  permis  entre  autre
l'identication  d'un  domaine  méthyltransférase  sur  la  protéine  L  des
Mononegavirales  et  la  dénition  de la  modularité  des protéines  N et  P des
Paramyxovridae. Par la suite, nous avons  construit la première cartographie
modulaire  du  génome  du  virus  du  Syndrome  Respiratoire  Aiguë  Sévère
Coronavirus lors de l'épidémie de 2003. En dehors des données structurales et
d'évolution  obtenues  à  partir  de  ce  travail  d'annotation  minutieux,  il  m'a
permis de mettre en place une méthode d'annotation particulièrement ebcace
pour identier et étudier les régions désordonnées des protéines. Ces régions
sont d'un intérêt fondamental dans la mesure où elles jouent un rôle dans le
recrutement  d'assemblage dynamique des macromolécules  du complexe  de
réplication, du déplacement cytoplasmique ou lors de la stratégie d'évasion à
la réponse de l'immunité innée.
En  2005,  après  la  soutenance  de  ma  thèse,  J'ai  rejoins  le  groupe  de  R.
Dominguez, d'abord au Boston Biomedical Research Institute à Boston, puis à
l'Université de Pennsylvanie à Philadelphie. Lors de ses stages post-Doctoraux,
je  me  suis  formé  à  la  cristallographie  aux  rayons  X  et  aux  méthodes
biophysiques (@uorescence, calorimétrie), en m'intéressant à la résolution de
complexe de macromolécules cellulaires ainsi qu'à leur recrutement dynamique
par des régions protéiques désordonnées. Ces travaux ont mené à la résolution
de plusieurs structures impliquées dans la régulation du lament d'actine ou de
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sa structuration près de la membrane. En particulier, nous avons pu mettre en
évidence que le recrutement du complexe de proline-actine par la protéine
VASP  se  fait  d'abord  par  une  région  désordonnée,  qui  ensuite  transfert  ce
complexe à une hélice transitoire (WH2) permettant le positionnement correct
de l'actine monomérique sur le lament d'actine. Ce mécanisme permet une
croissance rapide et contrôlée du lament d'actine.
En 2009, j'ai ensuite rejoins le groupe de J. Lescar à Singapour, qui souhaitait
développer dans le cadre d'un Projet International de Coopération Scientique
(PICS)  avec le  CNRS,  une partie  de ses  projets  dans le  laboratoire  AFMB à
Marseille. Grace à une ATIP j'ai pu co-diriger l'équipe de Marseille, et avec l'aide
d'un  ingénieur  d'étude,  j'ai  développé  un  projet  de  recherche  sur  la
caractérisation structurale des Nucléoprotéines de Phlébovirus. Dans ce cadre,
j'ai  établi  une  collaboration  internationale  avec  l'équipe  de  T.  Waltz  de
l'Université  de  Harvard.  Les  résultats  de  ce  post-doctorat  ont  mené  à  la
résolution de la structure à basse et haute résolution de la Nucléoprotéine du
virus de la vallée du Rift, sous forme d'anneaux hexamériques.
Après mon recrutement au CNRS en 2010 en tant que CR2, j'ai rejoint le groupe
de B. Canard à l'AFMB. Mon objectif était de pouvoir utiliser mes compétences
en  bio-informatique,  biochimie,  biologie  structurales  et  biophysique  an
d'étudier  le  processus  d'assemblage  du  complexe  de  réplication  des
Arenaviridae et Bunyaviridae. De plus, je me suis intéressé à la résolution des
structures  de protéines  impliquées dans le  processus de la  formation de la
coie chez les virus à ARN étudiés au laboratoire. La formation des structures
« coie » sur les ARN viraux messagers nécessite le recrutement de complexes
macromoléculaire  dynamiques  impliquant  parfois  des  régions  désordonnées
et/ou  probablement  des  changements  de  conformation  importants.  Nous
espérons que la caractérisation de ces diérentes interactions pourra mener à
l'identication d'inhibiteurs structuraux ciblant l'assemblage de ces complexes.
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 II. CONTEXTE DE CE MANUSCRIT
 A. Les assemblages macromoléculaires
 i. Fonction et assemblage dynamiques
L'étape primordiale et obligatoire dans la recherche biologique passe par
l'étude de l'activité et de la structure d'une protéine isolée de son contexte
biologique. Par ce biais, il est possible de caractériser la fonction de la protéine
ou par sa structure de l'utiliser comme outil dans le cadre de design rationnel
de molécules. Cependant, ce processus empirique d'accumulation des données
ne permet pas toujours une description correcte des processus biologiques ou
structuraux  qui  se  passent  dans  la  cellule.  La  plus  part  des  processus
biologiques ;  et  cela  est  encore  plus  vrai  pour  les  virus ;  sont  issus
d'assemblages  moléculaires  complexes  [1].  Ces  derniers  sont  souvent
dynamiques  et  vont  accomplir  une  ou  plusieurs  tâches  impliquant  des  ré-
assemblages structuraux au cours du cycle dans lequel ils sont impliqués. La
compréhension de ces mécanismes passe par la détermination des structures
correspondant  aux  diérentes  étapes  et  à  la  description  de  leurs  modes
d'action.  En  plus  du  problème  d'échelle  auquel  est  confronté  le  biologiste,
s'ajoute la stabilisation des complexes dans des états compatibles pour l'étude
structurale  et  garantissant  un  surplus  d'information  toujours  pertinent.  Les
premières données qui ont re@été ses grands assemblages structuraux furent
celles amenées par l'étude de capside de virus, puis des larges complexes des
« machines  cellulaires »,  membranaires  ou  non  [2].  Les  études  structurales
relatives aux protéines de la régulation du cytosquelette s'avèrent être l'un de
ces challenges majeurs. Ce sont des protéines dont l'assemblage forme des
architectures  transitoires  voir  furtives,  mais  stable  et  hautement  régulé.
« Transitoire  mais  stable »,  c'est  un  paradoxe.  Ainsi,  la  naissance  et  la
croissance d'un lament d'actine, font appel à des partenaires protéiques qui
tour à tour peuvent être initiateurs, élongateurs, inhibiteurs et dé-assembleurs.
Chacun va former un complexe stable correspondant à l'étape pour lequel il est
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aecté et dont l'état dépend de l'état structural ou fonctionnel qui le précède.
Après maint eorts, la biologie structurale a mis au point des stratégies pour
« geler » et étudier les diérentes étapes transitoires de ces complexes [3]. Ce
qu'il  y  a  de  plus  extraordinaire  dans  les  protéines  de  la  régulation  du
cytosquelette,  c'est  qu'elles  ont  intégré  une  panoplie  très  étendue  de
techniques pour contrôler l'actine [4]. En particulier, le contrôle d'une activité
par  l'activation  structurale  (formation  d'un  complexe  jouant  le  rôle  d'un
interrupteur  moléculaire),  ou  encore  l'usage  de  régions  désordonnées  qui
servent  de  plate-forme  de  recrutement  à  tout  un  panel  de  protéines
régulatrices en plus de l'actine elle-même [5–12]. Ce sont des caractéristiques
similaires que l'on retrouve chez les virus. La maturation de la polyprotéine de
nombreux virus à ARN (+) permet d'activer ou d'inhiber une activité au cours
du  cycle  virale  (i.e. Flavivirus  /  Coronavirus) ;  ou  l'usage  de  régions
désordonnées chez les virus à ARN (-) pour perturber la réponse à l'interféron
ou réguler les étapes de réplication / transcription, en sont de parfait exemples
[13–21].  Ainsi,  comme  nous  l'avons  montré  avec  les  nucléoprotéines  de
Phlébovirus, les protéines existent dans des états structuraux diérents pour
répondre à des contraintes structurales mécaniques, mais probablement aussi
pour temporiser le cycle réplicatif. 
Ce  qu'il  y  a  de  frappant  lorsque  l'on  étudie  et  compare  les  protéines  de
régulation  cellulaire  et  les  protéines  virales,  c'est  leur  capacité  à  modier
profondément leur environnement  [1]. En cela, il y a une certaine homologie
dans  le  résultat  aectant  la  cellule.  En  eet,  la  cellule  génère  des  micro-
environnements  lors  de  processus  d'adaptation,  de  restructuration  de  la
membrane ou lors de transport intracellulaire. De même, lors d'une infection
virale, l'une des premières conséquences pour la cellule est la création d'un
micro-environnement  (usine  à  virions)  créé  par  des  assemblages
macromoléculaires dynamiques [22]. Ce micro environnement est imposé par
le virus, mais montre combien les virus ont réussi à adapter leurs protéines aux
membranes  et  /  ou  aux  protéines  qui  s'occupent  de  l'architecture  des
membranes.  Ainsi,  la  description  au  niveau  atomique  de  ces  interactions
recèlent certainement des réponses sous-jacentes à la réplication tout autant
qu'à  l'encapsidation.  L'un  des  cas  les  plus  marquant,  se  trouve  chez  les
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Arenavirus. Le cycle viral des Arenavirus est assez bien connu d'un point de vu
de  sa  localisation  cellulaire  et  de  sa  cinétique  [23,24].  En  revanche,  les
données  structurales  et  fonctionnelles  restent  extrêmement  limitées  et  ce
malgré le fait que les Arenavirus utilisent un nombre limité de protéines pour
accomplir  leur  cycle  réplicatif.  La  dibculté  vient  de  l'obtention  de  large
complexe  ribonucléoprotéique  qui  permettent  de  comprendre  l'assemblage
fonctionnel  de  ces  machines  virales.  Un  autre  fait  surprenant  chez  les
Arenavirus est de retrouver des ribosomes dans leurs virions  [25]. Ils ne sont
plus actifs dans le virion mais leurs présence dans la particule virale montrent
combien ces derniers  se trouvent  complexés  aux protéines virales  au point
d'être  « arraché »  à  la  cellule.  Le  fait  de  retrouver  systématiquement  des
ribosomes  chez  les  Arenaviridae dans  le  virion  et  non  pas  chez  les
Bunyaviridae, une  famille  relativement  proche,  suggère  la  présence  de
mécanisme ou d'adaptation propre qui restent à être élucidé. 
Les études des complexes impliquant les protéines interagissant avec les
acides nucléiques ADN et ARN polymérases, ribosomes... se sont révélées être,
et  sont  encore  pour  la  plupart  d'entre  eux,  plus  complexes  à  obtenir
qu'originellement  pensé.  Les  conformations  des  structures  obtenues  des
protéines seules correspondent souvent à un état stable mais pas forcément à
l'état  actif.  Ainsi  si  la  cristallographie  est  la  seule  technique  qui  donne  un
résultat absolu, il est d'autant plus nécessaire de le discuter à la lumière de la
biologie. Les challenges qui s'orent aux cristallographes sont donc énormes
car  il  s'agit  de  résoudre  ces  assemblages  architecturaux  qui  constituent  la
nouvelle frontière.
L'étape primordiale et obligatoire dans la recherche biologique passe par
l'étude de l'activité et de la structure d'une protéine isolée de son contexte
biologique. Par ce biais, il est possible de caractériser la fonction de la protéine
ou par sa structure.
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 ii. Apport de la cristallographie dans la 
caractérisation des macromolécules biologiques
La contribution de la biologie structurale et de la cristallographie en particulier
représente une source de progrès qui génère des retombées non seulement en
recherche fondamentale mais aussi en recherche appliquée. Mais les bénéces
de cette contribution va au-delà.  A la n des années 1970, les cristallographes
sont  confrontés  à  tellement  de  dés  conceptuels  et  technologiques,  qu'ils
mettent en place un projet cristallographique global et collaboratif  [26], par
cette approche unique ils ont révolutionnés la façon de penser la recherche. En
une  vingtaine  d'année,  tout  les  aspects  théoriques  et  techniques  ont  été
couvert. Ils ont permis de sortir la cristallographie et la diraction aux rayons x
du  microcosme  d'experts  vers  une  communauté  plus  large,  tout  en
garantissant un accompagnement de tout les développements techniques [27].
C'est ce modèle qui in@uence encore aujourd'hui certaines communautés de
développeurs  et  d'universitaires.  L'omniprésence  de  la  cristallographie  en
biologie,  s'explique  par  la  valeur  ajouté  de  l'information  qu'elle  produit
éclairant  dénitivement  l'interprétation  du  biochimiste  ou  du  biologiste
cellulaire. Les processus biologiques complexes sont les résultats d’interactions
dynamiques soit de macromolécules (protéiques ou nucléiques) entre elles, soit
de macromolécules avec de petits substrats cellulaires. La fonction biologique
d'une macromolécule est dénie d'une part par sa conformation et d'autre part
par  sa  dynamique.  Pour  être  fonctionnelle,  une  protéine  doit  être  le  plus
souvent être « correctement » repliée ; ce qui veut dire être dans un état stable
(natif),  qui  lui  permet,  si  nécessaire,  de  changer  de  conformation  pour
accomplir ce pourquoi elle est faite. An de pleinement comprendre comment
la  protéine  fonctionne,  il  est  important  sinon  nécessaire  d'accéder  à  la
structure  « ne »  des  protéines.  La  cristallographie  est  la  méthode  par
excellence  pour  dénir  avec  une  quasi  certitude  au  niveau  atomique  la
structure de ces macromolécules seul ou en complexe. En combinaison avec
d'autres  méthodes spectroscopiques elle  permet  d'atteindre  le  rêve de tout
« voir » au cœur de la matière [28].
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Historique
La cristallographie ; dont on vient de célébrer le centenaire en 2014 [29–
31];  est  la  méthode  qui  a  probablement  le  plus  in@uencé  les  diérents
domaines de la science. De la géologie, à la nanotechnologie en passant par la
biologie,  c'est  par  elle  que  les  scientiques  ont  la  possibilité  de  décrire
l'organisation  de  la  matière  au  niveau  atomique.  C'est  par  les  recherches
appliquées de Max Von Laue et de William Henry et William Lawrence Bragg
(père et ls) [32] sur les cristaux de roche que le principe de la diraction des
rayons x pour remonter à la structure atomique fut posé (1913)  [32] . C'est
dans  les  année  1930,  que  l’on  démontra  la  possibilité  de  cristalliser  des
protéines [33], en 1937 Max Perutz commence un projet en ayant pour objectif
la détermination de la structure cristalline de l’hémoglobine. En 1945 Dorothy
Hodgkin et son équipe détermine la structure de la pénicilline [34].  En 1953,
Perutz  et  collègues  décrivent  l’application  de la  méthode de remplacement
isomorphe multiple  (MIR)  pour la détermination de structures cristallines  de
protéine. La même année, Watson J. et Crick F. décrivent la structure en double
hélice de l'ADN [35], grâce à la technique de diraction des rayons X [36] (à
partir du travail de Rosalind Elsie Franklin  [37,38]). Il faut attendre 1958 pour
que la technologie permette la résolution de la première structure atomique
d'une protéine, la Myoglobine par Kendrew J. [39]. Max Perutz après 25 années
de travaille  nit  la  structure  de  l'hémoglobine  (1962)  [40].  La  structure  du
lysozyme (1965)  [41] conrmait dénitivement que la méthode pouvait être
systématisée.  Dès  1959,  Michael  Rossmann  commence  à  développer  les
premiers codes pour la résolution et l'analyse de structure. En 1973, Rossmann
décrit  l'un des repliements  fondamentaux de la  biologie (le  Rossmann fold)
[42], qui est un motif structural protéique présent dans les protéines qui lient
les nucléotides, particulièrement dans la nicotinamide adénine dinucléotide, les
méthyltransférases,  les  déshydrogénases  ou  kinases  qui  lient  les  molécules
contenant une adénosine triphosphate.  En 1978,  Gérard Bricogne et Steven
Harrisson réussissent pour la première fois à déterminer des structures virales
à l'échelle atomique [43]. En 1979, A Jones développe les prémices de ce qui
va  être  l'outil  de  visualisation  des  cartes  de  densité  électronique  [44].
Bien sur la liste des contributeurs n'est pas exhaustive et bien trop courte pour
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rendre  hommage  à  tous  ceux  qui  ont  contribué  au  développement  de  la
méthode.
 Enn,  c'est  avec  la  maîtrise  et  l'amélioration  des  sources  de  lumière
synchrotron (1995)  [45,46] couplées à l'accélération des capacités de calculs,
et  l’avènement  de  la  biologie  moléculaire (2000);  qui  a  permis  de  produire
massivement  des  protéines  recombinantes ;  que  l’accélération  de  la
détermination de structure a vraiment commencé  [47–50]. Aujourd'hui,  nous
sommes à près de 96.000 structures de protéines déposées et le rythme de
dépôts par an ne cesse d'augmenter.
Principes
La  cristallographie  n'est  pas  une  méthode  de  visualisation  directe  qui
focalise la lumière des objets à travers des lentilles an d'obtenir une image
magniée. Elle nécessite tout d'abord que « l'objet » d’intérêt soit cristallisé. Le
cristal  étant  un  assemblage  dans  lequel  un  motif  atomique se  répète
périodiquement  dans  les  trois  directions  de  l’espace,  engendrant  ainsi  un
Figure 1: Statistiques des stuctures déposées à la PDB
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réseau. On peut décomposer ce dernier en série de parallélépipèdes dont les
arêtes  sont  parallèles  aux axes  cristallographiques.  Ensuite,  elle  exploite  la
caractéristique de la longueur d'onde des rayons X (comprise entre 0,05nm et
5nm) qui fait qu'ils sont dispersés par le nuage électronique des atomes des
objets  exposés.  Comme  un  réseau  optique  diracte  la  lumière,  le  réseau
cristallin va diracter les rayons X. Ce phénomène est lié aux interférences qui
existent entre les ondes diusées par les atomes. Dans certaines directions, les
interférences seront constructives et une intensité sera diractée, alors que
dans  d’autres  directions,  les   interférences  seront  destructives  et  aucune
ré@exion ne sera observée. Les ré@exions observées peuvent être collectées ;
elles se traduisent sous forme de taches plus ou moins intenses et organisées
sous  forme  de  motif.  L'interprétation  de  ces  motifs  permet  de  dénir  les
paramètres  de  la  maille  et  de  symétrie  du  cristal.  L'analyse  des  ré@exions
permet  d'obtenir  l'organisation  des  atomes  des  molécules  qui  forment  le
cristal.  Ces  ré@exions  contiennent  l'information  du  contenue  de  l'unité
asymétrique, mais l'information n'est pour autant pas directement accessible.
L'information  se  trouve  codée  dans  la  distribution  des  intensités des
ré@exions  dans  « l'espace  réciproque ».  L'espace  réciproque  est  une
construction  abstraite  qui  permet  de  représenter  et  caractériser  des
phénomènes  complexes  en  utilisant  un  espace  vectoriel.  L'utilisation  de  la
transformation  de  Fourrier  permet  de  ramener  cette  information  dans
« l’espace  réel »  donnant  une  image  de  la  molécule  cristallisée.  La
transformation de Fourier est une opération mathématique qui requiert deux
termes : (1) les amplitudes (facteur de structure) que l'on peut déterminer de
l'intensité  des  taches  de  diraction.  (2)  l'angle  relatif  de  la  phase
correspondante  à  chaque  tache  de  diraction  [51].  La  résolution  de  ce
problème, appelé « problème de la phase », est l’étape indispensable à toute
détermination  de  structure  cristalline.  Cette  dernière  information  doit  être
déduite  soit  de  phases  déjà  connus  d'un  modèle  proche  déjà  résolu
(remplacement moléculaire) ; soit de méthodes expérimentales qui permettent
de l'identier. 
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Figure 2: A) Loi de Bragg: les ondes di(usées par deux atomes localisés dans 
des plans réticulaires adjacents produiront des interférences constructives si la 
di(érence de chemin parcourue par ces ondes, ∆ , est un multiple entier de la 
longueur d’onde de la radiation incidente. Elle permet de prévoir l’angle 2 θ 
entre le faisceau incident et le rayon di(racté par une famille de plan hkl , qui 
est fonction de la distance réticulaire dhkl et de la longueur d’onde λ de la 
radiation incidente. B) Modèle simple de structure cristalline à deux atomes. 
Pour cet atome, le réseau est identique et la géométrie de di(raction restera la 
même. Lorsque le cristal est exposé au faisceau de rayons X de telle sorte 
qu’une famille de plans hkl soit en position de di(raction, tous les atomes de 
type 1 vont di(user les rayons X en phase l’un avec l’autre. Il en est de même 
pour tous les atomes de type 2. Toutefois, le second réseau, auquel appartient le
second atome, a été déplacé par rapport à l’origine d’un vecteur x2 , y2 , z2 . 
L’onde résultante di(usée par ces atomes de type 2 présentera par conséquent 
un déphasage par rapport à l’onde résultante di(usée par le premier atome. Ce 
déphasage sera di(érent pour chaque ré8exion considérée. La résultante de 
l'ensemble des ondes di(usées dans la direction de ré8exion hkl des atomes de 
la maille s’appelle le facteur de structure, caractérisé par une amplitude F et une
phase φ. C) Addition vectorielle des ondes diffusées par des atomes individuels, 
aboutissant au facteur de structure, d’amplitude F et de phase φ. Les intensités 
mesurées fournissent les amplitudes des facteurs de structure, mais pas leurs 
phases.
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• Dans  le  cas  du  remplacement  moléculaire,  on  utilise  un  modèle
« proche »  pour  calculer  la  phase initiale,  qui  permet  la  construction  de la
densité  électronique  à  partir  des  données.  Cette  méthode  implique  le
positionnement  correct  du  modèle  dans  le  cristal  puis  le  calcule  de  la
diraction théorique que l'on compare à celle qui est observée. Ceci permet de
calculer des phases théoriques initiales. La méthode est relativement rapide
pour déterminer les phases initiales, mais elle peut aussi produire une phase
biaisée. En eet la reconstruction de la densité électronique est dépendante
des phases,  du coup le modèle initiale re@étera surtout  caractéristiques du
modèle utilisé pour le remplacement moléculaire et non pas le vrai modèle. Il
est  important  alors  d'utiliser  des  méthodes  de  correction  du  biais  pour
construire  le  modèle  correcte.  Cette  méthode  est  massivement  utilisé,  soit
environ les 3/4 des structures déposées [52].
• Dans le cas où il est impossible de trouver un modèle compatible pour
déterminer les phases, il faut passer par la détermination expérimentale des
phases [53]. Leur détermination de novo, passe par la mesure d'une diérence
d'intensité  d'un  « marqueur »  atomique  (Soufre,  Sélénium  dans  des
Méthionines  modiées,  sels  de  mercure  ou Tantale,  etc),  avec et  entre  les
intensités de jeux de données isomorphes. Ainsi le remplacement isomorphe
multiple, consiste à faire diuser des atomes lourds (riches en électrons) dans
un cristal et à comparer la diraction avec et sans ces éléments lourds. Les
« atomes lourds » modient  légèrement  les intensités de diraction,  ce qui
permet  de  calculer  les  phases  par  triangulation.  La  limite  est  d'arriver  à
positionner les atomes lourds dans la maille du cristal. La diusion anomale,
consiste à faire varier la longueur des rayons X autour du seuil d'absorption
d'un  des  types  d'atomes  contenu  dans  la  molécule.  Le  sélénium  est
fréquemment  utilisé  car  il  possède  un  seuil  d'absorption  X  proche  des
longueurs  d'ondes  utilisées  (autour  de  0,1  nm).  Les  diérences  anomales
seront  les  plus  signicatives  lorsque  la  longueur  d'onde  des  rayons  x  est
légèrement supérieur au seuil d’absorption du marqueur. Dans ces conditions
les  photons  incidents  sont  alors  absorbés  et  provoquent  une  excitation
électronique de l'atome.  Cette excitation  génère une diusion anomale (ou
diusion résonante) ainsi qu'une variation signicative des intensités au sein
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même du jeu de donnée (pour une longueur d'onde d’excitation donnée) ou
entre les jeux de données si le cristal est soumis à plusieurs longueur d'ondes.
L'information  obtenue  de  ce  signal  permet  alors  de  déterminer  une  sous
structure  des  atomes  marqueurs  à  partir  de  laquelle  on  peut  calculer  les
phases  initiales  nécessaire  pour  reconstruire  la  densité  électronique.
L'avantage d'utiliser les marqueurs atomiques des acides aminés naturels ou
modiés (S ou Se-Methionine) c'est de fournir un signal anomal spécique de
la structure et de la séquence. Le phasage expérimentale a été utilisé pour 1/4
des  structures  résolues.  Le  phasage  anomale ;  du  fait  de  sa  simplicité  et
sensibilité ; est largement plus utilisé que les expériences par remplacement
isomorphe multiple. 
Évaluation des structures cristallographiques
Tout scientique amené à regarder une structure cristallographique, doit
(ou devrait) avoir les moyens d'évaluer la qualité de la structure qu'il observe.
Non pas pour la juger ; il n'est pas forcément expert ; mais pour garantir une
observation critique de la structure et éviter la surinterprétation. Les structures
cristallographiques des protéines sont déposées à la « Worldwide Protein Data
Bank (http://www.wwpdb.org/) ». Lors de la soumission d'une structure, la PDB
eectue un certain nombre de vérications pour garantir un contrôle qualité
minimal (vérication de la géométrie, distance, angles et torsion des liaisons
de la chaîne principale). Ainsi ces informations apparaissent sous la forme du
critère de la valeur quadratique moyenne de déviation (ou Root Mean Square
Deviation-RMSD) qui décrit de combien en Angström ou en degrés les liaisons
ou les angles dévies de la valeur idéale. Ainsi une structure, « able »devrait
avoir un RMSD de moins 0.015Å pour ses liaisons et de moins 1.5° pour ses
angles. Classiquement la qualité de la géométrie de la chaîne principale d'un
modèle est présentée sous la forme d'un diagramme de Ramachandran. Ce
diagramme définit  les  valeurs  de  l'angle  diédral  φ  en  abscisse  et  celle  de
l'angle diédral  ψ en ordonnée,  pour chaque acide aminé de la protéine.  Un
nombre limité de valeurs des angles φ et ψ sont possibles, ainsi les résidus
pour lesquels les angles sortent des régions autorisées sont instantanément
identiables  [54]. Une structure ne doit avoir  aucun résidu dans les régions
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interdites. 
Au delà des critères géométriques, un critère bien plus important est celui
de comment le modèle corrèle avec les données expérimentales [55]. En eet,
les structures observées ne sont pas la réalité mais une représentation de cette
réalité. L'avantage de la cristallographie sur les autres méthodes structurales
et la microscopie électronique en particulier, c'est que le cristallographe a les
moyens  d'évaluer  la  qualité  du  modèle  proposé  par  rapport  au  données
collectées.  Deux  paramètres  de  abilités  sont  associés  aux  structures
cristallographiques  les  valeurs  R-de  travail et  R-libre.  La  valeur  R-de  travail quantie
l'accord  global  entre  les  amplitudes  expérimentales  et  les  amplitudes
théoriques calculées de la structure du modèle. Ainsi un modèle qui est « en
accord » avec ses données va avoir des amplitudes calculées très similaires
aux amplitudes expérimentales  et un R-de  travail bas.  Le R-de  travail s'exprime en
pourcentage et une valeur correcte est comprise entre 15 % et 25 %. La valeur
R-libre est une valeur de validation croisée. Cette valeur permet d'éviter la sur
interprétation des données et d'éviter le biais introduit lors de la construction
et l'abnement. Le R-libre est calculé de la même façon que le R-de travail mais non
pas l'ensemble des amplitudes mais sur un échantillonnage qui a été séparé et
qui n'a subit aucune altération durant l'abnement. Ainsi, le comportement du
R-libre suit celui du R-de travail et lorsque le R-libre s'écarte du R-de travail, c'est le signe
que les données ne supportent plus l'interprétation du modèle. Une diérence
entre les 2 R de 5 % est acceptable, au-delà c'est une indication qu'il y a un
problème avec la structure. Le facteur de température (ou facteur B) est aussi
une indication  importante  quand à  la  mobilité  des  atomes présent  dans  le
cristal (protéine, acide nucléique, ligand ou solvant). Un facteur B élevé est une
indication d'une mobilité de position dans le cristal. Pour un complexe, il peut
être indicatif d'une faible occupation du site de liaison. 
Enn, la résolution à laquelle les ré@exions ont pu être mesurées donnent
aussi une idée générale au combien les détails sont ables au regard de la
qualité de la carte de densité électronique. Ainsi la majeur partie des structures
déposées  ont  une  résolution  comprise  entre  1.5Å  et  2.5Å.  A  plus  haute
résolution il est possible d'accéder aux détails n de la structure tels que : les
29
conformations alternatives des chaînes latérales, la position plus précise des
ligands et dans certains cas la déformation de la densité électronique permet
d'accéder  à  l'état de  charge  des  atomes  du  site  actif  et  de  leur  potentiel
électrostatique. Dans  ces  conditions  il  est  possible  d'envisager,  une
compréhension au niveau sub-atomique de processus biologiques complexes
tels que les transferts d'électrons et de protons, les réactions d'oxydo-réduction
faisant  intervenir  des  centres  métalliques  réactionnels,  l'activation  du
dioxygéne (hémoglobine) [56,57]. A moins de 3Å la structure reste informative,
elle fournit une information générale sur le repliement ou sur l'organisation des
domaines et  les  interactions éventuelles,  elle  ne permet pas d'accéder aux
détails  n de la structure ni du positionnement des chaînes latérales ou de
petit ligand.
Ainsi  la  conjonction  de  progrès  réalisés  tant  au  niveau  technologique
(biologie  moléculaire,  sources  de  rayons  X,  détecteurs  de  rayons  X,
supercalculateurs  miniatures)  qu’au  niveau  des  logiciels  de  traitement  des
données  de  diraction  (collecte,  phasage,  abnement)  et  la  rigueur  de  la
méthode ont permis à la cristallographie de prendre une place centrale. Cette
méthode  a  permis  la  détermination  des  structures  tridimensionnelles  de
plusieurs milliers de macromolécules biologiques dans des gammes de taille et
de  complexité  très  variées  :  petites  protéines,  oligonucléotides,  acides
ribonucléiques  de  transfert,  immunoglobulines,  assemblage  complexe  du
cytosquelette,  complexes  nucléoprotéiques,  macro-complexe  fonctionnels
(ribosome)  et  structuraux  (cytoskelette),  et  bien  évidement  des  virus :  de
bactéries, d’insectes, de plantes ou de mammifères. 
 B. Les virus
En  1957,  lors  de  la  troisième  conférence  commémorative  de  Marjory
Stephenson, A. Lwolf conclue sa présentation par la dénition suivante : « les
virus doivent être considérés comme des virus parce que c'est ce qu'ils sont. »
[58]. Lwo est le père de la virologie moderne en cela qu'il est le premier à
comprendre  la  portée  de  ses  résultats  à  la  lumière  des  60  années  qui  le
précède et qui lui permette d'énoncer les caractères fondamentaux qui font
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des virus des entités originales : « Les virus sont de petites tailles, infectieux et
potentiellement pathogènes ; ce sont des entités nucléo-protéiques possédant
un  seul  type  d'acide  nucléique  (ARN ou  ADN)  ;  ils  sont  reproduits  (par  la
cellule) à partir de leur matériel génétique ; ils sont incapables de croître et de
se diviser ; ils sont dépourvus de système de Lipmann. » 
Cette dénition est un peu désuète au regard de la virologie moderne mais
révolutionnaire à l'époque où elle fut énoncée. Elle mit dénitivement n au
dénigrement issus de la bactériologie qui dénissait les virus (non visible au
microscope, non cultivable, non ltrable) par opposition aux bactéries et permit
de fonder un nouveau domaine de recherche, la Virologie.
Pendant près d'un demi-siècle, les virus ont été perçus comme des structures
extrêmement  simples  dont  l’ensemble  des  éléments  protègent  quelques
« petits bouts » de matériel génétique, et dont la seule raison d'être, est de
s’inltrer  dans une cellule  pour  la  parasiter  [59].  Les  virus  ont  été  et  sont
encore parfois considérés comme de simples véhicules de gènes ayant joué un
rôle  mineur  dans  l'évolution.  Seulement  ce  paradigme  a  quelque  peu  été
ébranlé, depuis la découverte en 2003 de Mimivirus ; un virus géant [60,61]. La
découverte  de  Mimivirus  a  démontré  l’existence  d'une  nouvelle  famille  de
virus : les « géants », dont les caractéristiques hors normes ont remis en cause
une partie du cloisonnement viral du reste du monde du vivant. Les Mimivirus
ont  aussi  ouvert  la  voie  pour  la  découverte  de  nouveaux  virus  géants
(Amphoravirus  et  Pandoravirus)  dont  l'analyse,  qui  ne  fait  que commencer,
laisse entrevoir des perspectives encore mal dénies concernant l'évolution et
le rôle des virus [62,63]. Ces virus géants sont à l'origine d'une nouvelle façon
de percevoir les domaines de la vie et de la virologie. Ils ont fondamentalement
bouleversé le champ des connaissances en biologie. En eet, la découverte de
Mimivirus, le premier des « géants » ; est un virus en cela qu'il est un parasite
intracellulaire, incapable de division binaire et ne possédant pas de système
susceptible de subvenir à ses besoins énergétiques. Les Mimivirus ont remis en
cause la dénition des virus de plusieurs points de vue. D'une part, sa taille
(>0.7µm) qui dépasse celle que l'on attendait pour un virus (<0.25µm). D'autre
part, sa complexité génomique (plus de 1000 gènes dont 50 % sont des gènes
orphelins) [64]. Enn, la remise en cause de l'unicité du type d'acide nucléique
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chez les virus (Mimivirus possède de l'ARN et de l'ADN). Ce dernier point avait
été déjà démontré en 1998 chez les Cytomegalovirus indiquant que le dogme
n'était pas absolu [65].
Ainsi, la remise en cause de trois des cinq critères qui font d'un virus un virus
n'est pas encore de nature à exclure les virus géants du monde des virus. La
taille des virus et leur cycle de vie sont extraordinairement variables. Le plus
petit  d'entre eux, l'agent Delta qui ne possède qu'un seul gène, ne peut se
multiplier  que  lors  de  l'infection  d'une  cellule  eucaryote  par  le  virus  de
l'hépatite B. L'agent Delta agit alors comme un parasite de virus. A l'inverse,
les virus à ADN comportent plusieurs centaines (voire milliers) de gènes (dans
le cas des virus géants). Il existe ainsi une variation importante de la taille du
génome des virus, qui corrèle assez naturellement à la taille et la structure des
virions.  Depuis  la  victoire  du  virus  comme  concept  rationnel  sur
« l'observable », le virologiste a appris à se méer et à remettre en cause les
cadres « certains » qui dénissent le monde viral. Nous sommes tenus de nous
ré-interroger  sur  la  dénition  des  virus,  de  la  vie  et  son  origine.  Ainsi,  la
comparaison  des  virus  avec  les  cellules,  montre  que  l'un  des  constituant
protéique majeur  marqueur  du vivant  est  la  présence du ribosome,  de  ses
protéines  et  ARN  spécialisés.  Ce  dernier  critère  éclairé  de  la  biologie
moléculaire semble être un marqueur plus pertinent que celui de la taille ou la
complexité  du  génome  pour  dénir  ce  qui  est  ou  non  viral.  L'une  des
conséquences de ce raisonnement permet de s'aranchir  de la question de
dénir  si  les  virus  sont  des  « êtres  vivants »  ou  non.  En  fait  dans  la
comparaison mentionnée plus haut il s'agit de la comparaison des virions et
des cellules vivantes. La dénition du virus est intiment lié à son virion. Ors si
le virion est un « véhicule » pour le virus, il en est aussi la caractéristique, c'est
à  dire  qu'un  virus  tout  aussi  complexe  qu'il  soit,  se  caractérise  par  le  fait
d'avoir une information spécique pour la formation d'un virion (une capside).
Pour autant, le virus ne peut être limité à son virion, la partie du cycle du virus
qui implique la cellule, fait aussi partie du virus, ce qui a amené Patrick Forterre
à proposer le concept de cellule virale, qui correspond à « l'usine à virions »
[22]. 
Une autre conséquence de la découverte des virus géants a été la prise de
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conscience du nombre de gènes dits orphelins retrouvés chez les virus. Les
données  de  métagénomiques  (qui  vont  au  delà  des  données  sur  les  virus
géants) ont montré un nombre de gènes viraux inconnus bien supérieur à celui
relatif aux gènes cellulaires. En ce sens, les virus géants ont été un révélateur
de notre ignorance plus qu'un marqueur de divergence. Ces gènes orphelins
sont autrement dit, des gènes qui n'ont aucun homologue, et théoriquement
qui codent des protéines de fonction et de structure inconnues. Ces gènes ont
une histoire détachée du monde vivant étudié et suivent leur propre évolution.
Du fait du surclassement du nombre de gènes viraux inconnus, on peut aussi
considérer que les virus constituent un formidable réservoir de gènes prêts à
être injectés dans le cycle de la vie. De l’étude des virus et de leur hôte, de
leur génome, et de leur protéome, il semble bien que les virus aient joués (et si
c'est vrai, jouent toujours) un rôle décisif dans l'évolution. L'identication de
rétrovirus  endogènes  dans  les  génomes de tous  les  eucaryotes étudiés,  va
dans  le  sens  qu'au  moins  un  certain  nombre  de  virus  participent  à  la
dissémination  du  matériel  génétique. L'intégration  de gènes  viraux  dans  le
génome des cellules eucaryotes génère parfois des modications si drastiques,
qu'elles  contraignent  la  cellule  à  diverger  de  façon  irréversible.  Ces
diérentiations  peuvent  être  à  l'origine  de  pathologies  tout  aussi  bien  que
source d'adaptation et d'évolution. C'est par la séquence et la structure des
protéines virales que l'on peut décrire leur liation et leur évolution. 
Qu'il soit grand ou petit, il existe globalement une grande division parmi
les virus : ceux dont le virion contient un génome composé d'ADN ou d'ARN. En
fonction du type de matériel génétique caractérisant le virus, les stratégies de
réplication virales spéciques vont conditionner les étapes et la complexité du
cycle  viral  ainsi  que  les  assemblages  structuraux  nécessaires  pour  les
accomplir.
 i. Les stratégies de réplication virale
La réplication du matériel génétique est la singularité des êtres vivants et
pourtant  nul  part  dans la biosphère  ce processus est  accompli  avec autant
d'économie et de simplicité que dans le monde viral. En eet, pour arriver à
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l'expression, la réplication et la diusion de leurs gènes, les diérentes familles
virales ont mis en place des stratégies et des cycles de vie qui vont exploiter la
biologie et la biochimie de leur hôte. Comme nous l'avons vu précédemment,
les virus ne possède aucun système de production d’énergie, ils ne peuvent se
reproduire  qu’au  sein  de  cellules  vivantes.  A  l’aide  de  quelques  gènes,  ils
altèrent et modient les programmes de fonctions intracellulaires an d'utiliser
la machinerie cellulaire à leur prot pour se répliquer et assurer leur pérennité.
Ce sont des parasites obligatoires, et la conséquence la plus importante est la
dépendance de leur cycle de vie aux conditions proposées (imposées) par leur
hôte. Ainsi comprendre la réplication virale et tous les processus associés, nous
permet de comprendre la biologie de l'hôte à tous les niveaux physiologiques
(moléculaires,  cellulaires,  tissulaires,  organes,  organismes)  et  sociaux  (des
individus  et  de  leur  population).  Chaque  infection,  représente  la  mise  en
contact  de  matériel  génétique  exogène  à  la  machinerie  de  l'hôte  et  dans
certain  cas,  à  son  intégration  dans  le  matériel  génétique  de  l'hôte.  La
persistance de ce mécanisme re@ète l'état de la co-évolution entre le virus et
l'hôte.  Chaque  pièce  du  puzzle  que  représente  la  compréhension  du
mécanisme de réplication virale, nous enseigne sur la biologie de son hôte tout
autant  que sur  celui  du virus.  L'étude des  mécanismes et  enzymes virales
impliquées  dans la  réplication  virale  nous  permet  d'identier  des points  de
« faiblesse » du virus. Par exemple, des motifs ou des signatures structurales
conservées qui permettent de s'engager dans le design rationnel de molécules
antivirales spéciques.
 a) La diversité des génomes viraux et leurs stratégies de réplication
L'un des aspects des plus surprenants lorsque l'on regarde la virosphère,
c'est la grande diversité structurale des génomes viraux et leurs stratégies de
réplication  [66].  Contrairement  aux  cellules  qui  possèdent  leur  génome
exclusivement sous la forme d'ADN double brin, les génomes viraux peuvent
être  composé  d'ADN ou  d'ARN simple  ou  double  brin,  de  polarité  positive,
négative  ou  les  deux  (ambisens).  Ces  génomes  peuvent  être  linéaires  ou
circulaires,  segmentés  ou  non.  Chaque  variation  impose  des  stratégies
diérentes pour le cycle de réplication virale (machinerie réplicative virale, du
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virion, ou cellulaire) et sa localisation (nucléaire, cytoplasmique, ou les deux).
La plupart des virus à ADN vont se répliquer dans le noyau des cellules
infectées,  là  où  se  trouve  la  réplication  et  la  transcription  cellulaire.  Il  y  a
quelques  exceptions  à  cette  règle  chez  les  pox-,  irido-  et  asvirus  pour
lesquelles la réplication a lieu tout ou parti dans le cytoplasme. Les virus à ARN
ont un cycle réplicatif cytoplasmique à l'exception des rétrovirus (qui intègrent
une copie ADN de leur génome dans le génome cellulaire) et des Orhtomyxo-
et Bornavirus (des virus à ARN simple brin négatif qui se répliquent dans le
noyau).
 b) Di%érentes stratégies de production des complexes ou protéines 
virales
Pour les virus à ARN, les génomes viraux sont souvent composés d'un
seul  brin  d'ARN,  qui  souvent  code  pour  plusieurs  protéines  virales.
Paradoxalement,  les  ARN  polymérases  ARN-dépendantes  sont  rarement
capable  d'accéder  des  promoteurs  internes  du  génome.  Ceci  devient  un
obstacle pour la production de protéines virales, qui doivent être traduites à
partir  d'ARNm  viraux  compatibles  avec  le  mode  de  fonctionnement  du
ribosome. Pour résoudre ce problème, l'évolution a abouti à trois stratégies :
(1)  segmentation protéique   :  la  synthèse d'une polyprotéine  qui  est  ensuite
découpée  par  des  protéases  cellulaire  ou  virale  (i.e. picorna-,  toga-,  @avi-,
retrovirus) ;  (2)  segmentation  des  ARNm   :  la  production  d'ARNm  viraux
monocistroniques à partir de la même matrice (i.e. corona-, arteri-, rhabdo-,
paramyxovirus) ;  ou  enn  (3)  segmentation  du  génome   :  le  génome  est
segmenté et parfois ambisens. Chaque segment code en général pour un gène
ou deux si le segment est ambisens (i.e. reo-, orthomyxo-, bunya-, arenavirus).
Pour  les  virus  à  ADN, ces  stratégies  sont  plus  rarement  utilisées (i.e.
Asfarviridae : deux polyprotéines) car la transcription est prise en charge par la
machinerie transcriptionnelle du noyau, elle est donc capable de synthétiser
des ARNm à partir de promoteur interne. 
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 ii. Les virus à ARN
Les diérences entre les virus à ARN de polarité positive (+) et négative
(-) vont bien au delà de la polarité du génome encapsidé dans le virion. En
eet,  les  virus  à  ARN  (+)  relarguent  leur  génome  directement  dans  le
cytoplasme. Là, ils sont pris en charge par les protéines du ribosome an de
commencer la synthèse des protéines virales qui vont former le complexe de
réplication/  transcription  [67].  C'est  ce dernier  qui  va prendre  en charge la
multiplication virale. Par comparaison, les virus à ARN (-), embarquent en plus
de leur matériel génétique, leur machinerie replicative et transcriptionelle [68].
Ainsi, le génome se retrouve complexé en permanence à des protéines virales,
dont la fonction est d'autant de protéger le matériel génétique du virus que
d'en  assurer  la  transcription  et  la  réplication.  L'ensemble  de  ce  complexe
ribonucléoprotéique va bien au delà du concept d'empaquetage dans le virion,
il est un des moteurs actifs du cycle viral.
Ces  adaptations  fondamentalement  diérentes,  sont  probablement  le
fruit  de  contraintes  diérentes.  Les  virus  à  ARN (+)  sont  contraints  sur  un
critère d'ebcacité de la traduction de leurs génome, ce qui implique que les
génomes structurellement optimisés pour la traduction doivent être conservés
d'une génération à l'autre. Ces contraintes de compatibilités optimisées sur le
génome sont dictées par [la dépendance à] la cellule hôte. En revanche, la
contrainte sur le génome pour les virus à ARN négatif n'est pas imposée par
l'hôte; car ceux-ci ne sont jamais directement traduit. Cependant, le génome
des  virus  à  ARN  (-)  doit  rester  optimisé  pour  sa  ribonucléoprotéine  et  en
particulier vis-à-vis de sa nucléoprotéine pour son encapsidation et son ARN
polymérase ARN-dépendante pour la transcription et la réplication. De ce point
de vu, les virus à ARN (-), en ajoutant un niveau intermédiaire de complexité,
augmentent  leur  chance  de  survie  et  de  dissémination  en  se  donnant  la
possibilité  de  faire  évoluer  leur  ARN-polymérase  an  que  celle-ci  puisse
répondre à une modication du système de traduction de l'hôte.
Les ARN polymérases ARN dépendantes sont naturellement peu dèles,
ce qui a pour avantage de faciliter l'adaptation virale aux changements de la
cellule. Les ARN polymérases virales présentent des taux d'erreurs 10 000 fois
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plus  élevés  que leurs  homologues  cellulaires  à  ADN,  soit  en  moyenne  une
mutation par génome et par tour de réplication. A cela, s'ajoute l'absence de
mécanisme de validation et de correction d'erreurs (proof reading). Il faut donc
considérer que lors de l'infection virale, les virus produits dérivent tous du virus
original, et constituent une population dont les séquences génomiques varient
autour  d'une séquence consensus.  Le risque de passer un niveau d'erreurs
critiques  est  possible,  mais  les  virus  déviant,  s'ils  sont  produits,  ne  seront
simplement  pas  sélectionnés  lors  de  la  prochaine  infection.  Pour
contrebalancer le risque d'atteindre le taux d'erreurs critique trop rapidement,
la taille des génomes des virus à ARN reste limitée. En eet, la plupart des
virus à ARN ont une taille compris entre environ 5 et 15kb avec un maximum
de  30kb.  Les  recherches  récentes  sur  les  virus  appartenant  à  l'ordre  des
Nidovirales, renforcent ce paradigme tout en introduisant une description plus
complète de la contrainte. En eet l'ordre des Nidovirales inclus des virus dont
la  taille  des  génomes  varient  entre  12kb  à  32kb.  Bien  que  la  structure  et
l'organisation  générale  du  génome  soit  conservée,  les  génomes  des
Coronavirus  qui  dépassent  la  taille  de  20kb  codent  en  plus  une  3'-5'
exonucléase, homologue aux exonucléases à ADN impliquées dans l'activité de
validation et de correction des erreurs lors de la duplication des chromosomes
[69–71]. Il est encore trop tôt pour abrmer la présence d'activité de correction
d'erreurs chez les virus à ARN mais les résultats préliminaires montrent que
l'inactivation de cette enzyme entraîne une augmentation drastique du taux
d'erreur dans la réplication du génome des Coronavirus. Si elle est conrmée,
cette  découverte  est  fondamentale  en  cela  qu'elle  démontre  la  contrainte
physique imposée sur le génome pour le contrôle de sa taille et montre que
l'expansion de la taille d'un génome viral lorsqu'elle se produit, s'accompagne
d'un système de contrôle et de validation du génome. Passé une certaine taille,
il  est  possible  que  l'ARN  ne  soit  plus  la  molécule  de  choix  pour  stabiliser
l'information génétique. Dès lors que le support devient de l'ADN, l'économie et
l'optimisation  du  génome  n'est  plus  une  contrainte  aussi  drastique.  Ainsi,
l'analyse des génomes viraux et de leur machinerie réplicative si variée, nous
montre l'aspect fondamental qu'il y a à étudier les protéines des machineries
virales et surtout leur assemblage an de pouvoir saisir les mécanismes mis en
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place au cours de l'évolution.
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 III. TRAVAUX DE RECHERCHES
 A. Protéines d'assemblage et de régulation du 
cytosquelette
Boston Biomedical Research Institute, Watertown, MA, USA.
University of Pennsylvania, Philadelphia, PA, USA.
Laboratoire de R. Dominguez (2005-2008)
 i. Contexte scienti<que
Les cellules possèdent un squelette qui à la fois maintient la forme de la
cellule et peut s'adapter et se modier de façon quasiment instantanée. Cette
plasticité  est  responsable  de  processus  vitaux  tels  que  la  morphogenèse
embryonnaire,  la  surveillance  immunitaire,  angiogenèse,  la  réparation,  la
régénération  des  tissus  ou  la  mise  en  place  des  voies  de  transport
intracellulaire des vésicules  [72–76]. Ce squelette est composé de laments
d'actine  appelés  microlaments [77].  La  principale  caractéristique  de  ce
squelette  est  sa  capacité  dynamique  à  passer  d'une  forme  monomérique
(l'actine-G) à une forme lamenteuse (l'actine-F).
L'actine :
L'actine est l'une des protéines des plus abondante chez les eucaryotes. Très
conservée,  sa  structure  s'organise  autour  de  deux  domaines  se  composant
chacun de deux sous-domaines (Figure 3A). Les sous-domaines 1 et 2 forment
le domaine extérieur (qui sont à la surface du lament), et les sous-domaines 3
et 4 forment le domaine intérieur (domaines qui se font face dans la structure
en double hélice que forme le lament) (Figure 3B)  [78–80]. L'actine possède
une activité ATPase dont le site actif se situe entre les sous-domaines 2 et 4.
Son activité peut être régulée par l'occupation de la poche hydrophobe formée
par les sous-domaines 3 et 4. L'hydrolyse de l'ATP produit un changement de
conformation structurant une boucle désordonnée (D-loop ou DNAse-I loop) en
hélice (Figure 1A). Cette hélice joue un rôle structurant dans les interactions
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actine-actine  dans  le  lament  [81,82].  L'hydrolyse  de  l'ATP  est  donc  un
processus essentiel qui est concomitant avec le changement d'état de l'actine
G à F.
Figure  3:  Actine  monomérique  et  Clamenteuse.  (A)  Le  monomère
d'actine  s'organise  autour  de  deux  domaines  structurellement  liés,
subdivisés en deux sous-domaines 1-2 (formant le domaine externe),
et 3-4 (formant le domaine interne). La combinaison de ces quatre
domaines génère deux sillons profonds qui jouent un rôle fonctionnel
fondamental: le sillon formé par les sous-domaines 2-4 forment le site
de liaison à l'ATP et le sillon formé par les sous-domaines 1-3 forment
le site de recrutement/interaction par/avec les protéines régulant la
polymérisation  de  l'actine  (PLAs).  L'actine  est  une  ATPase,  lors  de
l'hydrolyse de l'ATP en ADP l'actine change de conformation (boucle D
dans le cercle vert) et modiCe son aGnité pour les PLAs. (B) Modèle
du Clament d'actine (PDB: 3B63). Le Clament d'actine est dit polarisé,
il  possède un coté  croissant  (+)  enrichi  en ATP-actine,  un coté  en
décroissance (-) enrichi en ADP-actine et entre les deux il s'agit d'une
actine qui a e(ectué l'hydrolyse de l'ATP et changé de conformation
mais qui séquestre encore le pyrophosphate. 
 Illustration dérivée de [141].
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Le lament d'actine :
Le lament d'actine peut se décrire comme deux ls organisés en double hélice
droite, composés de monomères d'actine empilés. Le lament est polarisé en
ce sens que le coté croissant (+) incorpore de l'actine monomérique liée à une
molécule d'ATP, alors que le coté opposé (-) décroit en relâchant de l'actine liée
à une molécule d'ADP (Figure 3B) [83]. Pour éviter la décroissance anarchique,
le coté (-) est souvent « coié » par des protéines qui régulent la structure du
lament. Entre les deux extrémités du lament l'actine hydrolyse l'ATP ce qui
permet la structuration de la boucle D (Figure 3B) et la stabilisation du lament
[79,84–87]. Ce changement d'état énergétique est strictement contrôlé dans
les cellules par un ensemble de protéines se liant spéciquement à l'actine-G
ou F (PLA ou plus connus sous le terme anglophone ABPs). Ces protéines sont
sous  le  contrôle  de  la  famille  des  Rho  GTPases  [88,89] (voir  paragraphe
dessous).  Les  PLAs  contrôlent  et  régulent  les  diérents  états  du  lament
d'actine :  nucléation,  élongation,  ramication,  réticulation,  découpage,
plafonnement  (coie).  Certaines  sont  impliquées  dans  la  séquestration  de
l'actine  monomérique  ou  sa   localisation  cellulaire  (Table  1  et  Figure  4)
[88,90,91].
Ce système polarisé et contrôlé permet d'assurer une croissance orientée du
lament. C'est grâce à ce système que la cellule peut déformer sa membrane
et/ou  provoquer  une  poussée  permettant  le  mouvement  en  réponse  à  des
signaux spéciques. (Figure 4)
Contrôle des PLAs par les GTPases :
L'activité des PLAs est sous le contrôle d'une cascade de signalisation. Cette
cascade  est  activée  au  niveau  des  récepteurs  membranaires  et  va  in  Cne
stimuler des GTPases appartenant en particulier à la famille des Rho GTPases
(Rho, Rac, CDC42) [92,93]. Ces activateurs vont ensuite répartir et répercuter
l'information  sur  les  PLAs  déclenchant :  les  mouvements  par  la  voie  acto-
myosin  [94],  la  restructuration  de  la  membrane  en  lamelipode  [95] ou  en
lopode  [96].  Le  rôle  central  de  cette  famille  de GTPases  a  été montré  en
exprimant des mutants négatifs dans des cellules de mammifères. Ces mutants
impactent sévèrement les mouvements et les processus cellulaires dépendant
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de l'actine tels que : la migration  [97], la cytokinèse (ou cytocinèse)  [98,99],
l'endo- et l'exocytose  [100], le guidage axonal  [101] et la morphogenèse lors
du développement [102,103]. La localisation des GTPases (à la membrane ou
autre)  semble induire le recrutement spécique des PLAs. Les PLAs possèdent
donc  au moins un domaine de recrutement ou d'interaction avec les GTPases.
Il a en eet été montré qu'un grand nombre de PLAs (WASP, Formins, IRSp53)
[104–106] interagissent directement avec CDC42 et Rac au niveau de motifs
conservés [104]
Table  1 :  liste  des  protéines  se  liant  avec  l'actine  et  leur  fonction
correspondante
Protéine Fonction cellulaire Référence
α-actinine Maintient les laments liés deux à deux 
parallèles 
[131]
Debrine Maintient les laments liés entre eux [132,133]
Fimbrine Maintient les laments liés entre eux [107]
Fascine Réticulation (cross-link) des laments des 
lopodes 
[134]
Tropomyosine Stabilisation des laments [135]
Spectrine Accroche les laments à la membrane 
plasmique
[136,137]
Talin Adaptateurs aux protéines membranaires [107]
Vinculin Adaptateurs aux protéines membranaires [107]
BAR protéine 
(MIM/IRSP53/Amphi
physine)
Stabilisation des laments [108] *
Cortactin Nucléation de branche et stabilisation des
laments 
[109]
Formine (mDIA) Nucléation et élongation [110,111]
CoBL / Spire / 
VoPL/VopF / Lmod
Nucléation [112–116]
ARP2/3 Nucléation de branche [117,118]
WASP Elongation [119]
ENA/VASP Elongation [120,121]
CAPZ Coie (+) [122]
EPS8 Coie (+) [123]
Gelsoline Coie (+) et fragmentation des laments [124,125]
Tropomoduline Coie (-) [126]
ADF/Coline Dépolymérisation [127,128]
Thymosine β4 Séquestration [129]
Proline Séquestration et régénération du pôle 
d'actine-ATP 
[130]
Note : * is a review
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Structure modulaire des PLAs et mécanismes de contrôle de l'actine :
Les  PLAs  sont  des  protéines  à  domaines  multiples  contenant  un  (parfois
plusieurs) domaine de liaison à l'actine monomérique (W, GAB ou WH2), parfois
un domaine de liaison à  l'actine lamenteuse (FAB),  un domaine de liaison
protéine-protéine ou d'arrimage membranaire, un domaine d'activation et ou
permettant ou non l'auto-inhibition, et un domaine de liaison aux GTPases. Ce
dernier  domaine induit  l'activation  et  le  recrutements  de  la  protéine  à  des
endroits précis de la cellule. Une fois la PLA recrutée et activée, seulement une
petite parti de la protéine est impliquée dans le contrôle de la polymérisation
de l'actine. En eet le mode de régulation des PLAs sur l'actine s'exerce par un
contrôle structural direct.
L'espace  formé  par  les  sous-domaines  1  et  3  de  l'actine  forme  une poche
hydrophobe, qui si elle est occupée empêche l'hydrolyse de l'ATP (Figure 3A).
Ce domaine est un site de liaison privilégié des PLAs régulant l'activité ATPase
et incidemment la croissance du lament (Table 1). Un grand nombre de PLAs
impliquées dans le contrôle et la séquestration de l'actine non polymérisée,
possèdent  par  conséquent  une  hélice-α  amphiphile  dont  la  fonction  est  de
recruter l'actine par sa poche hydrophobe [138,139]. Cette hélice est annotée
comme le domaine WH2 (ou W ou GAB). Malgré son rôle si important, cette
hélice présente une variabilité de taille. Elle se compose d'une extrémité amino
terminale  hydrophobe  suivi  d'une  signature  conservée  (LKKT(V))  prolongée
d'une région hydrophile plus ou moins structurée. Cette dernière peut se xer
le long de l'actine et remonter vers le site actif entre les domaines 2 et 4 [140].
Ce système de contrôle est retrouvé dans de nombreuses structures de PLAs
résolues en complexe avec l'actine (revue de Lee et Dominguez [141]
Malgré  une  faible  similitude  de  la  séquence  primaire,  on  observe  la
conservation structurale.  Il  y  a par conséquent probablement une évolution
convergente des systèmes de régulation de l'actine, et un nombre limité de
repliements possible des PLAs : Colin [142], Wiskott-Aldrich syndrome protein
(qui à donné le nom au domaine (WASP)-homology domain 2 (WH2))  [143],
gelsolin-homology domain  [144], domaine homologue calponine (CH domain)
[145],  le  domaine  2  homolgue  de  la  formine  (FH)  [146].  A  ceux-ci  il  faut
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rajouter le groupe particulier de PLAs qui appartiennent à la superfamille des
myosines  [147],  qui  utilisent  les  laments  d'actine  comme  des  rails  pour
assurer la motilité cellulaire. 
Figure 4: Multiples systèmes de régulation des réseaux de Clament d'actine
dans  la  cellule.  La  famille  des  Rho  GTPases  (Rho,  Rac,  and  Cdc42)  est  la
principale  voie  de régulation  de l'actine  dans  la  cellule.  Des récepteurs  au
niveau de la membrane de la cellule activent les protéines de cette famille,
engendrant  une  série  de  cascades  d'hydrolyse  et  de  phosphorylation,
interagissant avec les PLAs et déclenchant selon la position dans la cellule des
réarrangement du réseau d'actine. Les PLAs peuvent interagir spéciCquement
avec de l'actine monomérique (séquestration, dépolymérisation) ou de l'actine
Clamenteuse (coi(e du Clament, réticulation), ou encore les deux (branchage ,
élongation). Ces régulations peuvent mener à di(érent type de réseaux (câble
de Clament ou réseaux dense de soutient) et de phénotypes membranaires
(Clopodes, lamélipodes, adhésion).
Illustration dérivée de [141].
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Le contrôle de la croissance du lament d'actine nécessite la participation d'un
autre partenaire protéique : la proline dont l'un des rôle est d'assurer l'apport
exclusif d'actine-ATP aux PLAs. La proline est une PLA un peu particulière en
cela que son interaction avec l'actine ne se fait pas via une hélice mais par une
surface d'interaction sous les domaines 1 et 3. De plus, cette interaction n'est
pas  exclusive,  elle  permet  dans  certain  cas  une  liaison  simultanée  à  un
domaine WH2 [148]. La proline a une forte abnité pour l'actine monomérique,
et elle joue un rôle capitale dans la régénération du pôle actine-ATP. En eet,
du coté (-) du lament, la proline séquestre l'actine-ADP relarguée et stimule
le  remplacement  de  la  molécule  d'ADP  en  ATP  (1000  fois  plus  rapide  que
l'échange naturelle)  [149,150]. L'actine-ATP utilisable est donc sous forme de
complexe  protéique  proline-actine  également  appelé  prolactine.  L'autre
caractéristique de la proline est d'avoir une forte abnité pour les régions poly-
L-proline  que  l'on  retrouve  sur  de  nombreux  PLAs  comme  les  formins,
ENA/VASP, WASP....
La thématique du laboratoire s'organise autour de la description et de la
compréhension des événements moléculaires régulant  l'interaction entre les
PLAs et l'actine. En particulier, la description des protéines séquestrant l'actine
monomérique ;  des  mécanismes  moléculaires  du  système  WASP/Arp2/3  qui
engendre  un  réseau  arborescent  de  laments  "branchés"  (Nucléation  de  la
branche  et  élongation) ;  de  l'α-actinine  qui  réticule  le  réseaux  de  filament
d'actine,  d'ENA/VASP  qui  permet  l'élongation  rapide  de microlaments  pour
former  rapidement  des  lopodes ;  et  enn  aux  protéines  BAR  qui  sont
impliquées  dans  la  déformation  de  la  membrane  et  la  consolidation  des
laments ainsi formés. 
Au cours de mes stages post-doctoraux, je me suis intéressé aux domaines
d'interaction de l'actine de l'α-actinine et aux mécanismes de recrutement de
l'actine  de  deux  PLAs  particulier :  celui  d'ENA/VASP  responsable  de  la
croissance des laments rapides lors de la formation de lopodes et à MIM la
protéine impliquée dans la consolidation de ces structures.
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 ii. Objectif du travail et stratégies expérimentales
Les  objectifs  de  ces  travaux  étaient  d'identier  les  mécanismes  de
formation  des  lopodes.  Les  lopodes  sont  des déformations  membranaires
longilignes, formées par l'extension rapide de laments d'actine. La formation
d'un  lopode  implique  d'une  part  le  recrutement  et  l'assemblage  rapide
d'actine  par  la  protéine  ENA/VASP [151];  et  d'autre  part  la  consolidation  de
cette structure par la protéine MIM. Cette dernière participe à la restructuration
de  la  membrane  lors  de  sa  déformation  suite  à  l'élongation  rapide  des
laments d'actine [152].
La protéine ENA/VASP était identiée comme une des protéines responsable de
l'allongement  des  lopodes.  Sa  modularité  postulait  l'existance  de  trois
domaines : EVH1, une région centrale désordonnée et EVH2. EVH1 se lie aux
protéines de la membrane et sert d'ancrage. La région désordonnée sert de
site de régulation pour les GTPases et de recrutement des prolactines. Enn
EVH2  semble  interagir  avec  le  lament  d'actine  et  est  responsable  de  la
tétramérisation.  Si  la  modularité  de  la  protéine  était  déni  en  revanche  la
compréhension des mécanismes moléculaires de recrutement de l'actine et de
son incorporation au lament restaient à être décrit. En particulier : 
-Identier la région de recrutement des prolactines. 
-Dénir les domaines impliqués dans la liaison à l'actine.
-Identier si des complexes intermédiaires se formaient.
MIM est une protéine modulaire qui recrute l'actine via deux domaines N et C
terminaux. Le domaine N-terminal est un domaine de 250 résidus alors que
celui retrouvé en c-terminal un domaine de 30 résidus de type WH2. Les 475
résidus intermédiaires forment un domaine partiellement désordonné, riche en
résidus  Proline,  Serine  et  Thréonine.  Ce domaine  intermédiaire  semble  être
impliqué dans le recrutement et la régulation de l'activité de la protéine. Le
mécanisme d'action de MIM restait à être déni en particulier :
-Comprendre le rôle de la modularité de la protéine MIM. 
-Identier la fonction exacte de MIM dans son rôle de soutien et son  
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mécanisme d'interaction avec l'actine et la membrane plasmique.
 iii. Résultats obtenus et perspectives
• Rôle d'ENA/VASP dans l'élongation du Clament d'actine
ENA/VASP fait parti de la famille de protéines responsable de l'élongation
rapide du lament d'actine. Ce processus implique un domaine de liaison à
l'actine G (WH2) et un domaine de liaison à l'actine F. Il s'agit d'une protéine à
plusieurs domaines, qui tétramérise via son domaine C-terminal constitué par
une  hélice  super  enroulée  (Coiled-coil).  La  tétramérisation  permet
probablement  d'assurer  l'incorporation  ebcace  de  monomères  d'actine  sur
plusieurs laments regroupés le long de la membrane plasmique. La structure
globale de la protéine n'a pas été résolue à cause de la présence de longues
régions désordonnées. En revanche, la plus part des structures des diérents
domaines de régulation ou de multimérisation sont maintenant connus. 
Dans un premier temps, nous avons procédé à l'analyse bio-informatique de la
protéine, ce qui nous a permis de dénir la modularité des diérents domaines.
Il  était  notamment  nécessaire  d'étudier  les  régions  désordonnées  (>100aa
consécutifs), qui étaient présentées comme le site de recrutement de plusieurs
partenaires et dont les caractéristiques se retrouvent dans le domaine EVH2.
En appliquant une combinaison d'analyses bio-informatiques [153] nous avons
proposé que la région désordonnée présentait trois motifs distincts que nous
avons proposé comme sites : de régulation, de recrutement et de charge. La
position de ces sites correspondaient au phénotype de délétion décrit dans les
études biochimiques (i.e. perte du recrutement de la GTPase lors de la délétion
d'une  région  encadrant  le  site  de  régulation,  perte  de  du  recrutement  de
prolactine lors de la délétion des autres sites)[154]. L'analyse a également
montré que le domaine EVH2 était aussi en parti désordonné. Néanmoins la
nature  du  désordre  est  diérente  en  raison  du  nombre  d'acides  aminés
hydrophobes plus élevés. Par ces analyses de composition en acides aminés,
nous avons pu positionner et identier deux courtes régions  capables de se
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structurer. La prédiction de repliement induit se superposait à la composition
en acides aminés caractéristique des domaines de recrutement de l'actine G
(GAB  ou  WH2)  et  F  (FAB).  Entre  le  domaine  FAB  et  le  Coiled-coil  de
tétramérisation se trouve une région qui  a le  potentiel  de se structurer  en
longue hélices.  Ainsi nous avons pu décrire l'architecture de cette protéine de
la façon suivante : Un domaine N-terminal (EVH1), dont le rôle est l'adressage
de  la  protéine  au  complexe  ancré  à  la  membrane.  Une  région  centrale
désordonnée riche en prolines, dont on distingue 3 sites de recrutement, un
pour la GTPase qui régule l'activité de la protéine, et deux sites de poly-prolines
qui se lient à la prolactine. Enn, le domaine C-terminal (EVH2) est constitué
de 4 sous-domaines  dont  deux domaines  de  liaison  à  l'actine  (G et  F),  un
domaine moteur et un domaine de multimerisation.
L'observation  de  la  présence  de  nombreux  sites  de  poly-prolines  dans  les
protéines  de  régulation  du  cytosquelette  et  en  particulier  dans  celles
impliquées dans la nucléation et l'élongation de l'actine, suggérait que leur rôle
est de contribuer à l'augmentation de la concentration locale d'actine par le
recrutement des prolactines. Nous avons suivi cette hypothèse en obtenant
un complexe cristallographique prolactine poly-prolines. Le complexe obtenu
avec  une  ratio  molaire  ±1/1  demontre  que  les  domaines  de  poly-prolines
peuvent  recruter  les  prolactines  par  la  formation  de  complexes   stables
(Figure 3). Nous avons testé les diérentes séquences de poly-prolines (suite
de prolines, site de recrutement et de charge) et vérié qu'elles recrutaient
toutes les prolactines. Le site de proline le plus proche du site de recrutement
de l'actine (site de charge) présente une insertion d'une leucine conservée qui
impose  le  positionnement  et  l'orientation  du  complexe  prolactine  sur  la
séquence. Nous avons postulé que cette contrainte a pour but de positionner le
complexe de prolactine à bonne distance du domaine WH2 an de transférer
l'actine de la proline sur le domaine WH2 et ensuite sur le lament. Fort de
notre prédiction de domaines, nous avons donc synthétisé un peptide incluant
le domaine de charge, la région de liaison et le domaine WH2 an de vérier
cette hypothèse. Nous avons pu obtenir un complexe stable et fait la preuve
que le transfert implique un intermédiaire poly-proline prolactine WH2 avant
le passage sur le lament (Figure 5). En conclusion, les données structurales et
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biochimiques  suggèrent  que  l'élongation  du  lament  par  ENA/  VASP  est
processive. Les données structurales renforcent le modèle qui postule que les
complexes  de  prolactines  constituent  la  forme  d'actine  polarisable  la  plus
abondante  à  proximité  du  PLA,  et  que  ceux-ci  possèdent  un  système  de
recrutement  de ces  complexes  ebcace.  Une fois  l'actine positionnée  sur  le
domaine WH2, l'abnité pour la proline décroit et permet la dissociation. Dès
lors, la proche proximité du lament permet le transfert du monomère d'actine
et  son  incorporation.  ENA/VASP  glisse  alors  vers  la  nouvelle  extrémité
permettant  à  un  nouveau  cycle  d'incorporation  de  prendre  place.  Enn  la
tétramérisation permet également de répondre aussi à la polymérisation 
synchronisée de plusieurs laments. (Figure 5)
Ce modèle reste incomplet, il ne permet pas de comprendre l'ensemble des
processus de formation d'un lopode. Notamment, le phénomène intermédiaire
de dépolymérisation observé juste après une croissance rapide du lament.
Figure 5: La protéine Ena/VASP est responsable de l'élongation du Clament. (A)
Structure du complexe proClactine et du domaine de recrutement de VASP
(pdb: 2pbd).(B)Schéma de l'organisation modulaire de VASP et de sa probable
organisation quaternaire.  VASP a une organisation modulaire composé d'un
domaine de Cxation aux protéines d'encrage de la membrane (WH1), suivit d'
une région désordonnées (poly-proline), formant une zone d'activation par les
GTPases et de recrutement de proClactin, suivit de deux sites de Cxation de
l'actine monomérique (GAB) et Clamenteuse (FAB),  et enCn un domaine de
tetramérisation.  (C)  Modèle  mécanistique  d'incorporation  de  l'actine
(proClactine) sur le Clament par VASP. 1 recrutement 2 charge de l'actine 3
incorporation de l'actine et libération de la proCline. 
Illustration dérivée de [141]. 
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Cependant,  les  résultats  issus  de  ce  travail  ont  permis  de  proposer  un
mécanisme d'élongation ebcace impliquant une machinerie protéique dont la
dynamique nécessite l'intervention des régions désordonnées et structurées.
Ces  résultats  montrent  l'importance  de ne pas  négliger  le  rôle  des  régions
désordonnées  dans  la  dynamique  de  formation  de  complexes.  De  plus,  la
caractérisation  des  domaines  désordonnés  riche  en  poly-prolines  comme
plate-forme de recrutement pour la prolactine ouvre de nouvelles pistes de
recherche concernant le recrutement des monomères d'actine par les autres
PLAs.  En particulier,  ceux impliqués  dans  la  nucléation et  le  branchage du
lament.
• Rôle de la protéine MIM dans le soutien au Clament lors de la 
création des Clopodes
La déformation de la membrane plasmique par le cytosquelette lors de
processus  tels  que  l'endo-  ou  l'exocytose,  la  création  de  lopodes,  les
déplacements,  ou  les  mouvements  intracellulaires [155–157];  nécessite  une
coopération  et  une  coordination  entre  la  polymérisation  de  l'actine  et  les
protéines  structurant  la  membrane.  Les  protéines  BAR  sont  des  protéines
impliquées lors de ces modications, à la fois pour consolider les structures du
lament nouvellement crées et pour aider la membrane à accepter les forces
imposées  localement  [158].  An  d'assurer  la  coordination  spatiale  et
temporelle, ces protéines sont sous le contrôle des mêmes familles de GTPase
qui contrôlent les PLAs [157–162].
Les protéines BAR ont une structure modulaire qui leurs permet de se lier au
lament ou au monomère d'actine et en même temps à la membrane. Elles
tirent  leur nom de la présence d'un domaine de liaison à la membrane. Le
repliement  du  domaine  BAR  consiste  en  la  dimérisation  anti-parallèle  de
longues  hélices  allongées  et  repliées  sur  elles-mêmes.  La  particularité  des
diérents  domaines  BAR  résulte  de  la  courbure  que  peuvent  prendre  ces
dimères d'hélices (Figure 6A).
Du fait de la faible similarité de séquence et des variations structurales, les
domaines BAR n'étaient pas regroupés en famille et même étaient considérés
comme découlant d'une évolution indépendante [163–165].
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Figure  6:  Classement des di(érents  domaines BAR et  de leurs  e(et  sur  la
membrane.(A) Table des di(érentes protéines contenant les di(érents types
de domaines BAR.(B) Présentation des di(érentes courbures correspondantes
aux  types  de  domaines  présentés  en  (A).(C)  Exemple  d'utilisation  des
domaines  BAR  lors  de  l'endocytose  et  de  la  formation  de  Clopodes.(D)
Organisation modulaire des di(érents domaines BAR. Les domaines BAR font
toujours parti de protéines multi-domaines et en particulier des domaines de
régulation  de  l'actine,  de  liaison  au  protéine  de  régulation,  de  domaine
d'activation  et  de  signalement.  Ainsi  de  nombreux  domaines  BAR  ont  des
domaines  de  recrutement  pour  certaines  membranes  ou  protéines
d'échafaudages  (SH3).  Certain  domaines  BAR  présentent  les  site  de
recrutement  des  GTPases  (activation/inhibition)  (CRIB),  ainsi  que  des
domaines de liaisons à l'actine monomérique (WH2).
Illustration dérivée de [141,158,222].
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Lorsque nous avons commencé ce travail sur le rôle de la protéine d'adaptation
MIM qui  contient  deux sites  indépendant  de liaison à  l'actine  F  et  G,  nous
pensions  qu'il  s'agissait  d'une  protéine  appartenant  à  une  nouvelle  famille
(IMD)  de  protéines  impliquées  à  l'interface  du  cytosquelette  et  de  la
membrane,  dont  l'autre  représentant  était  IRSp53  (protéine  tyrosine  kinase
récepteur de l'insuline). La protéine MIM lie l'actine par l'intermédiaire de deux
domaines de nature et de structure diérentes, situés aux extrémités de la
protéine. En N-terminal par le domaine IMD de 250 acides aminés de structure
inconnue et en C-terminal  par un domaine de 30 acides aminés dont il  est
possible par alignement de séquence d'identier la signature du domaine WH2
de liaison à l'actine-G. La région intermédiaire (± 400 acides aminés) est une
région  de  régulation  et  de  structuration.  Ces  deux  protéines  avaient  été
regroupées  en  raison  de  la  similarité  de  leur  architecture  et  des  eets
similaires qu'elles induisent sur le cytosquelette (Figure 6D).
Nos études structurales ont permis de démontrer que le domaine IMD de MIM
formait  un  dimère  antiparallèle.  Il  est  composé  d'un  système de  3  hélices
repliées dont deux sous-unités interagissent et forment le cœur du domaine, ce
dimère forme une structure comparable à un étai et présente une très légère
courbure inversée.
La  comparaison  structurale  des  domaines  IMD  indique  que  la  seule  partie
structurellement  conservée  est  la  région  de  dimèrisation  du  domaine.  Les
extrémités chargées de la structure de MIM se révèlent être plus @exibles que
le  cœur du domaine et  avec une implication  assez faible  dans la  liaison à
l'actine  lamenteuse.  Ces  caractéristiques  suggèrent  que  l'ensemble  du
domaine est impliqué dans la liaison au lament. Les domaines BAR possèdent
également des régions chargées aux extrémités qui  ne sont pas impliquées
dans le recrutement des laments mais dans l'ancrage à la membrane. Bien
que distant  nous  avons comparé  les  structures  de MIM et  IRSp53 avec les
domaines  BAR  dont  plusieurs  structures  étaient  connues  (amphiphysine/
arfaptine/  endophiline).  L'étude  révèle  une  diérence  signicative  entre  les
extrémités  du  fait  de  la  courbure,  en  revanche  nous  avons  observé  une
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superposition  quasi  parfaite  au  niveau  de  la  zone  de  dimérisation.  Pour
l'arfaptine (protéine de la famille Bar), la zone de dimérisation sert de site de
régulation où vient se lier la GTPase. Nous avons pu montrer que la régulation
de MIM (ou de IRSp53) par la GTPase semble exclure l'actine au même endroit.
Les similarités structurales, fonctionnelles, architecturales ainsi que les modes
de recrutement et de régulation nous ont permis de proposer que les domaines
IMD soient regroupés dans la famille des domaines BAR. Trois grandes familles
de  domaine  BAR  sont  maintenant  identiées :  BAR-N ;  BAR-F ;  BAR-I.  Les
domaines N et F présentent une forme globale en banane ; la diérence venant
de la courbure prononcée pour BAR-N ; et plus douce mais allongée pour le
BAR-F. En revanche pour la famille des BAR-I la courbure est inversée. Pour
chaque  type  de  domaine  une  courbure  membranaire  spécique  peut  être
associée (Figure 6B /C ).
L'autre site de liaison à l'actine-G de MIM implique un site de type WH2 (Figure
6D).  La  résolution  du  complexe  actine  WH2  a  permis  de  montrer  que  le
domaine WH2 est plus étendu que les domaines WH2 observés chez d'autres
PLAs. Ce WH2 interagit dans la poche hydrophobe sous forme d'une hélice et
remonte le long de la surface de l'actine sans structure secondaire jusqu'au site
catalytique, bloquant le site de liaison à l'ATP. 
Si le rôle du domaine BAR-I est pratiquement déni, il reste encore a démontrer
le rôle exact du domaine de liaison à l'actine monomérique. Ainsi le modèle à
l'étude  propose  que  la  combinaison  des  deux  modules,  liant  deux  formes
d'actine, séparés par une grande région désordonnée, permet le renforcement
de structures tels que les lopodes et les lamelipodes tout en recrutant les
actines monomériques an de les diriger vers l'extrémité (+) du lament. 
Les articles des résultats présentés sont dans l'annexe A.
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 B. Structures des Nucléoprotéines de Phlébovirus
CNRS UMR 6098 – Architectures et Fonctions des Macromolécules Biologiques
Université de la Méditerranée (France) / Nanyang Technological University 
(Singapour)
Groupe : Protéines des virus émergents et Parasites.
Equipe de J. Lescar (2008-2010)
 i. Contexte scienti<que
Les  Phlébovirus  sont  des  virus  qui  appartiennent  à  la  famille  des
Bunyaviridae  et  qui  sont  transmis  par  des  piqures  de  petits  insectes :  les
phlébotomes  (mouches  des  sables),  les  moustiques  ou  les  tiques.  Ils  sont
principalement responsables d'infection touchant le bétails, ce qui en plus du
problème  sanitaire  à  pour  eet  de  fragiliser  les  économies  de  populations
précaires dont l'élevage est l'une des principale ressource  [166]. Cependant,
dix virus du genre sont liés à des pathologies humaines dont les symptômes
varient  de  la  èvre  à  l'encéphalite  et  dans  quelques  cas  à  la  èvre
hémorragique [167] (Table 2).
Les Phlebovirus ont un génome à ARN segmenté en trois brins (S, M, L)
[168,169]. Le brin S est ambisens et code pour une protéine non structurale
(NSs)  et  la  Nucléoprotéine  (N),  qui  protège  constamment  l'ARN  génomique
(ARNv),  et  antigénomique.  Le  polymère  de  N  associé  au  génome  sert  de
plateforme d'accueil de la protéine L formant le complexe ribonucléoprotéique
(RNP). Les segments M et L sont des brins d'ARNs négatifs. M code pour les
précurseurs de glycoprotéines d'enveloppe et une protéine non-structurale. L
code pour la protéine L qui est une protéine multi-domaines et multi-fonctions
qui inclut entre autre la polymérase [170,171] et un domaine endonucléase. Ce
dernier  est  impliqué  dans  le  vol  de  coie,  nécessaire  à  l'acquisition  de  la
structure coie des ARN messagers (ARNm) viraux  [172–174]. Pour tous les
virus  à  ARN  négatif  la  protéine  N  est  le  constituant  le  plus  abondant  du
complexe RNP. Les travaux réalisés sur ces protéines ces dernières années ont
montré une grande variabilité en terme de taille, de mécanisme d'assemblage
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(polymérisation sur l'ARN) et de mode de protection du génome (extérieur ou
intérieur). Contrairement à la plupart des virus à ARN négatif non segmenté,
les RNP de Phlébovirus ne présentent pas de super structure tubulaire mais un
serpentin  super  enroulé,  suggérant  l'existence  d'un  mécanisme
d’encapsidation original [175]. 
Table 2 : listes des Phlébovirus, de leurs vecteurs associés et des symptômes
correspondants
Virus Vecteur Symptômes associés
Virus Alenquer phlébotome èvre
Virus Candiru phlébotome èvre
Virus Chagres phlébotome èvre
Virus Heartland Tique
Fièvre, thrombocytopénie (chute 
du taux de plaquettes), avec 
parfois des troubles gastro-
intestinaux et parfois une 
leucocytopénie(chute du taux de 
globules blancs. 
Virus Naples phlébotome èvre
Virus Punta Toro phlébotome Anomalie hépatique
Virus de la Fièvre de la 
Vallée du Rift
Moustique
Fièvre, douleurs musculaire, 
céphalé, anomalie 
hépatique,èvre hémorragique, 
méningite
Virus du Syndrome de 
èvre sévère avec 
thrombocytopénie
Tique
Fièvre, thrombocytopénie, avec 
parfois des troubles gastro-
intestinaux et parfois une 
leucocytopénie. 
Mortalité 30 %
Virus Scilien phlébotome èvre
Virus Toscan phlébotome
Fièvre, douleurs musculaire, 
céphalé, méningite
Le virus de la èvre de la vallée du Rift est un membre du genre Phlebovirus
qui représente l'un des cinq genres de la famille des Bunyaviridae. La èvre de
la vallée du Rift est transmise par un arthropode (principalement le moustique).
C'est  une  maladie  virale  aiguë,  qui  touche  les  moutons,  les  bovins,  et  les
chèvres [176–185].
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Chez ces espèces, la maladie est caractérisée par des  niveaux d'avortement
élevés, une mortalité élevée des nouveau-nés, et une nécrose hépatique.
Les  humains y  sont  hautement  susceptibles mais  les  infections  sont
habituellement  asymptomatiques  ou  relativement  bénignes  incluant  de  la
èvre  et  des  anomalies  hépatiques.  Toutefois,  dans  certains  cas  (3%),  une
forme sévère peut se développer avec des  complications incluant des signes
cliniques  ressemblant  à  une  maladie  similaire  à  la  dengue  accompagnée
d'hémorragie, de méningo-encéphalite, de rétinopathie. Dans certains cas la
mort peut survenir. Dans le passé ce virus a fait l'objet de recherche dans le
cadre  de  développement  d'arme  biologique,  et  présente  dans  le  cadre  de
scénari  bioterroristes  un  risque  réel  pour  la  sécurité  publique.  Du  fait  du
manque de connaissance sur le mode de transcription et de réplication de ce
genre  viral  il  est  urgent  d'accumuler  de  nouvelles  données  structurales  et
biochimiques sur les constituants du complexe de réplication/ transcription an
de développer de nouvelles stratégies antivirales.
 ii. Objectif du travail et Stratégies expérimentales
Les  objectifs  de  ce  travail  étaient  de  comprendre  les  mécanismes
moléculaires  de protection de l'ARNv par la nucléoprotéine des phlébovirus.
Nous nous sommes intéressés à la Nucléoprotéine du virus de la èvre de la
vallée de Rift, an de comprendre son mode d'assemblage et de déterminer si
les  nucléoprotéines  forment  un  polymère  autour  de  l'ARN  ou  si  l'ARN
s'embobine autour du polymère. Les données structurales des nucléoprotéines
de  phlébovirus  disponibles  dataient  des  années  1970.  Ces  données  de
microscopie électronique présentaient un polymère circularisé très @exible et
non tubulaire. Ces structures laissaient penser qu'un mécanisme d'assemblage
diérent  prend  place  par  rapport  aux  autres  virus  à  ARN  tels  que  les
Orthomyxoviridae  (virus  de  la  grippe),  les  Arenaviridae  (Virus  CML)  ou  des
Mononegavirales (virus de la rougeole, virus de Sendaï, VSV, Virus Ebola... etc),
qui utilisent aussi des nucléoprotéines pour protéger leurs matériel génomique.
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 iii. Résultats obtenus et perspectives
Nous avons résolu la structure de la nucléoprotéine du virus de la èvre
de la vallée du Rift. Il s'agit d'une protéine uniquement composée d'hélices-α et
subdivisée en trois sous domaines : un bras amino terminal qui se détend et
permet la polymérisation, et un corps bi-globulaire en forme de haricot séparé
par un sillon central accommodant l'ARNv (ou complémentaire). Nos structures
ont permis de démontrer un système d'assemblage hexamérique permettant
une protection optimum de l'ARN. Nos observations indiquent que l'ARN est à
l'intérieur du polymère de nucléoprotéine et que le mécanisme d'assemblage
conserve pour chaque corps globulaire un certain degré de liberté permettant
au polymère la @exibilité observée en microscopie électronique. De toutes les
structures de Nucléoprotéines résolues, celle de Phlébovirus est la plus petite
(Figure 7), mais conserve les caractéristiques générales des nucléoprotéines :
un corps globulaire central creusé d'un sillon préservant l'ARN et au moins une
extension  plus  ou  moins  structurée  permettant  la  polymérisation.  La
comparaison de notre structure avec celle précédemment publié par Raymond
et collègues (2010) montre que le corps globulaire reste conservé mais que le
bras  peut  se  replier  sur  le  sillon  central  en  le  couvrant.  Cette  diérence
structurale suggère que cette conformation fermée peut être une conformation
d'attente ;  qui  permet  aux  monomères  de  N  d'être  en  solution  avant  leur
recrutement par les ARNv ou ARNc. Il se peut aussi qu'il s'agisse d'un artefact
structural  due  à  la  purication.  Cette  question  reste  à  débattre  car  si  les
tenants de la conformation fermée y voient un avantage sélectif, ils font  des
données biochimiques qui suggèrent que les N (en attentes) sont sous forme
de dimères ou trimères  [186] . De plus, cette hypothèse laisse en suspens le
mécanisme d'ouverture du sillon pour le recrutement de l'ARNv. Il est d'autant
plus important de se pencher sur cette question que de nouvelles structures de
Nucléoprotéines  d'Arenavirus  ont  été  résolues  [187,188].  Ces  nouvelles
données  structurales  proposent  un  nouveau  mécanisme  d'encapsidation.
Cependant en observant les structures en prenant en compte les données de
caractérisation de N de LCMV [189], il est possible de découvrir un sillon qui
peut accueillir l'ARNv et de proposer un système de multimérisation similaire à
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celui  de  la  Nucléoprotéine  de  RVFV.  Dans  cette  hypothèse  les  structures
résolues  peuvent  être  considérés  comme  des  systèmes  repliés  comme  le
montre le modèle proposé (Figure 7). 
L'article des résultats présentés est dans l'annexe B.
Figure 7: Comparaison structurales des di(érentes Nucléoprotéines de virus à
ARN négatifs. Présentation des di(érentes structures de Nucléoprotéines de
virus à ARN négatifs : Vesicular Stomatitis Virus (VSV)pdb :3pto / Lassa Virus
(LaV) modèle / Borna Disease Virus (BDV) pdb :1n93 / Rift Valley Fever virus
(RVFV)pdb :3OV9  /  Rabies  Virus  (RV)pdb :2gtt  /  In8uenza  Virus
(InfV)pdb :3zdp /  Respiratory Syncitial  Virus(RSV)pdb :2wJ8.  Pour toutes les
structures  sont  représenté  sous  forment  de  surface  colorée  selon  la
nomenclature arc-en-ciel (bleu vers rouge/ Nterminal vers Cterminal). (A) Top,
vue de dessus de VSV/BDV/RVFVRV/InfV/RSV modèle cristallographique des
monomères de nucléoprotéines. LaV est une modélisation reposant sur des
observations de  [169]. Les régions de multimérisation se retrouvent à l'une
ou  l'autre  des  extrémités  .  Side,  vue  de  coté  correspondante,  mise  en
évidence de la  région  de liaison  à  l'ARN.  (B)  structures  (LaV)pdb :3mwt  /
(RVFV)pdb :3lyf  observées  par  cristallographie  avec  un  bras  de
multimérisation  replié  et  ne  permettant  pas  la  polymérisation  de  la
nucléoprotéine, ni la protection de l'ARN.
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 C. Structures et fonctions de protéines de la formation de 
la coi%e et du complexe de transcription/réplication des 
virus à ARN.
CNRS UMR 7257 – Architectures et Fonctions des Macromolécules Biologiques
Aix-Marseille Université (France)
Groupe : Structure, mécanismes et drug design des réplicases virales.
Laboratoire de B. Canard (2010-Présent)
 i. Contexte scienti<que
Le génome d'une cellule eucaryote est constitué d'ADN localisé dans le
noyau. Il contient l'information génétique qui gouverne l'essentiel des aspects
du fonctionnement cellulaire. Cette information doit ou peut être traduite sous
la  forme  de  protéines  an  de  répondre  aux  besoins  fonctionnels  et
métaboliques  de  la  cellule.  La  traduction  de  l'information  génétique  en
protéines  est  assurée  par  les  ribosomes,  localisés  dans  le  cytoplasme.  Le
passage de l'information du noyau au cytoplasme nécessite un ARN messager
(ARNm) qui assure le transport de l'information génétique d'un compartiment
cellulaire à l'autre. Cet ARNm est une copie transitoire de la partie de l'ADN
contenant les  instructions de synthèse d'une protéine.  Sa présence dans le
cytoplasme est contrôlée et strictement régulée selon les besoins cellulaires
qui  peuvent  varier  en fonction :  des conditions  environnementales,  du type
cellulaire, du stade de développement, de l'âge de la cellule. Lorsque la cellule
régule négativement l'expression d'une protéine, la transcription nucléaire du
gène s'arrête et au niveau du cytoplasme l'ARNm est progressivement dégradé
par des ribonucléases (ou RNases). Ainsi la production de protéine peut être
stimulée ou réprimée en fonction des besoins.
Les cellules codent pour des senseurs cytoplasmiques tel que RIG-1 (retinoic
acid inducible gene 1 protein)  et MDA5 (melanoma-dierentiation-associated
gene  5).  Ces  molécules  sont  des  acteurs  de  l’immunité  innée  capables  de
reconnaitre l’ARN de pathogènes infectant une cellule. L'ARNm cellulaire n'est
pas reconnu par les senseurs de l'immunité (RIG-1 et MDA5) de la cellule car il
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répond à certains critères structuraux :  coié en 5'  de l'ARN (Figure 8A) et
polyadénylé en 3'. La coie joue également un rôle dans le recrutement du
facteur eIF4E (eukaryotic translation initiation factor 4E), qui initie la traduction
des ARNm au niveau des ribosomes. Les mécanismes de synthèse de la coie
des eucaryotes sont détaillés Figure 8B. L’inactivation de la voie de synthèse
de la coie (enzymes impliquées dans la formation de la coie) est létale pour
les cellules, ce qui démontre l’importance de la coie pour la survie cellulaire. 
Lorsque une cellule est infectée par un virus à ARN, les ARNs viraux relargués
dans le  cytoplasme (génomique et/ou messager),  déclenchent une série  de
réponses cellulaires qui résultent entre autre par l'activation de la RNAse L.
Cette ribonucléase assure  la dégradation des ARN viraux. An de retarder la
détection de leurs ARNs par les senseurs de l'immunité innée; et d'assurer la
traduction de leurs ARNs en protéines,  certains virus ont acquis au cours de
l'évolution la capacité de coier leurs ARNs. La formation de la coie chez les
virus peut résulter de diérentes stratégies : détournement  des mécanismes
céllulaires,  synthèse  ou  vol  de  coie  médiés  par  des  enzymes  virales
spéciques. Notre intérêt  se porte  sur la compréhension et la caractérisation
structurale de ces systèmes viraux de formation de coie.
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Figure 8:  Structure de la coi(e des ARNm et mécanismes de leur formation.
(A) Structure de la coi(e des ARN messagers : La structure coi(e-0 (fond bleu)
est composée d’un résidu guanosine méthylé en position N7 (cercle vert à
gauche) qui est lié par une liaison 5’-5’ triphosphate (fond rose) au nucléotide
en aval de la coi(e. Un groupement méthyl (cercle orange à droite) peut être
ajouté à la position 2’O du ribose du premier et du deuxième nucléotide de
l’ARNm pour former la coiffe-1 et -2.(B) Le phosphate γ À l’extrémité 5’ de
l’ARN pré-messager est hydrolysé par l’ARN triphosphatase (RTPase). L’ARN
guanylyltransférase (GTase) Cxe ensuite une molécule de GMP à partir du GTP
(Gppp) en libérant du pyrophosphate inorganique (PPi). La GTase transfère le
GMP sur l’extrémité diphosphate de l’ARN prémessager formant une liaison 5’-
5’ triphosphate.  La synthèse de la coi(e se termine par la méthylation du
résidu  guanosine  en  position  N7  par  la  N7-MTase  à  partir  du  donneur  de
méthyl  (SAM).  EnCn,  chez  les  eucaryotes  supérieurs,  la  formation  de  la
structure coi(e-1 fait intervenir une 2’O-MTase qui méthyle la position 2’O du
ribose du premier nucléotide de l’ARN.(C)Dans le mécanisme de vol de coi(e
(cap-snatching), une endonucléase viral coupe la coi(e de l'ARNm de l'hôte,
qui va servir d'amorce pour la synthèse de l'ARNm viral.
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 ii. Objectifs et stratégies expérimentales
La  structure  de  la  coie  se  compose  d’une  guanosine  méthylée  en
position  N7  liée  par  une  liaison  5’-5’  triphosphate  au  premier  nucléotide
transcrit  de  l’ARNm (7MeGpppN),  elle  peut  être  éventuellement  décorée de
méthylation sur les positions 2'O des riboses des premières bases de l'ARN.
Ainsi chez les eucaryotes supérieurs une coie peut se décomposer en trois
niveaux (Figure 8A): coie-0 (fond bleu) est composée d’un résidu guanosine
méthylée en position N7 (cercle vert à gauche) qui est liée par une liaison 5’-5’
triphosphate (fond rose)  au nucléotide en aval  de la coie.  Un groupement
méthyle (cercle vert à droite) peut être ajouté à la position 2’O du ribose du
premier nucléotide de l’ARNm pour former la coie-1, voir sur le second ribose
et dans ce cas là, la structure est appelée coie-2. 
Pour les ARNm de la cellule, la coie est synthétisée par l'action cordonnée et
séquentielle d'une série d'enzymes présentent dans le noyau. Cette synthèse
est concomitante au début de la synthèse de l'ARNm (Figure 6B). La première
étape consiste en l’hydrolyse du phosphate γ de l’extrémité 5’ triphosphate de
l’ARNm  naissant  par  une  ARN  triphosphatase  (RTPase).  L’ARN
guanylyltransférase  (GTase)  recrute  une  molécule  de  GTP  et  forme  un
intermédiaire  covalent  via  sa  lysine  catalytique,  avant  de  transférer  le
groupement  GMP  sur  l’extrémité  5’  de  l’ARN  diphosphate.  Enn,  une  N7-
méthyltransférase  (N7-MTase)  méthyle  la  guanosine  sur  la  position  N7  en
utilisant  comme  donneur  de  méthyle  le  S-adénosyl-L-méthionine  (SAM  ou
AdoMet).
Tous les virus utilisent la machinerie de la cellule infectée an de traduire leur
ARNm en protéines. Bien que certains virus comme les virus de l'hépatite C ou
Poliovirus,  possèdent  des  structures  IRES  (internal  ribosome  entry  site)  qui
permettent  la  traduction  de leur  ARNm en l'absence de structure  coie,  la
plupart  des  virus  coient  l’extrémité  5’  de  leurs  ARNm  an  d'assurer  leur
traduction par les ribosomes cellulaires. Trois stratégies virales d’acquisition de
coie sont connues :
-  Stratégie de détournement cellulaire. Dans cette stratégie,  les ARNm sont
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synthétisés par l’ARN Polymérase II  et la coie par les enzymes cellulaires .
C’est le cas des rétrovirus et de la plupart des virus à ADN (Hepadnaviridae et
Parvoviridae) à l’exception des Poxviridae et Herpesviridae.
-  Stratégie de synthèse embarquée   . Cette stratégie est utilisée par la plupart
des virus à cycle entièrement cytoplasmique et consiste à coder et synthétiser
l'intégralité  de la machinerie enzymatique nécessaire à la formation de leur
structure coie. Cette stratégie est retrouvée chez les Nidovirales, Flavivirus et
Mononegavirales.  Il  est  à  noter  une  certaine  diversité  structurale  dans  ces
machineries virales impliquées dans la formation de la coie, en revanche leurs
fonctions et mécanismes réactionnels sont similaires aux enzymes eectuant
les coies cellulaires. 
-  Stratégie  du  vol  de  la  coie des  ARNm cellulaires  (cap-snatching).  Cette
stratégie (Figure 8C) est utilisée par les virus à ARN segmenté ambisens de
polarité  négative  dont  le  cycle  est  cytoplasmique  (Orthomyxoviridae,
Arenaviridae et Bunyaviridae). Dans ce cas, le vol de coie précède l'initiation
de  la  synthèse  d'ARNm  et  implique  un  système  de  capture  des  ARNm
cellulaires, constitué entre autre d'une endonucléase dont la fonction est de
couper l'ARNm cellulaire en aval de la structure coie. Ces petits fragments
d’ARN  sont  ensuite  utilisés  comme  amorces  par  l’ARN  polymérase  ARN-
dépendante virale pour synthétiser les ARNm viraux.
Nous nous sommes intéressés à la caractérisation structurale de deux
méthyltransférases  de  deux  familles  virales  diérentes  (Flavivirus  et
Coronavirus) et impliquées dans la formation de structure coie-1 ainsi qu'à
l'endonucléase de la protéine L d'Arenavirus impliquée dans le mécanisme de
vol de coie [190–192].
 iii. Résultats obtenus et perspectives
• Méthyltransférase du virus du Syndrome Respiratoire Aigu Sévère (SRAS-
CoV)   :
Les coronavirus sont à l’origine de nombreuses maladies respiratoires et
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entériques chez le bétail et les animaux de compagnie et constituent de ce fait
un problème économique d’importance. Ils  causent également une part des
rhumes  communs  chez  l’homme avec  les  rhinovirus.  Ils  ont  été  largement
médiatisés en 2003 puis en 2013 lors des épidémies de syndrome respiratoire
aiguë  sévère  (SRAS)  dont  les  agents  étiologiques  sont  le  SRAS-coronavirus
(SRAS-CoV)  et  le  MERS-coronavirus  (Middle  East  Respiratory  Syndrome
Coronavirus).  Ces  derniers  appartiennent  à  l'ordre  des  Nidovirales  et  à  la
famille des Coronaviridae. Les coronavirus sont des virus à ARN simple brin de
polarité positive qui possèdent un génome d’une taille surprenante (27-32 kb),
au moins deux fois supérieure à celle des génomes des autres virus à ARN.
Leur génome encode une partie si ce n'est l'intégralité de la machinerie de
formation de la coie. Chez ces virus la conversion des structures coie-0 en
coie-1 est assurée par la protéine nsp16 (sous forme de complexe activé par
nsp10). Dès 2003, nous avions et d'autre identié par bio-informatique, le motif
caractéristique  d'une  activité  2'O-Méthyltransférase  sur  cette  protéine  et
l'activité fut caractérisée au laboratoire sur un coronavirus félin en 2008. Les
études d'interactions ont montrés qu'une petite protéine nsp10 interagissait
fortement avec nsp16. La caractérisation biochimique a montré que nsp10 joue
le  rôle  d'activateur  de  la  protéine  nsp16  suggérant  un  rôle  d'interrupteur
moléculaire.  Utilisant  ces  données  nous  avons  pu  résoudre  la  structure  de
nsp16 en complexe avec nsp10. Nsp16 présente globalement un repliement
typique  des  repliements  des  S-Adenosyl-Methionine  (SAM)  2'O-
Méthyltransférase, constitué d'un feuillet β central de 7 brins et entouré de 5
hélices  α.  Cependant  la  topologie  diverge  du  repliement  standard  des  S-
Adenosyl-Methionine  (SAM)  2'O-Méthyltransférase  (Figure  9).  En  eet,  la
structure  révèle  qu'il  manque  2  hélices  des  7  hélices  α  pour  avoir  un
repliement  canonique et  que ce manque est  compensé par  la  présence de
nsp10 qui vient stabiliser et rigidier le site de liaison au SAM (donneur de
méthyle)  et  du  sillon  potentiel  de  liaison  à  l'ARN.  Nous  avons  également
identié un ion magnésium dans la structure qui stabilise une partie de nsp16,
et prouvé son rôle indispensable pour l'activité de nsp16. Enn, nous avons
aussi résolu la structure du complexe en présence d'un inhibiteur (Sinefungin)
analogue de SAM, montrant ainsi que ce dernier est capable de cibler le site de
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liaison par compétition. In vitro, l'acide aurintricarboxylique (ATA) a été montré
comme étant un inhibiteur de l'activité méthyltransférase. Nous n'avons pas
encore obtenu de cristaux en présence de cet inhibitueur, il reste à comprendre
comment  il  fonctionne  et  son  mode  de  xation.  La  prochaine  étape  de
caractérisation du mécanisme de méthylation de l'ARN par nsp16 consiste en
l'obtention d'une structure de nsp10/16 en complexe avec de l'ARN.
Figure  9:  Structure  du  complexe  nsp10/16.  (A)  Représentation  cartoon  du
complexe nsp10/16  avec le  produit  de  réaction SAH et  un  ion  métallique.
nsp16 se lie à nsp10 par la face qui  n'implique pas les ions zincs.  Un ion
métallique se retrouve sur la face opposée du site de liaison au SAM. (B) Vue
plongeante du site de liaison du SAM en représentation surface, avec le site
de liaison potentiel de l'ARN. (C-E) Représentation cartoon de la structure de
nsp16 dans di(érentes orientations aCn de mettre en évidence le repliement
typique des 2'O-Methyltransférases : C/D de coté et E vue de dessus. Le code
couleur s'appliquant pour toute la figure : les brins β sont en vert, les hélices α
sont en rose, et les boucles en blanc; ions (Na violet, Mg jaune, Zn crème),
l'eau  en  rouge,  les  représentations  du  SAH  suivent  le  code  couleurs  des
atomes (N bleu, O rouge, S jaune, C blanc), surface en gris. 
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• Méthyltransférase du virus de la Dengue (Flavivirus)   :
La dengue est une arbovirose, transmise à l'homme par l'intermédiaire
de la piqûre d'un moustique diurne du genre Aedes (ægypti ou albopictus), lui-
même porteur du virus de la dengue (@avivirus).  Le génome du virus de la
Dengue est constitué d'un ARN simple brin de polarité positive coié en 5' mais
non  polyadénylé  en  3'.  Le  génome  de  11kb  code  pour  7  protéines  non
structurales (NS1-5) et 3 protéines structurales (C, prM et E). Le complexe de
Transcription/Réplication  associe  7  NS d'une  manière  dynamique  impliquant
des réarrangements structuraux au cours du cycle. Parmis les 7 protéines du
complexe,  NS3  et  NS5  ont  fait  l'objet  de  caractérisations  avancées.  Elles
portent  respectivement  les  activités  RTPase/Hélicase  et
Méthyltransférase/Polymérase.
NS5 est une protéine  organisée en deux domaines methyltransférase (NS5-
Mtase) et polymérase (NS5-Pol) séparés par un domaine de liaison @exible. 
NS5-MTase est responsable des N7 et 2'O méthylations lors de la formation de
la coie des ARNm viraux [193]. L'étude structurale du domaine NS5-MTase a
été eectuée en présence d'analogues de coie. Cette étude vient compléter
une  série  d'études  biochimiques  sur  les  8aviviridae dont  l'objet  était  la
caractérisation des intermédiaires réactionnels des étapes de méthylation lors
de la  formation  de la  coie.  Nous  avons résolu  au cours  de  cette  étude 5
structures en complexe avec GpppA, N7GpppA, GpppG, N7GpppG, N7GpppG2′O.
Dans ces structures, nous avons pu observer que l'analogue de coie est lié
dans  la  poche  de  xation  du  GTP,  à  une  distance  trop  éloigné  du  site
catalytique pour comprendre le mécanisme de la N7 méthylation. En revanche
cette étude a permis de dénir la poche de xation du GTP et les contacts
entre  la  protéine  et  la  guanine,  le  ribose  et  le  phosphate.  La  molécule  se
positionne dans cette poche du fait de la présence d'une phénylalanine (F25)
qui permet par un eet d'empilement avec le cycle, la stabilisation de la base
(Figure 10). Il  apparaît que lorsqu'on ajoute une base supplémentaire l'eet
d'empilement augmente, la guanine de la coie se trouve pris en sandwich
entre la F25 et la première base.
Les structures obtenues en complexe avec le GpppA et le GpppG semblent
66
présenter  des  caractéristiques  structurales  compatibles  avec  celles  d'états
intermédiaires de la réaction de coie. En eet l'analogue de coie GpppA se
retrouve dans une conformation repliée sur lui-même. Cette conformation ne
peut  pas  correspondre  à  une  conformation  permettant  la  N7  ou  2'O
methylation. En eet, ni la base ni le sucre se trouvent à bonne distance du site
AdoMet  pour  permettre  à  la  réaction  de se  faire.  En revanche,  nous avons
proposé l'hypothèse que cette conformation mime le produit  de réaction de
guanylyltransfert qui précède les réactions de méthylation. Cette structure est
compatible avec la présence d'un ARN (Figure 10). La structure en complexe
avec le GpppG présente la molécule étendue. Seule la première base et le
phosphate  sont  actuellement  visibles.  Le  degré  de liberté  trop  grand de la
seconde base laisse supposer la conformation du GpppG dans laquelle le ribose
de la seconde base est à bonne distance du site AdoMet pour permettre la 2'O
méthylation. Nous avons proposé un mécanisme réactionnel reconstituant les
diérentes étapes de la formation de la coie. (I) xation du GTP au site de
liaison du GTP de la méthyltransférase. (II) Réaction de guanylyl transfert sur
l'ARN (structure GpppA). (III)  Ouverture de la conformation empilé des deux
bases pour permettre la N7 méthylation. (IV) repositionnement de l'ARN pour
méthylation 2'O. Yap et collaborateurs [194] ont depuis résolu la structure de la
méthyltransférase en complexe avec un ARN coié qui se positionne comme le
GpppA. Cette structure montre que la guanine est à une distance compatible
avec l'étape (III) du modèle que nous avons proposé.
Sur la base de la conformation de ces structures, nous avons postulé que nous
avions reconstitué des complexes structuraux correspondant au produit d'une
réaction du transfert coie. Nous avons proposé une implication direct de NS5
dans cette étape, et cette nouvelle hypothèse ouvre la voie vers de nouvelles
approches antivirales.
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Figure 10: Modèle hypothètique pour la méthylation en N7 de la première base,
suite  à  l'observation  du  positionnement  de  plusieurs  complexes  de
Méthyltransférase en présence de GTP ou GpppA ou GpppG et  de SAH.  La
position observé dans la structure (G0) montre un empilement de base avec la
phénylalanine 25. L'extension du triphosphate ramène la base de la coi(e à
bonne distance du SAM pour la méthylation en position N7(G0(E)).
La liaison phosphate observé dans la structure est en orange celle modélisé est
en jaune. 
Illustration dérivée de [194]
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• Endonucléase du Virus de la Chorioméningite Lymphocytaire (VCML)   :
Le  virus  de  la  Chorioméningite  Lymphocytaire  est  un  Arenavirus,  qui
utilise une stratégie de vol de coie pour ses ARNm (Figure 11A).Cette activité
est portée par la Large (L) protéine une protéine multidomaines de plus de
2000 résidus. Contrairement aux L de Mononégavirales qui possèdent en plus
du domaine  polymérase une ligne de production de coie intégrée, la L des
Arenavirus  reste  d'architecture  et  fonctions  inconnues.  Les  études  bio-
informatiques  ont  identié  précocement  la  présence  du  domaine  ARN
polymérase, plus récemment et par analogie avec la polymérase du virus de la
grippe un domaine endonucléase a été postulé en amino terminal de la L. Nous
avons résolu la structure de ce domaine et réalisé une étude structure fonction.
Il s'agit d'une protéine qui présente un repliement typique des endonucléases
de type II, constituée d'un feuillet central entouré d'un coté de deux hélices-α
parallèles  et  de  l'autre  d'une  seule  grande  hélice-α  mais  dont  l'extrémité
regroupe 4 hélices-α (Figure  11B).  L'analyse  structurale  a  démontré  que le
repliement  est  globalement  conservé au seins  des  trois  familles  virales  qui
pratiquent  le  vol  de  coie  ainsi  que  le  site  catalytique.  Cela  étant  dit,  le
domaine endonucléase de VCML ne présente pas les résidus qui permettent de
dénir  une cavité  catalytique  capable  de  prépositionner  le  substrat.  Malgré
cette absence surprenante nous avons pu démontrer l'activité endonucléase.
Notre  étude  montre  que  l'activité  endonucléase  est  ions  manganèse
dépendante. Toutefois nous n'avons pas pu obtenir de structure en complexe
(Figure  11C)  et  ce  malgré  des  trempages  répétés  en présence d'ions.  Cela
suggère  qu'il  manque  encore  des  « pièces »  au  complexe  nécessaire  et
subsant  pour  reconstituer  le  mécanisme  de  vol  de  coie  complet.  Il  sera
nécessaire  en particulier  de  comprendre  le  mécanisme de recrutement  des
ARN coiés.
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Les articles des résultats présentés sont dans l'annexe C.
Figure  11:  Machinerie  virale  du vol  de  la  coi(e  d'ARNm céllulaire.  (A)  Le
complexe de réplication/transcription, formé de Nucléoprotéines polymérisés
sur l'ARNv et de la protéine L, possède un domaine de capture d'ARNm qui
recrute un ARNm de la cellule. Le domaine endonucléase présent sur L vient
couper l'ARN en aval de la coi(e, l'amorce ainsi récupéré est utilisé par le
domaine polymérase (toujours sur L) pour commencer la synthèse de l'ARNm.
(B) Structure cartoon du domaine endonucléase du VCML. (C) Vue plongeante
du site actif présumé, les résidus impliqués sont en en représentation bâton.
Illustration (A) dérivée de [221]  
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 IV. PERSPECTIVES DE RECHERCHE
Jusqu’en 2003 les virus émergents étaient considérés d’intérêts mineurs.
Suite aux épidémies du virus du « Syndrome Respiratoire Aigu Sévère » (SRAS)
en 2003, de grippe aviaire en 2004 et 2006 puis de Chikungunya en 2006,
2007 et 2013, et en 2012 et 2013 de l'émergence de nouveaux pathogènes
Coronavirus (MERS-CoV) et d'Arénavirus [195,196]; le monde a pris conscience
de  la  vulnérabilité  des  sociétés  (moderne  ou  non)  face  à  ces  nouvelles
menaces.  Ces pandémies ont montré que les autorités sanitaires mondiales
étaient  dépourvues  de  réponses  thérapeutiques  adéquates  et  ont  mis  en
évidence  l’importance  de  la  recherche  fondamentale  dans  ce  domaine.  Le
projet  de  recherche  que  je  développe  et  qui  fait  écho  à  mon  parcours
scientique, est l'étude des complexes structuraux des protéines du complexe
de transcription/réplication chez les  Arenaviridae. Cette famille constitue l'un
des principaux réservoirs de virus émergents à ARN segmenté simple brin et
qui inclus des pathogènes responsables entre autres : de la èvre de Lassa, de
la èvre de Lujo et de la èvre de Machupo. 
Si  l’on  veut  disposer  d'un  arsenal  thérapeutique  contre  l'émergence  des
Arenaviridae, il  est  nécessaire  de  mieux  comprendre  leurs  architectures
moléculaires et leurs modes de fonctionnement. 
 A. Rappels sur la biologie des Arenaviridae
Les Arenaviridae sont des virus enveloppés, à ARN simple brin ambisens
de polarité négative. Ils sont d'abord prévalents chez les rongeurs (avec une
exception  pour  le  virus  Tacaribe  qui  se  retrouve  chez  la  chauve  souris)  et
occasionnellement ils sont transmis à l'homme. Les Arenaviridae sont des virus
au genre simple Arenavirus. Composé seulement de 24 virus, leur classement
se fait sur la base de leur propriété antigénique. Le genre est ainsi divisé en
deux  sous-groupes,  ceux  de  l'ancien  monde  (Europe/  Asie/  Afrique)  et  du
nouveau monde (Amériques / Antilles / Océanie). Les virus du nouveau monde
sont répartis en trois sous clades (A, B et C). L'organisation des clades repose
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sur l'analyse des séquences des gènes des Nucléoprotéines [24]. 
Le virus de la chorioméningite lymphocytaire (VCML) ; virus de l'ancien monde ;
sert comme comme virus modèle pour l'analyse des Arenavirus . En eet, les
Arenavirus comptent des virus hautement pathogènes pour l'homme, comme
les virus Lassa ou Lujo, qui sont responsables de èvres hémorragiques chez
l'homme et que l'on retrouve en afrique de l'ouest ou au sud du continent.
Parmi  les  virus  du  nouveau  monde,  les  virus  responsables  de  èvres
appartiennent tous à la clade B (Sabia, Junin, Machupo, Guanarito, Amapari,
Tacaribe, Cupixi) [197].
 i. Structure du virion
Les Arenavirus sont des virus sphériques, de diamètre compris entre 110
et  130nm,  enveloppés  d'une  couche  lipidique  dans  laquelle  s'insère  les
glycoprotéines d'enveloppe en forme de club de golf.  Sous la membrane se
trouve une capside (composé de protéines Z assemblées) à laquelle s'associe
deux  ribonucleoprotéines  pseudo-circulaires  (Figure  12A).  Ces
ribonucléoprotéines  correspondent  au  génome  sous  forme  de  deux  brins
d'ARN. L pour le grand brin (Large ±7,5kb) et S pour le petit (Small ±3,5kb).
L'extrémité  3'  des  brins  (±19-30  nucléotides)  est  complémentaire  de
l'extrémité 5' ce qui permet l'appariement des extrémités dans le virion et de
donner  la  forme  circulaire  au  génome.  En  plus  d'être  complémentaire,  la
séquence se trouve être conservée entre les brins et au sein de la famille. Les
virions  contiennent  aussi  des ribosomes,  qui  donnent  l'aspect  granuleux en
microscopie électronique d'où cette famille tire son nom :arena= sable en latin
(Figure 12) [24].
 ii. Description du génome et des protéines
Le génome code au total pour quatre protéines NP / L / GP / Z qui sont
réparties sur le génome de façon à produire les protéines de façon séquentielle
lors des  diérentes étapes du cycle viral. 
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Le segment  L  comprend pour  deux gènes  L  en 3'  et  Z  en 5'  alors  que le
segment S porte NP en 3' et GP en 5'.  Les gènes de chaque segment sont
séparés  par  une  région  intergénique  qui  arrête  la  polymérase  lors  de  la
transcription (Figure12 B).
 L  est  une  protéine  de  plus  de  200kDa qui  porte  entre  autre  les  activités
polymérase et endonucléase. La protéine L est divisées en 4 sous domaines.
Le  premier  domaine  en  amino-terminal  de  la  protéine  L  est  un  domaine
endonucléase  impliqué  dans  le  mécanisme  de  vol  de  coie.  C'est  le  seul
domaine de la protéine L qui a été exprimé et dont la structure et l'activité ont
été caractérisés. Le troisième domaine correspond à l'ARN polymérase ARN-
dépendante.  Ce  domaine  a  été  identié  par  bioinformatique  grâce  à  la
présence des motifs ARN polymérase ARN-dépendante conservés et l'activité a
été conrmée par génétique inverse. Les autres domaines de la protéine sont
de fonctions et de structures inconnues .
 Le second gène en 5' de l'ARN génomique est Z : une petite RING protéine 10
Figure 12: Structure du virion d'Arenavirus. Panneau de gauche 
présente une image de microcscopie éléctrionique à transmission du 
virus de Lassa. (Photo du domaine publique du CDC auteur  C. S. 
Goldsmith ID#: 8699). Panneau de droite présente A) le schéma 
d'une coupe de virion et la position dans le virion des protéines 
virales (GP/Z/L/NP). B)  organisation du segment L du génome C) 
organisation du segment S et cycle de réplication en deux temps.
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kDa (Really INtersting Gene) qui possède un corps structuré par deux doigts de
Zinc et dont le reste est principalement désordonné. Z joue le rôle de protéine
de  matrice :  lors  du  bourgeonnement  Z  a  un  rôle  structural  majeur  dans
l'assemblage du virion par le recrutement de NP et des glycoprotéines. Bien
que Z ne soit pas essentiel à la réplication, elle joue un rôle régulateur dans
l'activité  de  la  protéine  L.  La  protéine  Z  interfère  aussi  avec  les  facteurs
cellulaires  PML  (promyelocytic  protéine)  pour  prévenir  l'apoptose  et  PRH
(proline-riche homeodomaine protéine) qui joue un rôle dans les processus de
régénération des cellules. Enn Z joue un rôle dans le recrutement de eIF4E ;
facteur permettant le recrutement de la sous-unité ribosomale 40S sur la coie
de l'ARN viral [19]. 
 NP est la nucléoprotéine, une protéine de 63 kDa qui à la fois protège l'ARN
génomique et antigénomique et qui possède un domaine exonucléase impliqué
dans l'inhibition  de  la  réponse à  l'interferon  de type I  [198,199].  NP est  la
protéine  la  plus  abondante du virus,  elle  polymérise sur  l'ARN et  forme un
cofacteur essentiel à la protéine L. La structure de la NP du virus de Lassa a été
résolu seul et sous forme de domaine en complexe. Ces études présentent des
résultats  contradictoires  quant  à  l'organisation  possible  du  polymère  de NP
avec l'ARN viral.  La  région  C-terminale  de  la  NP contient  un  domaine 3'-5'
exonucléasique spécique des ARN double brins (db), similaire à celui présent
dans les exonucléases de la famille DEDDh . La NP peut digérer les ARN db
marqueurs de l'infection virale, empêchant ainsi la cascade d’activation initiée
via la reconnaissance de ces ARN par l’hélicase RIG-I (et donc l’activation des
réponses IFN) [200]. Les structures apo et en complexe avec le substrat ont été
résolues pour plusieurs virus. Les acides aminés présents au niveau du site
catalytique ont  été identiés et leur  mutation abolit  la  capacité de la NP à
inhiber la réponse antivirale. Cependant, le virus Mopeia possède également ce
domaine DEDDh et est probablement capable d’inhiber la réponse IFN, bien
que  de  façon  moins  ebcace.  D’ailleurs,  des  virus  Lassa  recombinants
contenant des mutations dans ce domaine induisent des quantités d’IFN de
type I bien supérieures à celles sécrétées lors de l’infection par le virus Mopeïa
[201–203]. La capacité de lutter contre les défenses cellulaires ne se limite pas
seulement  à  la  fonction  exonucléase de NP.  En eet,  la  NP des  arénavirus
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empêche la phosphorylation d’IRF3 en se liant à la kinase IKKε  [204]. La NP
séquestre  IKKε  dans  une  forme  inactive  en  inhibant  son  activité  auto-
catalytique. Ce complexe inhibant le changement de conformation de la kinase
empêche l’induction des réponses immunes innées en amont des cascades de
régulation  cellulaire.  Enn,  la  NP  est  capable  d’inhiber  la  translocation
nucléaire  et  par  extension  l’activité  transcriptionnelle  du  facteur  de
transcription  NFκB ce  qui  a  pour  effet  d'inhiber  la  production  de cytokines
[205].  Cette observation corrèle en particulier avec l’absence d’activation des
cellules présentatrices d’antigènes et l’absence de production des cytokines
pro-in@ammatoires observées lors de l’infection par le virus Lassa. Ainsi,  les
Arenavirus ont développé des stratégies ebcaces pour empêcher l’induction de
l’immunité innée dont la pierre d'angle est la Nucléoprotéine.
 GPC (75 kDa) est un précurseur des deux glycoprotéines GP1, GP2 et d'un
petit peptide signal (SSP) de 58 acides aminés, responsable de la structure du
virion et de sa pénétration dans la cellule. Un fois produit, le peptide signal
adresse GPC à la membrane, GPC trimérise et forme un complexe tripartite
SSP/GP1/GP2.  Après  maturation  dans  le  Golgi,  par  la  protéine  site-1-
protease/subtilisin-like  kexin  isozyme-1  (S1P/SKI-1),  deux  protéines  et  un
peptide sont formés : GP1 est la protéine d'attachement au récepteur, GP2 est
la  protéine  de  fusion  et  enn  SSP  joue  un  rôle  de  transmetteur.  SSP  se
réarrange après modication an de traverser deux fois la membrane et d'avoir
son C-terminal  du  coté  cytosolique.  Les  deux  domaines  transmembranaires
sont  séparés  par  une  boucle  hydrophyle  exposée  qui  joue  un  rôle  dans  la
détection de l'acidication de l'endosome. 
Chez  les  virus  de  l'ancien  monde,  GP1  cible  les  récepteurs  d'entrées  α-
dystroglycan, alors que pour les virus du nouveau monde, GP1 s'accroche aux
récepteurs transferrin receptor-1 (TfR1).
GP2 est  une protéine  transmembranaire  avec un petit  domaine cytosolique
contactant l'extrémité C-terminal de SSP. GP2 contient un peptide bipartite en
N-terminal qui se retrouve exposé lors d'une modication de pH et qui assure la
fusion. 
 L'interaction  de  GP1  avec  le  récepteur,  déclenche  l'invagination  de  la
membrane  et  la  formation  par  la  cellule  d'un  endosome  autour  du  virion.
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L'acidication de l'endosome est détectée par la boucle de SSP qui va induire le
changement  de  conformation  de  la  protéine  de  fusion  GP2  déclenchant  la
fusion des membranes et l'injection du complexe ribonucléoprotéique dans le
cytoplasme [206]. 
 iii. Le cycle réplicatif. 
Du fait, de l'organisation du génome à ARN simple brin ambisens et de
polarité (-),  le cycle des Arenavirus se déroule en deux phases :  précoce et
tardive.  La  phase  précoce  correspond  à :(1)  la  synthèse  des  ARNm  des
protéines NP et L par la protéine L. La synthèse de l'ARNm commence par le vol
de coie d'ARNm cellulaires qui vont servir d'amorce pour la synthèse d'ARNm
viraux. Le mécanisme de recrutement de ces ARNm est encore peu clair, en
revanche  c'est  le  domaine  endonucléase  en  N-terminal  de  L  qui  génère  la
coupure  et  probablement  avec  l'aide  d'autres  domaines  de  L,  commence
l'initiation de la synthèse de l'ARNm viral. Ainsi les ARNm sont coiés en 5' et
possèdent 5 nucléotides n'appartenant pas à la matrice virale. L'extrémité 3'
de l'ARNm n'est pas poly-adényleé, en revanche elles sont stabilisée par une
boucle correspondant à la région intergénique du génome. (2) La traduction
des ARNm viraux en protéines. Après accumulation de NP, la L commence la
(3)  la  synthèse  de  l'antigénome  et  la  formation  d'un  complexe
ribonucléoptéique antigénomique. (4) Début de la réplication (Figure 12C) [24].
Pour  assurer  le  bon  positionnement  de  la  polymérase  pour  initier  la
réplication  viral,  il  faut  une  contrainte  particulière  sur  les  extrémités  du
génome. Cette contrainte assure en même temps la spécicité de la séquence
pour la polymérase au sein de la région conservée des 19 nucléotides en 3' et
la  conservation de l'intégrité  structurale  de la  structure  en queue de poêle
formée par l'assemblage complémentaire des extrémités 5' et 3' du génome
viral.  Une  des  traces  de  cette  contrainte  se  retrouve  au  niveau  de  la
conservation  d'un  motif  GC  au  niveau  de  l'extrémité  5'  du  génome  et  de
l'antigénome. Pour expliquer cette conservation, un mécanisme d'initiation et
de réalignement (prime and realign) a été proposé (Figure 13) [220]. 
 Dans ce mécanisme, la réplication du génome des Arenavirus commence par
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l'initiation avec un GTP en position +2 de la matrice au lieu de la base se
situant à l'extrémité 3' du brin d'ARN. Après formation d'un 5'pppGpC, il y a
réalignement  de  l'amorce  sur  la  matrice  suivi  par  son  élongation.  Ce
mécanisme de réarrangement a pour eet de laisser une base non appariées.
Cependant  comme la longueur  du  brin  d'ARN  reste  constant  cela  suppose
qu'en  3'  une  base  soit  enlevée.  Ce  mécanisme  présume  aussi  que  la
polymérase peut initier la synthèse d'ARN de novo avec un GTP. 
La phase tardive correspond à : (5) la synthèse des ARNm des protéines Z et
GPc par la L à partir du complexe antigénomique. (6) La traduction des ARNm
viraux  en  protéines.  Les  protéines  Z  et  GPc  ne  sont  pas  essentielles  à  la
transcription ni à la réplication.
 iv. La réponse Immunitaire innée
Les infections  virales  sont  régulées  chez les  vertébrés  par  l'action  du
Illustration dérivée de [220]
Figure 13: Mécanisme d'initiation et de 
réalignement de la polymérase.
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système  immunitaire  qui  détecte  l'infection  virale  et  initie  les  réponses
antivirales  [207–210].  Les  mécanismes  de  l'immunité  innée  constituent  la
première ligne de défense et joue un rôle particulièrement important dans le
contrôle  des  infections.  Au  cours  de  l'infection  précoce,  les  composés  du
système  de  l'immunité  innée  perçoivent  des  déterminants  viraux  appelés
« PAMPs »  (Pathogen-Associated  Molecular  Patterns)  [211–215].  Parmi  les
PAMPs, l'ARN db est un signal clé de l'infection par des virus à ARN (-). L'ARN
double  brin  est  détecté  dans  le  cytoplasme  de  la  cellule  infectée  par  les
récepteurs d'ARN viral  double brin comme le récepteur RIG-I  (Retinoic  acid-
inductible  gene) et MDA-5 (Melanoma dierenciation-associated gene).  RIG-I
reconnait  spéciquement  des  ARNb  db  courts  portant  une  extrémité  5’-
triphosphate  [216] alors que MDA-5 reconnaît  plutôt des ARN db plus longs
indépendamment de leur extrémité 5’ [217]. Après la reconnaissance de leurs
cibles, ces récepteurs activent plusieurs facteurs de transcription (comme IRF-
3,  IRF-7  et  NFκB).  IRF-3  et  IRF7  sont  des  facteurs  de  transcription  latents,
phosphorylés par les kinases IKKε ou TBK-1 lors de la transduction du signal
[218].  IRF-3  et  IRF-7  ainsi  phosphorylés  s’homo-  ou  s’hétéro-dimérisent  et
s’accumulent dans le noyau conduisant à la production de l'interféron (IFN) de
type I (α et β) et de cytokines pro-inflammatoires activant donc la réponse
antivirale de la cellule [219]. 
Les réponses précoces du système d'immunitaire innée peuvent être capables
de  contrôler  ou  ralentir  la  réplication  virale  et  permettre  a posteriori à
l'immunité adaptative de contrôler le virus et d'empêcher une ré-infection. Les
stratégies de survie sont mises en place non seulement par l'hôte mais aussi
par  les  virus.  Ainsi,  les  Arenavirus  ont  également  développé  comme nous
l'avons  vu  précédemment,  des  systèmes  qui  leurs  permettent  de  bloquer,
contourner ou réguler les défenses des cellules hôtes. NP et Z sont les deux
protéines les plus impliquées dans ces mécanismes et dérèglent les cascades
conduisant à la réponse immunitaire innée. 
Cette stratégie de contre, permet aux virus de se répliquer plus tôt et plus vite
avant que la réponse de l'immunité adaptative soit mise en place. 
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 B.  Projet de recherche à moyen terme
Mon projet vise à acquérir de nouvelles connaissances dans ce domaine en
proposant d’une part, une étude structurale pour un certain nombre de virus
représentatifs  de  ces  deux  familles.  Le  but  est  de  caractériser  au  niveau
moléculaire,  les  enzymes  impliquées  dans  la  transcription/réplication  virale.
D’autre part, la mise en place d’une stratégie d’inhibition des mécanismes de
la transcription des ARNm viraux, et des enzymes impliquées dans la réponse
innée.
Pour cette famille, le virus a développé une série de mécanismes permettant
d'échapper à la détection et aux défenses de la cellule hôte. On peut classer
ces mécanismes comme moyens de défense « passif », d'autres sont de nature
« actif ». Parmi les stratégies d'évasion passive on peut nommer par exemple
la formation de structures polymérisées pour cacher l'ARNv, le recrutement de
protéines du ribosome près des complexes de réplication an de favoriser les
ARNm viraux, le détournement de kinases perturbant les cascades d'activation,
ou  l'utilisation  d'ARNm utilisant  une  coie  cellulaire.  Les  stratégies  actives
impliquant  une  activité  enzymatique,  sont  le  vol  de  la  coie  des  ARNm
cellulaires, l'activité de dégradation des ARN db marqueur de l'infection virale.
Ainsi, je souhaite caractériser et comprendre les stratégies de protection des
ARNs viraux (génomiques, complémentaires et messagers,) acquis ou mis en
place par les Arenaviridae aCn d'échapper à la réponse antivirale de la cellule.
Ce projet implique de décrire un modèle mécanistique qui repose sur l'étude
structurale  et  fonctionnelle  des  protéines  impliquées  L  et  NP.  Plus
spéciquement se pose les questions des diérentes étapes de recrutement
des partenaires et leur régulation ? Des changements dynamiques impliquées
dans l'assemblage et l'ouverture des NP pour laisser L accéder à l'ARN ? De la
régulation des activités nucléases (endo / exo) pour ne pas aecter les ARNs
viraux ?  Ces  questions  sont  fondamentales  dans  la  compréhension  du
fonctionnement de la machinerie de transcription/réplication et passent par la :
* Caractérisation biochimique et structurale du mécanisme de recrutement de
l'ARNm  coié  par  l'endonucléase  an  de  voler  la  coie,  ainsi  que  de
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caractériser le mécanisme qu'utilise la polymérase pour initier la transcription
avec  cette  amorce.  J'espère  pouvoir  valider  mes  résultats  par  génétique
inverse grâce à notre collaborateur (S. Emonet) de l'unité de virologie de l'
Institut de Recherches Biomédicales des Armées.
* Caractérisation de la structure à haute résolution de la NP seul et en
complexe avec de l'ARN, de façon à comprendre le mécanisme d'assemblage
de  ce  polymère.  A  cet  eet  je  développe  une  stratégie  similaire  à  celle
développée avec succès pour la N de RVFv. Il est particulièrement important de
comprendre  ce  processus  de  polymérisation  et  décrire  les  changements  de
conformations  possibles  chez  les  Arenaviridae an  de  déterminer  si  la
polymérisation  induit  ou  non  une  activation  ou  une  inhibition  du  domaine
exonucléase.
* Caractérisation de la structure à haute résolution de la NP en complexe
avec  la  kinase  IKKε  afin  de  mieux  comprendre  quel  est  le  mécanisme
d'inhibition de la cascade de signalisation.  Il  sera intéressant d'identier les
résidus impliqués dans cette interaction et d'identier peut être une surface
utile pour développer une stratégie pour bloquer la formation de ce complexe. 
* Caractérisation biochimique et structurale des domaines exonucléases
de  diérents  Arenavirus  (virus  CML,  Machupo  et  Mopeïa)  ainsi  que
l'identication  d'une  classe  de  molécules  inhibant  spéciquement  cette
activité.  Je  souhaite  vérier  son  rôle  dans  l'inactivation  de  la  réponse  à
l'interféron.  Aussi  sur  la  base  de  résultats  obtenus  au  laboratoire  sur  une
exonucléase de coronavirus qui est impliquée dans la stabilité du génome et
qui présente un comportement similaire face aux substrats ARN ; je souhaite
vérier  que  cette  exonucléase  participe  à  un  mécanisme  de  correction
d'erreurs. Grâce à notre collaborateur de l'Institut Pasteur (Dr. Baize) j'espère
valider par génétique inverse mes hypothèses chez ces diérents virus.
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Structural basis for the recruitment of
profilin–actin complexes during filament
elongation by Ena/VASP
Franc¸ois Ferron, Grzegorz Rebowski,
Sung Haeng Lee and Roberto Dominguez*
Department of Physiology, University of Pennsylvania School of
Medicine, Philadelphia, PA, USA
Cells sustain high rates of actin filament elongation by
maintaining a large pool of actin monomers above the
critical concentration for polymerization. Profilin–actin
complexes constitute the largest fraction of polymeriza-
tion-competent actin monomers. Filament elongation fac-
tors such as Ena/VASP and formin catalyze the transition
of profilin–actin from the cellular pool onto the barbed end
of growing filaments. The molecular bases of this process
are poorly understood. Here we present structural and
energetic evidence for two consecutive steps of the elonga-
tion mechanism: the recruitment of profilin–actin by the
last poly-Pro segment of vasodilator-stimulated phospho-
protein (VASP) and the binding of profilin–actin simulta-
neously to this poly-Pro and to the G-actin-binding (GAB)
domain of VASP. The actin monomer bound at the GAB
domain is proposed to be in position to join the barbed end
of the growing filament concurrently with the release of
profilin.
The EMBO Journal (2007) 26, 4597–4606. doi:10.1038/
sj.emboj.7601874; Published online 4 October 2007
Subject Categories: cell & tissue architecture; structural
biology
Keywords: actin; cytoskeleton dynamics; filament elonga-
tion; profilin
Introduction
The enabled/vasodilator-stimulated phosphoprotein (Ena/
VASP) family is implicated in diverse cellular processes
involving dynamic actin assembly, such as fibroblast migra-
tion, axon guidance and the movement of the bacterial
pathogen Listeria monocytogenes (Krause et al, 2003). Ena/
VASP proteins share a tripartite domain organization
(Figure 1), consisting of N- and C-terminal Ena/VASP homol-
ogy 1 and 2 (EVH1 and EVH2) domains and a central Pro-rich
region. The EVH1 domain targets Ena/VASP proteins to focal
adhesions, filopodia and lamellipodia by binding to target
proteins containing the consensus sequence ‘FPPPP’, such as
vinculin (Brindle et al, 1996; Reinhard et al, 1996), lamelli-
podin (Krause et al, 2004), zyxin (Reinhard et al, 1995b),
migfilin (Zhang et al, 2006) and palladin (Boukhelifa et al,
2004). The Pro-rich region of Ena/VASP binds profilin and the
SH3 and WW domains of various signaling and scaffolding
proteins, including Abl, Src and IRSp53 (Gertler et al, 1995;
Ahern-Djamali et al, 1999; Krugmann et al, 2001). The EVH2
domain comprises globular and filamentous actin-binding
sites (GAB and FAB), as well as a C-terminal coiled-coil
(CC) region that mediates VASP tetramerization (Bachmann
et al, 1999; Walders-Harbeck et al, 2002).
Ena/VASP functions primarily as an actin filament elonga-
tion factor, whereas it is a relatively weak nucleator (Bear
et al, 2002; Barzik et al, 2005). Thus, depletion of Ena/VASP
produces shorter and more densely branched filament net-
works, whereas its overexpression causes the opposite effect
(Skoble et al, 2001; Bear et al, 2002). Since profilin–actin
constitutes the major pool of polymerization-competent actin
in eukaryotic cells (Pollard and Borisy, 2003), filament elon-
gation by Ena/VASP will depend upon its ability to ‘process’
profilin–actin complexes for their incorporation onto the
barbed end of growing filaments. Consistent with this notion,
the recruitment of profilin–actin by the central Pro-rich region
of VASP enhances Listeria motility (Chakraborty et al, 1995;
Kang et al, 1997; Geese et al, 2000, 2002; Auerbuch et al,
2003; Grenklo et al, 2003). Furthermore, a covalently cross-
linked profilin–actin complex, which cannot function as a
source for filament elongation, markedly reduces Listeria
motility, and this effect depends on the ability of profilin to
interact with the poly-Pro region of Ena/VASP (Grenklo et al,
2003). Profilin also appears to enhance actin polymerization
by increasing the anti-capping activity of VASP (Barzik et al,
2005). The role of profilin–actin in filament elongation is not
unique to Ena/VASP. Most formins also recruit profilin–actin
via their Pro-rich FH1 domain, which increases the rate of
filament elongation (Kovar et al, 2006). Despite the impor-
tance of profilin–actin in filament elongation, the molecular
bases for this function are poorly understood. Here, we
investigate the energetics and structural bases for the inter-
actions of profilin–actin with the last poly-Pro and the poly-
Pro-GAB regions of human VASP. Based on the results, we
propose a model for the recruitment and processing of
profilin–actin complexes during filament elongation by
Ena/VASP.
Results
The Pro-rich region of Ena/VASP consists of three
distinct poly-Pro sites
To better understand the modular organization of VASP, and
in particular that of its Pro-rich region, we analyzed the
distribution of clusters of hydrophobic amino acids using
the program HCA (Callebaut et al, 1997) (Figure 1).
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Predictably, the EVH1 and CC regions, whose crystal
structures have been determined (Prehoda et al, 1999;
Kuhnel et al, 2004), are characterized by a higher density of
clusters of hydrophobic amino acids. Two small clusters,
displaying a characteristic helical pattern (Callebaut et al,
1997), correspond to the GAB and FAB domains. The ex-
tended Pro-rich region located between the EVH1 and GAB
domains lacks hydrophobic clusters and is therefore pre-
dicted to be mostly unfolded. Although this region is more
divergent, we identify three distinct groups of proline resi-
dues that are present in all members of the Ena/VASP family
(Figure 1). The first group, amino acids 116–135 (human
VASP sequence numbers), consists of a mixture of proline
and hydrophobic amino acids, a signature feature of SH3- and
WW-binding sequences. Thus, programs such as iSPOT
(Brannetti and Helmer-Citterich, 2003) and SCANSITE
(Obenauer et al, 2003) predict that this poly-Pro site binds
the SH3 domains of a number of signaling proteins, including
Abl, Nck, Crk and cortactin. The interactions of Ena/VASP
with some of these proteins have been demonstrated (Gertler
et al, 1995; Sparks et al, 1996; Coppolino et al, 2001),
although not always mapped specifically to this site.
Because this site does not correspond to a canonical profi-
lin-binding sequence (Perelroizen et al, 1994; Petrella et al,
1996; Kang et al, 1997), and since it is most likely involved in
regulation, we identify it as the ‘regulatory’ poly-Pro site. The
second group of proline residues (amino acids 160–194)
comprises three repeats of the specific profilin-binding se-
quence GPPPPP (or GP5), and has therefore the potential to
bind multiple profilin–actin complexes (Mahoney et al,
1999). For this reason, we identify this site as the ‘recruiting’
poly-Pro site. Most of the studies on the profilin–poly-Pro
interaction have focused on this GP5 region or plain poly-Pro
sequences (Perelroizen et al, 1994; Reinhard et al, 1995a;
Petrella et al, 1996; Kang et al, 1997; Lambrechts et al, 1997;
Jonckheere et al, 1999). The third group of proline residues is
located between the recruiting poly-Pro site and the GAB
domain, and is flanked on both sides by short flexible linkers
rich in Gly residues. Because of its location, immediately N-
terminal to the GAB domain, and its apparent role in deliver-
ing profilin–actin from the poly-Pro region to the GAB
domain (see below), we identify this site as the ‘loading’
poly-Pro site. The loading site is highly conserved among all
members of the Ena/VASP family, and always presents a
hydrophobic amino acid at the penultimate position, most
commonly Leu (Supplementary Figure 1). The loading poly-
Pro site and the GAB domain are the central focus of this
study.
Binding of profilin and profilin–actin to the loading
poly-Pro site of VASP
As mentioned above, various studies have investigated the
binding of profilin to plain poly-Pro sequences and GP5
sequences of the kind found in the recruiting site of VASP
(Perelroizen et al, 1994; Reinhard et al, 1995a; Petrella et al,
1996; Kang et al, 1997; Lambrechts et al, 1997; Jonckheere
et al, 1999). In particular, profilin has been reported to bind
the GP5 sequence of VASP with relatively low affinity (KD of
84–250mM) (Petrella et al, 1996; Kang et al, 1997). However,
neither the binding of profilin to the highly conserved loading
poly-Pro site nor the binding of profilin–actin to any poly-Pro
sequence has yet been investigated. Here, we used two
different methods, isothermal titration calorimetry (ITC)
and intrinsic tryptophan fluorescence, to measure the binding
affinities of both profilin and profilin–actin for a 16-aa
synthetic peptide (198GAGGGPPPAPPLPAAQ213) containing
the loading poly-Pro site of human VASP (Figure 2;
Supplementary Figure 2). Both methods consistently showed
that the binding of profilin–actin for this peptide in high ionic
strength buffer is 6- to 11-fold higher affinity than that of
profilin alone (KD of 7.5–8 mM for profilin–actin vs 50–84 mM
for profilin alone). Although not specifically addressed here,
similar results were obtained for a GP5 triplet peptide,
resulting in a KD of 23 mM for profilin–actin vs 230mM for
profilin alone (data not shown). We also found that the
affinity of profilin for actin in G-buffer increases twofold
when profilin is bound to the loading poly-Pro peptide of
VASP (KD of 0.8 vs 1.6 mM) (Supplementary Figure 3, and
Figure 1 Modular organization of VASP. The diagram shown on the upper part of the figure represents the modular organization of the human
VASP sequence (UniProt P50552) based on the distribution of clusters of hydrophobic amino acids determined with the program HCA
(Callebaut et al, 1997). Symbols are as follows: Pro, ; Gly, E; Thr, & and Ser, . Amino acids are colored according to their chemical
characteristics: green, hydrophobic; red, negatively charged; blue, positively charged; black, Ala and Cys. The EVH1 and CC domains, which
are stably folded and whose structures have been determined (Prehoda et al, 1999; Kuhnel et al, 2004), are characterized by a higher density of
clusters of hydrophobic amino acids (contoured black). In contrast, the extended Pro-rich region (amino acids 116–213) lacks hydrophobic
clusters, and is predicted to be mostly unfolded. Within this region, we identify three distinct groups of Pro residues, which are present in all
members of the Ena/VASP family: regulatory site (116–135), recruiting site (160–194) and loading site (201–211). Finally, the region preceding
the CC domain has the typical HCA pattern of an inducible a-helix.
Recruitment of profilin–actin by Ena/VASP
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the legend). Together, these results suggest that poly-Pro
sequences bind preferentially profilin–actin than profilin
alone. This finding may have important functional implica-
tions, since profilin–actin constitutes the major pool of poly-
merization-competent actin in cells, and the affinities
determined here for poly-Pro sequences fall within the in-
tracellular range of concentrations of profilin–actin (5–
40 mM) (Condeelis, 1993; Stossel, 1993; Kang et al, 1999;
Dickinson and Purich, 2002; Dickinson et al, 2002; Pollard
and Borisy, 2003).
Structure of profilin–actin bound to the loading poly-Pro
site of human VASP
Crystal structures of profilin bound to decameric and penta-
decameric L-Pro peptides have been determined (Mahoney
et al, 1997, 1999). These structures revealed that profilin,
like SH3 domains (Feng et al, 1994), binds plain poly-Pro
sequences in two distinct backbone orientations. It was
proposed at the time that non-Pro residues in profilin ligands
may dictate the actual polarity and register of binding
(Mahoney et al, 1999). These two factors, polarity and
register, become particularly important if there is, as we
speculate, a mechanism whereby profilin–actin complexes
are transferred directly from the last poly-Pro site to the GAB
domain of Ena/VASP during filament elongation. To test this
hypothesis, we determined the structure of the ternary com-
plex of profilin–actin bound to the 16-aa peptide correspond-
ing to the loading poly-Pro site of human VASP. In the
structure, determined to 1.8-A˚ resolution (Table I), actin
and the VASP peptide bind on opposite sides of the profilin
molecule (Figure 3A; Supplementary Figure 4A). The con-
formation of skeletal a-actin is very similar to that of b-actin
in the structure of its complex with profilin determined
previously to 2.55-A˚ resolution (Schutt et al, 1993). In
particular, in both structures the nucleotide cleft is in the
closed conformation, different from the open cleft conforma-
tion suggested by another study (Chik et al, 1996). Compared
to other actin structures, the two profilin–actin complexes
also display a slightly closed target-binding cleft, consisting of
the cleft between actin subdomains 1 and 3 (Dominguez,
2004). This effect, which appears to be directly linked to the
binding of profilin, may explain the increased affinity of the
GAB domain for profilin–actin compared with actin alone
(Chereau and Dominguez, 2006).
One noticeable difference between the two profilin–actin
structures occurs in the DNase I-binding loop, which is
disordered in the ternary complex studied here, but was
visualized in the original structure of profilin–b-actin
(Schutt et al, 1993). Also, the C-terminal Phe 375 of actin is
rotated around the main chain backboneB1801 between the
two structures. This amino acid is at the center of the
profilin–actin interface, an area that is strictly conserved
between a- and b-actin, and which is very well defined in
the electron density map (Supplementary Figure 4B). The
conformation of profilin is also very similar in the two
structures, except for the binding interface of the VASP
peptide (Figure 3C), where the side chains of residues His
133, Ser 137 and Tyr 139 adopt different rotamer orientations.
The N-terminus of profilin also forms part of the binding
interface and moves in the current structure toward the VASP
peptide, making contacts with it.
The first three amino acids of the loading poly-Pro peptide
are disordered in the structure, whereas the remaining 13
(Gly 201–Gln 213) are all very well defined in the electron
Table I Crystallographic data and refinement statistics
Profilin–actin–
poly-Pro
Profilin–actin–poly-
Pro-GAB
Diffraction statistics
Space group P 21 21 21 C 2
Cell parameters
a, b, c (A˚) 37.47, 75.46, 180.74 119.09, 56.59, 75.23
a, b, g (deg) 90.0, 90.0, 90.0 90.0, 104.75, 90.0
Resolution
Total (A˚) 47.09–1.8 35.05–1.5
Outer shell (A˚) 1.86–1.8 1.55–1.5
Completeness (%) 98.1 (97.7) 99.1 (98.2)
Redundancy 7.0 (5.9) 8.3 (7.5)
Unique reflections 47041 (4579) 76 002 (7370)
R-mergea (%) 7.6 (34.5) 7.1 (29.4)
Average I/s 28.1 (5.7) 32.44 (7.8)
Refinement statistics
R-factorb (%) 15.8 15.6
R-freec (%) 20.1 19.0
R.m.s. deviations
Bond length (A˚) 0.013 0.015
Bond angles (deg) 1.402 1.701
Average B-factor
All atoms (A˚2) 14.92 10.84
Actin/profilin/
VASP (A˚2)
13.18/14.26/28.82 9.13/7.17/12.34
Solvent atoms (A˚2) 23.29 22.5
PDB code 2PAV 2PBD
GAB, G-actin-binding domain; VASP, vasodilator-stimulated phos-
phoprotein.
Values in parentheses correspond to highest-resolution shell.
aR-merge¼
P
(I"/IS)/
P
I; I and /IS are the intensity and the
mean value of all the measurements for an individual reflection.
bR-factor¼
P
|Fo"Fc|/
P
|Fo|; Fo and Fc are the observed and
calculated structure factors.
cR-free, R-factor calculated for a randomly selected subset of the
reflections (5%) that were omitted during the refinement.
Figure 2 Binding of profilin and profilin–actin to the loading
poly-Pro site of VASP. Binding of the VASP peptide (198GAGGGPPP
APPLPAAQ213) produces a significant change in the intrinsic tryp-
tophan fluorescence of profilin alone (&) and profilin–actin (&). In
this experiment, the concentration of profilin and profilin–actin was
5 mM and the concentration of the VASP peptide varied for 0–320mM
(see Materials and methods). Each data point corresponds to the
average of five independent measurements. Least-square fitting of
the data, using a single-site binding model, resulted in dissociation
constant (KD) estimates of 84 and 7.5mM for profilin and profilin–
actin, respectively.
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density map (Figure 3B). The orientation of the VASP peptide
is both unambiguous and unique, with the C-terminal end of
the peptide pointing toward actin (Figure 3A). The interac-
tions with profilin are limited to the eight amino acids
between Pro 203 and Pro 210, and include stacking and
hydrogen bonding interactions with profilin residues Trp 3,
Asn 9, Trp 31, His 133 and Tyr 139 (Figure 3C). Profilin Tyr 6
also plays a critical role in the interaction, making both a
hydrogen-bonding contact with a main-chain atom and a
hydrophobic stacking interaction with Leu 209 of the peptide.
The conformation of the VASP peptide is significantly
different from the two backbone conformations of the deca-
meric L-Pro peptide, but somewhat similar to that of the
pentadecameric L-Pro peptide studied previously (Mahoney
et al, 1997; Mahoney et al, 1999) (Supplementary Figure 5).
However, important differences occur, which correlate with
substitutions of some of the Pro residues in the all-Pro
pentadecameric peptide by non-Pro residues in VASP. Thus,
although the N-terminal portions of the two peptides super-
impose well, the chains diverge slightly after Ala 206, and
this effect becomes more pronounced after Leu 209 of the
VASP peptide. In about 50% of Ena/VASP sequences, Ala 206
is replaced by Pro (Supplementary Figure 1) and this sub-
stitution is unlikely to have any major effect in the general
conformation of the complex. However, Leu 209 is strictly
conserved and is also found in WASP (Supplementary Figure 1).
The role of this Leu residue appears to be twofold; it
determines the orientation of the C-terminal portion of the
loading poly-Pro region (toward actin), and also determines
the register and polarity of the interaction. As we demon-
strate next, these factors are in turn critical in defining the
position of the GAB domain C-terminal to the loading poly-
Pro site so that it can bind to actin.
Structure of profilin–actin bound to the loading
poly-Pro-GAB region of VASP
We had previously shown that profilin–actin binds the GAB
domain of VASP with higher affinity than actin alone, leading
to the proposal that profilin–actin complexes might transition
from the loading poly-Pro site to the GAB domain during
filament elongation (Chereau and Dominguez, 2006). We had
also proposed that the GAB domain is related to WH2 and
would therefore be expected to bind in the cleft between actin
subdomains 1 and 3 (Chereau et al, 2005). However, an
important question remained; the structures of WH2–actin
indicated that the binding sites for profilin and WH2 partially
overlap and a conformational change would be necessary if
the two were to bind actin simultaneously (Chereau et al,
2005). To test this hypothesis we determined the 1.5-A˚
resolution crystal structure of the ternary complex of profi-
lin—actin, with a 43-aa peptide comprising the loading poly-
Pro and GAB domains of human VASP (residues Gly 202–Ser
244) (Figure 4A). The length of the VASP peptide was defined
on the basis of the structures of the loading poly-Pro region
described above (Figure 3), and that of the WH2 of WASP
bound to actin (Chereau et al, 2005), ensuring that none of
the amino acids involved in interactions with profilin and
actin were excluded.
This ternary complex crystallized in a different space
group than that of the loading poly-Pro site (Table I), yet
the profilin–actin portions of the two structures are very
similar. Differences in three loops of actin (amino acids
199–203, 241–247 and 322–329) can all be attributed to
different crystal packing contacts. The electron density map
is generally very well defined, and includes two portions of
the VASP peptide, amino acids Gly 202–Ala 212 (loading poly-
Pro site) and Ala 222–Ser 238 (GAB domain) (Figures 4B and
C). The conformation and interactions of the loading poly-Pro
site are very similar to those described above (Figures 3C and
4B). The only noticeable difference is that in this structure the
loop Tyr 24–Pro 28 of profilin moves toward the peptide and
makes one additional hydrogen-bonding contact with it.
As anticipated, the GAB domain binds roughly at the same
site as the WH2 of WASP (Figure 4D). Both domains consist
of an N-terminal helix that binds in the cleft between actin
subdomains 1 and 3, and a C-terminal extended region that
binds along the actin surface, climbing toward the pointed
end of the actin monomer. Based on this observation, the
GAB domain of Ena/VASP can be unambiguously classified as
a WH2 domain. However, comparison of the structure with
those of WH2 and Tb domains determined in the absence of
profilin (Hertzog et al, 2004; Chereau et al, 2005; Lee et al,
2007) also reveals important differences. Thus, the helix of
the GAB domain is rotated B451 and shifted forward half a
helical turn (Figure 4D). These changes add to a displacement
of the GAB domain away from profilin, whereas profilin is
unaffected. It is unclear if these changes can all be attributed
to the presence of profilin, since the sequence of the GAB
domain contains some important differences compared to
classical WH2 domains. In particular, the helix of the GAB
domain is only two turns long, interrupted at the N-terminus
by a combination of Gly and Pro residues, whereas in most
Figure 3 Crystal structure at 1.8-A˚ resolution of the ternary com-
plex of profilin–actin with the loading poly-Pro site of human VASP.
(A) General view of the structure (actin, gray; profilin, cyan; VASP
peptide, all-atom representation). The view is rotatedB901 relative
to the ‘classical’ orientation of actin shown in Supplementary
Figure 3A. (B) Electron density map around the VASP peptide,
contoured at 1.0s. (C) Illustration of the main interactions of the
VASP peptide with profilin amino acids (colored red, under a
transparent surface representation of profilin).
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WH2s the helix is at least one turn longer and would be
expected to conflict with profilin (Figure 4D). Despite these
differences the interaction of the helix of the GAB domain
presents the same hydrophobic character as the helices of
other actin-binding proteins that commonly bind in this cleft
(Dominguez, 2004). Thus, VASP residues Leu 225 and Ile 229,
on the hydrophobic side of this helix, face the hydrophobic
cleft in actin (Figure 4E).
C-terminal to the helix of the GAB domain is the sequence
234LRKV237. This sequence, conserved in all members of the
Ena/VASP family (Supplementary Figure 1), corresponds to
the so-called ‘LKKT’ motif found in a number of actin-binding
proteins, including thymosin b (Hertzog et al, 2004), gelsolin
(Irobi et al, 2003) and WH2 (Paunola et al, 2002; Chereau
et al, 2005). The interactions of the LKKT motif with actin are
conserved in these proteins as well as in the GAB domain of
VASP. The most important element of this interaction is the
binding of VASP residue Leu 234 in a hydrophobic pocket on
the actin surface, surrounded by actin residues Ile 341 and Ile
345 (Figure 4E). In the current structure, as well as in the
structure of the WH2 of WASP (Chereau et al, 2005), the
amino acids C-terminal to the LKKT motif are disordered and
do not appear to interact with actin.
Also disordered in the structure is the linker between the
poly-Pro and GAB domains, not a surprising result given
the high content of Gly residues in this linker
(213QGPGGGGAG221). Since the VASP peptide is not observed
as a continuous chain, the possibility exists that two different
peptides are bound. However, this is unlikely since the
complex was crystallized using an actin–profilin peptide
stoichiometry of 1:1.1:1.1 (see Materials and methods), and
no traces of density are observed in the 1.5-A˚ resolution map
that would correspond to the significant unbound portions of
two peptides. Another possibility is domain swapping of the
VASP peptide between symmetry related molecules, although
again there is no direct evidence of this in the electron density
map. Nevertheless, none of these possibilities change the fact
that profilin–actin binds the poly-Pro and GAB domains
simultaneously in the structure. Furthermore, the missing
amino acids of the linker can be easily modeled along a
groove at the profilin–actin interface, so that they span the
distance between the two sites (Supplementary Movie 6).
Note also that GAB is followed by FAB, which tethers Ena/
VASP to the elongating filament, thereby directing the incor-
poration of profilin–actin from the poly-Pro-GAB onto the
barbed end of a specific filament (Figure 5).
Discussion
Two monomeric actin-binding proteins, profilin and thymo-
sin-b4, contribute to maintaining a large fraction (B50%) of
the cellular actin in the unpolymerized pool at a concentra-
tion (B20–100 mM) that is 200- to 1000-fold higher than the
critical concentration for barbed-end polymerization
(B0.1 mM) (Pollard and Borisy, 2003). While free ATP–actin
is present in low amounts (0.1–1 mM) and thymosin-b4–actin
is polymerization incompetent, profilin–actin (present at
5–40 mM intracellular concentration) constitutes the main
source of actin monomers for polymerization (Dickinson
and Purich, 2002; Dickinson et al, 2002). Multiple properties
allow profilin to play such a central role in filament assembly
(dos Remedios et al, 2003; Witke, 2004; Yarmola and Bubb,
2006); (1) profilin catalyzes the exchange of ADP for ATP on
actin, which replenishes the pool of ATP–actin monomers
Figure 4 Crystal structure at 1.5-A˚ resolution of the ternary complex of profilin–actin with the loading poly-Pro-GAB region of human VASP.
(A) General view of the structure (actin, gray; profilin, cyan). The two portions of the peptide visualized in the electron density map are colored
differently (corresponding to the colors used in Figures 1 and 3): poly-Pro, all-atom representation with carbon atoms in yellow and GAB in
magenta. The linker between these two sites is missing in the structure (represented by a discontinuous blue line), but can be modeled along
the proposed path (see also Supplementary Movie 6). (B, C) Electron density map contoured at 1.0s around the poly-Pro and GAB,
respectively. (D) Superimpositions of the structures of the GAB of VASP (magenta) and the WH2 of WASP (green) (Chereau et al, 2005). Only
the side chains of hydrophobic amino acids that interact with actin are shown. Note that the helix of the GAB is both shifted forward and
rotatedB451 relative to that of WH2, which is at least in part due to the presence of profilin in the current structure. The LKKT portions of the
two structures, however, superimpose well. (E) Illustration of the main interactions of the GAB (magenta) with hydrophobic amino acids
(green) of the cleft between actin subdomains 1 and 3.
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ready for polymerization, (2) it inhibits filament nucleation,
which explains in part the need for nucleation promoting
factors, (3) profilin-bound actin monomers cannot add to
pointed ends, but can elongate filament barbed ends at
approximately the same rate as free actin monomers, (4)
profilin competes effectively with thymosin-b4 for actin,
which is due to its greater affinity for actin than thymosin-
b4 and high dissociation constants of their respective com-
plexes with actin, and (5) profilin binds poly-Pro sequences
in various cytoskeletal proteins, including the Arp2/3 com-
plex activator WASP and the elongation factors Ena/VASP
and formin. Thus, recruitment of profilin–actin increases
the elongation rates of formin (Kovar et al, 2006) and
Ena/VASP-dependent Listeria motility (Chakraborty et al,
1995; Kang et al, 1997; Geese et al, 2000, 2002; Machner
et al, 2001; Auerbuch et al, 2003; Grenklo et al, 2003).
How filament elongation factors process profilin–actin for
its incorporation at the barbed end of the filament has
Figure 5 Model of filament elongation by Ena/VASP. (A) Ena/VASP tetramers are recruited to the sites of active filament assembly via
interactions of the EVH1 domain with FPPPP-containing scaffolding proteins such as zyxin (Reinhard et al, 1995b), vinculin (Brindle et al,
1996; Reinhard et al, 1996), lamellipodin (Krause et al, 2004), migfilin (Zhang et al, 2006) and palladin (Boukhelifa et al, 2004). These proteins
are connected to the plasma membrane directly or via interactions with membrane-binding scaffolding proteins (indicated by dashed arrows).
VASP tetramerization and tethering via the EVH1 domain are likely important for processivity in cells (see Discussion). The recruiting poly-Pro
site contains multiple profilin–actin binding modules, which may serve to increase the local concentration of actin monomers for assembly. It is
unclear if each subunit of Ena/VASP supports the elongation of one filament or, as shown in the figure, two subunits per filament are required
(one per each long-pitch helix). (B) Close view of the elongation machinery showing three steps of the elongation mechanism (indicated by
black arrows): (1) recruitment of profilin–actin to the poly-Pro regions, (2) loading of profilin–actin from the last poly-Pro site onto the GAB
domain and (3) filament elongation (red arrow) resulting from the addition of the actin subunit at the barbed end and the release of profilin.
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remained a mystery. A view commonly held is that the role of
the Pro-rich region of Ena/VASP (as well as formin) is to
increase the local concentration of profilin–actin available for
assembly (Kang et al, 1997; Geese et al, 2000; Machner et al,
2001; Dickinson and Purich, 2002; Grenklo et al, 2003; Kovar
et al, 2006). This work provides evidence for a more active
role of the Pro-rich region of Ena/VASP in elongation, by
directing the transition of profilin–actin to the GAB domain,
from where the actin monomer can join the barbed end of the
growing filament (Figure 5). Thus, we have shown here that
the Pro-rich region of Ena/VASP has a complex organization,
consisting of three discrete modules: the regulatory, recruit-
ing and loading poly-Pro sites (Figure 1). While the binding of
profilin to poly-Pro sequences of the kind found in the
recruiting site had been previously studied (Petrella et al,
1996; Kang et al, 1997), the loading site had not yet been
investigated. This site is particularly important since it is
highly conserved among all the members of the Ena/VASP
family and WASP, and is connected to the GAB domain by a
short Gly-rich linker (Supplementary Figure 1).
We found that the loading poly-Pro site binds profilin–
actin with significantly higher affinity than profilin alone
(Figure 2; Supplementary Figure 2). The implication of this
finding is that Ena/VASP has the ability to discriminate
between polymerization-competent profilin–actin complexes
and profilin alone, which could jam the elongation machin-
ery. We had previously reported that the GAB domain also
has higher affinity for profilin–actin than actin alone
(Chereau and Dominguez, 2006). Therefore, both the loading
poly-Pro and GAB domains have a clear preference for
profilin–actin. However, the two sites must cooperate, and
not compete, for the transfer of profilin–actin from the
cellular pool onto the barbed end of the elongating filament.
To test this hypothesis, we determined the high-resolution
structures of profilin–actin bound to the loading poly-Pro
(Figure 3) and poly-Pro-GAB of human VASP (Figure 4).
Among the main results of the structures are the following:
(1) the conformation of profilin–a-actin in the two structures
is very similar to that of profilin–b-actin determined pre-
viously (Schutt et al, 1993), (2) the presence of non-Pro
amino acids in the loading poly-Pro site, and in particular
Leu 209 that is conserved in Ena/VASP and WASP, define the
register, polarity and orientation of binding, (3) these factors
are in turn essential in determining the position of the GAB
domain, so that it can access its binding site on actin within
the profilin–actin complex, (4) the GAB domain is related to
the WH2 of WASP and makes similar interactions with actin,
(5) the GAB domain can bind actin concomitantly with
profilin, which requires significant repositioning compared
with WH2 domains crystallized in the absence of profilin,
and most importantly (6) the loading poly-Pro and GAB
domains of Ena/VASP do not compete for profilin–actin,
which they can bind simultaneously (Figure 4).
The structures do not provide clear insights as to why the
loading poly-Pro binds more tightly to profilin–actin
(Figure 2; Supplementary Figure 2). However, compared
with other actin structures, profilin produces a slight closure
of the cleft between subdomains 1 and 3, known as the target-
binding cleft (Dominguez, 2004), which may explain the
increased affinity of profilin–actin for the GAB domain ob-
served previously (Chereau and Dominguez, 2006). Another
possibility is the mutual stabilization of profilin and actin
within their complex, making the binding of both the GAB
and poly-Pro domains more favorable. This latter effect
appears to work both ways, since the affinity of actin for
profilin also increases when profilin is bound to the loading
poly-Pro peptide of VASP (Supplementary Figure 3).
What is the next step after profilin–actin has been recruited
to the loading poly-Pro and GAB domains? We would like to
suggest that the actin monomer bound to the GAB domain is
already in contact with the barbed end of the FAB-tethered
filament (Figure 5B). This idea is based strictly on structural
constraints imposed by the short length of the linker between
the GAB and FAB domains (Supplementary Figure 1), inde-
pendently of where on F-actin the latter binds. However, as
noted before (Chereau and Dominguez, 2006), the FAB
domain is related to the C region of WASP and the two appear
to be related to WH2. In other words, the GAB-FAB of Ena/
VASP is related to the WH2-C of WASP, a relationship that
extends at both ends to the loading poly-Pro and, to a lesser
extent, to the acidic region (Supplementary Figure 1). WH2
domains often occur in tandem repeats (Paunola et al, 2002)
and, if this proposal is correct, GAB-FAB and WH2-C con-
stitute specialized forms of tandem WH2 domains, involved
in filament elongation and Arp2/3 activation, respectively.
FAB would then be expected to bind in the cleft between
subdomains 1 and 3 of the last actin subunit at the barbed
end of the elongating filament. The transition of an actin
monomer from the GAB domain to the barbed end of the
elongating filament would then trigger a series of events,
including the release of profilin and the stepping of Ena/VASP
(Figure 5B).
What is the driving force of these events? The mechanism
proposed here is generally in agreement with the direct-
transfer polymerization model of Dickinson and Purich
(2002) (Dickinson et al, 2002). According to this model,
ATP hydrolysis by actin is the driving force for the processive
stepping of actin polymerization-based motors. However, the
precise role of ATP hydrolysis in elongation remains contro-
versial. While it has been suggested that ATP hydrolysis is
required for profilin dissociation (Romero et al, 2007), other
experiments show that filament elongation rates can exceed
the ATP hydrolysis rate by at least 20-fold (Blanchoin and
Pollard, 2002). Furthermore, phosphate dissociation after
hydrolysis is slow (Carlier and Pantaloni, 1986), implying
that a significant fraction of the filament consists of ADP-Pi-
actin, which is considered to be structurally and functionally
indistinguishable from ATP–actin (Pollard and Borisy, 2003).
Therefore, based on the evidence to date, it is unclear
whether ATP hydrolysis or a nucleotide-independent confor-
mational change due to the G- to F-actin transition triggers
profilin dissociation and Ena/VASP stepping.
How does this mechanism apply to all four subunits of the
full-length Ena/VASP tetramer? Although the core of the
elongation machinery consists of the poly-Pro-GAB-FAB re-
gion (Figure 5), it is very likely that all the domains of Ena/
VASP are necessary for processive elongation in cells (the
exception may be the motility of Listeria, which has evolved
different recruitment mechanisms). Ena/VASP tetramers are
recruited to sites of rapid assembly by interactions of the
EVH1 domains with FPPPP-containing proteins such as zyxin
(Reinhard et al, 1995b), vinculin (Brindle et al, 1996;
Reinhard et al, 1996), lamellipodin (Krause et al, 2004),
migfilin (Zhang et al, 2006) and palladin (Boukhelifa et al,
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2004). Filaments associated with Ena/VASP tend to be
unbranched, longer and form crosslinked bundles (Skoble
et al, 2001; Bear et al, 2002; Svitkina et al, 2003). A tetramer
may be more efficient at generating such actin bundles, in
particular if the subunits of Ena/VASP work cooperatively,
both within and between neighboring tetramers. But more
importantly, tetramerization via the CC domain and tethering
via the EVH1 domain may enable Ena/VASP to hold on to a
particular filament during processive stepping, by sequen-
tially allowing each subunit to release and advance while the
others remain attached. Consistent with this idea, recent
evidence shows that all the domains of Ena/VASP are re-
quired for proper localization and continued polymerization
at filopodial tips (Applewhite et al, 2007). In particular, the
GAB domain was found to play a key role in maintaining
filopodial tip localization, which is consistent with recent
evidence that the WH2 of N-WASP transiently tethers actin
filament to the membrane (Co et al, 2007).
Many questions will require further investigation. For
instance, it is unclear whether a single subunit of Ena/VASP
can support the elongation of a whole filament, or whether
two subunits per filament are required (one for each of the
long-pitch helices of the filament). It is also possible that
cycles of elongation by Ena/VASP alternate with short periods
of depolymerization, or backward steps. Finally, we have
stressed here the striking resemblance between the loading
poly-Pro-GAB-FAB of VASP and the equivalent region in WASP
(Supplementary Figure 1). Some of the results obtained here
may therefore be applicable to WASP-Arp2/3-mediated
branch nucleation. However, there also are important differ-
ences, notably that the helix of WH2 is longer than that of the
GAB domain (Figure 4D), which may preclude the transfer of
profilin–actin from the last poly-Pro of WASP to WH2.
Materials and methods
Preparation of proteins and peptides
The cDNA encoding for human profilin I was purchased from ATCC,
amplified by PCR and inserted into vector pET29/T7 (Novagen).
BL21(DE3) competent cells (Invitrogen) were transformed with this
constructs and grown in LB medium at 371C until the OD at 600nm
reached a value of 0.6. Expression was induced by the addition of
1mM isopropyl-b-D-1-thiogalactopyranoside and carried out for 4h at
371C. Cells were harvested by centrifugation, resuspended in 10mM
Tris pH 7.5, 100mM glycine, 100mMNaCl, 1mM DTTand lysed using
a French press. The soluble lysate was purified on an affinity poly-L-
proline sepharose column. Profilin was eluted from the column using
30% (v/v) DMSO, dialysed against 10mM Tris pH 7.5, 50mM NaCl
and concentrated to B14mg/ml. Actin was prepared from rabbit
skeletal muscle as described (Graceffa and Dominguez, 2003).
Peptides corresponding to human VASP residues 198–213 (loading
poly-Pro) and 202–244 (loading poly-Pro and GAB domain) were
synthesized on an ABI431 peptide synthesizer and purified by
HPLC (see Supplementary Figure 1 for sequence information). The
concentrations of the peptides were determined by amino-acid
analysis (Dana-Farber Cancer Institute, Boston, MA, USA).
Crystallization, data collection and structure determination
The complexes of profilin–actin with the two VASP peptides were
prepared by mixing 66 mM actin in G-buffer (2mM HEPES pH 7.4,
0.2mM CaCl2 and 0.2mM ATP) with 73mM profilin (in 10mM Tris
pH 7.5, 50mM NaCl), followed by the addition of 73mM VASP
peptide (same buffer as profilin). The complexes were stored on ice
and used at this concentration during crystallization trials at 4 and
201C. The best crystals of profilin–actin with the loading poly-Pro
peptide were obtained at 41C in 4ml sitting drops, consisting of a 1:1
(v/v) mixture of protein solution with 200mM sodium formate
and 20% (w/v) PEG 3350 well solution. The best crystals of
profilin–actin with the poly-Pro-GAB peptide were obtained at 41C
in 3ml sitting drops, consisting of a 1:2 (v/v) mixture of the protein
solution with 150mM DL-malic acid pH 7.0 and 18% (w/v) PEG
3350 well solution. The crystals were flash-frozen in liquid
nitrogen, using 20% glycerol as cryoprotectant. X-ray data sets
were collected at the BioCARS beamline 14-BM-C (Advance Photon
Source, Argonne, IL, USA). The data sets were indexed and scaled
with program HKL-2000 (HKL Research Inc.). The structures were
determined by molecular replacement using the CCP4 program
AMoRe and the structure of profilin–b-actin (Schutt et al, 1993) as a
search model. Model building and refinement were performed with
the program Coot (Emsley and Cowtan, 2004) and CCP4 program
Refmac (Table I).
Binding of VASP peptide measured by tryptophan
fluorescence
Binding of the loading poly-Pro peptide of human VASP to profilin
and profilin–actin was measured by the change of intrinsic
tryptophan fluorescence using a Cary Eclipse Fluorescence spectro-
photometer (Varian). The excitation wavelength was set to 295 nm
and the emission spectra were recorded from 300 to 400nm. The
experiments were performed at 201C in 10mM sodium phosphate
pH 7.4 and 150mM NaCl. The concentration of profilin and
profilin–actin in the cell was 5 mM. The VASP peptide was added at
varying concentrations (0, 0.15, 0.30, 0.6, 1.25, 2.5, 5, 10, 20, 40,
80, 160 and 320mM). Each data point represents the average of five
independent measurements (Figure 2). Least-square fitting of the
data, using a single-site binding model, resulted in dissociation
constant (KD) estimates of 84 and 7.5mM for profilin and profilin–
actin, respectively.
Binding of VASP peptide measured by ITC
Binding of the VASP peptide to profilin and profilin–actin was
also measured using ITC on a VP-ITC instrument (MicroCal,
Northampton, MA, USA). To determine DH and Ka of association,
the VASP peptide, at a concentration of 1mM, was titrated in 10-ml
injections, into 1.44ml of 100mM profilin (or 80 mM profilin–actin).
The experiments were all performed at 251C in 10mM sodium
phosphate pH 7.4 and 150mM NaCl. The duration of each injection
was 10 s, with an interval of 3min between injections. The heat of
binding was corrected for the small exothermic heat of injection,
determined by injecting VASP peptides into buffer. Data were
analyzed using the MicroCal’s Origin program.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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SUMMARY
The adaptor protein missing-in-metastasis
(MIM) contains independent F- and G-actin
binding domains, consisting, respectively, of
an N-terminal 250 aa IRSp53/MIM homology
domain (IMD) and a C-terminal WASP-homol-
ogy domain 2 (WH2). We determined the crystal
structures of MIM’s IMD and that of its WH2
bound to actin. The IMD forms a dimer, with
each subunit folded as an antiparallel three-
helix bundle. This fold is related to that of the
BAR domain. Like the BAR domain, the IMD
has been implicated in membrane binding.
Yet, comparison of the structures reveals that
the membrane binding surfaces of the two
domains have opposite curvatures, which may
determine the type of curvature of the interact-
ing membrane. The WH2 of MIM is longer than
the prototypical WH2, interacting with all four
subdomains of actin. We characterize a similar
WH2 at the C terminus of IRSp53 and propose
that in these two proteins WH2 performs a
scaffolding function.
INTRODUCTION
Missing-in-metastasis (MIM) and insulin receptor tyrosine
kinase substrate p53 (IRSp53) form part of a new family
of actin cytoskeleton adaptor proteins (Bompard et al.,
2005; Funato et al., 2004; Miki et al., 2000; Woodings
et al., 2003). Like most actin binding proteins, MIM and
IRSp53 are multidomain proteins, containing protein-
protein interaction modules, involved in signaling and lo-
calization, and structurally conserved actin bindingmotifs.
A gene coding for a 356 aa C-terminal fragment of MIM
was originally isolated using mRNA differential display,
and this fragment was identified as a protein whose
expression appeared to be downregulated in certain
bladder cancer cell lines (Lee et al., 2002). Full-length
MIM was subsequently cloned and shown to contain
759 aa (Woodings et al., 2003). Although it was initially
proposed that MIM might function as a metastasis sup-
pressor protein (Lee et al., 2002), this role has not been
confirmed (Bompard et al., 2005; Nixdorf et al., 2004). In-
stead, MIM seems to play a role in cytoskeleton remodel-
ing (Lin et al., 2005; Mattila et al., 2003; Yamagishi et al.,
2004), possibly downstream of tyrosine kinase signaling
(Gonzalez-Quevedo et al., 2005; Woodings et al., 2003)
and Rho-family GTPases (Bompard et al., 2005). MIM
localizes to areas of dynamic actin assembly, and its over-
expression induces the formation of actin-rich protrusions
resembling surface ruffles and microspikes (Woodings
et al., 2003). MIM has also been identified as a sonic
hedgehog inducible protein that potentiates Gli transcrip-
tion (Callahan et al., 2004).
MIM is a modular protein (Figure 1A). Its actin binding
function can be attributed to two spatially separated
actin-binding domains: an N-terminal 250 aa IRSp53/
MIM homology domain (IMD) (Yamagishi et al., 2004)
and a C-terminal 30 aa WASP-homology domain 2
(WH2) (Mattila et al., 2003). The 475 aa central region
sandwiched in between these two actin-binding domains
is rich in Pro, Ser, and Thr residues. This region appears to
play regulatory/scaffolding roles; it binds receptor protein
tyrosine phosphatase d (RPTPd) (Gonzalez-Quevedo
et al., 2005;Woodings et al., 2003), the transcription factor
Gli and the tumor suppressor Sufu (Callahan et al., 2004),
and the SH3 domain of cortactin (Lin et al., 2005), a protein
implicated in the nucleation and stabilization of Arp2/3-
mediated filament branches (Uruno et al., 2001; Weaver
et al., 2001).
The relationship between MIM and IRSp53 first
emerged from the discovery that the two proteins share
similar N-terminal IMDs, an actin-binding domain that
has also been implicated in actin bundling (Yamagishi
et al., 2004). Like MIM, IRSp53 is an adaptor protein that
plays a role in actin cytoskeleton remodeling by linking
Rho-family GTPases, such as Rac and Cdc42, to effector
proteins, such as Mena (Krugmann et al., 2001) and the
Arp2/3 complex activator protein WAVE (Miki et al.,
2000). The crystal structure of the IMD of IRSp53 has
been determined, consisting of a dimer, with each subunit
forming an extended four-helix bundle (Millard et al., 2005).
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Here we describe the crystal structures of the IMD of
MIM and that of its WH2 bound to actin. Despite low
sequence similarity, the IMDs of MIM and IRSp53 are
structurally similar and, therefore, may bind actin and
Rac in a similar fashion. The structure of the IMD is gener-
ally related to that of the BAR (Bin-Amphiphysin-Rvs)
domain, a fold involved in membrane binding (Peter
et al., 2004). However, the overall shape of the two
domains is markedly different, which probably explains
their different roles in membrane curvature sensing. The
WH2 of MIM is unusual, both because of its localization
in the protein and the way in which it interacts with actin.
We characterize a similar WH2 in IRSp53, further expand-
ing the relationship between these two adaptor proteins.
Figure 1. Crystal Structure of the IMD of Mouse MIM
(A) Schematic representation of MIM (yellow/blue, IMD; purple, middle regulatory/scaffolding region; red, WH2).
(B) Ribbon representation of the structure of the IMD dimer (figure made with the program PyMOL, http://www.pymol.org). The two subunit of the
dimer are colored blue and yellow. Helices 1 to 3 of each subunit are labeled H1, H2, and H3. Also shown is a sequence alignment corresponding
to the conserved basic cluster at the symmetric ends of the IMD dimer (highlighted cyan in one of the subunits of the structure). In this alignment,
red, blue, and green represent negatively charged, positively charged, and hydrophobic conserved amino acids, respectively. Accession numbers
are: MIM_MOUSE, Q8R1S4;MIM_HUMAN, O43312; ABBA_HUMAN, Q765P7; IRSp53_HUMAN, Q9UQB8. Red arrows point to amino acids Leu 145
and Leu 147, which were mutated in this study.
(C) Slice cut through the middle of the molecular surface of the IMD dimer revealing the interior cavity.
(D) Close-up view of the ‘‘flap’’ loop between helices 3 and 4 that covers the ‘‘signature sequence’’ (Yamagishi et al., 2004) of the IMD, which is
a charged and conserved sequence that is buried in the structure (red colored area of helix 3).
(E) Superimposition of the structures of the IMDs of MIM and IRSp53. The two structures were superimposed based on the best overlapping central
region (amino acids 26–68, 72–110 and 24–66, 69–107 of both chains of MIM and IRSp53, respectively). The view is as in (B) and Figure 3. This ori-
entation highlights the differences between the A chains of the two proteins (blue). Although not well seen from this angle, similar differences occur
between the B chains (yellow). Notice that helix 4 of the IMD of IRSp53 is missing in MIM.
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RESULTS
Structure of the IMD of MIM
The crystal structure of the IMD of MIM (N-terminal
250 amino acids) was determined to 1.85 A˚ resolution,
by using the single anomalous dispersion method and
X-ray data collected from a Se-Met-substituted crystal
(Experimental Procedures and Table 1). The IMD forms
a dimer (Figure 1B). The structure is well defined in the
electron density map, except for three areas, which are
disordered: the last six amino acids of chain A, the last
eight amino acids of chain B, and amino acids Asp
155 to Ser 168 of chain B. The electron density map also
reveals three amino acids from the expression vector
(Ala-Gly-His) at the N-terminal ends of both chains.
Each chain is folded as an extended (!135 A˚) antiparal-
lel three-helix bundle (Figure 1B). The two subunits in the
dimer are oriented opposite to one another and interact
extensively. Thus, the contact area between subunits is
2941 A˚2 (calculated with CCP4 program AreaIMOL, using
a 1.4 A˚ probe). The six helices that comprise the IMD
dimer form a twisted ellipsoid !183 A˚ in length and
!30 A˚ in diameter (at the widest point). Despite extensive
contacts between adjacent helices, the IMD cannot be
classified as a coiled-coil structure. Indeed, an analysis
of the structure using the program Socket (Walshaw and
Woolfson, 2001) reveals that there exist short, scattered
regions of coiled-coil between pairs of helices, but not
a single region of the six-helix bundle displays the classi-
cal knobs-into-holes layer extending through all the
helices.
The dimer features a sizable 1396 A˚3 (calculated with
the program Swiss-PDB using a 1.4 A˚ probe) cavity in
the middle (Figure 1C). This cavity contains a number of
water molecules. Although the side chains that are di-
rected toward the cavity are predominantly hydrophobic,
a number of polar amino acids, including Thr 47, His 86,
Glu 213, and Glu 195, also point toward this cavity. These
Table 1. Crystallographic Data and Refinement Statistics
IMD
WH2 High-Resolution Se-Peak
Diffraction Statistics
Space group P 21 21 21 P 21 P 21
Cell parameters
a, b, c (A˚) 42.1, 75.5, 229.0 53.5, 37.3, 129.0 53.5, 37.3, 128.9
a, b, g (") 90.0, 90.0, 90.0 90.0, 94.07, 90.0 90.0, 94.08, 90.0
Resolution
Total (A˚) 41.4–2.5 48–1.85 48–2.1
Highest shell (A˚) 2.59–2.5 1.92–1.85 2.17–2.1
Completeness (%) 88.7 (80.1) 98.7 (86.7) 99.4 (99.1)
Redundancy 8.9 (5.1) 10.7 (4.5) 6.8 (6.5)
Unique reflections 23,589 (2,069) 43,479 (3,873) 30,686 (3,335)
R mergea (%) 7.2 (23.2) 5.7 (38) 8.6 (33.3)
Average I/s 25.8 (7.2) 30.4 (3.6) 11.8 (3.5)
Refinement Statistics
R factorb (%) 21.7 18.4
R freec (%) 28.4 22.9
Rms deviations
Bond length (A˚) 0.012 0.014
Bond angles (") 1.38 1.13
Average B factor
Protein atoms (A˚2) 59.1 33.2
Solvent atoms (A˚2) 43.7 39.9
PDB code 2D1K 2D1L
Values in parentheses correspond to highest resolution shell.
a R merge=S(I # <I>)/SI; I and <I> are the intensity and the mean value of all the measurements of an individual reflection.
b R factor=SjFo # Fcj/S jFoj; Fo and Fc are the observed and calculated structure factors.
c R free; R factor calculated for a randomly selected subset of the reflections (5%) that were omitted during the refinement.
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amino acids are involved in interactions among them.
Thus, the Og of Thr 47 of one chain is hydrogen bonded
to the same atom from the other chain. Similarly, Glu
213 and Glu 195 of one chain form salt bridges with His
86 and Arg 69 from the other chain.
The structure of the IMD of IRSp53 has also been deter-
mined (Figure 1E) (Millard et al., 2005). The fact that this
structure could not be used as a molecular replacement
model to determine the current structure suggested from
the beginning that important differences were to be ex-
pected. Indeed, an alignment of the sequences based
on a superimposition of the structures reveals that the
IMDs of MIM and IRSp53 share only !19.3% sequence
identity, and although generally similar, the structures su-
perimpose with a relatively large rms deviation of 2.8 A˚.
The differences remain important within the core (or mid-
dle) region (rms deviation 1.64 A˚), defined as the region
where the two subunits of the dimer overlap (MIM residues
22–119 and 192–235). However, the two structures differ
more significantly toward the N- and C termini and the dis-
tal ends of the ellipsoid (corresponding to the loop be-
tween helices 2 and 3). These differencesmay be ascribed
mainly to increased flexibility in these regions, since the
identical molecules that form the IMD dimers also display
large rms deviations (2.0 A˚ for MIM and 1.5 A˚ for IRSp53).
The IMD of IRSp53 presents a short helix at the C ter-
minus (helix 4). In the structure of MIM’s IMD, only one turn
of this helix is observed for chain A (Figure 1E), whereas
the helix is fully missing in chain B, possibly due to local
disorder in the structure (Figure 1B). In contrast, the loop
Thr 234–Ser 242 preceding helix 4 (Figure 1D) is well de-
fined in the electron density map for both chains. The con-
formation of this loop is very similar between the two
chains of MIM, as well as between the two chains of
IRSp53. However, the conformation of the loop differs
quite significantly between the two proteins, which may
have functional implications. This loop forms a ‘‘flap’’
that covers the so-called signature sequence of the IMD
(Yamagishi et al., 2004) of the other molecule in the dimer
(Figure 1D). The signature sequence, EER[R/G]R (MIM
residues Glu 194–Arg198), is located within helix 3. MIM
presents a Gly at the fourth position of this motif, whereas
a bulkier residue (Arg 192) at this position in IRSp53 is di-
rected toward the flap loop and affects its conformation.
Another important difference is that a putative disulfide
bond in IRSp53 (Millard et al., 2005), between Cys 195
of the signature sequence and Cys 230 of the flap loop,
is missing in MIM, which lacks the latter Cys (correspond-
ing to Thr 234 in MIM).
Because the signature sequence forms part of a helix,
some of the charged amino acids in this sequence are
directed inward, while others are covered by the flap loop
(Figure 1D). As a result, MIM amino acidsGlu 195, Arg 196,
and Arg 198 are all buried in the structure and make elec-
trostatic contacts with main chain atoms, as well as a salt
bridge between Glu 195 of one chain and Arg 69 of the
other chain. Charged amino acids are rarely buried, and
their occurrence typically points to important regions of
the structure. The occurrence of buried and charged
side chains within the signature sequence and the interac-
tion with the ‘‘flap’’ loop, which connects the IMD to other
domains of the protein, suggest an important role for this
region of the IMD, possibly in the control or protein-protein
interactions involving the IMD.
Actin-Binding and -Bundling Activities
of the IMD of MIM
The IMD was originally described as an actin-binding
and -bundling domain (Yamagishi et al., 2004). However,
the ability of the IMD of humanMIM to bundle actin in vitro
has lead to conflicting results, ranging from significant
bundling (Bompard et al., 2005) to weak (Yamagishi
et al., 2004) or no bundling activity (Gonzalez-Quevedo
et al., 2005). We decided to test the actin-binding
and -bundling activities of the IMD of mouse MIM, which
presents a four amino acid insert (154VDAQ157) (Mattila
et al., 2003) near what has been described as the actin-
binding site (Bompard et al., 2005; Millard et al., 2005).
F-actin binding by the IMD of mouse MIM was confirmed
using a high-speed cosedimentation experiment (Fig-
ure 2A and Experimental Procedures). A similar experi-
ment, carried out at varying IMD concentrations, resulted
in a Kd estimate of!17 mM (Figure 2B). This value is similar
to that obtained for IRSp53 (5 mM) (Millard et al., 2005).
A cluster of basic amino acids at the distal ends of the
IMD dimer has been implicated in actin binding in
IRSp53 (Millard et al., 2005). Although mutations of indi-
vidual amino acids in this cluster had no effect in actin
binding, a construct where Lys residues 142, 143, 146,
and 147 were simultaneously mutated to Glu showed
somewhat reduced actin binding (10 mM versus 5 mM
for the wild-type IMD) (Millard et al., 2005). This result
was interpreted as evidence that the basic cluster is
involved in actin binding. However, the change in binding
affinity appears minor, in particular considering the effect
that a substitution of four positive charges by negative
charges could have on the general stability and electro-
static properties of the IMD dimer. The IMD of MIM also
presents positively charged clusters at the extremes of
the dimer (Figure 3A), featuring a total of ten positively
charged side chains in the region between Lys 131 and
Lys 153 (Figures 1B). The same group reported a similar
reduction in the actin binding affinity of MIM’s IMD when
Lys residues 149, 150, 152, and 153 in this cluster were
simultaneously replaced by Asp (Bompard et al., 2005).
Amino acids Ile 137, Leu 145, and Leu 147 (equivalent to
IRSp53 Leu 134, Lys 142, and Leu 144) are the only hydro-
phobic amino acids within the basic cluster of MIM
(Figure 1B). While Ile 137 is buried in the structure, Leu
147 is partially exposed and Leu 145 is fully exposed.
Given the general importance of hydrophobic amino acids
in protein-protein recognition (Jones and Thornton, 1996),
we decided to mutate these two Leu residues. Ten muta-
tions were generated, with both leucine residues being
replaced individually to Ala, Trp, Arg, and Glu, and simul-
taneously to Ala or Trp. Thesemutations were designed to
change the electrostatic character of the basic patch, as
well as to increase or reduce the size of the two exposed
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hydrophobic side chains within this area. In addition, we
expected these mutations to alter the local conformation
of the basic patch, and thereby actin binding. To our
surprise, none of the mutations affected actin binding sig-
nificantly (Figure 2C). More importantly, the double muta-
tions did not contribute additively to a lesser actin-binding
efficiency. These results, which are quantitatively similar
to those obtained for IRSp53 (Millard et al., 2005), suggest
that the basic cluster is unlikely to form amajor (or a single)
actin-binding site. Thus, although the actin-binding inter-
face appears to involve the region around the basic clus-
ter, other parts of the IMD are most likely also involved.
Note further that the structurally related BAR domain
(see below) presents a similar cluster of basic amino acids
at the distal ends of the dimer (Peter et al., 2004), and yet
the BAR domain is not typically implicated in actin binding.
Instead, the basic cluster of the BAR domain binds nega-
tively charged phospholipid membranes (Peter et al.,
2004). Similarly, the basic cluster of the IMD has been
recently implicated in membrane binding (Suetsugu
et al., 2006).
We further tested the ability of the IMD of MIM to bundle
actin at physiological salt concentration. First, the quality
of F-actin for this experiment was checked using low-
speed sedimentation (10,000 3 g) and rotary-shadowing
electron microscopy, to guarantee that no bundles were
formed in the absence of the IMD. In contrast with two
previous reports (Bompard et al., 2005; Yamagishi et al.,
2004), we found that the IMD of MIM did not bundle F-
actin under any of the conditions tested (Figure 2D and
Figure 2. Testing the Actin Binding and Bundling Activities of the IMD of MIM
(A) Purified IMD (left panel) and high-speed F-actin binding assay (right panel). 10 mM aliquots of IMD were ultracentrifuged at 400,000 3 g in the
presence (+) and the absence (!) of 5 mM F-actin. Equal aliquots of supernatant (S) and pellet (P) were analyzed on a SDS-PAGE gel.
(B) Quantification of the F-actin binding affinity of the IMD. 2 mMF-actin aliquots were incubated with increasing amounts of IMD (0, 1, 2, 4, 6, 8, 10, 15,
and 20 mM) and analyzed on gel as in (A). Each point corresponds to the average densitometric reading of three independent experiments. The line
represents the best fit of the data to the Michaelis-Menten equation.
(C) High-speed cosedimentation analysis of IMDmutants. 10 mMaliquots of eachmutant were incubatedwith 5 mMF-actin and analyzed on gel (upper
panel). The percentage of F-actin-bound IMDwas calculated as the IMD fraction in pellet. Before each experiment the mutants were ultracentrifuged
at 400,0003 g to eliminate potential aggregates. The lower panel illustrates the percentage of bound (empty bars) versus unbound (black-filled bars)
mutants from three independent experiments.
(D) Low-speed analysis of the F-actin bundling activity of the IMD. 5 mMF-actin was centrifuged at 10,0003 g in the absence (!) and the presence (+)
of 10 mMwild-type IMD, and the supernatant (S) and pellet (P) were analyzed on gel (upper panel). F-actin stays in the supernatant, indicating the lack
of bundling activity. This result was confirmed by experiments carried out at increasing ratios IMD to F-actin (1, 2, 4, 6, 8, 10) (lower panel).
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Experimental Procedures). This result is in agreement,
however, with another report that a slightly longer MIM
construct (amino acids 1–277) showed markedly reduced
bundling activity compared to the full-length protein
(Gonzalez-Quevedo et al., 2005). The disagreement
between different laboratories concerning the bundling
activity of the IMD may have resulted from nonspecific
aggregation of the IMD at low ionic strengths, or the use
of F-actin preparations that appear to sediment even in
the absence of the IMD construct.
However, it could be also questioned whether the IMD
construct studied here is dimeric in solution. To answer
this question, we determined the molecular mass of the
IMD in solution using multi-angle light scattering com-
bined with particle separation by asymmetric field flow
fractionation (Figure S1 and legend; see the Supplemental
Data available with this article online). The molar mass of
the elution peak determined by this method was 56.7 ±
3.4 kDa, which is in excellent agreement with the expected
theoretical mass of the dimer (56.3 kDa). Combined, the
lack of bundling activity and the finding that the IMD is a di-
mer in solution would suggest that the actin binding sur-
face of the IMD spans over the two subunits of the dimer.
Structure of the WH2 of MIM Complexed with Actin
MIM presents a second actin-binding site at the C termi-
nus, consisting of a WH2 domain (Mattila et al., 2003).
We made a synthetic peptide corresponding to this
WH2, comprising amino acids Asp 724 to the C terminus
(Ser 755) of human MIM. With the exception of the first
two amino acids, which display conservative mutations,
this sequence is identical to that ofmouseMIM (Figure 4A).
The crystal structure of this WH2 (Figure 4B) was deter-
mined as a ternary complex with actin-DNase I. DNase I,
which was necessary in order to prevent actin polymeriza-
tion during crystallization, does not appear to have a signif-
icant effect on the actin-binding affinity of WH2 (Chereau
et al., 2005), andmakes no contacts with theWH2 peptide
in the current structure. However, the last two amino acids
of the peptide (Phe 754 and Ser 755) are disordered in the
structure, and we cannot distinguish whether this is due to
a local effect of DNase I, or that these amino acids do not
normally interact with actin and therefore become disor-
dered. Also disordered in the structure is the first amino
acid of the WH2 peptide, which does not appear to be im-
portant for actin binding, since the interactions with actin
start after residue Gly 728 of the WH2 peptide.
The structure of the WH2 of MIM can be conceptually
subdivided into two parts, an N-terminal amphiphilic helix,
comprising amino acids Gly 728 to Gly 738, and aC-termi-
nal extended region from Val 739 to Arg 753 (Figure 4B).
As previously shown (Chereau et al., 2005), the most im-
portant contribution to the interaction with actin comes
from the N-terminal helix that binds in the hydrophobic
cleft between actin subdomains 1 and 3. In the current
structure, amino acids Met 731, Leu 732, and Ile 735, on
the hydrophobic side of this helix, are embedded within
the hydrophobic cleft in actin (Figure 4B). The extended
portion of theWH2 ofMIM follows a path alongside the ac-
tin surface, climbing to the top of actin subdomains 2 and
4. Amino acids Val 739 and Leu 741 within this region bind
in a hydrophobic pocket on the actin surface formed by
amino acids Ile 341, Ile 345, and Leu 349. Residue Leu
741 of the WH2 peptide forms part of the canonical
LKKT sequence, found in other actin-binding proteins,
such as thymosin b4 (Paunola et al., 2002) and the linker
region between gelsolin domains 1 and 2 (Irobi et al.,
2003). Interestingly, the two Lys residues of this canonical
sequence bind atop actin residues Asp 24 and Asp 25, but
interact with actin only via main chain atoms. Thus, the
main-chain nitrogen and oxygen atoms of Lys 742 are
hydrogen bonded to the oxygen and nitrogen atoms of
actin residues Gly 23 and Asp 25, respectively. The other
important element of the interaction for this part of the
WH2 peptide involves the segment Thr 746 to Arg 749,
which is incorporated as an additional b strand into
a b sheet in actin subdomain 1 (running parallel to actin
b strand Arg 28 to Phe 31). Finally, Arg 749 of the WH2
Figure 3. Structural and Functional Relationship between the
IMD and BAR Domains
(A) Electrostatic surface representation of the IMD dimer calculated
with the program APBS (Baker et al., 2001) and displayed with the pro-
gram PyMOL (http://www.pymol.org). Red and blue indicate nega-
tively and positively charged regions, respectively (red, !6 kTe!1;
blue +6 kTe!1). Note the positively charged and slightly convex sur-
face, which is thought to mediate the interactions with membranes
of the IMD (Suetsugu et al., 2006).
(B) Similar electrostatic representation of the BAR domain of amphi-
physin (Peter et al., 2004). The orientation is the same as in (A). Note
that the shape of the positively charged membrane binding surface
of the BAR domain is concave.
(C) Superimposition of the structures of the IMD of MIM (blue, yellow)
with that of the BAR domain of arfaptin complexed with Rac (Tarricone
et al., 2001) (gray). The orientation is the same as in (A) and (B). The two
folds have different curvatures, but superimpose well in the middle
section where the dimers overlap, suggesting that this region may
also mediate the binding of Rac in MIM and IRSp53.
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peptide forms a salt bridge with actin residue Glu 93. The
remaining portion of WH2 extends across the cleft be-
tween actin subdomains 2 and 4, and appears to interact
only weakly with actin, which is consistent with the limited
contribution of this portion of WH2 to the actin binding
affinity (Chereau et al., 2005).
An Alternatively Spliced WH2 at the C Terminus
of IRSp53
IRSp53 is another actin cytoskeleton adaptor protein,
which like MIM presents an N-terminal IMD. Six isoforms
of IRSp53 have been identified. In addition to the IMD,
all six isoforms present identical CRIB, SH3, andWW pro-
tein-protein interaction modules. The differences between
isoforms occur at the C termini. Two of the isoforms pres-
ent a C-terminal extension consisting of a PDZ binding
sequence (Soltau et al., 2004), another two present
WH2-related extensions, and the remaining two appear
to have no functionally identifiable extensions. The WH2
of IRSp53 is unusual (Figure 4A). While the C-terminal
portion of this WH2 is nearly identical to that of MIM, the
N-terminal helix, known to play a critical role in actin bind-
ing (Chereau et al., 2005), has a noncanonical sequence.
Indeed, the periodicity of hydrophobic amino acids in
the segment corresponding to the helix is altered, and
there are conserved Pro and Gly residues in this region,
which could prevent the formation of a helix. In addition,
one of the Lys residues in the canonical LKKT sequence
is replaced by Pro in IRSp53 (Figure 4A). Taken together,
these observations raised doubts about the capacity of
this WH2 to bind actin. We decided to study the binding
of this WH2 to actin using ITC (Figure 4C). A peptide cor-
responding to theWH2 of human IRSp53 isoform 2, amino
acids Gly 506 to Ser 534, was synthesized (Figure 4A). The
actin-binding affinity of this peptide (Kd = 0.28 mM) was
found to be surprisingly similar to that measured previ-
ously by us under identical conditions for the WH2 of
MIM (Kd = 0.23 mM) (Chereau et al., 2005). Therefore, we
conclude that, like MIM, certain isoforms of IRSp53 pres-
ent two independent actin-binding domains at the N- and
Figure 4. The WASP-Homology Domain 2 of MIM and IRSp53
(A) Comparison of a classical WH2 (represented by WASP, Wiskott-Aldrich syndrome protein) with the WH2s of MIM, ABBA, and IRSp53. Red, blue,
green, and yellow correspond to negatively charged, positively charged, hydrophobic, and small (Thr, Val, Ser, Ala) conserved amino acids, respec-
tively. The diagram above the sequences represents a secondary structure assignment based on the structure determined here (cylinder, a helix;
arrow, b strand). Accession numbers are as in Figure 1, and WASP_HUMAN, P42768. Red arrows point to noncanonical amino acids present in
the WH2 of IRSp53.
(B) Structure of theWH2 of MIM (red ribbon) bound to actin (gray surface). Numbers 1–4 indicate actin’s four subdomains. The side chains of some of
the amino acids involved in interactions with actin are shown (green, hydrophobic; blue, positively charged).
(C) Binding of the WH2 of IRSp53 to actin measured by ITC. The upper graph corresponds to the heat evolved upon repeated 10 ml injections of
a 100 mM solution of the WH2 peptide into a 10 mM solution of actin in G buffer. The lower graph shows the binding isotherm produced by integration
of the heat for each injection. The line represents a nonlinear least squares fit to the data using a single-site binding model. The following thermody-
namic parameters were determined from the fitting: dissociation constant Kd = 0.28 ± 0.04 mM; molar enthalpy DH = !7.2 ± 0.1 kcal.mol!1; and
stoichiometry n = 0.9.
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C-terminal ends, which in both proteins enclose a large
central region featuring various protein-protein interaction
modules.
DISCUSSION
The IMD of MIM is an all a-helical structure, which dimer-
izes to form a twisted ellipsoid !183 A˚ in length, with
a large cavity in the middle (Figure 1). Despite low
sequence similarity, the structures of the IMDs of MIM
and IRSp53 (Millard et al., 2005) are generally similar.
The loop following helix 3 of MIM’s IMD forms a ‘‘flap’’
that covers the so-called ‘‘signature sequence’’ of the
IMD, a conserved and charged sequence that is conspic-
uously buried in the structure (Figure 1D).
While we were able to confirm that the IMD binds F-
actin with !17 mM affinity (Figures 2A and 2B), we found
that the symmetric patches of basic amino acids at the
distal ends of the dimer (Figure 3A) play only a limited
role in this interaction (Figure 2C). Furthermore, the IMD
is also a dimer in solution (Figure S1), but it does not bun-
dle actin (Figure 2D), as would have been expected if the
symmetric ends of the dimer were solely responsible for
actin binding. If, as previously suggested (Yamagishi
et al., 2004), MIM is an actin-bundling protein, this function
may require other parts of the molecule that lie outside the
IMD. Gonzalez-Quevedo et al. (2005) reached a similar
conclusion by studying various fragments of MIM. They
showed that most of the bundling activity could be
restored by a construct comprising amino acids 1–408
of MIM. Another possibility is that bundling is regulated
(or potentiated) in vivo by still unknown factors.
The IMD of IRSp53 interacts with Rac, possibly func-
tioning as an intermediate for the activation of WAVE,
which is recruited by the SH3 domain of IRSp53 (Miki
et al., 2000). Similarly, the IMD of MIM has been shown
to bind and activate Rac, suggesting that MIM could link
Rac to effector proteins involved in lamellipodia formation,
such asWAVE (Bompard et al., 2005). The structural basis
for the Rac-IMD interaction is unknown. Interestingly, the
structure of the IMD resembles that of the BAR domain,
which also binds small GTPases (Habermann, 2004).
The crystal structures of various BAR-domain proteins,
including arfaptin (Tarricone et al., 2001), amphiphysin
(Peter et al., 2004) and endophilin (Weissenhorn, 2005),
have been determined. Although the BAR domain is
curved and the IMD is relatively straight, the two folds
superimpose remarkably well in the middle section, where
the two subunits that conform these two domains overlap
(Figure 3C). It is via this well-overlapping middle section
that the binding of small GTPases appears to take place.
Indeed, the structure of arfaptin was also determined
bound to Rac (Tarricone et al., 2001). One molecule of
Rac sits at the midpoint of the arfaptin BAR dimer. It is
likely that the IMDs of MIM and IRSp53 bind Rac in a sim-
ilar fashion, as illustrated by a superimposition of the
structures of MIM and arfaptin-Rac (Figure 3C). Note,
however, that this superimposition does not represent
an accurate model of the interaction, since there is no
obvious sequence similarity between the IMD and BAR
domains and local changes are likely.
The binding of Rac and actin by the IMD of MIM appear
to be mutually exclusive (Bompard et al., 2005). Although
this study did not determine the total extent of the actin-
binding interface, the lack of bundling activity (Figure 2D)
and the fact that the distal ends of the IMD dimer do not
constitute a major actin-binding site (Figure 2C) would
suggest that the middle section of the IMD dimer also
participates in actin binding. As suggested by the analogy
with the BAR domain, the binding of Rac may also involve
the middle section of the IMD dimer (Figure 3C), possibly
explaining why actin and Rac bind in a mutually exclusive
manner.
We have stressed here the striking resemblance
between the IMD and BAR folds, including their shared
ability to bind small GTPases. In addition, both domains
present similar clusters of positively charged amino acids
(Figures 3A and 3B), which in the BAR domain coincide
with the concave surface of the dimer and are involved
in phospholipid membrane binding (Peter et al., 2004).
The most noticeable difference between the two folds is
that the IMD forms relatively straight dimers (Millard
et al., 2005), whereas the BAR domain forms curved,
‘‘banana-shaped’’ dimers (Peter et al., 2004; Tarricone
et al., 2001; Weissenhorn, 2005). However, the curvature
of theBARdomain varies fromprotein to protein (arfaptin >
amphiphysin > endophilin), which may facilitate the bind-
ing to membranes with different curvatures. The IMD was
discovered independently and due to the lack of se-
quence similarity was not originally considered a member
of the BAR domain family (Yamagishi et al., 2004). A com-
parison of the structures of the IMD and BAR domains
would now suggest that the two domains are not only
structurally but also functionally related to each other (Fig-
ure 3). Indeed, it was recently reported that, like the BAR
domain, the IMDalso bindsmembranes and that this func-
tion is mediated by the clusters of basic amino acids at
the distal ends of the dimer (Suetsugu et al., 2006; P. Lap-
palainen, personal communication). Interestingly, the
directionality of membrane deformation by the IMD (out-
ward) was found to be opposite to that produced by the
BAR domain (inward). The structures may provide an ex-
planation for this observation, because the concave and
positively charged surface implicated in membrane bind-
ing in the BAR domain adopts a somewhat convex shape
in the IMD (Figure 3). Therefore, the evidence to date sug-
gests that the IMD is a multifunctional module, linking the
actin cytoskeleton to the formation of membrane protru-
sions by direct interactions with both F-actin and mem-
branes, all under the control of the small GTPase Rac.
The WH2 of MIM interacts with all four subdomains of
actin (Figure 4B). It consists of an N-terminal amphiphilic
helix that binds in the cleft between actin subdomains 1
and 3 and a C-terminal extended region that binds along
the actin surface and the nucleotide cleft, reaching the top
of actin subdomains 2 and 4. Note that the end of thisWH2
coincides with the C terminus of the MIM protein. The
prototypical WH2 found among WASP-family proteins
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tends to be shorter (Figure 4A) and presents few or no
interactions with actin after the LKKT sequence (Chereau
et al., 2005).
We demonstrated here that certain isoforms of IRSp53
present a C-terminal WH2 that binds actin with similar
affinity to that of the WH2 of MIM, further extending the
relationship between these two actin-cytoskeleton scaf-
folding proteins. WH2 is the smallest actin-binding motif
known. Based on their sequences and structures, we
have identified two types of WH2s: long and short
(Chereau et al., 2005). Short WH2s consist solely of the
N-terminal helix and the LKKT-related sequence (for
example, WASP’s WH2; Figure 4A). Long WH2s present
an additional!10 amino acids at the C terminus. The extra
amino acids of long WH2s share sequence similarity with
Tb4 and make similar contacts with actin (Irobi et al.,
2004), supporting a previously proposed relationship
between the WH2 and Tb families (Paunola et al., 2002).
However, it remains unclear whether the extra amino
acids of long WH2s play any specific role, since they do
not seem to contribute significantly to the actin binding
affinity nor the nucleotide exchange inhibition by actin
(Chereau et al., 2005).
What is the role of WH2 inMIM and IRSp53?WH2 could
serve two possible functions: recruit actin monomers, or
recruit a protein to a specific actin cytoskeletal network.
Actin filament nucleation and elongation factors, including
WASP, Ena/VASP and spire, form themain group ofWH2-
containing proteins. These proteins present short WH2s,
typically positioned C-terminal to Pro-rich sequences
(Figure 4A). In WASP, WH2 is followed by the central (or
C) region that binds one of the subunits of Arp2/3 com-
plex, whereas, in VASP, WH2 is known as the G-actin
binding domain (GAB) and is followed by the F-actin bind-
ing domain (FAB). The C region of WASP and the FAB
domain of VASP are related to each other, and both
constitute specialized forms of WH2 (Chereau and
Dominguez, 2006). Spire, on the other hand, contains
four WH2s in tandem (Quinlan et al., 2005). We have pro-
posed that in these proteins WH2 becomes involved in
nucleation and elongation by bridging actin subunits along
a single filament strand and by mediating the incorpora-
tion of profilin-actin at the barbed end of growing filaments
(Chereau and Dominguez, 2006; Chereau et al., 2005). So
far, we have identified long WH2s in actobindin, WIP, MIM
(Chereau et al., 2005), and now in IRSp53. It appears that,
in MIM and IRSp53, WH2 occurs within a different domain
organization than inmost cytoskeletal proteins (Figure 4A).
Thus, in MIM and IRSp53, WH2 is found in isolation at the
C-terminal end; i.e. not immediately preceded by Pro-rich
sequences nor followed by other WH2s (or WH2-related
sequences). Unlike the actin monomer-trapping molecule
Tb4 and the nucleation-elongation factors described
above, MIM and IRSp53 function as scaffolding proteins.
It is therefore likely that WH2 helps recruit MIM and
IRSp53, as well as their multiple binding partners, to
specific cytoskeletal networks. Consistent with this idea,
images of cells overexpressing full-length MIM show a
significant loss of stress fibers (Gonzalez-Quevedo et al.,
2005; Mattila et al., 2003; Woodings et al., 2003), but
this effect appears diminished for MIM constructs lacking
theWH2 region (Bompard et al., 2005; Gonzalez-Quevedo
et al., 2005).
What is the spatial relationship between the IMD and
WH2 domains? Hydrophobic cluster analysis (Callebaut
et al., 1997) suggests that the region sandwiched in
between the IMD andWH2 of MIM is mostly unstructured,
with only two segments with predicted globular or induc-
ible folding (Figure S2). Given these characteristics and
the antiparallel organization of the IMD dimer, the two
WH2s could be located far apart from each other in the
protein, which would imply a lack of communication
between them. More likely, however, the various domains
of MIM and IRSp53 fold back into a more compact struc-
ture, possibly mediated by autoregulatory interactions
involving the IMD and other parts of the molecule.
EXPERIMENTAL PROCEDURES
Preparation of Proteins and Peptides
The cDNA encoding for full-length mouse MIM was purchased from
ATCC. Amino acids 1–250, corresponding to MIM’s IMD, were ampli-
fied by PCR and inserted into vector pTYB12 (New England Biolabs).
This vector comprises a chitin affinity purification tag and an intein
self-cleavage domain. IMD mutants (Leu 145 to Ala, Trp, Asp, Arg;
Leu 147 to Ala, Trp, Asp, Arg; and the double mutants Leu 145 and
Leu 147 to Ala; Leu 145 and Leu 147 to Trp) were generated using
the QuikChange Site-Directed Mutagenesis Kit (Stratagene).
BL21(DE3) cells (Invitrogen) were transformed with the various IMD
constructs and grown in LB medium at 37"C until the OD at 600 nm
reached a value of 0.8. Expression was induced by addition of 1 mM
isopropylthio-b-D-galactoside (IPTG) and carried out overnight at
20"C. Cells were harvested by centrifugation and resuspended in chi-
tin-affinity-column equilibration buffer (20 mM Tris [pH 7.5], 500 mM
NaCl, 1 mM EDTA, 100 mM PMSF), followed by standard purification
on a chitin affinity column at 4"C (New England Biolabs manual). The
proteins were eluted from this column following DTT-induced self-
cleavage of the intein. The proteins were then dialyzed against
20 mM Tris (pH 7.5), 50 mM NaCl, and 1 mM DTT and purified to
homogeneity on a MonoQ column (Pharmacia). A Se-Met-substituted
IMD protein was obtained following a similar procedure by growing
cells in M9 media, supplemented with 70 mg/ml Se-Met. Actin was
prepared from rabbit muscle as described (Graceffa and Dominguez,
2003). Ultra-pure-grade bovine pancreatic DNase I was purchased
from BioWorld. WH2 domains, corresponding to human MIM724–755
and human IRSp53506–534, were synthesized on an ABI431 peptide
synthesizer and purified by HPLC. The concentrations of the peptides
were determined by amino acid analysis (Dana-Farber Cancer
Institute, Boston, MA).
F-Actin-Binding Assay
For this experiment actin underwent additional purification through
a gel filtration Sephacryl S300HR column (Pharmacia). Actin in G buffer
(2 mM Tris [pH 7.4], 0.2 mM CaCl2, 0.2 mM ATP, 1 mM DTT, 1 mM
NaN3) was polymerized by addition of 100 mM KCl, 2 mM MgCl2,
and 2mMEGTA (F buffer). IMD and IMDmutantswere dialyzed against
the same F buffer and centrifuged at 400,0003 g for 30 min before the
experiments, to remove potential aggregates. 10 mM IMD (or IMD mu-
tants) was mixed with 5 mM F-actin on ice and incubated for 30 min.
The protein mixtures were then centrifuged at 400,000 3 g for
30 min. Equal volumes of supernatant and pellet were analyzed on
a 15% SDS-PAGE gel. A quantification of the F-actin binding affinity
was obtained by adding increasing amounts of IMD (0, 1, 2, 4, 6, 8,
10, 15, and 20 mM) to 2 mM F-actin and analyzed as described above.
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The Coomassie blue-stained gels were then scanned at high resolu-
tion, and the intensities of the bands were quantified using the program
ImageJ version 1.34S (http://rsb.info.nih.gov/).
F-Actin-Bundling Assay
Actin was purified and polymerized as described above. Before each
bundling experiment, both F-actin and the IMD were centrifuged for
30 min at 10,000 and 400,000 3 g, respectively. Note that this step
is important in order to remove potential high molecular weight aggre-
gates. F-actin samples were then visualized on a Philips EM 300 elec-
tron microscope to ensure that actin bundles were not present prior to
the addition of the IMD. 10 mM IMD was then mixed with 5 mM F-actin
and incubated for 1 hr at room temperature. Next, the mixture was
centrifuged at low speed (10,0003 g) for 30 min at room temperature.
Supernatant and pellet were analyzed by SDS-PAGE gel as described
above. A quantitative bundling assaywas done in a similar way by add-
ing increasing amounts of IMD (1, 2, 4, 6, 8, and 10 mM) to 1 mMF-actin.
Crystallization, Data Collection and Structure Determination
Actin-DNase I complex at a 1:1 molar ratio wasmixed with MIM’sWH2
domain peptide at 1.5 molar excess. The ternary complex was then di-
alyzed against G-buffer (2 mM Tris [pH 7.5], 0.2 mM CaCl2, 0.2 mM
ATP, 1 mM NaN3) and concentrated to !10 mg/ml using a Centricon
device (Millipore). The complex was crystallized at 20"C, using the
hanging drop vapor diffusion method. The 2 ml hanging drops con-
sisted of a 1:1 (v/v) mixture of protein solution and a well solution con-
taining 13%–14% PEG 3350, 50 mM Na cacodylate (pH 6.8–7.2), and
100 mM Na-formate. Before crystallization MIM’s IMD was dialyzed
against 20 mM Tris (pH 7.4), 50 mMNaCl, and 5 mMDTT and concen-
trated to !20 mg/ml. Crystals were obtained at 4"C in 0.1 M Tris
(pH 7.4), 0.2 M LiCl, and 16% PEG 2000 MME. The crystals were
flash-frozen in propane, using 25% glycerol as cryoprotectant. X-ray
data sets were collected at the BioCARS beamlines 14-BM-D (IMD)
and 14-BM-C (actin-WH2) at the Advance Photon Source (Argonne,
IL). The data sets were indexed and scaled with program HKL-2000
(HKL Research, Inc.). The structure of the actin-WH2 complex was
determined by molecular replacement using CCP4 program AMoRe
and the structure of WIP-actin-DNase I as a search model (Chereau
et al., 2005). Model building and refinement were done with the
programCoot (Emsley and Cowtan, 2004) and CCP4 program Refmac
(Table 1).
The structure of the IMD was determined from the anomalous signal
of a Se-Met-substituted crystal, using the single anomalous dispersion
(SAD) method and data collected to 2.1 A˚ resolution at the absorption
peak wavelength of the Se atoms (Table 1). The positions of 11 out of
18 Se atoms in the structure were found with the program SnB (Weeks
and Miller, 1999). These positions were then refined and phases were
calculated with the program Solve (Terwilliger and Berendzen, 1999).
About 70% of the model was built automatically with the program
ARP/wARP (Morris et al., 2003) and using a 1.85 A˚ resolution X-ray
dataset collected from the same Se-Met substituted crystal. Further
model building and refinement were carried out with the program
Coot (Emsley and Cowtan, 2004) and CCP4 program Refmac. Data
collection and refinement statistics are given in Table 1.
Isothermal Titration Calorimetry
Thesemeasurements were done using a VP-ITC (MicroCal, Northamp-
ton, MA). To determine DH and Ka of WH2-actin association, the WH2
peptide of IRSp53 at a concentration of 100 mM was titrated, in 10 ml
injections, into 1.44 ml of 10 mM actin in G buffer at 25"C. The duration
of each injection was 10 s, with an interval of 3 min between injections.
The heat of binding was corrected for the small exothermic heat of
injection, determined by injecting WH2 peptides into buffer. Data
were analyzed using MicroCal’s Origin program.
Supplemental Data
Supplemental Data include two figures and are available at http://
www.structure.org/cgi/content/full/15/2/145/DC1/.
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The Hexamer Structure of the Rift Valley Fever Virus
Nucleoprotein Suggests a Mechanism for its Assembly
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Abstract
Rift Valley fever virus (RVFV), a Phlebovirus with a genome consisting of three single-stranded RNA segments, is spread by
infected mosquitoes and causes large viral outbreaks in Africa. RVFV encodes a nucleoprotein (N) that encapsidates the viral
RNA. The N protein is the major component of the ribonucleoprotein complex and is also required for genomic RNA
replication and transcription by the viral polymerase. Here we present the 1.6 A˚ crystal structure of the RVFV N protein in
hexameric form. The ring-shaped hexamers form a functional RNA binding site, as assessed by mutagenesis experiments.
Electron microscopy (EM) demonstrates that N in complex with RNA also forms rings in solution, and a single-particle EM
reconstruction of a hexameric N-RNA complex is consistent with the crystallographic N hexamers. The ring-like organization
of the hexamers in the crystal is stabilized by circular interactions of the N terminus of RVFV N, which forms an extended
arm that binds to a hydrophobic pocket in the core domain of an adjacent subunit. The conformation of the N-terminal arm
differs from that seen in a previous crystal structure of RVFV, in which it was bound to the hydrophobic pocket in its own
core domain. The switch from an intra- to an inter-molecular interaction mode of the N-terminal arm may be a general
principle that underlies multimerization and RNA encapsidation by N proteins from Bunyaviridae. Furthermore, slight
structural adjustments of the N-terminal arm would allow RVFV N to form smaller or larger ring-shaped oligomers and
potentially even a multimer with a super-helical subunit arrangement. Thus, the interaction mode between subunits seen in
the crystal structure would allow the formation of filamentous ribonucleocapsids in vivo. Both the RNA binding cleft and the
multimerization site of the N protein are promising targets for the development of antiviral drugs.
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Introduction
The Bunyaviridae family comprises more than 330 viruses that
affect vertebrates and plants. La Crosse virus, a member of the
Orthobunyavirus genus, causes pediatric viral encephalitis in North
America. The Bunyaviridae family also includes several other
emerging human pathogens, such as the Hantaan and Sin
Nombre viruses (genus Hantavirus) and the Crimean-Congo
hemorrhagic fever virus (genus Nairovirus). Viruses of the Tospovirus
genus infect plants [1]. Bunyaviridae have either arthropods- or
rodent-borne vectors and are amplified by vertebrate hosts. The
Rift Valley fever virus (RVFV), a Phlebovirus within the Bunyaviridae
family, is transmitted by Aedes and Culex mosquitoes and is a
medically and agriculturally important cause of epizootics in
Africa. Although this virus primarily affects livestock, humans can
be infected as well, and infections can lead to several syndromes
ranging from a febrile illness to blindness, encephalitis and lethal
hemorrhagic fever. The virus is currently found in the sub-
Saharan area, as well as in Egypt, Yemen, Saudi-Arabia, Mayotte
and Madagascar [2]. The continuing geographical expansion of
RVFV draws concern for Europe, where the virus is considered to
be an emerging threat [3,4]. Current vaccines to prevent RVFV
epizootics are only partially attenuated, expensive and only induce
short-lived immunity [5]. No specific drugs are available to cure an
infection, and preventive efforts to avoid new outbreaks are mostly
based on weather monitoring [6].
The genome of RVFV consists of three single-stranded RNA
segments of either negative or ambisense polarity designated as L
(6,404 nucleotides [nt]), M (3,885 nt), and S (1,690 nt). Within
each of these three segments, coding regions are flanked at their 59
and 39 termini by non-translated regions that comprise two
stretches of complementary nucleotides, leading to the formation
of RNA panhandle structures [7]. The L and M segments are of
negative polarity, while S has ambisense polarity, encoding the
nucleoprotein (N) in antisense and the non-structural protein NSs
in sense orientation. The L segment expresses a multifunctional
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protein that comprises an N-terminal endonuclease [8] and a large
RNA-dependent RNA polymerase domain [1]. The M segment
codes for glycoproteins GN and GC that are inserted in the virus
lipid envelope and are responsible for cell tropism and membrane
fusion. The endodomain of GN interacts with N, and this
interaction is critical for genome packaging into infectious virus
particles.
As in other negative-stranded viruses, the genomic RNA (vRNA)
in RVFV is packaged with two virally expressed proteins, N and L,
into a ribonucleoprotein (RNP) complex that is competent for
(+)RNA synthesis and transcription. Contrary to RNPs of Mono-
negavirales, RVFV N does not assemble into a tube-like structure
[9–14] but rather forms a flexible serpentine-like structure [15]. The
precise organization of RNA, N and L in this macrostructure is
unknown. In addition to its critical role in protecting the vRNA and
the antigenome (cRNA), the N protein also plays an active role in
RNA transcription and replication [1], as well as in virion assembly
[16]. Biochemical studies have shown that RVFV N forms dimers
through aromatic residues located in the N terminus of the protein
[17]. Recently, a crystal structure was reported for the RVFV N
protein [15], which revealed the basic fold of the protein, but raised
a number of questions. For example, the crystal structure provided
little insight into the mechanism of N multimerization into an RNP
complex, and it was unclear how to relate the crystal structure to
EM images of N polymers. Furthermore, the RNA binding site
identified in the crystal structure of RVFVN differed from that seen
in other viral N proteins. Here, we present the crystal structure of
RVFV N forming a hexameric ring. The structure reveals the likely
binding site for vRNA, and comparison with the previous crystal
structure of RVFV N allows us to speculate on the mechanism that
underlies the multimerization of N and its encapsidation of viral
RNA.
Results
Recombinant N protein forms oligomers and can bind
RNA
To produce sufficient amounts of protein for structural studies
in the absence of other viral proteins, we expressed RVFV N in E.
coli with an N-terminal cleavable thioredoxin tag and purified it
under non-denaturing conditions to preserve its structural
integrity. The final gel filtration column showed two peaks,
denoted as N1 and N2 (Figure 1A). SDS-PAGE analysis revealed
that both peaks contained a protein of the size expected for N
(27 kDa), suggesting that N was the only protein present and
ruling out protein contaminants that could have influenced the
oligomeric state of N (Figure 1A, inset). The position of peak N1
corresponds to a protein species with an apparent molecular mass
of 300 kDa, suggesting that N formed higher-order oligomers. The
position of peak N2 corresponds to a protein species with an
apparent molecular mass of 94 kDa and would thus suggest the
presence of smaller oligomers. This notion was confirmed by cross-
linking experiments that indicated the presence of dimers, trimers
and tetramers in fraction N2 (Figure 1B). We also measured the
OD260nm/OD280nm ratio for the two peak fractions to test for the
presence of bound nucleic acids. Peak N1 had an OD260nm/
OD280nm ratio of 1.19, clearly indicating that the higher-order N
oligomers co-eluted with nucleic acids [18], presumably RNA
from the expression host. In contrast, the OD260nm/OD280nm ratio
of the N2 peak was 0.72, showing that this fraction contained
much less RNA than fraction N1 [18]. The variability in the
oligomeric state of N expressed in E. coli is consistent with previous
studies that used either N purified from infected cells or
recombinant N expressed in insects cells, although in the latter
case multimers with a higher MW were observed [16,17].
We next used surface plasmon resonance experiments to test
whether the recombinant protein in fraction N2 retained its
capacity for non-specific RNA binding. We measured the
interaction of N with a 20-nucleotides-long RNA, and determined
that the Kd of N for RNA is 3.8 mM (Figure S1). This result
demonstrated that the recombinant N protein present in peak N2
can still bind RNA and therefore presumably has the native fold.
We therefore used this protein for 3D crystallization and structure
determination.
Structure determination, crystal packing and structure of
the RVFV N protein
Using the N2 fraction, crystals were obtained in the P6 space
group with unit cell parameters of a = b=180.9 A˚ and c= 47.4 A˚.
The selenomethionyl protein crystallized in the same space group
with similar unit cell parameters, a = b= 175.5 A˚ and c= 47.4 A˚
(Table 1). The structure was determined using the SAD
technique with data recorded at the Se absorption edge from
crystals of the selenomethionyl protein that diffracted to 2.3 A˚
Figure 1. Oligomeric state of recombinant N protein.
(A) Chromatogram of N run on an S200 size exclusion column. The
grey line shows the absorbance at 280 nm, and the green line the
absorbance at 260 nm. The inset shows a 12.5% SDS-PAGE gel of peaks
1 (N1) and 2 (N2). (B) A 12.5% SDS-PAGE gel showing the presence of
dimers, trimers and tetramers after cross-linking fraction N2 with 0.05%
glutaraldehyde for one hour at room temperature.
doi:10.1371/journal.ppat.1002030.g001
Author Summary
The Rift Valley fever virus (RVFV), a negative strand RNA
virus spread by infected mosquitoes, affects livestock and
humans who can develop a severe disease. We studied the
structure of its nucleoprotein (N), which forms a filamen-
tous coat that protects the viral RNA genome and is also
required for RNA replication and transcription by the
polymerase of the virus. We report the structure of the
RVFV N protein at 1.6 A˚ resolution, which reveals
hexameric rings with an external diameter of 100 A˚ that
are formed by exchanges of N-terminal arms between the
nearest neighbors. Electron microscopy of recombinant
protein in complex with RNA shows that N also forms rings
in solution. A reconstruction of the hexameric ring at 25 A˚
resolution is consistent with the hexamer structure
determined by crystallography. We propose that slight
structural variations would suffice to convert a ring-shaped
oligomer into subunits with a super-helical arrangement
and that this mode of protein-protein association forms
the basis for the formation of filamentous ribonucleocap-
sids by this virus family. Both the RNA binding cleft and the
multimerization site of the N protein can be targeted for
the development of drugs against RVFV.
Structure of the Rift Valley Fever Virus N Hexamer
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resolution. The structure was subsequently refined using a native
data set that extended to 1.6 A˚ resolution (Table 1).
The asymmetric unit contains three N molecules, labeled a, b
and c in Figure 2A, that form two distinct hexameric rings in the
crystal, labeled I and II in Figure 2B. Hexamer I is formed by
six copies of subunit a that surround the crystallographic 6-fold
axis, whereas hexamer II is formed by three b,c dimers that
surround the crystallographic 3-fold axis (Figure 2B). The two
sets of hexamers, which face in opposite directions and are offset
by 10 A˚ in the direction of the crystallographic c axis
(Figure 2C), form layers along the [a,b] plane of the crystal.
Stacking of the layers in the crystal results in the formation of two
sets of tubes, one set formed by hexamers I and the other by
hexamers II, that both run along the crystallographic c axis but in
opposite directions (Figure S2).
The crystal structure reveals that the N monomer consists of an
orthogonal bundle of thirteen a-helices (Figure 3). The structure
can be divided into three domains. Residues 1–32 form a flexible
N-terminal arm containing two a-helical segments that extends
away from the globular core of the protein. The globular core itself
consists of two domains, one formed by six helices spread over
residues 36–90, 110–122, 211–220 and the other one formed by
four helices spread over residues 103–110 and 130–204 (Figure 3).
The core domain in our structure is virtually identical to that in
the previously reported crystal structure of N [15] with an rms
deviation between the backbone atoms of the two structures
of,0.7 A˚ (Figure S3B). The position and conformation of the N-
terminal arm, however, are very different in the two structures
(Figure S3), a finding that will be discussed below. The fold of
RVFV N is currently unique in the PDB, but considering the high
level of conservation in their amino-acid sequences (average
identity.30%) (Figure S4), other Phlebovirus N proteins are likely
to adopt a similar fold.
Multimerization of the N protein
In our crystals, N forms ring-shaped hexamers (the subunits are
denoted A to F as shown in Figure S2) that have a thickness of
45 A˚, an external diameter of approximately 100 A˚, and a central
funnel-like aperture with a diameter that narrows from 50 to 30 A˚
(Figure 2C). Multimerization appears to be driven by the
extended N-terminal arm, which wraps around the external
surface of the globular core of the adjacent subunit, fitting snuggly
into a hydrophobic groove and burying a surface of 1456 A˚2
(Figure 4A). In particular, the aromatic rings of residues Y3, F11,
W24, F28 and Y30 and the aliphatic side chains of residues L7, V9,
V16, I21 and V25 project from the N-terminal arm and fill up the
hydrophobic groove formed by regions 36–82, 108–126, and 207–
210 of the core domain of the adjacent molecule (Figure 4B/C).
This arm-core interaction is repeated in a directional manner, such
that the arm of subunit A extends into the hydrophobic groove of
subunit B, B into C, C into D, D into E, E into F and F into A,
creating the hexameric rings seen in the crystal. This mode of
multimerization is consistent with mutagenesis data that mapped
the interacting domain of the Phlebovirus N protein to its N-terminal
arm [17].
Hexamers I and II in the crystals of the native protein
superimpose very well, but the two rings in the crystals of the
selenomethionyl protein are slightly different (Figure S5A). While
hexamer II formed by seleniated N is the same as the two
hexamers formed by native N (Figure S5B), the subunits in
hexamer I are more closely packed about the 6-fold symmetry
axis. The domain of N that is near the center of the ring,
comprising the loop connecting helices a10 and a11, occludes part
of the central aperture, suggesting a twist in the assembly of the
ring subunits (Figure S5A). Superimposition of native and
seleniated hexamers I based on subunits A, creates an 11u
deviation between the planes of the two rings (Figure S5C).
Furthermore, comparison of the subunits in hexamers I formed by
native and seleniated protein shows that the contraction of the ring
is due to a lateral slippage between adjacent subunits (Figure S6).
As a result of the slightly different subunit organization, the
asymmetric unit is shorter in crystals of the seleniated protein and
the length of the crystallographic a and b axes is decreased by
about 5 A˚ (Table 1). The existence of two types of rings in the
crystals demonstrates the natural ability of N to form oligomers
with different subunit organizations, providing a basis for the
formation of serpentine-like RNP structures.
RNA binding
The core of the N protein has a concave crescent shape and the
relative orientation of its two domains is reminiscent of a head of
pliers, suggestive of a role in grabbing genomic RNA (Figure 3C).
Table 1. Data collection and refinement statistics.
Data collection and
refinement statistics of
RVFV nucleoprotein Se-METa Nativeb
Instrument ESRF - ID14–4 ESRF - ID14–4
Wavelength 0.9790 0,9770
Space group P6 P6
Cell dimensions
a, b, c (A˚)/a, b, c (u)
175.5, 175.5,
47.4/90, 90, 120
180.9, 180.9,
47.7/90, 90, 120
Resolution range (A˚) 47.44– 2.30
(2.42–2.30)*&
47.1–1.6
(1.69 – 1.6)*
Total number of reflections 524146 (73999)* 575561 (39900)*
Number of unique reflections 37702 (5378)* 111024 (13148)*
Completeness (%) 99.6 (97.6)* 93.8 (76.5)*
I/S(I) 27.5 (15.6)*& 10.9 (2.0)*
Rsym ** 0.072 (0.130)*
& 0.084 (0.510)*
Multiplicity 13.9 (13.8)* 5.2 (3.0)*
Refinement
R*** 0.2015 0.2221
Rfree ***** 0,2505 0.2536
No. atoms
Protein 5781 5901
Water 347 965
B-Factors
Protein 14.14 19.16
Water 19.14 33.2
R.m.s. deviations
Bonds lengths (A˚) 0,0078 0.0061
Bonds angles (u) 1.023 0.883
aPDB code: 3OUO
bPDB code: 3OU9
&A resolution cutoff of 2.3 A˚ was chosen to retain only the most reliable data for
phasing purposes.
*Values in parentheses give the values in the highest resolution shell (1.69–
1.6 A˚ ).
**Rsym =S |I-,I.|/S I
***R =S||Fo|-|Fc||/S |Fo|
*****Rfree = R factor calculated using 5% of reflections not included in
refinement.
doi:10.1371/journal.ppat.1002030.t001
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Figure 2. Hexamers formed by N in the crystal. (A) The three N monomers in the asymmetric unit are shown in pink, cyan and green and
labeled a, b and c, respectively. (B) Subunit packing in the crystal layer corresponding to the crystallographic [a,b] plane. The six copies of subunit a
that surround the crystallographic 6-fold symmetry axis (black dot) form one hexamer (labeled I), and the three bc dimers that surround the
crystallographic 3-fold symmetry axis (grey dot) form a second hexamer (labeled II). (C) The dimensions of the hexameric ring are labeled. Hexamers I
and II face in opposite directions and are offset by approximately 10 A˚ in the direction of the c axis.
doi:10.1371/journal.ppat.1002030.g002
Figure 3. Structure of the N monomer. (A) Sequence of the RVFV N protein with secondary structure elements indicated above. The colors
correspond to those used to color the different sub-domains in the crystal structure of N shown in panels B and C. (B) Ribbon representation of the
crystal structure of the RVFV N protein showing that the N terminus forms an arm (red) that extends from the globular core domain (brown and
green). The C terminus, which is not involved in RNA binding, is shown in blue. The a-helices are labeled. (C) View of the RVFV N protein in surface
representation. The orientation and color code are the same as in panel B.
doi:10.1371/journal.ppat.1002030.g003
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This cleft is sandwiched between three helices on one side (a4, a5,
a7) and two 310-helices (g4, g5) followed by three a-helices on the
other (a9, a10, a11), a fold in accordance with the ‘‘(5H+3H)’’
structural motif for RNA binding [19]. Furthermore, analysis of
the electrostatic surface potential reveals a positively charged patch
located within the inner part on one side of the hexamers
(Figure 5). This patch includes residues R64, K67 and K74 that
are evolutionary conserved across Phleboviruses (Figure S4). To test
whether this positively charged patch indeed constitutes the RNA
binding site, we expressed and purified a triple RVFV N mutant
(R64D, K67D, K74D). The triple mutant eluted from the gel
filtration column as a single peak, corresponding to N2 (Figure
S7A). SDS-PAGE analysis revealed that the peak fractions
contained a protein of the size expected for N (27 kDa) (Figure
S7A, inset), and mass spectrometry confirmed the protein to be
RVFV N. The OD260nm/OD280nm ratio of the peak fraction was
0.52, indicating that this fraction contained only protein [20].
Binding studies using surface plasmon resonance spectroscopy
with a 20-nucleotides-long RNA showed that the triple mutant lost
its ability to bind RNA, supporting the notion that the positively
charged patch serves as the RNA binding cleft (Figure S7B).
Taking as a guide the structure of the rabies virus N protein
bound to single-stranded RNA (PDB code: 2GTT [11]), we could
position an RNA molecule in the concave surface between the two
core domains of the RVFV N protein, such that the RNA sugar
phosphate backbone interacts with the positive charges in the basic
cleft. The model of RVFV N protein bound to RNA further
showed that each N subunit can accommodate approximately six
RNA bases (Figure S8).
Electron microscopy of N-RNA complexes
The crystal structure showed that RVFVN forms hexameric rings.
To assess whether N also forms hexamers in solution, we prepared
negatively stained samples for analysis by electron microscopy (EM).
EM images of fraction N2, which contained only protein and was
used for 3D crystallization, did not show any ring-shaped complexes
(data not shown), consistent with the SEC result that showed that this
fraction contains only small oligomers. By contrast, EM images of
fraction N1, which contained both protein and RNA, revealed
distinct circular structures with diameters ranging from,70 to 100 A˚,
which were stable over a period of one month (Figure 6A). The
images thus suggest that the formation of stable higher-order N
oligomers requires the protein to associate with RNA and that the
resulting higher-order oligomers have a ring-shaped structure.
To obtain a better understanding of the structure of N-RNA
complexes, we calculated 3D reconstructions of the ring-shaped
complexes seen in fraction N1. The small size of the complexes
prevented us from using vitrified specimens for EM imaging, and
we therefore prepared samples by cryo-negative staining. This
specimen preparation method provides the high contrast of stain
but minimizes the artifacts associated with conventional negative
staining [21]. The N-RNA complexes adsorbed to the carbon
support film preferentially with the flat side of the ring, making it
necessary to use the random conical tilt approach to calculate 3D
Figure 4. Interaction between adjacent N subunits in the hexamer. (A) Overview of how the N-terminal arm of one subunit, shown in orange
mesh, fits into the hydrophobic pocket in the surface of the adjacent subunit, shown as grey surface with the hydrophobic pocket highlighted in
green. (B) Magnified view of the interaction. The N-terminal arm is shown in ball-and-stick representation and the surface of the hydrophobic pocket
is shown transparent to reveal details of the hydrophobic interactions. (C) Amino acid sequence of an RVFV N polypeptide, showing above the
secondary structure elements derived from the crystal structure. Below the sequence, residues are labeled that are involved in inter-subunit
interactions in the hexamer. The yellow dots indicate residues of the arm that interact with residues in the oligomerization groove. The colored bars
indicate the character of the residues in the oligomerization groove: green, hydrophobic; blue, positively charged; red, negatively charged.
doi:10.1371/journal.ppat.1002030.g004
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reconstructions [22]. We recorded a total of 30 image pairs at tilt
angles of 50u and 0u, from which we selected 10,764 particle pairs.
The particles from the images of the untilted specimen were
classified into 100 classes, which revealed a variety of oligomers,
ranging from tetramers to octamers (Figures 6B and S9). About
57% of all the particles were ring-shaped oligomers. The hexamer
was the most abundant species with 24%, followed by the
pentamer (22%), the heptamer (7%), and finally the octamer (4%).
The averages of the various oligomers revealed a large variability
in the ring shape, pointing to structural flexibility in the various N-
RNA complexes. Because the hexamer was most prevalent and
because N alone formed hexamers in the 3D crystals, we focused
on calculating a 3D reconstruction of the hexameric N-RNA
complex. We combined the particles from classes that produced
the most similar averages (399 particles from 2 classes) and
calculated a 3D density map using the particles selected from the
images of the tilted specimen and the best 10% of particles selected
from the untilted specimen. According to the Fourier shell
correlation (FSC) = 0.5 criterion, the final density map had a
resolution of 25 A˚ (Figure S10).
With a diameter of about 100 A˚ and a thickness of about 45 A˚
(Figure 6C), the EM density map of the N-RNA complex has
virtually identical dimensions as the crystal structures of the N
hexamer. Accordingly, the EM density map nicely accommodated
the crystal structure of the hexamer, illustrating that the hexamers,
and by extension also the other ring-shaped oligomers, are
compatible with RNA binding (Figure 6D).
Discussion
The N protein is the most abundant viral protein in the
Phlebovirus virion and plays a key role in encasing vRNA in a
protective coat. We have determined the crystal structure of
RVFV N in a hexameric form, which shows largely the same fold
that was previously seen in a crystal structure of monomeric N
[15]. The two structures differ, however, in the position of the N-
terminal arm. In the previous structure, the N-terminal arm packs
closely against the core domain, while it extends away from it in
our structure (Figure S3). Extension of the N-terminal arm is
crucial for the oligomerization of N, as it mediates the interaction
with the adjacent subunit in the crystallographic hexamer. We
believe that the RVFV N hexamer is biologically relevant, because
oligomers have been observed for many other N proteins
[9,10,11,12,13,14] and EM revealed that the RVFV N-RNA
complex also forms ring-shaped oligomers in solution (Figure 6).
The different position of the N-terminal arm in our and the
previous structure is intriguing as it may reflect the structural
change that has to occur for N to multimerize, thus potentially
providing a clue to the mechanism underlying the formation of a
ribonucleocapsid. In the hexamer, the N-terminal arm lies in a
hydrophobic pocket of the adjacent subunit, thus mediating an
inter-molecular interaction (Figure 4). By contrast, in monomeric
N, the N-terminal arm makes an intra-molecular interaction and
binds to the same hydrophobic pocket but in its own core domain,
burying a surface area of 1179 A˚2 (Figure S11). The inter- and
intra-molecular interactions with the N-terminal arm are mediated
largely by the same residues of the core domain (Figure 4C and
Figure S11B). Interestingly, the intra-molecular interaction of the
N-terminal arm not only fills the hydrophobic pocket of its own
core domain, thus preventing oligomerization, but also covers the
RNA binding cleft, so that N in this conformation is incapable of
binding RNA. For a monomer, the closed conformation is
presumably more favorable, because it reduces the hydrophobic
surfaces on both the N-terminal arm and oligomerization groove.
Figure 5. Electrostatic surface potential of the N hexamer. Mapping of the electrostatic surface potential, from 210 kT in red to+10 kT in
blue, onto the surface of hexamer I formed by native N protein reveals a patch of positive charges in the inner part of the ring, which likely
accommodates the vRNA. Key residues in the RNA binding site are labeled on the electrostatic surface of a single monomer.
doi:10.1371/journal.ppat.1002030.g005
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In case the closed conformation is a ‘‘waiting’’ conformation
before oligomerization; residues involved in the molecular
interaction would have to compete for the oligomerization groove
and expose the hydrophobic side of the arm (Video S1).
Our SEC analysis shows that peak N2, which lacks RNA,
contains only small oligomers, suggesting that the inter-molecular
interactions mediated by the N-terminal arm are not very strong
on their own, potentially because the intra-molecular interactions
outcompete the inter-molecular interactions, and thus do not
support large oligomer formation. The weak interactions between
N proteins would allow easy addition and removal of subunits.
The fact that we see hexamers in our crystals may be explained by
the high protein concentration used for crystallization trials that
drives the small units of nucleoproteins to assemble into larger
stable oligomers. In solution, however, stabilization of the
oligomers may require the additional association of the subunits
with RNA. Binding to RNA would align N proteins to each other
and increase their local concentration, thus stabilizing the inter-
molecular interactions of the N-terminal arms and resulting in the
stable, ring-shaped oligomers seen in SEC peak N1 (Figure 6).
This model of RNA-stabilized oligomers provides an elegant
molecular explanation for why N proteins can have an inherent
tendency to multimerize without forming undesired, large
oligomers in the absence of RNA.
With only six subunits and a diameter of 100 A˚, the RVFV N
ring is the smallest one among the ring-shaped oligomers seen in
crystal structures of N proteins from negative strand viruses
(Figure 7). Although there are clearly common structural features
in the oligomers, the mode of how the subunits interact with each
other varies. In rabies virus (RV), vesicular stomatitis virus (VSV),
respiratory syncytial virus (RSV) and influenza virus, extensions at
both the N and C termini of the polypeptide are involved in
organizing adjacent subunits into an ordered assembly [11,12,14].
By contrast, it is only the interaction of the N-terminal arm of
RVFV N with the hydrophobic pocket of the neighboring subunit
that mediates the contacts between adjacent subunits in oligomers.
While this interaction appears sufficient to promote efficient
protein polymerization, it leaves a significant degree of freedom at
the level of lateral interactions. This plasticity is illustrated by the
slightly different positions of the N-terminal arm on the core
domain of the neighboring subunit seen in hexamers I and II in
the crystals of the native and seleniated proteins (Figure S5). As a
result, like the N proteins of RV and RSV, RVFV N can form
rings with deformed shapes and a variable number of subunits
(Figure 6B) and, although not yet observed, N may even have the
capacity to form oligomers with a superhelical arrangement of the
subunits.
Although EM of RVFV N-RNA complexes also showed ring-
shaped oligomers (Figure 6), it is not clear whether rings are the
building block of the native ribonucleocapsid. The RNPs of several
Mononegavirales have a superhelical subunit arrangement,
including those of RV [11], VSV [12], RSV [14], measles
[9,10] and mumps [13]. However, the RNPs of Phleboviruses do not
assemble into a highly ordered structure, but rather into flexible
filamentous assemblies [15,23,24,25,26]. In particular, EM images
of RNPs from RVFV [15] and other Bunyaviridae [23,24,25]
display an extended filament-like structure, but they do not rule
out some degree of symmetry in the way the vRNA is packaged.
While it thus remains uncertain whether the RVFV ribonucleo-
capsid is formed by stacked rings or a superhelical oligomer or
even a mixture thereof, the flexibility in the interaction between
adjacent subunits would allow great variability in the architecture
of the ribonucleocapsid. Flexibility in the contacts between N
subunits allows the assembly to readily adapt to distortions
introduced by external constraints or signals within the infected
cells, while maintaining the connectivity of the RNA.
The crystal structure of the hexamer reveals that several
positively charged residues are clustered in a cleft that can
accommodate a single molecule of RNA (Figures 5 and S8).
This finding is in agreement with the proposal of Luo and
collaborators that N RNA binding site is formed by two domains
that contain a ‘‘(5H+3H)’’ structural motif [19]. Genomic RNA
would thus run like a belt inside the ring and be completely
concealed from the innate immune system of the host cell, in a
manner similar to the ribonucleocapsid of the rabies virus [11].
Each N subunit can accommodate up to six bases, so that one turn
of the RNA inside the hexameric ring would translate to,36
bases. Our single-particle EM reconstruction of the hexameric
RVFV N-RNA complex is consistent with the crystallographic
hexamer of N, but it does not show the RNA inside the ring
(Figure 6D). Considering the limited resolution of the EM density
map of 25 A˚, the small mass of 30 RNA bases and the negative
charge of RNA, which would favor positive staining of the RNA, it
is not surprising that the RNA is not visible in the EM map. By
considering that the thickness of the hexameric N-RNA complex is
about 45 A˚ (Figure 6C) and making the simplifying assumption
Figure 6. Electron microscopy of N-RNA complexes.
(A) Representative electron micrograph of the N1 fraction in negative
stain, revealing ring-shaped particles of different sizes. Scale bar is
100 nm. (B) Representative class averages of N-RNA rings. (C) 3D
reconstruction of a hexameric N-RNA complex obtained with cryo-
negatively stained samples. (D) Docking of the crystal structure of
hexamer I formed by native N into the EM density map of the hexameric
N-RNA complex.
doi:10.1371/journal.ppat.1002030.g006
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that the entire nucleocapsid is formed by stacked hexamers, the
ribonucleocapsid of the S segment of 1690 nt would span a total
linear distance of about 0.25 mm. This value is consistent with the
size of 0.27 mm of the ribonucleocapsid of Uukuniemi virus seen in
EM images [27], whose genome is only slightly larger than that of
RVFV.
Earlier studies showed that transcription and replication require
not only the polymerase L but also the N protein [28], implying that
naked vRNA cannot be transcribed [1]. While it has been
established that the two proteins are positioned in close proximity
to each other, as L is recruited to the vRNA through a panhandle
structure [29] and N through a short region in the 59 region of the
ORF [30], how the two proteins interact with each other remains
unclear. A recent study found a conserved region in the second
domain of N consisting of helices a4, a5, a6 [31]. This domain may
well play a role in the stacking of N subunits in the oligomer, but it
could also mediate a transient interaction with L and promote a
temporary release of N, thus liberating the RNA to become
accessible for transcription by L. Additionally, helices a1, a12 and
a13 are located at the periphery of the hexameric ring, and residues
projecting from these helices are also likely to form a significant part
of the L-binding surface on the ribonucleocapsid. Given the
substantial contribution of the N-terminal arm to the buried
interface (1456 A˚2 out of a total of 1640 A˚2 buried surface between
two adjacent N subunits), it is conceivable that interactions of a1 of
the N-terminal arm with L could lead to a local unwinding of the
filament structure and the exposure of vRNA while avoiding
complete disassembly of the ribonucleocapsid.
In conclusion, the structure of the hexamer formed by the
RVFV N protein presented here shows that oligomerization is
mediated by a flexible N-terminal arm, which binds a hydrophobic
pocket in the adjacent subunit. The different hexamers seen in our
crystals and the variability in the oligomeric state of N-RNA
complexes seen in EM images demonstrate substantial flexibility in
the interaction between subunits. Furthermore, comparison with a
previous structure of the RVFV N protein suggests an elegant
mechanism that allows the formation of stable N oligomers only in
the presence of RNA. Finally, the nucleoprotein structure
identifies potential sites that could be targeted for drug
development. For instance, compounds blocking ribonucleocapsid
assembly either by interfering with RNA binding or by trapping
the N-terminal arm of N in a conformation that is not compatible
with oligomerization, could serve as starting points to design
specific antiviral molecules.
Materials and Methods
Cloning, mutagenesis, protein production and
purification
cDNA corresponding to the RVFV N protein (strain Smithburn
DQ380157.1) was cloned by recombination (Gateway, Invitrogen)
into the pETG20A vector (kindly provided by Dr. Arie Geerlof),
which adds a cleavable N-terminal thioredoxin-hexahistidine tag,
and used to transform E. coli strain C41 (Avidis) carrying the
pRARE plasmid (Novagen). Bacteria were grown in TB medium
(Athena Enzyme) at 37uC to an OD600nm of 0.5. Expression was
Figure 7. Gallery of crystal structures of N proteins from different negative strand RNA viruses. The structures shown are those of the N
proteins from the rabies virus (RV; PDB code: 2GTT), the vesicular stomatitis virus (VSV; PDB code: 2GIC), the Rift Valley fever virus (RVFV; this work),
the respiratory syncytial virus (RSV; PDB code: 2WJ8), and the influenza virus (InfV; PDB code: 2IQH). The model fro the influenza NP ring is derived
from an EM reconstruction into which the crystal structure of the monomer was modeled (PDB code: 2WFS). The top three rows show different views
of the ring structures in surface representation, in which each subunit is shown in a different color. The fourth row shows two views of the monomers
in ribbon representation. The arrows indicate the cavity that binds the vRNA.
doi:10.1371/journal.ppat.1002030.g007
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induced with 0.5 mM IPTG, and bacteria were grown overnight
at 17uC. Cells were pelleted, resuspended in 30 ml of lysis buffer
(50 mM Tris, pH 8, 300 mM NaCl, 5 mM imidazole, 5%
glycerol, 0.1% Triton X-100, 2 mM EDTA), frozen, and stored
at -80uC.
N was purified at 4uC. A frozen pellet was melted on ice,
sonicated, and the lysate was cleared by centrifugation at
20,000 rpm for 30 min. The protein was first purified by metal
affinity chromatography using a 5 ml HisPrep column (GE
Healthcare). The tag was then removed by cleavage with TEV
protease, and the protein was further purified with a second metal
affinity column followed by size exclusion chromatography (SEC)
using a Superdex 200 column (GE Healthcare) in 10 mM HEPES,
pH 7.5, 300 mM NaCl.
The R64D/K67D/K74D triple mutant was generated by first
simultaneously introducing the R64D and K67D mutations
followed by introducing the K74D mutation into the RVFV N
cDNA using the QuickChange Site-Directed Mutagenis Kit
(Agilent). The sequences of the primers used to introduce the
point mutations were:
R64D/K67D forward: CTGGCTCTAACTgaTGGCAACg-
AcCCCCGGAGGATG,
R64D/K67D reverse: CATCCTCCGGGGgTcGTTGCCAt-
cAGTTAGAGCCAG,
K74D forward: CGGAGGATGATGATGgAcATGTCAAAA-
GAAGGC, and
K74D reverse: GCCTTCTTTTGACATgTcCATCATCATC-
CTCCG.
The complete coding region of each mutant was sequenced to
confirm the desired modification. The triple mutant was expressed
and purified analogous to the wild-type protein, and the expressed
protein was verified by mass spectrometry.
Analytical SEC was performed on a KW 803 column (Shodex)
using a High Pressure Liquid Chromatography Alliance 2695
system (Waters), and absorbance was measured at both 260 nm
and 280 nm. The SEC column was calibrated with Kit LMW
markers (GE Healthcare). The protein eluted in two peaks, with
apparent molecular weights of,300 kDa (N1) and 94 kDa (N2).
The N1 peak was used for EM analysis of N-RNA complexes and
the N2 peak for 3D crystallization screens of N.
Characterization of N-RNA interactions by surface
plasmon resonance spectroscopy
Binding affinities of wild-type and mutant N protein for ssRNA
were determined using a ProteOn XPR36 instrument (Bio-Rad
Laboratories, Inc). NeutrAvidin (Thermo Scientific) was amine-
coupled to a carboxylated sensor surface (GLM sensor chip) to a
final immobilized level of 6000 RU. To test non-specific binding by
N, biotin-labeled ssRNA oligonucleotides with a non-relevant
sequence from the dengue virus 59 non-translated region (RNA20-
39biotin: GAGUUGUUAAUCUUUUUUUU-biotin; Sigma) were
diluted to 10 nM in sodium acetate (pH 5.5) and injected for two
minutes at a flow rate of 25 ml/min. Association and dissociation
phases were measured for 240 sec and 600 sec, respectively.
Measurements were performed in buffer containing 10 mM
HEPES, pH 7.5, 300 mM NaCl, 0.005% NP-20. Data were
analyzed in ProteOn Manager version 2.0.
Crystallization
N protein in 10 mM HEPES, pH 7.5, 300 mM NaCl collected
from fraction N2 was concentrated to 7.8 mg/ml, and 2 ml of
protein solution was mixed with 2 ml of reservoir solution
containing 200 mM MgNO3 and 17% (w/v) PEG 3350 for
crystallization at 20uC using the hanging drop method. SDS-
PAGE analysis of dissolved crystals confirmed that they contained
full-length N protein. The crystals were flash-frozen in liquid
nitrogen using 5% glycerol as cryo-protectant.
Data collection, structure determination and refinement
The RVFV N protein crystallizes in space group P6 with unit
cell parameters of a = b=180.9 A˚, c = 47.7 A˚ for the native
protein and a= b= 175.5 A˚, c = 47.4 A˚ for the seleniated protein.
A native data set extending to 1.6 A˚ resolution and a Se-Met data
set extending to 2.3 A˚ resolution were collected on beamline
ID14–4 at the ESRF (Grenoble, France). The Se-Met data set was
collected at the Se absorption edge. Data were processed using the
program XDS [32]. Of a total of 33 Se sites for the three
monomers in the asymmetric unit, the position of 27 sites were
identified using the program SHELXD [33] to analyze anomalous
data ranging from 10 to 2.3 A˚. After initial phase calculation and
modifications with the SHELX suite, a readily interpretable map
was obtained with an overall figure of merit of 0.62. The program
ARP/wARP [34] was used to generate an initial model, and a
complete model for the three independent monomers was built
using COOT [35]. Using this model, the native data set was
subsequently solved by molecular replacement using the program
Phaser [36]. The program REFMAC5 with the TLS option was
used for crystallographic refinement [37]. The final models were
assessed with PROCHECK [38]. Surface electrostatics were
calculated using DELPHI [39]. Sequences were aligned using
Muscle [40] and seaview [41]. Intermediate structures for the
morphing were generated using LSQman [42]. Figures and movie
were generated with the programs ENDscript, ESPript [43] and
PyMOL (http://www.pymol.org).
Sample preparation, electron microscopy and image
processing
Samples were prepared by negative staining and cryo-negative
staining with uranyl formate as described [44]. For specimens
prepared by conventional negative staining, images were taken
using Philips CM10 electron microscope equipped with a tungsten
filament and operated at an acceleration voltage of 100 kV.
Images were recorded on a 1 k61 k Gatan CCD camera at a
magnification of 52,0006using a defocus value of –1.5 mm. For
cryo-negative staining specimens, images were recorded using a
Tecnai F20 electron microscope (FEI), equipped with a field
emission gun and operated at an acceleration voltage of 200 kV.
Grids of cryo-negatively stained specimens, used to collect image
pairs of specimens tilted to 50u and 0u, were loaded on an Oxford
cryo-transfer holder and maintained at liquid nitrogen tempera-
ture during image acquisition. Images were taken at a magnifi-
cation of 50,0006, with a defocus value of –2.0 mm for images of
untilted specimens and –1.8 mm for specimens tilted to 50u. All
images were recorded using low-dose procedures on Kodak film
SO163 and developed for 12 min with full-strength Kodak D-19
developer at 20uC.
Electron micrographs were digitized with a SCAI scanner
(Zeiss) using a step size of 7 mm, and 363 pixels were averaged to
obtain a pixel size of 4.2 A˚ on the specimen level for cryo-
negatively stained specimens. 3D reconstructions from the cryo-
negatively stained preparations were calculated using the SPIDER
software package [45]. 10,764 particle pairs were interactively
selected from a total of 30 image pairs using WEB, the display
program associated with SPIDER, and windowed into small
images of 60660 pixels. The particles from the images of the
untilted specimens were classified over 10 cycles of K means
classification and multi-reference alignment specifying 100 output
classes. 3D density maps of individual classes were calculated with
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the corresponding particles selected from the images of the tilted
specimen and using the back-projection, back-projection refine-
ment, and angular refinement procedures implemented in
SPIDER. The final 3D reconstruction of the hexameric N-RNA
complex included 439 particles (399 particles from images of tilted
specimens and 40 particles from images of untilted specimens) and
its resolution was estimated by Fourier shell correlation (FSC) to be
25 A˚ according to the FSC=0.5 criterion. The crystal structure of
hexamer I formed by native RVFV N was first manually docked
into the EM density map and then refined using the program
UCSF Chimera [46].
Supporting Information
Figure S1 Surface plasmon resonance spectroscopy analysis of
RNA binding by RVFV N.A 20-nucleotides-long RNA was
immobilized on a NeutrAvidin chip, and association and
dissociation phases were measured for 240 sec and 600 sec,
respectively, using the indicated concentrations of RVFV N. Data
are representative of two independent experiments.
(TIF)
Figure S2 Hexamers in the crystals form tubes in the direction
of the c axis. Top and side view of the tubes formed by hexamers I
and II (same color code as in Figure 2) in the direction of the c axis.
The six subunits in hexamer II are labeled A to F. The arrows
indicate that the two tubes run in opposite directions.
(TIF)
Figure S3 Comparison of the two crystal structures of RVFV N.
(A) Ribbon representation of the two crystal structures of an
RVFV N subunit in the hexamer (PDB code: 3OU9) and as
monomer (PDB code: 3LYF). Color code is the same as in Figure 3.
(B) Side and top view of a superimposition of the two crystal
structures based on the core domain. The hexamer structure is
shown in orange (PDb code: 3OU9) and the monomer structure in
purple (PDB code: (PDB code: 3LYF [15]). The rmsd between the
backbone atoms of the core domains is,0.7 A˚. The U-shaped
arrow indicates the movement of the N-terminal arm.
(TIF)
Figure S4 Multiple sequence alignment of N proteins from the
Phlebovirus family. Invariant residues are shown in white with red
background, conserved residues are shown in red with white
background, and variable residues are shown in black with white
background. The secondary structure elements are indicated
above the alignment with the same color code used in Figure 3.
The sequence alignment was generated with ClustalW, and
secondary structure was assigned with ESPript. The sequences and
their database accession numbers are: Rift Valley fever virus (GI
9632367), Phlebovirus sp. Be Ar 371637 (GI 146336853),
Phlebovirus sp. VP-161A (GI 146336850), Phlebovirus sp. PAN
483391 (GI 146336925) Phlebovirus sp. Pa Ar 2381 (GI
146336916), Punta Toro virus (GI 146336898), Phlebovirus sp.
GML 902878 (GI 146336904), Phlebovirus sp. VP-366G (GI
146336907), Phlebovirus sp. Co Ar 171616 (GI 146336901),
Buenaventura virus (GI 146336910), Sandfly fever sicilian virus
(GI 146336868), Corfou virus (GI 146336856), Massilia virus (GI
208610196), Sandfly fever Naples virus (GI 146336886), and
Uukuniemi virus (GI 38371708).
(TIF)
Figure S5 Comparison of hexamers formed by native and
seleniated RVFV N. (A) The left panel shows hexamers I and II
formed by native protein in pink and cyan, respectively, and the
right panel shows hexamers I and II formed by seleniated protein
in marine and yellow, respectively. Hexamer I formed by
seleniated N has a different organization from all the other
hexamers. (B) Superimposition of hexamer I formed by native N
(pink) with hexamers II formed by native and seleniated N (cyan
and yellow), showing that the subunits in these rings have an
identical arrangement. (C) Superimposition of hexamer I formed
by native N (pink) with hexamer I formed by seleniated N
(marine), revealing an 11u rotation between the planes of the two
rings.
(TIF)
Figure S6 Structural variability in the N protein and in N-N
interactions. (A) N-N interaction in hexamer I formed by the
native protein. In panels A to C, the subunit shown in grey surface
representation is fixed, with the hydrophobic groove shown in
color, and the interacting subunit is shown in wire mesh. (B) N-N
interaction in hexamer I formed by the seleniated protein.
(C) Comparison of the N-N interactions shown in panels A and
B. The superimposition reveals a shift of the protein core with
respect to the N-terminal arm (lateral slippage). (D) Comparison
of the relative position of the N-terminal arm in hexamer I formed
by the native protein (top panel) and hexamer I formed by the
seleniated protein (bottom panel). In panels D to G, the native
proteins are shown in cyan and yellow and the seleniated proteins
in marine and brown. (E) Comparison of the angle between two
subunits in hexamer I formed by the native protein (top panel) and
hexamer I formed by the seleniated protein (bottom panel),
showing that the angle is identical. (F) Comparison of the relative
position of two subunits in hexamer I formed by the native protein
(left panel) and hexamer I formed by the seleniated protein (right
panel), showing a deviation of 11u between the two monomers.
(G) The arrangement of the cores of two subunits shows a lateral
slippage of 2.3 A˚.
(TIF)
Figure S7 The R64D/K67D/K74D triple mutant fails to bind
RNA. (A) Elution profile of the R64D/K67D/K74D triple N
mutant from a S200 size exclusion column. The blue line shows
the absorbance at 280 nm. The inset shows a 12.5% SDS-PAGE
gel of the elution fractions of the peak, revealing a protein band at
27 kDa. (B) Surface plasmon resonance profile for binding of a
20-nucleotides-long RNA by wild-type N (blue line) and the triple
mutant (red line). Association and dissociation phases were
measured for 100 sec and 500 sec, respectively.
(TIF)
Figure S8 Modeling of an RNA molecule into the basic cleft of
an RVFV N dimer. The RNA molecule was positioned based on
the RNA seen in the structure of the N protein from RV (PDB
code: 2GTT; [11]) with some manual adjustments in order to fit
the RNA molecule into the cavity. The RNA is colored according
to the atoms, with carbon in white, oxygen in red, phosphate in
orange, and nitrogen in blue. Positively charged residues that were
substituted in the triple mutant are shown as sticks and labeled.
(TIF)
Figure S9 Class averages of cryo-negatively stained N-RNA
oligomers. The 100 class averages, obtained from the classification
of 10,764 particles, are arranged according to particle number
such that the upper-left panel shows the average with the most
particles and the lower-right panel shows the average with the least
particles. The side length of the individual panels is 24 nm.
(TIF)
Figure S10 Fourier shell correlation (FSC) curve of the single-
particle EM reconstruction of the hexameric N-RNA complex.
The actual FSC curve (dashed line) and a smoothened
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representation (continuous line), suggesting that the density map
has a resolution of 25 A˚ according to the FSC=0.5 criterion.
(TIF)
Figure S11 Intra-molecular interaction of the N-terminal arm
with its own core domain. (A) Surface representation of the N
protein in monomeric form (PDB code: 3LYF; [15]). The surface
is shown transparent and in purple except the hydrophobic
residues that interact with the N-terminal arm, which are shown in
green. The Ca backbone of N is shown in red and the side chains
of the residues of the N-terminal arm that interact with the
hydrophobic groove in the core domain are shown as yellow sticks.
(B) Amino acid sequence of the RVFV N polypeptide, showing
above the secondary structure elements derived from the crystal
structure. Below the sequence, residues are labeled that are
involved in intra-subunit interactions. Yellow dots indicate
residues of the N-terminal arm interacting with the core domain
and green bars indicate residues of the core domain interacting
with the N-terminal arm in the monomer (PDB: 3LYF). For
reference, residues involved in intermolecular interactions with the
N-terminal arm of an adjacent molecule are indicated by an
orange dot below the sequence (hexameric structure).
(TIF)
Video S1 Transition of the N-terminal arm between the
positions seen in the two crystal structures.The crystal structures
of monomeric N (PDB codes: 3LYF; [15]) and hexameric N (PDB
codes: 3OU9) were overlayed based on the core domain, and the
movement of the N-terminal arm between the positions seen in the
two crystal structures was simulated using the program LSQMAN.
The N-terminal arm is shown in red, the globular core domain in
brown and green, and the C terminus in blue.
(MOV)
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Cellular and viral S-adenosylmethionine-dependent methyltransferases are involved in many regulated processes such as
metabolism, detoxification, signal transduction, chromatin remodeling, nucleic acid processing, and mRNA capping. The
Severe Acute Respiratory Syndrome coronavirus nsp16 protein is a S-adenosylmethionine-dependent (nucleoside-29-O)-
methyltransferase only active in the presence of its activating partner nsp10. We report the nsp10/nsp16 complex structure
at 2.0 A˚ resolution, which shows nsp10 bound to nsp16 through a,930 A˚2 surface area in nsp10. Functional assays identify
key residues involved in nsp10/nsp16 association, and in RNA binding or catalysis, the latter likely through a SN2-like
mechanism. We present two other crystal structures, the inhibitor Sinefungin bound in the S-adenosylmethionine binding
pocket and the tighter complex nsp10(Y96F)/nsp16, providing the first structural insight into the regulation of RNA capping
enzymes in (+)RNA viruses.
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Introduction
Most eukaryotic cellular and viral mRNAs are modified by the
addition of a polyadenine tail at the 39- terminal and a cap
structure at the 59-terminal. The RNA cap protects mRNA from
degradation by 59 exoribonucleases, ensures efficient mRNA
translation, and prevents recognition of viral RNA via innate
immunity mechanisms[1,2,3,4]. The RNA cap is made of an N7-
methylated guanine nucleotide connected through a 59-59
triphosphate bridge to the first transcribed nucleotide, generally
an adenine. Through 29-O methylation of the latter, this cap-0
structure (7MeGpppA…) may be converted into a cap-1 structure
(7MeGpppA29-O-Me…). In the eukaryotic cell, the cap is added co-
transcriptionally in the nucleus by three sequential enzymatic
reactions[1,5]: (i) an RNA triphosphatase (RTPase) removes the 59
c-phosphate group of the nascent mRNA; (ii) a guanylyltransferase
(GTase), dubbed capping enzyme, catalyses the attachment of
GMP to the 59-diphosphate mRNA; and (iii) an S-adenosylme-
thionine (SAM)-dependent (N7-guanine)-methyltransferase
(N7MTase) methylates the cap onto the N7-guanine, releasing
S-adenosylhomocysteine (SAH). In general, a SAM-dependent
(nucleoside-29-O-)-methyltransferase (29-O-MTase) further inter-
venes, in higher eukaryotes, to yield a cap-1 structure.
The viral RNA capping machinery is structurally and
mechanistically diverse, and RNA viruses often deviate from the
paradigmic eukaryotic mRNA capping scheme. For example,
alphaviruses methylate GTP onto the N7-guanine before the
presumed attachment of 7MeGMP to the nascent viral 59-
diphosphate mRNA[6]. In the case of single-stranded negative-
sense (-)RNA viruses, such as the vesicular stomatitis virus, the L
polymerase attaches GDP rather than GMP to a nascent viral 59-
monophosphate mRNA, covalently linked to the viral capping
enzyme[7]. Other viruses, such as influenza virus capture a short
capped RNA oligonucleotide from host cell mRNAs and use it as
an RNA synthesis primer. This process is known as « cap
snatching »[8].
In 2003, a novel coronavirus named Severe Acute Respiratory
Syndrome coronavirus (SARS-CoV[9]) was responsible for the first
viral pandemic of the new millennium with ,8000 cases globally
and a 10 % case-fatality rate. Coronaviruses encode an unusually
large membrane-associated RNA replication/transcription machin-
ery comprising at least sixteen proteins (nsp1-to-16)[10]. For
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SARS-CoV, the RNA cap structure likely corresponds to a cap-1
type[11,12,13]. As in many other (+)RNA viruses, the RTPase
activity is presumably embedded in the RNA helicase nsp13,
whereas the GTase remains elusive. RNA cap 29-O-MTase activity
was first discovered in the feline coronavirus (FCoV) nsp16[14].
Shortly after, SARS-CoV nsp14 was shown to methylate RNA caps
in their N7-guanine position[15]. Curiously, although closely
homologous to that of FCoV, recombinant SARS-CoV nsp16
alone was devoid of enzymatic activity. It was demonstrat-
ed[16,17,18,19] that nsp10 interacts with nsp16, conferring 29-O-
MTase activity to nsp16 on N7-methyl guanine RNA caps
selectively[16]. The latter selectivity implies that RNA cap
methylation obeys an ordered sequence of events during which
nsp14-mediated N7-guanine methylation precedes nsp10/nsp16
RNA 29-Omethylation. Nsp10 is a double zinc finger protein of 148
residues whose crystal structure is known[20,21]. Together with
nsp4, nsp5, nsp12, nsp14, and nsp16, nsp10 has been found to be
essential in the assembly of a functional replication/transcription
complex[22]. Drawing on these observations, nsp10 has been
proposed to play pleiotropic roles in viral RNA synthesis[23] and
polyprotein processing through interaction with the main protease
nsp5[24].
SAM-dependent MTases belong to a large class of enzymes
present in all life forms. These enzymes catalyze the transfer of the
SAM methyl group to a wide spectrum of methyl acceptors,
indicating that a common chemical reaction is used on a variable
active-site environment able to activate the methyl acceptor atom.
Although SAM-dependent MTases share little sequence identity,
29O-MTases exhibit a KDKE catalytic tetrad and a very
conserved folding made of a seven-stranded b-sheet surrounded
by one to three helices on each side[25], always similar to the
paradigmatic catechol-O-MTase[26]. The SAM binding site
general location is conserved, suggesting that evolutionary pressure
on the MTase fold has maintained the same SAM-binding region
whilst accommodating the versatile chemistry of the methyltrans-
fer reaction.
Structural and functional studies of viral MTases involved in
RNA capping is an expanding research area, since these enzymes
show unexpected diversity relative to their cellular counterparts,
and thus constitute attractive antiviral targets. Crystal structures of
viral RNA cap MTases exist for only three viral families, namely
Poxviridae, Reoviridae, and Flaviviridae. The Vaccinia virus VP39
crystal structure was the first to be elucidated in 1996[27]. The
structure of this DNA virus RNA 29-O-MTase revealed a
conserved MTase fold similar to that of RrmJ (also named FtsJ),
the canonical reference folding for RNA cap MTases[26]. More
recently, the crystal structure of a second Vaccinia virus N7-
guanine RNA cap MTase domain (D1) was determined in
complex with its activator protein D12[28]. The study revealed
that D12 also bears an MTase fold, but has lost catalytic capability
due to truncation of its SAM binding site. In turn, Reoviridae
provided the first RNA cap MTase structures at 3.6 A˚ resolution
as forming part of the reovirus core[29]. Another RNA cap
machinery was more recently described for the non-turreted
orbivirus Bluetongue virus VP4 protein at 2.5 A˚ resolution[30],
which revealed a three-domain protein, with a ‘‘head’’ guanylyl-
transferase domain, a central N7-guanine MTase, and a ‘‘bottom’’
29-O-MTase domain. This architecture illustrates the sequence of
three out of the four chemical reactions involved in RNA capping
described above.
Regarding (+)RNA viruses, MTase structural information at the
atomic level is only available for a single genus. The flavivirus N-
terminus domain (residues 1–265) of the NS5 RNA-dependent
RNA polymerase harbors an RrmJ fold with an N-terminus
extension able to accommodate RNA cap structures[31,32]. This
enzyme carries both N7-guanine MTase and 29-O-MTase
activities on a single domain with one shared active site[33].
Homologous domains have been crystallized for a number of
flaviviruses, revealing a conserved fold and activity[34], suggesting
that MTases might represent interesting targets for drug design.
No other (+)RNA virus RNA cap MTase crystal structures have as
yet been defined.
In 2003, the identification of the 29-O-MTase signature
sequence in the SARS-CoV genome added nsp16 to the list of
putative targets for antiviral drugs[35]. Several compounds have
been shown to inhibit viral MTases, such as the co-product of the
MTase reaction SAH, Sinefungin, and aurintricarboxylic acid
(ATA)[14,36,37,38,39]. In this paper, we report the crystal
structure of the SARS-CoV 29-O-MTase nsp16 in complex with
its activator, the zinc finger protein nsp10, at 2.0 A˚ resolution, in
conjunction with mutagenesis experiments, binding and activity
assays. These results lay down the structural basis for the nsp10
function as an activator of nsp16-mediated 29-O-MTase. We
identify residues playing key roles in the nsp10/nsp16 interaction,
as well as other residues involved in 29-O-MTase catalysis and
RNA binding. We also report the crystal structure of the nsp10/
nsp16 complex bound to the inhibitor Sinefungin. Comparison
with known cellular SAM binding sites points to the nsp16
nucleobase binding pocket as a possible target for the design of
selective antiviral molecules.
Results
Crystallization and Structure Determination of an Active
nsp16 29-O-MTase
We observed that purified nsp16 was unstable in solution,
impeding crystallogenesis. Yeast double-hybrid and co-immuno-
precipitation experiments on purified SARS-CoV nsp10 and
nsp16 have uncovered the reciprocal interaction of these two
proteins[16,17,18]. Indeed, SARS-CoV nsp16 exhibits 29-O-
MTase activity only when complemented with SARS-CoV
nsp10, raising the interesting possibility that nsp10 acted as a
Author Summary
A novel coronavirus emerged in 2003 and was identified as
the etiological agent of the deadly disease called Severe
Acute Respiratory Syndrome. This coronavirus replicates
and transcribes its giant genome using sixteen non-
structural proteins (nsp1-16). Viral RNAs are capped to
ensure stability, efficient translation, and evading the
innate immunity system of the host cell. The nsp16 protein
is a RNA cap modifying enzyme only active in the presence
of its activating partner nsp10. We have crystallized the
nsp10/16 complex and report its crystal structure at atomic
resolution. Nsp10 binds to nsp16 through a ,930 A˚2
activation surface area in nsp10, and the resulting complex
exhibits RNA cap (nucleoside-29-O)-methyltransferase ac-
tivity. We have performed mutational and functional
assays to identify key residues involved in catalysis and/
or in RNA binding, and in the association of nsp10 to
nsp16. We present two additional crystal structures, that of
the known inhibitor Sinefungin bound in the SAM binding
pocket, and that of a tighter complex made of the mutant
nsp10(Y96F) bound to nsp16. Our study provides a basis
for antiviral drug design as well as the first structural
insight into the regulation of RNA capping enzymes in
(+)RNA viruses.
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scaffold for nsp16. Co-expression of nsp10 and nsp16 using a bi-
cistronic prokaryotic expression vector facilitated affinity chroma-
tography purification and crystallization of the complex[16,40].
Crystals diffracted to ,1.9 A˚. The position of the nsp10 protein
was determined using molecular replacement with the SARS-CoV
nsp10 protein structure[20] as a search model. Strong peaks in
both the residual and anomalous Fourier maps confirmed the
presence of two zinc ions. Nsp16 was well defined by its electron
density except for two flexible loops (residues 19–35 and 135–137)
with high B factors and weak or missing electron density. These
loops are solvent-exposed at each side of the putative RNA-
binding groove (see below). Structure determination data and
refinement statistics are reported in Table 1.
Structure of the nsp10/16 Heterodimer
The heterodimer can be conveniently viewed as nsp16 sitting on
top of a nsp10 monomer (Fig. 1A). The nsp10 overall structure in
the complex remains essentially unchanged relative to published
structures of nsp10 alone, with its N-terminus comprising two a-
helices, a central b-sheet domain, and a C-terminus domain
containing various loops and helices (see[20,21], Fig. 1B).
Comparison with existing crystal structures of nsp10 using
DaliLite[41] rendered nsp10 atomic coordinates very similar to
those of nsp10 in our nsp10/nsp16 complex. The average RMSD
is about 0.77 A˚ in 118 residues (PDB codes 2FYG, 2G9T and
2GA6[20,21]). This indicates that neither significant conforma-
tional change nor surface modification occurs in nsp10 when
binding to nsp16. The nsp10 structural Zn2+ ions are not directly
involved in the nsp10/nsp16 interface (Fig. 1A).
Nsp16 adopts a canonical SAM-MT fold (Figs. 1B, 2A and B),
as defined initially for the catechol O-MTase[25]. The seven-
stranded b-sheet MTase fold has been described as having a
secondary structure topology defining two binding domains, one
for SAM and the other for the methyl acceptor substrate (Fig. 2A).
The nsp16 topology matches those of dengue virus NS5
N-terminal domain and of vaccinia virus VP39 MTases[27,31].
Nsp16 lacks several elements of the canonical MTase fold, such as
helices B and C (Fig. 2B).
S-adenosylhomocysteine- and Sinefungin-Binding
Electron density corresponding to one molecule of S-adeno-
sylhomocysteine (SAH), the co-product of the methylation
reaction, was identified in the putative SAM-binding site
(Figs. 1A and 3A). Neither SAM nor SAH was added to the
purification or crystallization buffers, therefore it must have been
captured from the medium by nsp16 during bacterial growth. The
SAH molecule is found with its adenine in an anti conformation
and the ribose pucker in a southern (29-endo/39-exo) conformation.
All the residues involved in SAM/SAH binding are absolutely
conserved in coronavirus np16s (Fig. S1). Binding specificity for
SAM/SAH is achieved by holding distal SAM/SAH carboxylic
and amino groups through five hydrogen bonds (G81, N43, Y47,
G71, and D130) (Fig. 3A and Fig. S2A). The ribose moiety is held
by three hydrogen bonds involving Y132, G73, and D99. As in the
case of other MTases[25], the SAH binding cleft is globally
positively charged. However, an aspartic acid (D99) acts as the
ribose-sensing residue with its side chain carboxyl making strong
hydrogen bonds with both ribose hydroxyls (Fig. S2A). Binding of
the adenine base involves few contacts. The nucleobase occupies a
loose hydrophobic pocket engaging two hydrogen bonds of
moderate strength with side chain and main chain atoms of
conserved residues D114 and C115, respectively.
Soaking the crystals into a Sinefungin-containing buffer
captured this MTase inhibitor in the SAH binding site almost
perfectly superimposable on SAH (Fig. 3B and Fig. S2B). Binding
involved the same residues and contacts as SAH. Inhibition of the
MTase reaction by Sinefungin therefore probably occurs compet-
itively. The Sinefungin amino group quasi-isosteric to the donated
SAM methyl group indicates a cavity where the 29-hydroxyl of the
capped RNA is expected to bind. Lining this empty substrate
Table 1. Crystal, collection, structure determination data and refinement statistics.
DATA wild-type (SAH) nsp10(Y96F)/nsp16 wild-type (SFG)
Instrument SOLEIL, Proxima I ESRF ID14-1 ESRF ID23-1
Wavelength 0.9792 0.9334 0.9792
Space group C2221 C2221 C2221
Cell dimensions a, b, c (A˚) 68.07 184.62 128.83 68.15 184.80 129.01 68.42 185.04 129.46
Resolution range (A˚) 37.52-2.00 (2.11 – 2.00)* 45.51-2.05 (2.17 – 2.05) 45.58 -2.50 (2.64 – 2.50)
Total number of reflections 201703 (29338) 187379 (27241) 211213 (30837)
Number of unique reflections 54947 (7963) 51033 (7362) 28921 (4163)
Completeness (%) 99.7 (100) 99.6 (100) 100 (100)
I/s(I) 7.1 (2.7) 7.5 (3.2) 12.5 (4.3)
Rsym ** 0.114 (0.430) 0.112 (0.350) 0.102 (0.400)
Multiplicity 3.7 (3.7) 3.7 (3.7) 7.3 (6.7)
Refinement (20 cycles)
R*** 0.213 0.200 0.201
Rfree 0.227 0.234 0.215
RMSD bond length (A˚) 0.007 0.007 0.011
RMSD bond angle (A˚) 1.015 0.968 1.250
*Values in parentheses give the high resolution shell values.
**Rsym =S |I-,I.|/S I.
***R =S||Fo|-|Fc||/S |Fo|.
doi:10.1371/journal.ppat.1002059.t001
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cavity are the residues proposed to be involved in the catalytic
reaction: K46, D130, K170, and E203[16]. Alanine substitutions
in the catalytic tetrad (K46, D130, K170, or E203) almost
completely block 29-O-MTase activity without jeopardizing
binding to nsp10 (Table 2, and [16]). Several SAM-binding
residues (N43, G73, D99 and Y132, Fig. S2A) were substituted by
alanine. Although they conserve their specific nsp10 binding
properties, indicating that they are correctly folded, they all show a
drastically reduced MTase activity (Table 2), validating the
structural description of the nsp10/nsp16/SAH ternary complex.
A Mg2+ Cation is Present in nsp16, Outside the Active Site
We recently reported[16] that nsp10/nsp16 MTase activity
requires Mg2+. Although the crystallization buffer contains Mg2+,
we were unable to locate any such cation in the nsp16 active site.
In enzyme activity assays, the Mg2+ ion can be substituted by
Mn2+ or Ca2+, but not Zn2+ (data not shown, see also[16]). A peak
of electron density presumably corresponding to Mg2+ is localized
onto nsp16, distant from the SAH-binding cavity. The Mg2+
coordination mode is through six first-shell water molecules in an
octahedral geometry (Fig. 4). Binding via water molecules, involves
T58 and S188 side chain hydroxyls and the main chain carbonyl
of E276. Since there are no carboxylic acids involved in binding
this cation, it was suspected that its presence resulted from the
crystallization procedure[42], with no biological relevance.
However, the T58A, T58N, T58E and S188A substitutions show
43, 70, 99 and 72% loss of activity, respectively (Table 2), with no
significant effect on the stability of the nsp10/nsp16 complex
except for T58E whose association was 54 % that of wild-type.
These residues are located on three distinct structural elements at
the C-terminus of helix Z (T58), the N-terminus of b6 (S188), and
in the central part of helix A3 (E276), respectively (Fig. 4 and Fig.
S3). The cation may thus hold these elements together.
The Putative RNA Binding Site: Mutagenesis and Effect
on Activity
The nsp10/nsp16 complex absolutely requires an N7-methyl
guanine capped RNA substrate to exhibit MTase activity[16]. The
structural basis for the preferential binding to methylated N7-
guanine versus non-methylated caps has been elucidated in four
cases, those of VP39[27], eIF4E[43], CBC[44], and PB2[45]
proteins (PDB codes 1AV6, 1EJ1, 1H2T, and 2VQZ, respectively)
Figure 1. Cartoon representation of the nsp10/nsp16 complex with the reaction product SAH and metal ions. A) The nsp16 protein
(green) is bound to nsp10 (yellow) through an interface which does not involve Zn ions (grey spheres) present in nsp10. One metal ion (blue sphere)
is found in nsp16 on the opposite face from the active site to which a SAH molecule is found (red sticks). B) Ribbon representation of nsp16, rainbow
colors from N- to C-terminus. Top: Each secondary structure element is labeled according to[25] (see also Fig. S3). The SAH molecule shown in sticks
colored following atom type. Bottom: View of interface involving nsp16 (green surface) and nsp10 (yellow ribbons) showing the nsp10 secondary
structure elements involved in the interface.
doi:10.1371/journal.ppat.1002059.g001
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bound to cap analogues or capped RNAs. In these cases, the
methylated base specificity is achieved through increased
binding energy resulting from the stacking of the N7-methyl
guanine between parallel aromatic residues of the cap binding
protein. The presence of the methyl group greatly enhances p-p
stacking, providing a dominant effect over unmethylated
guanine[46]. Despite numerous attempts, cap analogues
(m7GpppA, GpppA, m7GpppG, GpppG) and short capped
RNA substrates (m7GpppA(C)n) could neither be co-crystallized
with nsp10/nsp16 nor soaked and bound onto preformed
nsp10/nsp16 crystals. However, the atomic coordinates of the
N7-methyl guanine RNA oligomer in complex with VP39[47]
provided data from which a model of RNA binding to the nsp16
protein was derived. SAM molecules identified in both
structures were superimposed, and the VP39-bound RNA was
positioned onto the nsp16 structure. After minimal manual
adjustments not exceeding 5 A˚, the VP39 RNA was a
reasonably good fit into an nsp16 hydrophobic groove radiating
from the catalytic site (Fig. 5), establishing very few contacts
with nsp10. We note that the protein side diametrically opposite
Figure 2. Topology diagram of MTase secondary structure elements. A) The consensus topology diagram is shown with a two domain
organization for methyl acceptor substrate and SAM, as defined[25] with the catechol O-MTase and its canonical seven strand beta sheet. B) Topology
diagram of nsp16 colored according to rainbow colors from N-to C-terminus as in Fig. 1B. The missing helix B and helix C are indicated by dashed
ovals. The approximate general binding site of nsp10 is shown (yellow oval).
doi:10.1371/journal.ppat.1002059.g002
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to the proposed hydrophobic RNA binding groove is highly
positively charged (not shown), an observation that may account
for the difficulty of achieving experimental RNA binding in the
proposed RNA binding site. In the absence of robust data to
guide docking of the guanine cap, the m7Gpp cap structure was
not positioned in the structure but two possible N7-methylated
cap guanine binding areas are indicated by arrows (Fig. 5). The
first transcribed nucleotide together with its ribose receiving the
methyl group fit well in the active site (Fig. 5, panel B) as
predicted in the proposed mechanism. The same holds for the
immediately preceding three nucleotides. The base of the first
transcribed nucleotide may be held by contact with P134 and
Y132, bending the extending RNA cap structure. Accordingly,
the substitution of Y132 greatly depresses MTase activity
(Table 2). We also note that Y132 is located in the vicinity of
a highly mobile loop (residues 135-138) not always visible in our
crystal structures suggesting that this loop may move in order to
wrap the triphosphate moiety of the RNA cap and/or the RNA
cap itself. The solvent exposed side chain of Y30 may also
participate in RNA binding. In the model, the highly mobile
side chain of Y30 was flipped out in an alternative conformation
in order to open the groove. In that position, Y30 should
specifically contact the third transcribed nucleotide. Our
mutagenesis data confirms the importance of Y30 since its
replacement with either Ala or Phe severely impairs MTase
activity without affecting the interaction with nsp10 (Table 2).
Interface of the Heterodimer
All nsp10 secondary structure elements but helices 2 and 5
contact nsp16 (Fig. 1). The nsp10 contact points can be viewed as
5 small patches A to E (residues 40–47, 57–59, 69–72, 77–80, and
93–96, respectively, Fig. 6A). In turn, these five patches contact
most of the nsp16 SAM-binding structural elements in 4 areas, I to
IV (Fig. 6B, Fig. S3)), mainly involving b2, b3, aA, aZ, and for
area IV, the loop connecting helices A2 and A3 at the C-terminus
(Figs. 1 and 6). In total, the interface of the heterodimer involves
53 residues, 23 and 30 from nsp10 and nsp16, respectively. In
nsp10, a single residue (Asn10, at the edge of the interaction
surface) is not conserved out of 23 (4.3 %), whereas in nsp16 there
are 8 non-conserved residues out of 30 (26.7 %) (Fig. S1). The
interface has a buried surface area of 1820 A˚2, with nsp10
contributing to 930 A˚2 and nsp16 to 890 A˚2.
Four nsp10 patches included in the 5 interaction patches
identified here were recently mapped using reverse yeast two-
hybrid methods coupled to bioluminescence resonance energy
transfer and in vitro pull-down assays (see[18] and below). To probe
the observed crystal structure of the interface further, we
engineered 5 new nsp10 alanine mutants (N40A, L45A, T58A,
G69A, and H80A, see Table S1) sitting in patches A, B, C and D.
Whereas T58A, G69A and H80A showed limited effect on nsp16
binding, N40A reduced it to 64% of wild type affinity, and L45A
almost abrogated it. The crystal structure indicates that the nsp10
interface proposed by Lugari et al.[18], is a correct and
conservative estimation, as the interface also includes L45
belonging to patch A. We also confirm the positive co-relation
of the detected nsp10/nsp16 interaction with MTase activity. In
no instance can nsp16 be active in the absence of nsp10/16
complex formation.
The Y96 position is of particular interest. Alanine substitution
(Y96A) abrogates interaction whereas a phenylalanine (Y96F)
increases both interaction and MTase activity[18]. In order to
understand how residue 96 plays such a pivotal role, we
determined at 2.0 A˚ resolution the crystal structure of this
nsp10(Y96F)/nsp16 complex (Table 1). Strikingly, the absence of
the hydroxyl group does not alter the topology of the interface.
Wild-type and Y96F residues superimpose without significant
difference at all atomic positions (not shown). Either Y96 or F96 is
in direct contact with nsp16 helix aZ, which carries the catalytic
residue K46. Detailed surface analysis using PISA indicates that
the position of K46 in Y96F nsp10 is identical to that of K46 in
wild-type nsp10, ruling out a better alignment of catalytic residues
of the Y96F mutant. The nsp10(Y96F)/nsp16 differs from wild-
type nsp10/nsp16 in the SAH binding site, though. When
compared to that of wild-type, the SAH occupancy is much lower
Figure 3. The SAM binding site of nsp16. A) SAH modeled in a simulated annealing Omit map contoured at 1s. Carbons, oxygens, sulfur, and
nitrogens are in grey, red, yellow, and blue sticks, respectively. Water molecules are shown as red spheres. B) Sinefungin bound in the SAM/SAH
binding site, with main catalytic residues and the water molecule indicative of a catalytic mechanism. Colors as in A). C) SAH modeled in a 2Fo-Fc map
(green) of Sinefungin contoured at 1s with a Fo-Fc difference map (red) contoured at 3s. A peak of negative density appears clearly on the sulfur
atom of the SAH molecule showing that SAH was indeed replaced by Sinefungin. Colors as in A).
doi:10.1371/journal.ppat.1002059.g003
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(,0.3 versus ,1), leading to poor density definition. SAH is
known to be a fairly good inhibitor of the methylation reaction.
Therefore, a lower binding affinity might translate into less end-
product inhibition, and account for the observed increased
activity. We measured the affinity of nsp16 for SAH using
fluorescence spectroscopy, but no significant differences were
found (not shown). Likewise, the MTase inhibition pattern by
SAH was identical for wild-type and nsp10(Y96F)/nsp16 (not
shown). We therefore infer that the previously observed ,10-fold
increased stability of the heterodimer[18] may be responsible for
the increased activity. A more hydrophobic character of the
interaction may appear upon the loss of the tyrosine hydroxyl
which, in the wild-type protein, was not engaged in any polar
contact. We thus attribute the increased activity of the
nsp10(Y96F)/nsp16 complex relative to wild-type to a stronger
equilibrium association of nsp10(Y96F) with nsp16 than that of
wild-type nsp10 with nsp16.
Mutation analysis was also conducted on nsp16 residues
presumably involved in the interface and interfacial activation
(Tables 2 and S2). Several mutants (V78A, V104A, L244A,
M247A) in patches II, III and IV completely disrupt the nsp10/
nsp16 complex and annihilate nsp16 MTase activity. Interestingly,
we also identified nsp16 mutants still interacting with nsp10, but
with a strongly reduced 29-O-MTase activity (I40A, M41A, V44A,
T48A, Q87A, D106A) suggesting, that these mutations in the
nsp10/nsp16 interface may alter the fine positioning of catalytic
residues without any significant effect on nsp10 binding.
Accordingly, most of these mutants are localized in aZ helix of
Table 2. Mutational analysis, complex formation, and enzyme activity of the nsp10/nsp16 complex.
Number Function* Mutant % associated** % MTase act. ***
1= Wild-Type Wild-TypE Wild-Type 100 100
2 Catalytic K46A 97 1
3 Catalytic D130A 104 2
4 Catalytic K170A 95 0
5 Catalytic E203A 93 0
6 SAM-BS N43A 144 11
7 SAM-BS G73A 119 18
8 SAM-BS D99A 57 0
9 Mg2+-BS T58A 123 57
10 Mg2+-BS T58N 110 30
11 Mg2+-BS T58E 54 1
12 Mg2+-BS S188A 102 28
13 RNA/SAM-BS Y132A 86 5
14 RNA/SAM-BS Y132T 95 5
15 RNA/SAM-BS Y132F 123 9
16 RNA/SAM-BS Y132H 106 0
17 RNA-BS Y30A 89 1
18 RNA-BS Y30F 113 6
Interface mutants
Number Location* Mutant % associated** % MTase act. ***
19 Patch I I40A 84 8
20 Patch I M41A 122 4
21 Patch I V44A 113 1
22 Patch I T48A 123 20
23 Patch II V78A 3 0
24 Patch II R86A 61 0
25 Patch II Q87A 114 62
26 Patch III V104G 6 4
27 Patch III D106A 101 38
28 Patch IV L244A 30 0
29 Patch IV M247A 4 0
*as inferred from the crystal structure.
**nsp10/nsp16 complex formation as determined using pull-down experiments, SDS-PAGE analysis, and quantitation (see Methods).
***The % of MTase activity was determined using filter binding assays (see Methods) relative to wild-type.
SAM-BS: S-adenosylmethionine binding site.
Mg2+-BS: Magnesium binding site.
RNA-BS: RNA binding site.
doi:10.1371/journal.ppat.1002059.t002
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patch I which contains the K46 catalytic residue. On the other
hand, patch II and III mutants tend to have more mitigated
phenotypes, yielding to full-blown interaction with only about half
of the expected activity. Finally, patch IV mutants were totally
inactive. Using all mutants reported in Table 2, a plot (Fig. 6C) of
interaction versus activity shows that the nsp10/nsp16 interaction
is strictly required to obtain significant nsp16 MTase activity.
Discussion
Mechanism of 29-O-Methyltransfer
The SARS-CoV RNA cap 29-O-MTase is a heterodimer
comprising SARS-CoV nsp10 and nsp16. When bound to nsp10,
nsp16 is active as a type-0 RNA cap-dependent 29-O-MTase, ie.,
active only when the cap guanine is methylated at its N7
position[16]. The nsp10/nsp16 crystal structure shows that nsp16
adopts a typical fold of the S-adenosylmethionine-dependent
methyltransferase family as defined initially for the catechol O-
MTase[25]. A good alignment (170u) is found between the SAH
sulfur atom, a water molecule present in both SAH- and sinefungin-
bound nsp16 structures, and the K46 e-amino group (Fig. 3A and
B). This geometry provides interesting hints for a catalytic
mechanism, as the positions of the catalytic residues (K46, D130,
K170, E203) match spatially those of the vaccinia virus VP39 29-O-
MTase[47]. At the initial stage of the reaction the 29-hydroxyl of the
capped RNA substrate would occupy the position of the water
molecule. In turn, E203 and K170 decrease the pKa of the K46 e-
amino group that becomes a deprotonated general base (-NH2) able
to activate the RNA 29-hydroxyl at neutral pH. In VP39, K175 has
been identified as the general base catalyst[47] with a pKa
depressed by , 2 pH units by the neighbouring D138 and R209
residues[48]. These findings indeed suggest a related mechanism:
once K46 has activated the 29-hydroxyl group, the 29-oxygen would
produce an in line attack through a SN2-like mechanism onto the
electrophilic SAM methyl group. The methyl group would pass
through a pentavalent intermediate with the 29-O and sulfur at
apical positions. D130 is positioned to stabilize the transient positive
charge on the donated methyl atom of SAM before the sulfur
recovers a neutral electric charge during SAH generation (Fig. 3B).
Role of Mg2+ on MTase Activity
Unlike most SAM-dependent MTases, the SARS-CoV nsp10/
nsp16 enzyme requires a divalent cation, either magnesium,
manganese or calcium[25]. We have found that this cation does
Figure 4. Position and coordination of a metal ion. Left, the putative Mg2+ ion (blue sphere) is shown solvated in its first atomic shell by six
water molecules (red spheres). The corresponding 2Fo-Fc electron density map (contoured 1s) with a cross shape is shown in purple. Residues of
Nsp16 involved in coordination of Mg2+ ion via water molecules are labeled. Right, a global view of the bound metal ion in its electron density on the
opposite side from the SAH molecule (red sticks). Nsp16 is shown as green ribbons, nsp10 as yellow ribbons with its two bound Zn2+ as grey spheres
as in Fig. 1.
doi:10.1371/journal.ppat.1002059.g004
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not reside in the active site. Instead, the cation is coordinated
through water molecules by three residues located on three distinct
structural elements. It is thus possible that one divalent cation,
presumably Mg2+, present in the host cell at millimolar levels,
plays a structural role in holding these three nsp16 structural
elements together and so regulate the enzyme activity. It is
intriguing that T58A is more active than T58N or T58E that can
still bind the water that chelates to the metal. Alternatively, it is
possible that divalent cations such as Mg2+ or Ca2+ act as a
phosphodiester charge shield to allow RNA binding in the
hydrophobic binding groove[49].
MTase Activity is Regulated via Protein-Protein
Interactions
The main regulation mechanism of nsp16 is through its physical
association with nsp10. Nsp16 is unstable in solution, and nsp10
acts as a scaffold for nsp16, yielding a stable dimer active as an
RNA cap-dependent (nucleoside-29-O)-MTase. The complex is
assembled through a ,890 A˚2 contact surface in nsp16, an area
typically in the intermediate zone differentiating strongly from
weakly associated dimers[50]. This finding is consistent with a Kd
estimated at,0.8 mM[18] that qualifies the nsp10/nsp16 complex
as a rather weak heterodimer. The nsp10 interaction surface
identified in the crystal structure was confirmed by site-directed
mutagenesis and overlaps that previously identified by indirect
methods[18]. Remarkably, the nsp10 surface in the nsp10/nsp16
complex is essentially identical to that of uncomplexed nsp10
crystallized alone by others[20,21](Fig. S4). It is therefore
reasonable to see this heterodimer as a non-permanent species
which would tolerate nsp10 or nsp16 engaging in interactions with
other partners. This notion is actually in line with the involvement
of nsp10 in a network of protein-protein interactions that we and
others have proposed[17,19]. Donaldson et al.[23] have engi-
neered mutations in nsp10 using reverse genetics. Out of eight
mutations that turned out to be in the nsp10/nsp16 interface (this
work), five, two and one rendered lethal, debilitated, and viable
phenotypes, respectively[23]. Interestingly, the nsp10(Q65E)
mutant providing a temperature-sensitive phenotype[22,23] does
not map in the nsp10/nsp16 interface, confirming that nsp10 has
a pleı¨otropic role.
Our mutagenesis analysis shows that the formation of an nsp10/
nsp16 complex is a pre-requisite for MTase activity (Fig. 6C)
indicating that physical association of nsp10 and nsp16 is essential
to activate nsp16 29-O-MTase activity and foster efficient virus
Figure 5. Stick model of RNA bound to the nsp16 RNA binding groove and Sinefungin in the methyltransferase active site. A) In this
representation, Sinefungin was preferred over SAH because one of its NH2 groups approximates the direction of a transferred CH3 group from the
SAM substrate. Carbon is white, oxygen is red, nitrogen is blue and phosphorous is orange. Nsp16 and nsp10 are rendered as a solvent-accessible
surface colored grey and wheat respectively. The Sinefungin molecule defines the methyltransferase active site. Missing residues in the 135-137 loop
(see text) are indicated by a shaded blue dotted box. Position of Y30 and Y132 are indicated. Y30 generated poor electron density (see « Methods »)
and its aromatic ring position has been manually adjusted before generation of this image. B) Close caption of the methyltransferase active site
showing distance between the NH2 of Sinefungin to the 29-O of the ribose of the first base, thus mimicking the position of the methyl of the S-
adenosylmethionine.
doi:10.1371/journal.ppat.1002059.g005
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replication. We note that most interface mutants exhibit a severe
loss of their 29-O-MTase activity, whereas the apparent associa-
tion affinity is often only modestly affected. That minor changes in
the interface translate into potent effects is also dramatically
illustrated by the Y96F mutation, where the loss of a single
hydroxyl provokes a significant change in affinity[18]. Remark-
ably, it is not the most active complex that was selected in nature,
since the nsp10(Y96F)/nsp16 complex is both more stable and
more active than the wild-type heterodimer (this work and[18]).
This is yet another observation hinting at the involvement of nsp10
in protein-protein interaction networks including other partners
than nsp16, such as nsp5 and nsp14[17,19]. In most other
coronaviruses, the nsp10 residue at position 96 is a phenylalanine.
It would be interesting to determine whether this polymorphism is
relevant to the SARS-CoV pathogenicity at any (direct or indirect)
level, or if compensating polymorphisms in other coronaviral
nsp10 (or nsp16) restore a weaker nsp10/nsp16 association
equivalent to that of the SARS-CoV pair. Since a bona fide viral
RNA cap is key in evading the host cell innate immunity[4,51], a
minimal level of 29-O-MTase activity would be expected to be
critical to virus survival.
MTase activation through dimerisation of two viral protein
partners has already been reported in the case of the vaccinia virus
D1/D12 N7-guanine MTase[28]. However, the activating D12
subunit does not contact the D1 subunit through a homologous
surface mainly defined by canonical aA and aZ helices. Rather,
the D1/D12 activation surface would be located at a 90u clockwise
rotation relative to the nsp10/nsp16 interface depicted in Fig. 1A.
In the case of dengue virus, the bi-functional N7-guanine and 29-
O-MTase is part of the N-terminus of the dengue NS5 protein.
Based on reverse genetic data and modeling[52], the MTase
domain would be associated with the Pol domain through an
interface topologically similar to that of nsp10/nsp16, i.e.,
involving mainly helices aA, aZ and strands b2 and b3 as
depicted in Fig. 1A.
We have previously shown that the nsp10/nsp16 is only active
as N7-guanine methylated capped RNA, implying that RNA cap
methylation obeys to an ordered sequence of events where nsp14-
mediated N7-guanine methylation precedes nsp10/nsp16 RNA
29-O methylation[16]. In the absence of data regarding the RNA
substrate, we built a model of RNA binding based on that of the
vaccinia virus VP39 ternary complex structure. Interestingly, our
model proposes that the RNA interacts only with nsp16 residues,
in keeping with what was recently suggested based on RNA
binding assays[14]. Although the position of the cap structure on
the nsp16 surface remains to be determined, our model suggests a
well-defined position for the ribose of the first transcribed
nucleotide in the active site. In agreement with mutagenesis
analysis, the model also suggests that the transcribed RNA 59-end
stacks between Y132 and Y30. Furthermore, this model is
consistent with the observation that coronavirus MTase requires
RNA substrates of at least 3 transcribed nucleotides in length[14].
It is also worth to know that a comparison of nsp16 and VP39
electrostatic surfaces reveals that the putative RNA-binding groove
of nsp16 is mostly hydrophobic, whereas the VP39 RNA-binding
groove is positively charged. This variation would imply a change
in the nature of the RNA/protein interaction.
Binding of Sinefungin to nsp16/nsp10 Suggests
Feasibility of a Drug Design Approach to Inhibit MTase
Activity
Viral MTases are increasingly evaluated as potential drug
design targets[34,37,53]. We have crystallized the inhibitor
Sinefungin with the nsp10/nsp16 complex. Sinefungin exhibits
an IC50 of 0.74 mM, 16-fold lower than that of SAH as reported by
Bouvet et al.[16] using purified nsp10/nsp16. Analysis of the
structure suggests a likely mechanism of action that also accounts
for the observed inhibitory effect of this drug. We note that the
adenine nucleobase does not fit snugly into its binding pocket,
raising interest regarding structure-based drug design. Preliminary
examination of eukaryotic non-viral MTase structures from main
classes as defined in Martin and McMillan[25] indicates that the
SAH adenine is bound tighter in any of the latter enzymes than in
the nsp16 SAM-binding site, indicating a possible breach to
achieve anti-coronavirus selectivity with a small molecule inhibitor
of nsp16.
In conclusion, the crystal structures presented here extend our
general understanding of the mechanism and regulation of viral
RNA cap MTases in (+)RNA viruses, and point to both the nsp10/
nsp16 interface and the substrate binding sites as putative antiviral
targets.
Methods
Crystallization and Data Collection
Both nsp10 and nsp16 were expressed from the same dual
expression vector pmCOX [16]. Nsp10 had a N-terminal strep-tag
(WSHPQFEK), and nsp16 a N-terminal hexa-histidine tag. The
purification and crystallogenesis of the nsp10/nsp16 complex was
performed as described in [40]. Typical crystals of the wild-type
nsp10/nsp16 appear in hanging drops after 24 h at 20uC in 0.1 M
CHES pH 9, 1.52 M MgCl2 hexahydrate. Crystals (a = 68.53 A˚,
b = 184.74 A˚, c = 129.01 A˚, C2221) contain one nsp10/nsp16
complex per asymmetric unit, with a solvent content of 70 % and
Vm of 4.17 A˚
3/Da. Crystals of nsp10(Y96F)/nsp16 were grown in
67 mM CHES pH 8.5, 0.99 M MgCl2 hexahydrate, 33 mM Tris-
HCl, 8.3 % PEG 8000. Both crystallization conditions yielded
crystals diffracting to 1.9 A˚ when exposed to synchroton radiation
at the ID14-1 beamline of the European Synchrotron Radiation
Facility, Grenoble, France. Crystals were cryo-cooled in the same
buffer supplemented with 15 % glycerol. Crystal soaking was
performed in the same buffer supplemented with 5 mM SAH or
Sinefungin during 24 h.
Structure Determination and Refinement
The position of the nsp10 protein was unambiguously
determined by molecular replacement using the program
PHASER[54] with the nsp10 protein (2FYG), as search probe[20].
Strong peaks in both the residual and anomalous Fourier maps
confirmed the presence of two Zinc ions at the expected positions
within the nsp10 protein, thus giving confidence in the validity of
the MR solution. Phases calculated from this partial model were
combined with SAD phases from the Zn atoms using PHASER.
To ameliorate the resulting low quality density map, phases were
improved with PARROT[55]. An initial model, comprising both
Figure 6. Detailed definition of nsp16 and nsp10 elements involved in the interface. A) nsp16 (left) and nsp10 (right) are rendered as a
solvent-accessible surface colored green and yellow, respectively. Residues involved in the interface are rendered as sticks with the same color code,
in transparency into respective proteins. B) Separate representation of the nsp16 (left) and nsp10 (right) interface. Nsp16 residues defining patch I, II,
III, and IV are rendered as sticks as above in transparency into nsp16. Nsp10 residues defining patch A, B, C, D, and E are rendered as sticks as above in
transparency into nsp10. C) A plot of MTase activity as a function of nsp10/nsp16 complex formation using the data reported in Table 2.
doi:10.1371/journal.ppat.1002059.g006
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nsp10 and nsp16, was automatic built by successive use of
BUCCANEER[56] and ARP/wARP[57]. The resulting model
was subject to several cycles of manual rebuilding using COOT
[58] and refinement with REFMAC [59]. The protein structure
model could be built, except the strep and hexahistidine tags. In
nsp16, density was too weak for the mobile, solvent exposed nsp16
loop 136–139, Y30 (see ‘‘Results’’), and 2 and 6 residues in N- and
C-terminus, respectively. Likewise, nsp10 solvent exposed 9 and 8
residues in N- and C-terminus were missing, respectively.
Overall, the chain traces are unambiguous, with clear electron
density including for a single SAH residue bound to the nsp16
protein. Solvent accessible surfaces were calculated using program
AREAIMOL [60] with a 1.7 A˚ radius sphere as the probe
(Table 1) and values rounded to the nearest 5 A˚2. Conformational
differences were analyzed using the DynDom server (http://www.
cmp.uea.ac.uk/dyndom/main.jsp). Figures were created using
PYMOL (http://www.pymol.org). The coordinates of the wild-
type/SAH, mutant, and wild-type/Sinefungin structures have
been deposited at the Protein Data bank under PDB codes 2XYQ,
2XYV, and 2XYR, respectively.
RNA Cap Structure Modeling
The modeling of the RNA cap structure in the nsp10/nsp16
complex structure is derived from the analysis of the structure of
the vaccinia virus methyltransferase VP39 crystallized in complex
with a capped RNA and a S-Adenosylhomocysteine[47] (SAH)
(pdb code: 1AV6). The two structures are manually aligned using
COOT[58] based on the position of SAH binding sites, as well as
SAH, and Sinefungin (SFG) molecules. The RNA binding site of
VP39 is only partly overlapping that of nsp16 whilst the shape of
the cavity is similar; thus local adjustments necessary to
accommodate the RNA molecule in its binding groove were done
manually using COOT. The side chain of tyrosine 30 of
nsp16initially pointed to the putative RNA binding site, preventing
any bona fide modeling. In order to fit the RNA molecule in the
cavity, an alternative conformation was sought for this side chain.
The second most common conformation for the tyrosine side
chain was selected. Due to the biochemistry data and surface
electrostatic analysis, it is not possible to describe with certainty the
final position of the cap, thus the cap was removed and replaced
by arrows symbolizing possible positions. No other modification
was performed on the RNA, the Sinefungin molecule or the nsp16
structure.
Plasmids
The SARS-CoV nsp10 and nsp16-coding sequences were
amplified by RT-PCR from the genome of SARS-CoV Frank-
furt-1 (accession number AY291315) as previously described[16].
The nsp10 and nsp16 genes (encoding residues 4231–4369, 5903–
6429, and 6776–7073 of replicase pp1ab) were cloned into a
Gateway modified dual-promotor expression plasmid and in the
gateway pDest 14 expression vector. In this backbone, SARS CoV
nsp10 can be expressed under a tet promoter and encodes a
protein in fusion with a N-terminal strep tag, whereas nsp16 is
expressed under a T7 promoter and encodes a protein in fusion
with a N-terminal hexahistidine tag. The mutants were generated
by PCR using the Quickchange site–directed mutagenesis kit
(Stratagene), according to the manufacturer’s instructions.
Reagents
AdoMet and cap analogs GpppA and 7MeGpppA were
purchased from New England BioLabs, the[3H]-AdoMet was
purchased from Perkin Elmer and Sinefungin (adenosylornithine)
from Sigma-Aldrich.
Expression and Purification of SARS-CoV nsp10, nsp16
and nsp10/nsp16 Complex
E. coli C41 (DE3) cells (Avidis SA, France), containing the pLysS
plasmid (Novagen), were transformed with nsp10 or nsp16 cloned
in pDest14, or nsp10/nsp16 cloned in pmCox, and grown in 2YT
medium supplemented with appropriate antibiotics. The expres-
sion of strep-tagged nsp10 or 6His-tagged nsp16 mutants was
induced (DO600 = 0.6) by adding 50 mM IPTG, and the expression
of the nsp10/nsp16 complex by adding 50 mM IPTG and 200 mg/
L of anhydrotetracycline. After an incubation for a 16 h at 24uC,
the cell were pellets, frozen and resuspended in lysis buffer
(50 mM HEPES, pH 7.5, 300 mM NaCl, 5 mM MgSO4, 5 mM
b-mercaptoethanol (only for nsp10) supplemented with 1 mM
PMSF, 40 mM imidazole, 10 mg/ml DNase I, and 0.5% Triton
X-100. After sonication and clarification, proteins were purified
either by IMAC (HisPurTM Cobalt Resin; Thermo Scientific)
chromatography[16] (nsp10 mutants and nsp16 mutants), and the
nsp10/nsp16 complex was purified by using Strep-Tactin
sepharose (IBA Biotagnology) as previously described[16]. All
purified proteins were analyzed by SDS-PAGE. The binding of
wild-type nsp10 to mutant nsp16, and that of mutant nsp10 to
wild-type nsp16 was quantified using ImageJ as described[16].
Radioactive Methyltransferase Assay
MTase activity assays were performed in 40 mM Tris-HCl,
pH 8.0, 5 mM DTT, 1 mM MgCl2, 2 mM 7MeGpppAC5 or
GpppAC5, 10 mM AdoMet, and 0.03 mCi/ml [3H]AdoMet (GE
Healthcare). Short capped RNAs (7MeGpppAC5, GpppAC5, were
synthesized in vitro using bacteriophage T7 DNA primase and were
purified by high-performance liquid chromatography (HPLC) as
previously described[61]. In the standard assay, nsp10 and nsp16
were added at final concentrations of 600 nM, and 200 nM,
respectively, and the amount of 3H-CH3 transferred onto
7MeGpppAC5 substrates was determined by filter binding assay
as previously described[16].
Supporting Information
Figure S1 Sequence alignment and amino acid conservation in
coronavirus nsp16. The alignment of coronavirus nsp16 sequences
was generated withMuscle program (http://www.ebi.ac.uk/Tools/
msa/muscle/), and the resulting alignment converted using the
ESPript program, (http://espript.ibcp.fr/ESPript/cgi-bin/ESPript.
cgi). Residues that are conserved in all or .70% sequences are
boxed in red and yellow, respectively. National Center for
Biotechnology Information (NCBI) accession numbers for replicase
polyprotein sequences that include nsp16 are as follows: Severe
acute respiratory syndrome virus SARS-CoV Frankfurt isolate
(SARF), Severe acute respiratory syndrome virus SARS-CoV Tor2
isolate (SART), NP_828873.2; Turkey coronavirus (Turk),
YP_001941189; Infectious Bronchitis Virus (IBV), NP_066134;
Feline Coronavirus (Feli), YP_239426;Porcine Transmissible Gas-
troenteritis Coronavirus (PTGC), P18457; Transmissible Gastro-
enteritis coronavirus (TGEV), NP_840013; Porcine epidemic
diarrhea virus CV777 (PEDV), NP_839969; Bat coronavirus
512/2005 (BATC), YP_001351683; Human coronavirus NL63
(NL63), AAS58176; Human coronavirus 229E (229E), NP_073549;
Murine hepatitis virus strain JHM (MurJ), YP_209243; Mouse
Hepatitis virus strain A59 (MA59), NP_740613; Human coronavi-
rus HKU1 genotype A (HKU1), YP_460023; Human enteric
coronavirus 4408 (4408), ACJ35483; Bovine coronavirus (BCoV),
NP_742142; Human coronavirus OC43 (OC43), AAT84359.
Numbering was made using SARF as a reference.
(TIF)
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Figure S2 Binding determinants in the SAM/SAH/Sinfungin
binding site. A) LIGPLOT diagram (www.ebi.ac.uk/thornton-srv/
software/LIGPLOT/) of the SAH ligand molecule interacting
with the nsp16 binding site. Ligand bonds are in purple, neighbor
residue (non-ligand) bonds are in light brown, hydrogen bonds are
green dashed lines. Ligand atoms surrounded by a yellow circle
are highly accessible. Non-ligand residues in hydrophobic contacts
with the ligand are presented by red semi-circles with radiating
spokes. B) Superimposition of SAH and Sinefungin molecules. The
nsp16 residues are green sticks, the SAH is represented in red
sticks, and Sinefungin and water molecules are in sticks and
spheres as in Fig. 3, respectively.
(TIF)
Figure S3 Primary and secondary structure elements of nsp16.
Helices and sheets are colored according to rainbow colors from
N- to C-terminus as in Fig. 1. Patches I to IV are boxed in grey,
labeled above the sequences, and correspond to residues
represented in Figs. 6A and B.
(TIF)
Figure S4 Nsp10 interface comparison between the nsp10/
nsp16 complex and nsp10 homo multimer. A) For the corre-
sponding nsp10/nsp16 interface nsp10 (cyan) interacts with 2
monomers (green and orange). Left: Cartoon representation of 3
nsp10 monomer part of the dodecamer structure (PDB: 2G9T).
Right: Cartoon representation of the nsp10(cyan)-nsp16(dark red)
complex. Nsp10 molecules in cyan are in the same orientation. B)
Nsp10 sequence is presented with above the corresponding
secondary structure elements. Below dark red colored dots indicate
residues involved in the interaction between nsp10 and nsp16
while green and orange dots indicate residues involved in the
homomultimer in the dodecamer complex.
(TIF)
Table S1 Effect of alanine mutations in nsp10 interface residues.
Residues were identified using PISA (http://www.ebi.ac.uk/
msd-srv/prot_int/pi_link.html). Bold on grey background: strictly
conserved residues amongst coronaviruses; Bold on white back-
ground: conserved a.a. (.70%) amongst coronaviruses (see Fig. S1).
The % of Bioluminescence Resonance energy Transfer (BRET)
signal was previously reported[18]. The interaction of each nsp10 or
nsp16 mutant was determined using strep-tactin pull-down
experiments of strep-tagged nsp10 co-expressed with nsp16
followed by SDS-PAGE analysis, and quantitation (see Methods).
The interaction of wild-type nsp10 with wild-type nsp16 was
normalized to 100%. The % of MTase activity was determined
using filter binding assays (see Methods) relative to wild-type.
(DOC)
Table S2 Effect of alanine mutations in nsp16 interface
residues. Residues were identified using PISA (http://www.ebi.
ac.uk/msd-srv/prot_int/pi_link.html). Same legend as Table S1
except that no BRET experiments were performed.
(DOC)
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Structural and Functional Analysis of Methylation and
5′-RNA Sequence Requirements of Short Capped RNAs
by the Methyltransferase Domain of Dengue Virus NS5
Marie-Pierre Egloff, Etienne Decroly, Hélène Malet, Barbara Selisko
Delphine Benarroch, François Ferron and Bruno Canard⁎
Architecture et Fonction des
Macromolécules Biologiques,
CNRS and Universités
d'Aix-Marseille I et II,
UMR 6098, ESIL Case 925,
13288 Marseille, France
The N-terminal 33 kDa domain of non-structural protein 5 (NS5) of dengue
virus (DV), named NS5MTaseDV, is involved in two of four steps required for
the formation of the viral mRNA cap 7MeGpppA2′OMe, the guanine-N7 and
the adenosine-2′O methylation. Its S-adenosyl-L-methionine (AdoMet) de-
pendent 2′O-methyltransferase (MTase) activity has been shown on capped
7Me±GpppACn RNAs. Here we report structural and binding studies using cap
analogues and capped RNAs. We have solved five crystal structures at 1.8 Å to
2.8 Å resolution of NS5MTaseDV in complex with cap analogues and the co-
product of methylation S-adenosyl-L-homocysteine (AdoHcy). The cap
analogues can adopt several conformations. The guanosine moiety of all cap
analogues occupies a GTP–binding site identified earlier, indicating that GTP
and cap share the same binding site. Accordingly, we show that binding of
7MeGpppAC4 and 7MeGpppAC5 RNAs is inhibited in the presence of GTP,
7MeGTP and 7MeGpppA but not by ATP. This particular position of the cap is in
accordance with the 2′O-methylation step. Amodel was generated of a ternary
2′O-methylation complex of NS5MTaseDV, 7MeGpppA and AdoMet. RNA-
binding increasedwhen 7Me±GpppAGCn-1 startingwith the consensus sequence
GpppAG, was used instead of 7Me±GpppACn. In the NS5MTaseDV–GpppA
complex the cap analogue adopts a folded, stacked conformation uniquely
possiblewhen adenine is the first transcribed nucleotide at the 5′ end of nascent
RNA, as it is the case in all flaviviruses. This conformation cannot be a functional
intermediate of methylation, since both the guanine-N7 and adenosine-2′O
positions are too far away fromAdoMet.Wehypothesize that this conformation
mimics the reaction product of a yet-to-be-demonstrated guanylyltransferase
activity. A putative Flavivirus RNA capping pathway is proposed combining
the different steps where the NS5MTase domain is involved.
© 2007 Elsevier Ltd. All rights reserved.
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Introduction
Despite a wide diversity in genome organization
and replication mechanism, many eukaryotic cellu-
lar and viral RNAs are modified by addition of a cap
structure consisting of a guanine connected through
an 5′–5′ triphosphate bridge to the first transcribed
nucleoside and methylated at the N7 position. This
cap 0 structure (7MeGpppN…) is often converted in a
cap 1 structure (7MeGpppN2′OMe…) by methylation
of the 2′-O position of the first nucleotide. The main
role of the cap structure is to protect mRNA from
degradation by 5′ exoribonucleases and to enhance
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initiation of mRNA translation.1–3 The interest in
viral capping is reinforced by the fact that inhibiting
the cap formation may prevent viral replication.4–7
Consequently, structural and biochemical work
deciphering viral mRNA capping mechanisms may
add some other names than that of proteases and
polymerases to the enzyme target list for antiviral
drug research.
In eukaryotic cells, the cap is added co-tran-
scriptionally in the nucleus on nascent transcripts
and is completed by three sequential enzymatic
activities1,3: (i) an RNA triphosphatase (RTPase)
removes the 5′ γ-phosphate group of mRNA; (ii) a
guanylyltransferase (GTase), or capping enzyme,
catalyzes the transfer of GMP to the remaining 5′-
diphosphate end of mRNA; and (iii) a S-adenosyl-
L-methionine (AdoMet)-dependent (guanine-N7)-
methyltransferase (N7MTase) methylates the cap at
the N7 position. Whereas lower eukaryotes includ-
ing yeast contain a cap 0 structure, in higher
eukaryotes a nuclear AdoMet-dependent (nucleo-
side-2′-O-)-methyltransferase (2′OMTase) com-
pletes the cap 1 structure. In the case of viruses,
which replicate in the cytoplasm and code for their
own RNA capping machinery, cap formation may
follow the sequential three or four-step strategy of
eukaryotic mRNA cap formation. Nonetheless,
some of them have acquired specific capping stra-
tegies, as shown for alphaviruses that methylate
GTP prior to the transfer of 7MeGMP to the 5′-
diphosphate end of the RNA.8 Another example
is the negative-sense (−) single-stranded (ss) RNA
vesicular stomatitis virus, which transfers GDP
rather than GMP onto the 5′-monophosphate end
of RNA.9 In addition to viruses replicating in the
cytoplasm, some replicate in the nucleus and ac-
quire their RNA cap by hijacking the host cell
capping apparatus (i.e. positive-sense (+) ssRNA
retroviruses such as HIV10), or by stealing a cap
structure from cellular mRNAs in a process called
cap snatching (i.e. negative strand (-) ssRNA
viruses such as influenza virus11).
Despite the cap structures being conserved in
many organisms, there is a large diversity in the
molecular organization of the RNA cappingmachin-
ery. In metazoans and plants the RTPase and GTase
reactions are performed by a single two-domain
protein, while the MTase activities reside in two
separate single-domain enzymes.1 In yeast, three
separate proteins are each responsible for one of the
three catalytic activities. For viral capping machi-
neries a variety of combinations have been des-
cribed. In the case of the DNA vaccinia virus, one
protein bears RTPase, GTase and N7MTase activities
on separate domains and another protein bears the
2′OMTase activity.1 For double-stranded (ds) RNA
orthoreovirus, the RTPase activity resides in one
domain of either protein λ112 or μ2,13 and the other
three activities in three separate domains of protein
λ2.14 For (+) ssRNA alphaviruses the RTPase
activity is found on one domain of non-structural
protein 2 (nsp2), while the GTase and N7MTase are
located on separate domains of protein nsp1.15
The (+) ssRNA genome of viruses of the genus
Flavivirus bears a cap 1 structure 7MeGpppA2′OMeG
where the first two nucleotides are strictly con-
served.16 There are over 70 flaviviruses, including
important human pathogens, i.e. dengue, yellow
fever and West Nile virus. They seem to code for
their own capping machinery although it has not
yet been entirely established. The multifunctional
non-structural protein NS3 was shown to carry
RTPase activity within the C-terminal helicase
domain.17–19 The GTase activity has not been
identified. The 2′OMTase activity was first demon-
strated for the 33 kDa N-terminal domain of
dengue virus (DV) protein NS5 (NS5MTaseDV)
using small capped RNA substrates 7Me±GpppACn
(meaning both methylated and non-methylated at
guanine-N7).20,21 Recent works demonstrated that
the same MTase domain of dengue virus, and also
of the cognate West Nile virus (WNV) NS5 and
yellow fever virus (YFV), bears both the N7 and
the 2′O-MTase activities when longer capped
RNAs were used with the 5′ sequence of the
WNV genome.7,22,23 Thus, the Flavivirus MTase
domain seems to have an active center that is able to
conduct a methyl transfer reaction onto two distinct
acceptor positions, which are rather different in their
chemical characteristics and conformational context.
The only other example, which has been reported
recently, is the MTase domain of the large protein of
the (−) ssRNA vesicular stomatitis virus.24 To
accomplish this task the mRNA cap substrate has
to be accommodated in two very different positions:
one with the guanine-N7 position and the other with
the nucleoside-2′O position facing the AdoMet
methyl group. Thus, it has to be repositioned bet-
ween the two methylation steps. The authors also
showed that the N7-methyltransfer precedes the 2′
O-methyltransfer.7,22
The crystal structure of NS5MTaseDV was solved
with an S-adenosyl-L-homocysteine (AdoHcy), the
co-product of the methyltransfer, in the AdoMet-
binding site.20 When a non-hydrolyzable GTP ana-
logue was soaked into the crystals, it did not fix in
the active site but went exclusively to a second
binding pocket at 12 Å from the AdoMet binding
site (complex structure deposited under PDB code
2P1D).20 This site binds selectively GTP and was
interpreted as a site that accommodates the cap
during the methyltransfer to the nucleoside-2′O
position of nascent RNA.
In order to further understand the molecular
mechanism of RNA cap binding and methyla-
tion by NS5MTaseDV, we conducted binding and
structural studies using cap-analogues and small
uncapped or capped RNAs. Here we report the
crystal structures of complexes of NS5MTaseDV with
five different cap analogues. NS5MTaseDV accom-
modated these molecules in three different confor-
mations, two of which are proposed to have
relevance in the Flavivirus RNA capping pathway.
The binding assays with specific 2′O-methylation
substrates 7Me±GpppACn showed that NS5MTaseDV
binds exclusively the capped form and binding
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increases with chain length. Competition experi-
ments with GTP analogues demonstrate that the
GTP-binding site of NS5MTaseDV serves effectively
as a RNA-cap binding site. Binding can be further
increased when the RNA sequence is changed to
7Me±GpppAGCn-1. Finally, we present an hypoth-
esis that combines different steps of Flavivirus RNA
cap formation where the NS5MTase domain is
involved.
Results
Structural analysis of NS5MTaseDV complexes
with cap analogues
In order to get insight into structural require-
ments of cap and RNA recognition by NS5MTaseDV,
we soaked protein crystals in solutions of differ-
ent cap analogue molecules (GpppA, 7MeGpppA,
GpppG, 7MeGpppG, 7MeGpppG2′OMe). Additionally,
small capped RNAs 7MeGpppAC3 and 7MeGpppAC5
were produced using DNA-dependent RNA pri-
mase of bacteriophage T7 (T7 DNA primase) and
purified using an optimized protocol.21 Subse-
quently we used these small capped RNAs for
soaking experiments. Unfortunately, they either
destroyed the crystals or the soaked crystals did
not diffract. Co-crystallization assays were not
successful either. In contrast, we could solve the
crystal structures of all cap analogue-NS5MTaseDV
complexes using the co-ordinates of NS5MTaseDV
(PDB code 1L9K) as a starting model. No
conformational change of the protein was ob-
served upon cap analogue binding. The rmsd
value on Cα atoms 7 to 264 between the different
structures is between 0.16 Å and 0.5 Å. After the
first round of refinement, two distinct strong
residual (Fo–Fc) electron densities were revealed
in each complex, and were assigned to one
molecule of AdoHcy and one molecule of the
cap analogue (Figure 1(a)). In one of the five
structures, that of NS5MTaseDV in complex with
7MeGpppG, the AdoHcy was absent, which did
not cause any significant change of the protein
conformation in general or the AdoMet binding
site in particular. In all cases, there is no am-
biguity about the identification of the nucleosides
(G, 7MeG, A or G2′OMe). A guanosine analogue is
always bound at the GTP-binding site, which has
been proposed to accommodate the cap of nascent
RNA upon 2′O-methylation.20 The electron density
is very well defined for the ligands in the GTP-
binding site. As shown in Figure 1(b), this site and
the AdoHcy binding site are connected by a
positively charged surface groove, which continues
below AdoHcy. This continuation corresponds
topologically to the RNA-binding region of a
complex between the vaccinia virus mRNA cap
2′OMTase VP3925 and a capped RNA substrate. It
may thus represent the NS5MTaseDV RNA binding
groove.
A common guanosine–binding mode in the
GTP-binding site
The positioning of the guanosine of GpppN and
7MeGpppN in the GTP-binding site is similar in all
complexes. There are a number of common features
with the GTP-binding mode observed in the com-
plex of NS5MTaseDV with the GTP analogue,20
consistent with the competitive binding of these cap
analogues with GTP.20 Figure 1(c) shows as an
example the 7MeG-moiety of 7MeGpppA. The gua-
nine base stacks against the aromatic ring of residue
F25. The ribose adopts a 3′-endo configuration. Its
2′-hydroxyl group interacts via hydrogen bonding
with the amino group of the K14 side-chain and the
oxygen of the N18 side-chain. The 3′-hydroxyl
group is hydrogen-bonded to the main-chain
carbonyl group of S151 and to the side-chain
amino group of K14. As for GTP, specificity for
guanine is ensured by hydrogen bonds between
main-chain carbonyl groups of residues L17, N18
and L20 and the 2-amino-group of the nucleobase.
Apart from aromatic stacking, these hydrogen
bonds are the only contacts established by the base
moiety with the protein, whether or not the base is
methylated at its N7-position.
Three different conformations for the second
nucleotide
The five crystal structures presented here revealed
that the protein can accommodate a cap analogue in
at least three different manners. Figure 2 represents
a summary of the observed binding modes.
Four cap analogues adopt two different stacked
conformations (referred to as S1 and S2), both
displaying an overall hairpin-like shape in which
the two nucleobases stack against each other. The S1
conformation is found in the complexes between
NS5MTaseDVand N7-methylated cap analogues, i.e.
7MeGpppA, 7MeGpppG, and 7MeGpppG2′OMe (see
Figure 2(b)–(d) and Figure 3(a)). In these crystal
structures, the 7MeG is sandwiched between F25 and
the second base moiety of the cap analogue. The
aromatic side-chain of F25 and the two base moieties
of the cap analogue molecules are arranged in a
nearly perfect parallel alignment, with an average
interplanar spacing of 3.4 Å between F25 and 7MeG,
and of 3.70 Å between 7MeG and the second base
moiety. The A face of the guanine interacts with the
B face of the second nucleotide. The triphosphate
linker adopts a U shape; the first phosphate is
hydrogen-bonded to the amino group of the K29
side-chain (as observed for the GTP analogue),
the second interacts with the Oγ atom of the S150
side-chain and the third is free of any hydrogen
bond, as is the ribose of the second nucleotide of
the cap. This ribose adopts a C2′-endo form with
its 3′-hydroxyl position pointing towards the pro-
tein loop (P150 to S152) connecting β-strand 4 to
α-helix D. The 3′-hydroxyl position is thus blocked
so that no longer RNA chain could be accommo-
dated. The adenine of 7MeGpppA does not establish
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any interaction with the protein, whereas the N2-
position of the second guanine in 7MeGpppG and
7MeGpppG2′OMe analogues interacts with both the
main-chain and the side-chain oxygen atoms of N18.
The S2 conformation is adopted by cap analogue
GpppA (Figures 2(e) and 3(b)). The overall hairpin-
like conformation and the interplanar distances
between the two stacks (the first one between the
Figure 1. Ligand binding to NS5 MTaseDV. (a) A ribbon representation in rainbow color of NS5MTaseDV in complex
with AdoHcy (AdoHcy colored with carbon in cyan, nitrogen in blue, oxygen in red and sulfur in orange) and GpppA
(colored with carbon in yellow, nitrogen in blue, oxygen in red and phosphorus in orange). The Fo–Fc electron density
map, contoured at 3σ, was calculated at 2.2 Å resolution from a model in which the ligands were omitted. (b) Electrostatic
surface representation of NS5MTaseDV in complex with AdoHcy and GpppA. Both ligands are colored in as in (a). The
positively charged (blue) surface region connecting the cap analogue binding site and the AdoHcy and continuing
towards the bottom might be the RNA binding groove. (c) Coordination of the moiety of 7MeGpppA in the GTP-binding
pocket (colored as GpppA in (a)). Amino acids of NS5MTaseDV that interact with 7MeG are numbered and colored in slate,
blue and red for C, N and O, respectively. Hydrogen bonds between the protein and the 7MeG are represented by black
dotted lines. F25 engages into a stacking interaction with guanine.
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aromatic ring of residue F25 and the guanine
nucleobase, and the second between the guanine
and the adenine nucleobases) are similar to those
observed in the S1 conformation. However, the
triphosphate linker and the adenosine positioning
are different and the adenine base is in the same
plane but flipped upside down. As a result, the A
face of the guanine interacts with the A face of the
adenine. The S2 conformation allows specific inter-
actions of N6-position of the adenine, which is
hydrogen-bonded to both the main-chain and side-
chain oxygen groups of N18. Only the amino-group
at position 6 of a purine base (i.e. an adenine) can
ascertain these interactions. Thus exclusively an
adenine can be positioned on top of the guanosine in
that manner which corresponds, again, to the
absolute conservation of an adenosine as the first
transcribed nucleotide of the Flavivirus RNA gen-
ome. Finally, in S2 the 3′-hydroxyl group of the
adenosine ribose points down to the positively
charged zone where nascent RNA may be bound
(see Figure 1(b)).
The third binding mode is that observed for
GpppG (Figures 2(f) and 3(c)). As for the others and
the GTP analogue,20 the density is well defined in
the cap-binding site, up to the first phosphate. Then,
there is a clear interruption in the density. Addi-
tional density is found following the groove towards
the AdoMet binding site, which cannot be clearly
assigned. Thus the second guanosine seems to be
rather flexible and this conformation is referred to as
flexible (F).
Binding of small RNAs to NS5MTaseDV
To complement our efforts to obtain complexes
of NS5MTaseDV with cap analogues and small
capped RNAs, binding studies were conducted. In
continuation of earlier binding assays of GTP and cap
analogues to NS5MTaseDV using UV cross-linking,20
here we explored the binding of small capped and
non-capped RNAs of different lengths and sequences
but without UV cross-linking. In analogy to the
Flavivirus (+) RNA genome, all RNAs contained an
adenosine at the first position. We performed in vitro
binding assays of [32P]-radiolabelled RNAs on
NS5MTaseDV immobilized on nickel agarose beads.
Short oligonucleotides carrying at their 5′end
7MeGppp, Gppp or ppp were produced using
7MeGpppA, GpppA or ATP, respectively, in conjunc-
tion with [α-32P]CTP and the T7 DNA primase to
synthesize NpppACn. Likewise Escherichia coli pri-
mase was used with 7MeGpppA, GpppA or ATP,
[α-32P]GTP and CTP to synthesize NpppAGCn
RNAs, which contain a guanine at the second po-
sition as observed in all Flavivirus (+) RNA genomes.
His-tagged NS5MTaseDV was expressed in E.coli and
immobilized on the nickel beads. NS5MTaseDV-
beads were incubated with capped or non-capped
[32P]-radiolabelled RNAs. After incubation, bound
[32P]-RNAs were extracted, analyzed by PAGE, and
quantitated by autoradiography. As illustrated in
Figure 4(a), RNAs do not bind to control nickel beads.
NS5MTaseDV fails to bind the non-capped pppAC3to5
RNA but binds significantly 7Me±GpppAC3to5. When
the second transcribed nucleotide is replaced by a G,
even the non-capped RNA binds significantly to
NS5MTaseDValbeit less than capped 7Me±GpppAGCn.
Figure 4(b) showsquantitated data, i.e. the percentage
of bound RNA for single band products. A compar-
ison of the percentage of bound 7Me±GpppACn
(panels 1 and 2) and 7Me±GpppAGCn-1 (panels 5
and 6), i.e. substrates of the same chain length, clearly
shows that the presence ofG as the second transcribed
Figure 2. Schematic representations of GTP and cap analogue binding. Green rectangles represent F25, yellow and
orange rectangles represent A, G, 7MeG, G2'OMe bases as indicated, and red circles represent phosphate groups. (a) GTP
complex reported earlier20; (b)–(d) first stacked conformation (S1) adopted by 7MeGpppN cap analogues; (e) the second
stacked conformation (S2) adopted by GpppA; (f) flexible conformation (F) adopted by GpppG.
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nucleotide increases binding significantly. The bind-
ing of 7MeGpppAC3-4 to NS5MTaseDV is enhanced
compared to that of GpppAC3-4 (panels 1 and 2)
whereasmethylation of the guanine-N7 position does
not influence significantly the binding of GpppAGC
to GpppAGC3 (panels 4 to 6). We also note an
influence of chain length on binding. 7Me±GpppAC4
(panel 2) binds stronger than of 7Me±GpppAC3
(panel 1), 7Me±GpppAGC (panel 4) binds stronger
than 7Me±GpppAG (panel 3) but then increasing
chain length does not further increase binding.
In order to determine if capped RNA binds to the
specific GTP-binding site, we performed interfer-
ence assays, studying binding of 7MeGpppAC4 and
7MeGpppAC5 in the presence of GTP, 7MeGTP, ATP
and 7MeGpppA. As illustrated in Figure 5, GTP,
7MeGTP, and 7MeGpppA interfered with binding of
7MeGpppAC4 rendering apparent IC50 values of
0.34 mM, 0.23 mM and 1.70 mM, respectively;
whereas ATP had no significant binding inhibition
effect until 10 mM. Similar IC50 values were
obtained for the inhibition of 7MeGpppAC5 binding.
Discussion
Here, we address structural pre-requisites for cap
and RNA-binding as well as mRNA cap methyla-
tion by the MTase domain of protein NS5 of dengue
virus (NS5MTaseDV). Our crystallographic studies
rendered structures of NS5MTaseDV in complex
with five cap analogues. Three different conforma-
tions were captured, two of them are proposed to
have biological relevance.
The first stacked conformation S1, was adopted by
all cap analogues methylated at the N7-position. We
consider it an artifactual conformation for two
reasons. (i) The 3′-hydroxyl position of the adeno-
sine is pointing towards the protein and is thus not
compatible with longer RNA substrates where it
would be engaged in a regular 3′ to 5′ phosphodie-
ster bond. (ii) The adenine of 7MeGpppA does not
establish any interaction with the protein, whereas
the N2-position of the second guanine in 7MeGpppG
and 7MeGpppG2′OMe interacts with both the main-
chain and the side-chain oxygen atoms of N18. This
denies the importance of the conservation of
adenosine as the first transcribed nucleotide in all
Flavivirus RNA genomes. Why do all the N7-
methylated cap analogues adopt the S1 conforma-
tion with the 7MeG as the central part of the stack
although there are no specific interactions involving
the N7-methyl group in this position? All crystal
structures were determined at pH 5.8, a value at
which the N7-methylated guanine is predominantly
positively charged. The overall sandwich-like con-
formation with a positively charged 7MeG nucleo-
base in the middle is similar to the Phe-Tyr and Trp-
Trp 7MeG-cap binding slot of vaccinia virus 2′
OMTase VP39 and eukaryotic initiation factor 4E
(eIF4E), respectively.26,27 There, the presence of the
central positive charge was proposed to strengthen
the interactions within the stack.28 Since the pKa
Figure 3. Cap analogue conformations. (a) Binding of
7MeGpppA in the first stacked (S1) conformation in the
same orientation as in Figure 1. Colors of the cap analogue
and of the interacting amino acids are the same as in Figure
1(c). Hydrogen bonds are represented in black dotted lines.
The Fo–Fc electron density map, contoured at 3σ, was
calculated at 2.8 Å resolution from a model in which the
ligand was omitted. In this conformation the 3′-OH of the
adenosine cannot engage into a 3′ to 5′ phosphosdiester
bond as it points towards the protein loop P150 to S152. (b)
Binding of GpppA adopting the second stacked (S2)
conformation. The representation is the same as in (a)).
No steric clash would preclude the 3′-hydroxyl group to
engage into a 3′ to 5′ phosphodiester bond. Specific
interactions of the N6-position of the adenine to both the
main-chain and side-chain oxygen groups of N18 are
shown. (c) Binding of GpppG in a flexible (F) conforma-
tion. AGMP can bemodelledwithout any ambiguity in the
electron density map. A clear interruption in the electron
density map is visible between the GMP and an additional
density in the continuity of the positively charged groove
joining the AdoMet binding site.
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value of the N1 atom of free 7MeG nucleobase is
7.5,28 at pH values higher than 7.5, the positive
charge at N7 is neutralized by a negative charge at
the N1 atom. Alternate conformations might there-
fore exist at a more physiological pH value. This
contributes to our conclusion that the S1 conforma-
tion observed at pH 5.8 is an artifact.
The GpppA cap analogue adopts the second
conformation, the stacked conformation S2 in which
the guanosine is positioned in the GTP-binding site.
Two arguments suggest that this conformation
might be biologically relevant. (i) Longer mRNA
molecules may be appended without problems
because the 3′-position of the ribose is oriented
towards the positively charged surface region
that may accommodate the nascent RNA (see
Figure 1(b)). (ii) Only an adenine base can be used
in this binding mode involving specific hydrogen
bonding with residue N18. This would coincide
with the absolute conservation of an adenosine as
the first nucleotide of the Flavivirus genome. Note
that the N18A mutant does not bind GpppA
(KdN1 mM,20). Concerning the non-physiological
pH value used in the soaking experiments, for
GpppA (in contrast to 7MeGpppA) no change of
conformation is expected at more physiological pH
values because the N1 and N7 atoms of G have pKa
values of 9.4 and 3.3,29 respectively. It is obvious
that conformation S2 does not represent a func-
tional conformation corresponding to the MTase
activities of NS5MTaseDV, because both the gua-
nine-N7 or the adenosine-2′O position of the
GpppA substrate are too far away from the AdoMet
binding site. In fact NS5MTaseDV harbored only the
MTase activities there would be no need for the
GTP-binding site to accommodate non-methylated
GTP. We propose the hypothesis that the S2 con-
formation of GpppA mimics the reaction product of
Figure 4. Binding of capped or non-capped RNAs to NS5MTaseDV. Short [32P]-radiolabelled RNAs bearing a
cap 7Me±Gppp or being uncapped were incubated with NS5MTaseDV immobilized on Sepharose beads (see
Experimental Procedures). After three washes, bound [32P]-labelled RNAs were separated by PAGE and quantitated
by phosphor-imager analysis. (a) PAGE analysis of non-capped and capped RNA binding of NpppACn (left) and
NpppAGCn (right). Input (1/20) indicates that input RNA was diluted 20 times before loading it on the gel. Ni-
beads (CTL-) stands for negative control using beads loaded with Ni2+. (b) The percentage of bound RNA was
calculated comparing the amount of RNA bound to the beads with the corresponding RNA present in the input lane
analyzing three independent experiments.
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a putative Flavivirus guanylyltransferase (GTase)
activity: pppG + ppAGN leading to GpppAGN +
pyrophosphate. A guanylyltransfer reaction prece-
ding the MTase reactions would be the only occa-
sion where the GTP-binding site of NS5MTaseDV
needs to accommodate a non-methylated GTP.
The third conformation, adopted by GpppG,
shows no stacked cap analogue. One guanosine is
located in the cap-binding site and density is
interrupted after the first phosphate group. The
second guanosine is not visible. One reason for this
might be a cleavage of GpppG into GMP and non-
identified fragments. The observed residual density
(Figure 3(c)) might correspond to either a pyropho-
sphate, which can be fitted in one part of the density
(not shown), or residual density of a GDP fragment.
In order to test the possibility of a cleavage, we
incubated the concentrated protein with 2 mM
GpppG in the crystallization buffer for 30 min at
room temperature. The subsequent HPLC analysis
of the mixture in comparison with control GpppG
did not show any cleavage (data not shown). A
second possible explanation is that the second
guanosine adopts an extended orientation compa-
tible with 2′O-methylation but with an increased
mobility, since (i) it does not correspond to the
conserved, first transcribed adenosine nucleotide of
Flavivirus (+) RNA genomes, and/or (ii) a longer
RNA is needed to stabilize an extended conforma-
tion. This extended conformation would correspond
to NS5MTaseDV in the 2′O-methylation mode.
Binding experiments were conducted using small
capped and non-capped RNAs containing the
strictly conserved first nucleotide, adenosine, and
in some cases also the second strictly conserved nu-
cleotide, guanine, of the Flavivirus (+) RNA genome
(Figure 4). In agreement with methyltransferase
activity assays,20 NS5MTaseDV does not bind the
non-capped pppAC3to5 RNA. In contrast, it binds
significantly to capped 7Me±GpppAC3-5, which
have been shown to be efficient substrates of
NS5MTaseDV being exclusively methylated at the
2′O-position.20,21 We observe that an increase of
chain length from 7MeGpppAC3 and 7MeGpppAC4
leads to an increase of affinity. Competition experi-
ments usingGTP, 7MeGTP, 7MeGpppA andATP show
that binding of 7MeGpppAC4 and 7MeGpppAC5 is
specifically inhibited by guanine-containing com-
pounds (Figure 5). This observation indicates that
the guanine-cap of these RNAs preferentially occu-
pies the GTP-binding site observed for the cap
analogues in all NS5MTaseDV–complex structures
Figure 5. Inhibition of 7MeGpppAC4 and 7MeGpppAC5 binding to NS5MTaseDV by GTP, 7MeGTP, and 7MeGpppA. (a)
PAGE analysis of 7MeGpppAC4 and 7MeGpppAC5 binding was performed in presence of 0 to 10 mM GTP. The input was
diluted 40 times. (b) Inhibition curve of 7MeGpppAC4 binding by GTP. Binding in absence of GTP was set to 100 %. The
standard deviation of three independent experiments is shown. The IC50 value was calculated as given in Experimental
Procedures. (c) Interference of GTP, 7MeGTP, ATP and 7MeGpppA with 7MeGpppAC4 and 7MeGpppAC5 binding. IC50
values were calculated as given in Experimental Procedures. ATP does not inhibit binding up to 10 mM.
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and that this site serves effectively as the cap-binding
site upon 2′O methylation. There was no difference
in inhibition of 7MeGpppAC4 and 7MeGpppAC5-
binding by GTP and 7MeGTP. The higher IC50 value
of 7MeGpppA in comparison to 7Me±GTP is in
accordance with the lower affinity of 7MeGpppA
compared to GTP, 7MeGTP and GpppA observed
earlier.20 The specific interactions between the ade-
nine of GpppA and NS5MTaseDV in S2, which are
missing for 7MeGpppA in S1 may explain the higher
affinity of GpppA compared to 7MeGpppA. The
binding and affinity measurements were done at pH
values 7.5 and 7.6, respectively, indicating that the
differences observed between S1 (7MeGpppA) and S2
(GpppA), may still be maintained at these pH values.
Binding improves when the RNAs contain the
correct first and second nucleotide, guanosine, of
the Flavivirus (+) RNA genome. In this case even
non-capped RNA binds to some extent, albeit
weaker than their capped counterparts (Figure 4).
This observation is in agreement with the finding
that a capped RNA corresponding to the exact (+)
RNA genomic 5′ sequence served as efficient
substrate for both MTase activities of Flavivirus
NS5MTase.7,22,23 Thus, these substrates might bind
in different modes mimicking the guanylyltransfer
as well as the N7 and 2′O-methyltransfer. One or
several of these positions may provide specific
interactions for the conserved guanosine. As in the
case of 7Me±GpppACn, for 7Me±GpppAGCn RNAs an
increase of chain length leads to an increase of af-
finity, here the plateau is reached at 7Me±GpppAGC.
In conclusion, 7Me±GpppAGC should be an excel-
lent candidate to be tested in soaking or co-crys-
tallization experiments with NS5MTaseDV. This has
not yet been possible because yields of producing
7Me±GpppAGCn by E.coli primase are considerably
lower in comparison to the optimized production of
7Me±GpppACn by T7 DNA primase.21 Optimization
experiments are under way.
In a modeling approach we built an extended
7MeGpppA–complex representing NS5MTaseDV in
2′O-methylation mode. The model (Figure 6(a)) is
based on (i) the existent complex structures, (ii)
the known catalytic tetrad KDKE, which plays a
pivotal role in the 2′O methyl transfer reaction of
NS5MTaseWNV7 and is situated next to the 2′O
position in vaccinia virus VP39 complexed to a short
RNA substrate (see Figure 6(b) for comparison).25
The position of the guanine nucleobase, the ribose
and the phosphorus atom of the α-phosphate were
maintained in the common position that is found in
all the complexes. The remaining torsion angles of
the 7MeGpppA molecule were released allowing the
β and γ-phosphate groups to be positioned in the
positively charged crevice connecting the GTP
binding site and the AdoHcy binding site. In
particular, the γ-phosphate was positioned in the
same position as a sulfate ion present in several
complexes. This sulfate ion originates from the
crystallization condition and could mimic a phos-
phate group. The ribose of the adenosine nucleoside
was placed in such a way that it allows the reaction
to take place and the cap analogue to be continued
via a hypothetical 3′–5′ linkage pointing towards the
putative RNA-binding region of NS5MTaseDV. The
AdoHcy was completed to AdoMet using chemical
restraints and superposition with VP39 in complex
with AdoMet (PDB code 1VPT30). The position of
the ribose 2′O atom allows its nucleophilic attack of
Figure 6. Model of the ternary complex of NS5MTase of DV in 2'O methylation mode compared to the 2'OMTase
VP39 of vaccinia virus. (a) Model of NS5MTaseDV in complex with 7MeGpppA in the proper conformation for 2'O-
methylation. The electrostatic surface representation of NS5MTaseDV is shown. 7MeGpppA and AdoMet are represented
and colored as for Figure 1(a). The G moiety of 7MeGpppA binds to the GTP-binding site. The 2'O position of the ribose of
the adenosine lies within 2.6 Å from the carbon atom of the methyl group of AdoMet. The catalytic tetrad K61, D146, K181
and E217 is shown in the catalytic center around the 2'O position. A sulfate ion is shown in the putative RNA binding
groove. (b) Crystallographic structure of 2'OMTase VP39 in complex with a capped RNA substrate 7MeGpppGA5 (PDB
code 1AV6). The catalytic tetrad in the catalytic center is indicated and located around the 2'O position of the second
guanosine of the RNA substrate. This second base stacks to the following adenine bases, as shown in the center. The first
three nucleobases GAA are bound without apparent specificity.
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the C atom of the AdoMet methyl group following a
proposed in-line SN2 reaction.31 The angle between
Sδ–Cε of AdoMet and the ribose 2′O is 162°, and the
distance between the AdoMet-Cε and the ribose 2′O
is 2.6 Å, comparable with the values found in VP39
complexed with short RNA.25 This places the ribose
2′O atom 3.2 Å away from the catalytic lysine K181
in similar conformation to the VP39 complex. The
adenine base was positioned in a way to avoid any
steric clash with AdoMet and the protein. The ribose
3′O atom of the 7MeGpppA model points towards
the positively charged groove where the nascent
RNA chain might be accommodated in a similar
way as observed in VP39 (Figure 5(b)). A sulfate
group, which originates from the crystallization
conditions and is present in all the refined structures
could mimic one of the inter-nucleotidic phosphates
in an actual RNA strand as indicated in Figure 6(a).
Since the RNA is expected to be repositioned
between the N7- and 2′O-methylation step, binding
to the RNA-binding groove of NS5MTaseDV should
not be sequence-specific but based on ionic interac-
tions with the phosphate backbone. Apart from
binding the cap in the GTP-binding site, base
stacking of the second, third and fourth nucleotide
might be necessary to stabilize the conformation of
the 2′O-methylation ternary complex explaining
why we were not able to crystallize cap analogues
in the conformation of the model. The adenine ring
could stack with the following bases of the nascent
Figure 7. A proposition for the different activities of the FlavivirusNS5MTase domain involved in RNA cap formation
(see Discussion).
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RNA strand, as it was observed for VP39. Consi-
dering the length of the positively charged crevice
(approximately 17 Å), a maximum of five consecu-
tive nucleotides with stacked bases could be accom-
modated after the adenosine (mean of 3.4 Å between
the stacked bases), indicating why 7Me±GpppAC4
binds stronger than 7Me±GpppAC3.
In conclusion, a hypothetical scheme of the
Flavivirus capping pathway is presented in Figure
7 that combines different steps where the NS5MTase
domain seems to be involved. This model hypothe-
sizes both that conformation S2 represents the pro-
duct of the GTase activity and that NS5MTaseDV
methylates the guanine-N7 position7 before methy-
lating the adenosine-2′O position.20,21 (I) GTP binds
to the GTP-binding site of NS5MTase20 followed
by a hypothetical guanylyltransfer on nascent di-
phosphate RNA (II to III). Repositioning of the
capped RNA (III to IV) allows subsequent methy-
lation at the guanine-N7 position22 (IV to V).
During N7-methyltransfer, the binding of the RNA
substrate cannot be supported by the accommoda-
tion of the cap guanine in the GTP-binding site.
We suspect that stacking interactions within the
RNA substrate might be important for the forma-
tion of the ternary complex. Stacking interactions
between purine bases are stronger than interac-
tions between purine and pyrimidine bases.32 This
might explain the stronger binding of GpppAG
compared to GpppAC3 observed here and the ab-
sence of N7MTase activity using GpppACn20 com-
pared to GpppAGN substrates.22,23 After the N7-
methyltransfer cofactor AdoMet is reloaded and the
cappedRNA is repositionedwith themethylated cap
being in the GTP binding site (V to VI). Finally, 2′O-
methylation occurs20–22 (VI to VII) and the capped
and methylated nascent RNA dissociates.
The expected multiple movements of the RNA sub-
strate between various positions on NS5MTaseDV,
necessary to accomplish its functions, might explain
the difficulties to obtain complex structures with
small capped RNAs. Nevertheless, more biologi-
cally relevant complex structures of Flavivirus
NS5MTase domains with its substrates and/or
products are needed to better understand the
Flavivirus capping machinery. Likewise, more bio-
chemical data are required on the mechanism of
both methyltransfer reactions, and especially data
on the putative guanylyltransferase activity being
presented here as a hypothesis. These studies will
pave the way into the further exploration of
Flavivirus capping as a target of antiviral therapy.
Experimental Procedures
Expression and purification of NS5MTaseDV
Recombinant NS5MTaseDV corresponds to residues 1 to
296 of NS5. The protein used for crystallization was ex-
pressed and purified as described.20 For the NS5MTaseDV
binding assay, the following modifications were applied.
NS5MTaseDV was expressed in E.coli Rosetta(pLysS)
transformed with pQE30/NS5MTaseDV. Cells were
grown in Luria-Bertani medium containing ampicillin
(100 μg/ml) and chloramphenicol (17 μg/ml). At an A600
of 0.6, isopropyl β-D-thiogalactopyranoside (IPTG) was
added to a final concentration of 50 μM, and expression
was allowed to proceed for 4 h at 30 °C. The cellular pellet
was resuspended in lysis buffer (10 mM Bicine (pH 7.5),
300 mM NaCl, 1 mM phenylmethylsulfonyl fluoride
(PMSF)) supplemented with 1 mM benzamidine, 10 mM
imidazole, 100 μg/ml of lysozyme and 1 μg/ml of DNase I
before sonication. After clarification, the His-tagged
soluble protein was immobilized on chelating Sepharose
fast flow resin (Amersham Biosciences) loaded with Ni2+.
After several washes with Bicine buffer containing 25 mM
imidazole, 20 μg of bead-bound NS5MTaseDV was used
for pull-down assay.
Crystallization
Crystals of NS5MTaseDV were grown at room tempera-
ture in hanging drops, by mixing 1 μl of protein solution
with the same volume of a reservoir solution containing
0.4 M ammonium sulfate, 0.1 M sodium citrate (pH 5.8),
and 1.2 M lithium sulfate. Crystals were soaked for 3 h at
room temperature in the mother liquor supplemented
with 25% (v/v) glycerol for cryo-protection and 2 mM of
cap analogue (New England Biolabs) and then flash
frozen in a nitrogen stream. Crystals belong to the space
group P3121. Data were collected in ESRF on the beamline
ID14-EH2 (Table 1). Images were processed using
DENZO33 and MOSFLM,34 and intensities were merged
with SCALA.35
Structure determination
The cap-analogue soaked crystals have the same space
group but slightly different cell parameters compared to
the native NS5MTaseDV. The structures were solved by
molecular replacement using AMoRE36 with the native
NS5MTaseDV (PDB code 1L9K) as a search model. After an
initial rigid body refinement of the MR solution, Fo–Fc
SIGMAA-weighted electron density map clearly indicated
the presence of AdoHcy (excepted for the data of the
7MeGpppG–complex), sulfate ions and cap analogue in
three different conformations depending on the nature of
the cap (see Results). Citrate and glycerol were also seen in
some electron density maps. Refinement was carried out
with REFMAC using the maximum likelihood approach
and bulk solvent correction.37 Reflections omitted from
refinement for Rfree calculation,38 where those used for the
Rfree calculation of the native NS5MTaseDV (PDB code
1L9K). Manual rebuilding between refinement cycles were
done using Coot.39 The final models include residues 7 to
264 for all the models. The residue 6 can be seen in some
electron density maps. Residues up to 269 are ordered and
can be refined in the electron density map of the
NS5MTaseDV–7MeGpppG complex only. Stereochemistry
was evaluated using PROCHECK.40 Statistics of data
collection and refinement for all five complexes are
provided in Table 1.
RNA synthesis
Capped and non-capped RNAwere synthesized in vitro
using either bacteriophage T7 or E. coli DNA primase. The
T7 primase fragment was produced in E. coli BL21(DE3)
cells (500 ml) transformed with pET19b/PrDT as
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detailed.21 The E. coli DNA primase (dnaG gene) cDNA
was amplified by PCR using primers 5′-CCATGAAA-
CATCACCATCACCATCACGCTGGACGAATCC-
CACGCGTATTC-3′ and 5′-GGGGACCACTTTGTACAAG-
AAAGCTGGGTCTTACTTTTTCGCCAGCTCCTGG 3′
and cloned into the pDest14 (Invitrogen) expression vector
using the Gateway technology. E. coli Rosetta(pLysS) cells
were transformedwith pDest14/6His-DNAG and grown in
Luria-Bertani medium containing ampicillin and chloram-
phenicol. At an A600 of 0.6, IPTG was added to a final
concentration of 200 μM, and expression was allowed to
proceed for 4 h at 37 °C. The cellular pellet was resuspended
in 10 ml lysis buffer (50 mM Tris (pH 8.5), 300 mM NaCl,
10% glycerol, 5 mM β-mercaptoethanol, antiprotease cock-
tail (complete, Roche)) supplemented with 10 mM imida-
zole, 100 μg/ml of lysozyme, 1 μg/ml of DNase I and
0.5% (v/v) Triton X100. After lysis by sonication and cla-
rification, immobilized-metal-affinity chromatography was
used for one-step purification (chelating Sepharose fast flow
resin (Amersham Biosciences) loaded with Ni2+). The E. coli
DNA primase was eluted with lysis buffer (pH changed to
pH7.5) containing 250 mM imidazole, adjusted to 50%
glycerol and stored at −20 °C.
The 32P-labelled pppACn or 7Me±GpppACn RNAs were
produced as described21 with the following minor
modifications: in a reaction volume of 10 μl, 10 μM DNA
template CCCCGGGTCT25 was incubated with 4 μM T7
DNA primase, 5 mMCTP (containing 5 μCi of [α-32P]CTP;
Amersham Biosciences) and 1 mM ATP or cap analogue
(New England Biolabs) in 40 mM Tris (pH 7.5), 10 mM
MgCl2, 50 mM potassium glutamate, 1 μM ZnCl2, 10 mM
dithiothreitol (DTT) and 50 μg/ml of bovine serum
albumin (BSA; New England Biolabs) for 4 h at 37 °C.
The 32P-labelled pppAGCn or 7Me±GpppAGCn RNAs were
produced by incubating purified E. coli DNA primase in a
reaction volume of 20 μl with 10 μM DNA template
GGGGCTGCAAAGCTGG, 0.5 mM ATP or cap analogue,
0.5 mM CTP and 0.5 mM GTP (containing 2 μCi of [α-32P]
GTP; Amersham Biosciences) in 50 mM Hepes (pH 7.5),
10 mM magnesium acetate, 50 mM potassium glutamate,
10 mM DTT and 50 μg/ml of BSA for 20 h at 30 °C.
Reactions were stopped by the addition of RNase-free
DNase I (Amersham Biosciences; 500 units/ml, 30 min at
37 °C) and proteinase K (Invitrogen; 100 μg/ml, 16 h at
37 °C) in order to eliminate the DNA template and the
primase present in the reaction mixture. Proteinase K was
inactivated at 70 °C during 5 min and after clarification,
the RNA were, respectively, diluted to 100 μl of 10 mM
Tris (pH 7.5), 50 mM NaCl, 2.5% glycerol, BSA (500 μg/
ml) and stored at −20 °C.
Table 1. Statistics of data collection and refinement
7MeGpppA 7MeGpppG 7MeGpppG2’OMe GpppA GpppG
Space group P 3121 P 3121 P 3121 P 3121 P 3121
Cell dimensions a=b=111.56 a=b=114.72 a=b=108.35 a=b=108.72 a=b=111.5
a,b,c (Å) c=56.33 c=56.43 c=55.87 c=55.92 c=56.53
α,β,γ (°) α=β=90 α=β=90 α=β=90 α=β=90 α=β=90
γ=120 γ=120 γ=120 γ=120 γ=120
X-ray source ID14-EH2 ID14-EH2 ID14-EH2 ID14-EH2 ID14-EH2
Wavelength (Å) 0.933 0.933 0.933 0.933 0.933
Resolution range (Å) 27.96–2.8
(2.95–2.8)
35.00–2.70
(2.85–2.70)
38.9–1.80
(1.90–1.80)
35.0–2.20
(2.32–2.20)
35–2.75
(2.90–2.75)
Total reflections 52,349 (7375) 97,271 (14,569) 24,1820 (20,960) 66,764 (8763) 54,461 (7458)
Unique reflections 10,025 (1448) 12,029 (1750) 35,115 (4976) 19,614 (2825) 10,782 (1551)
Completeness (%) 97.1 (97.1) 99.9 (99.9) 99.5 (97.3) 99.9 (99.8) 99.9 (99.7)
bI/σ(I)N 27.4 (3.4) 21.7 (5.1) 37.6 (6.1) 15.5 (2.7) 21.7 (2.7)
Rsym (%)a 8.3 (51.5) 8.8 (33.0) 3.4 (21.5) 6.1 (38.2) 5.6 (50.8)
Multiplicity 5.2 (5.1) 8.2 (8.3) 6.9 (4.2) 3.4 (3.1) 5.1 (4.8)
Rwork (%)b 19.5 20.4 16.3 19.7 20.8
Rfree (%)c 24.4 25.5 19.6 22.8 27.1
Number of atoms
Protein 2022 2077 2105 2055 2025
Water molecules 27 42 203 98 8
Cap analogue 51 52 64 (alternative
conformation)
50 25 (Gp)
AdoHcy 26 0 30 (alternative
conformation)
26 26
SO4 45 (9 SO4) 55 (11 SO4) 35 (7 SO4) 25 (5 SO4) 35 (6 SO4)
Glycerol 0 0 18 (3 glycerol
molecules)
6 (1 glycerol) 0
Citrate 13 (1 citrate) 0 13 (1 citrate) 13 (1 citrate) 0
rms deviations
Bond lengths (Å) 0.013 0.010 0.012 0.012 0.015
Bond angles (°) 1.615 1.433 1.542 1.476 1.779
Ramachandran analysis (%)
Most favored 86.3 90.6 93.6 95.0 87.2
Additionally allowed 12.8 9.0 5.9 4.5 12.3
Generously allowed 0.9 0.4 0.0 0.0 0.5
Disallowed 0.0 0.0 0.5 0.5 0.0
PDB code 2P3O 2P40 2P41 2P3L 2P3Q
a Rsym=∑|I – bIN|/∑I, where I is the observed intensity and bIN is the average intensity. Values in parentheses refer to the highest-
resolution shell.
b R=∑||Fo|–|Fc||/∑|Fo|.c A 5% of all reflections that are never used in crystallographic refinement are used to calculate the Rfree (same calculation as for R
factor).
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NS5MTase binding and competition assays
Binding reactions were performed during 2 h at 4 °C in
10 mM Tris (pH 7.5), 50 mM NaCl, 2.5% glycerol and
BSA (500 μg/ml) in a total volume of 150 μl. For
competition experiments incubation mixtures con-
tained increasing concentrations of GTP, 7MeGTP, ATP,
7MeGpppA (see Figure 5). NS5MTaseDV linked to Ni
beads was produced as described above. For each
experiment, we used 30 μl of NS5MTaseDV beads
(≈4 μg/μl) and 10 μl of 32P-radiolabelled RNA. Accord-
ingly, if we suppose that 100% of the cap analogues were
incorporated during capped RNA synthesis, which is the
case for the optimized T7 DNA primase reactions, 1 nmol
of RNA was incubated with around 4 nmol of protein
linked to Ni beads. After three washes with binding
buffer, the RNA bound to the beads was resuspended in
10 μl of formamide/EDTA gel-loading buffer. Bound RNA
was separated by polyacrylamide gel electrophoresis
(PAGE, 14% acrylamide/bisacrylamide (19:1), 7 M urea)
using TTE buffer (89 mM Tris (pH 8.0), 28 mM taurine,
0.5 mM EDTA). RNA bands (input corresponds to 1/20
or 1/40 of the RNA incubated with NS5MTaseDV-beads)
were visualized using photo-stimulated plates (Fluore-
scent Image Analyzer FLA3000 (Fuji)). Quantification
of single bands was performed using Image Gauge
(Fuji) software. Three independent experiments were
done for each RNA and two for each inhibitor except
for GTP inhibition where three independent experiments
were conducted. The IC50 (inhibitor concentration at
50% binding) values were determined using Kaleida-
graph. Data were adjusted to a logistic dose–response
function (% activity=100/(1+ [I] /IC50)b, where b corres-
ponds to the slope factor that determines the slope of
the curve.41
Protein Data Bank accession codes
The atomic coordinates and structure factors (codes
2P3L, 2P3O, 2P3Q, 2P40 and 2P41) have been deposited in
the Protein Data Bank, Research Collaboratory for
Structural Bioinformatics, Rutgers University, New Bruns-
wick, NJ†.
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Abstract
Arenaviridae synthesize viral mRNAs using short capped primers presumably acquired from cellular transcripts by a ‘cap-
snatching’ mechanism. Here, we report the crystal structure and functional characterization of the N-terminal 196 residues
(NL1) of the L protein from the prototypic arenavirus: lymphocytic choriomeningitis virus. The NL1 domain is able to bind
and cleave RNA. The 2.13 A˚ resolution crystal structure of NL1 reveals a type II endonuclease a/b architecture similar to the
N-terminal end of the influenza virus PA protein. Superimposition of both structures, mutagenesis and reverse genetics
studies reveal a unique spatial arrangement of key active site residues related to the PD…(D/E)XK type II endonuclease
signature sequence. We show that this endonuclease domain is conserved and active across the virus families Arenaviridae,
Bunyaviridae and Orthomyxoviridae and propose that the arenavirus NL1 domain is the Arenaviridae cap-snatching
endonuclease.
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Introduction
The Arenaviridae family includes 22 viral species into a single
genus Arenavirus, with new species awaiting classification [1,2].
They cause chronic and asymptomatic infections in rodents, and
occasional transmission to man may result in life-threatening
meningitis and/or hemorrhagic fever. Lymphocytic choriomeningitis
virus (LCMV) is the prototypic species and first arenavirus isolated
in 1933. Because its natural host is the common house mouse (Mus
musculus), LCMV is the only known arenavirus presumably
exhibiting a worldwide distribution. LCMV is a human pathogen
of significant clinical relevance, causing central nervous system
disease, congenital malformation, choriomeningitis, and systemic
and highly fatal infection in immuno-compromised, organt
transplant recipient patients [3,4,5,6]. Humans are generally
infected through the respiratory tract after exposure to aerosols, or
by direct contact with infectious material.
Arenaviruses are enveloped viruses with a bisegmented negative
single-strand RNA genome. Each RNA segment, called large (L;
,7.2 kb) and short (S;,3.5 kb), contains two open reading frames
in mutually opposite orientations and use an ambisense coding
strategy to direct the synthesis of two polypeptides [7]. Between the
two open reading frames of each segment resides a non-coding
intergenic region (IGR), composed of a sequence predicted to form
a stable hairpin structure [8]. The S RNA encodes the viral
nucleoprotein (NP; ,63 kDa) and glycoprotein precursor (GPC;
,75 kDa), whereas the L RNA encodes a small RING finger
protein (Z; ,11 kDa) and a large protein (L; ,250 kDa) which is
the viral RNA-dependent RNA polymerase (RdRp). The two RNA
genomes are encapsidated by the NP, which is the most abundant
protein in virions and infected cells, and act as templates for two
fundamentally different processes, RNA replication and transcrip-
tion. During RNA replication, the L protein first binds to the 39-end
of RNA templates and reads them from end to end to direct the
synthesis of encapsidated full-length anti-genomes. During tran-
scription, the RdRp stops RNA synthesis at a pause site located near
the IGR [7]. The newly synthesized mRNA molecules have a non-
polyadenylated 39-end with a heterogeneous sequence mapped
within the predicted hairpin in the IGR [9]. Furthermore, non
template-directed sequences have been identified at the 59-end of
the subgenomic mRNA [10]. These sequences are variable in length
[9,10,11] and terminate with a 59-cap structure, which suggests the
presence of a cap-snatching mechanism for arenaviruses. In this
process, originally described for influenza viruses [12,13] and
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bunyaviruses [14], the viral RdRp binds cellular mRNAs caps and
‘steals’ them using an endonuclease activity, located in the influenza
PA subunit [15,16], and presumably in L protein of bunyaviruses.
These short capped RNAs are then used as primers for mRNA
synthesis. The arenavirus L protein is an essential element in
genome replication and transcription [17]. It is the largest viral
protein composed of approximately 2200 amino-acid (aa) residues,
and sequence analysis using homologous proteins led to the
prediction of several conserved domains [18,19]. A biological
function can be inferred for the L3 domain containing conserved
and typical RdRp signature sequence motifs [19,20]. For Tacaribe
virus, both domains L1 and L3 interact with the Z protein [21]. By
analogy with influenza and bunyaviruses, the L protein may also
carry activities and domains responsible for a cap-snatching
mechanism that would account for the sequence diversity found
at the 59-end of RNA transcripts. The expression and purification of
such a large viral polymerase is problematic and has not been
documented.
We report here the first crystal structure of an Arenaviridae L
protein domain at 2.13 A˚ resolution, that of the N-terminus
domain of the LCMV L protein. We show that this domain is able
to bind nucleotides, with a preference for UTP, and RNA.
Structural comparison with the N-terminal part of the influenza
virus PA protein characterizes unambiguously the domain as an
endonuclease. Sequence and secondary structure analysis of L
proteins from various Bunyaviridae family members predict that
their N-terminal end carries a similar endonuclease activity, that
we demonstrate for Toscana virus (TOSV) (genus Phlebovirus,
family Bunyaviridae). Activity assays and mutagenesis show that the
arenavirus endonuclease exhibits sequence-specificity with a
preference for uracil-containing substrates. Lastly, reverse genetics
studies correlate expression of endonuclease activity with the
selective production of mRNA, making the N-terminus domain of
the L protein a likely candidate to be involved in the cap-snatching
mechanism of arenaviruses.
Results
Delineation of an Arenavirus L Protein Domain and its
Crystal Structure
Based on aa sequence conservation across arenaviruses and on the
presence of a potential nucleotide-binding site, we designed cDNA
constructs encoding aa residues 1 to ,250 for the N-terminal end of
four arenavirus (Pirital virus (PIRV), Lassa fever virus (LASV),
Parana virus (PARV), and LCMV) L proteins. All four domains were
expressed as soluble recombinant proteins. We observed a self-limited
proteolysis of the Parana arenavirus N-terminus L domain which
prompted us to refine boundaries into a shorter 196 aa form,
hereafter named ‘‘NL1’’, fully included in the previously predicted
arenavirus L1 domain (1–250 aa) [19]. The construct was expressed
in E.coli and purified, but yielded crystals diffracting to 8 A˚. However,
the homologous 196 residues domain of LCMV yielded well-
diffracting crystals. The atomic structure of NL1 was first determined
by the SAD technique with seleno-methionylated crystals that
diffracted to 3.4 A˚. The structure was refined using a native data
set at 2.13 A˚ resolution (Table 1). Two NL1 molecules are present
within the asymmetric unit. Residues 1–191 are visible for one
molecule whilst only 1–175 could be modelled for the other NL1
molecule owing to high mobility of the C-terminal end of helix a7.
The LCMV NL1 Domain Exhibits a Type II Endonuclease
Fold
The LCMV NL1 monomer structure has approximate
dimensions of 59 A˚ 637 A˚ 627 A˚. It features four mixed b-
strands forming a twisted plane surrounded by seven a-helices
(Figure 1A). The two anti-parallel strands b1 and b2 are connected
by helix a4, whereas the two parallel strands b3 and b4 are
Table 1. Data Collection and Refinement Statistics.
Data collection and refinement statistics LCMV NL1
Space group C2221
Cell dimensions
a, b, c (A˚) 145.0, 159.3, 52.6
Resolution (A˚) 107.2522.13 (2.19–2.13)*
Measured/unique reflections 231,821/33,999
Rmerge 3.9 (45.2)
,I/sI. 27.1 (1.9)
Completeness (%) 97.9 (97.8)
Redundancy 6.8 (2.9)
Resolution (A˚) 72.5022.13
No. reflections 33,931
Rwork/Rfree(%) 19.86/22.21
No. atoms 3,297
Protein 3,011
Water 253
B-factors
Protein 57.6
Water 68.2
R.m.s. deviations
Bond lengths (A˚) 0.010
Bond angles (u) 1.14
*Values in parentheses are for the highest-resolution shell.
doi:10.1371/journal.ppat.1001038.t001
Author Summary
The Arenaviridae virus family includes several life-threat-
ening human pathogens that cause meningitis or hemor-
rhagic fever. These RNA viruses replicate and transcribe
their genome using an RNA synthesis machinery for which
no structural data currently exist. They synthesize viral
mRNAs using short capped primers presumably acquired
from cellular transcripts by a ‘cap-snatching’ mechanism
thought to involve the large L protein, which carries RNA-
dependent RNA polymerase signature sequences. Here, we
report the crystal structure and functional characterization
of an isolated N-terminal domain of the L protein (NL1)
from the prototypic arenavirus: lymphocytic choriomenin-
gitis virus. The NL1 domain is able to bind and cleave RNA.
The 2.13 A˚ resolution crystal structure of NL1 reveals a
type II endonuclease a/b architecture similar to the N-
terminal end of the influenza virus PA protein. Superim-
position of both structures and mutagenesis studies reveal
a unique spatial arrangement of key active site residues
related to the PD…(D/E)XK type II endonuclease signature
sequence. Reverse genetic studies show that mutation of
active site residues selectively abolish transcription, not
replication. We show that this endonuclease domain is
conserved and active across the virus families: Arenavir-
idae, Bunyaviridae and Orthomyxoviridae and propose that
the arenavirus NL1 domain is the Arenaviridae cap-
snatching endonuclease.
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connected by the long helix a5. These two helices run parallel to
the central b-sheet and are disposed at the same side of the latter.
On the opposite side of the b-sheet, helix a3 is surrounded at its
extremity by two N-terminal (a1 and a2) and C-terminal helices
(a6 and a7). A search for similar protein folds using the DALI
server [22] returned the PA N-terminal domain structure that was
recently identified as a type II endonuclease domain [15,16]. The
structural match with published molecular structures of the
influenza PA N-terminal domains (PAN) returns a Z-score of 5.7
and an r.s.m.d. of 3.9 A˚ for 121 superposed aa (PDB code 3EBJ)
and Z-score 5.2, r.m.s.d. 4 A˚ for 122 aa (PDB code 2W69). As was
the case for PAN, other type II endonuclease proteins are also
recovered: the Tt1808 hypothetical protein from Thermus Thermo-
philus HB88 (PDB code 1WDJ, Z-score 3.8, r.m.s.d. 3.4 A˚ for 81
aa), and the restriction endonuclease SdaI (PDB code 2IXS, Z-
score 3.6, r.m.s.d. 6.3 A˚ for 104 aa).
The b-sheet forms a negatively charged cavity creating a
binding site for divalent cations, whilst above that cavity, the C-
terminal end of helix a5 forms a positively charged patch and a
concave surface that is likely to accommodate the RNA substrate
(Figure 1B, arrow). The PA protein constitutes one subunit that
associates with PB1 and PB2 to form the heterotrimeric influenza
Figure 1. NL1 structure and comparisons with the influenza PAN structure. A, Cartoon-representation of the NL1 structure. Secondary-
structure elements are labelled and colored as follows: a-helices, blue, b-strands, orange, and loops, green. Side-chains for residues within the NL1
endonuclease active site are shown as red sticks and labelled. B, Electrostatic surface representation showing NL1 in the same orientation as in panel
(A). The arrow indicates the putative RNA binding groove and the active site crevice. Negative charges are in red and positive charges in blue and
neutral in white. C, Superimposition (view in the same orientation as in A) of the structures of NL1 (grey) and PAN (PDB code:2W69, cyan) highlighting
their shared structural core as well as variations in the form of an extra loop only present in the PAN structure (circled). The two Mn
2+ ions in the PAN
structure active site are depicted as green spheres. D, Topology diagrams of the NL1 (left) and PAN (right) structures. a-helices are represented as
yellow tubes and b-strands are blue arrows. The extra-loop of PAN protein is circled as in panel C. Key residues from the endonuclease active site (PD,
E/D, and K), are schematically depicted by colored dots and labelled, highlighting the fact that they project from conserved structural elements
between the influenza PAN protein and the arenavirus NL1 domain.
doi:10.1371/journal.ppat.1001038.g001
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virus polymerase. Its N-terminal domain PAN hosts the RNA cap-
snatching endonuclease activity [15,16]. Both NL1 and PAN share
a similar core structure. Except for the absence of a fifth b-strand
in NL1, all other secondary structure elements are conserved
(Figure 1C) and the overall topology of these two structures is very
similar (Figure 1D), albeit with interesting differences in the
vicinity of the PAN active site (discussed below). At the aa sequence
level, NL1 shares the conserved active site sequence motif
characteristic of type II endonucleases: PD…(D/E)XK. In NL1,
the corresponding residues are P88, D89…E102, and either K115
or K122 (Figure S1A, B). The identity of the distal lysine is not
certain since it is found at different positions in the primary
sequence, as is the case for influenza virus. The influenza PAN
domain was crystallized either in the presence of magnesium or
manganese ions in the active site which comprises five conserved
catalytic residues: H41, E80, D108, E119 and K134. A structural
superimposition of the arenavirus NL1 and influenza PAN active
sites shows that the side-chains of three evolutionary-conserved
residues within arenaviruses (P88, D89 and E102) closely
superimpose with P107, D108 and E119 of the influenza virus
PAN protein, pointing to a common function for these residues
(Figure 2A and Figure S1B). Upon superimposition with PAN, one
Mn2+ ion needed for the enzymatic reaction coordinated by D108
in the PAN active site, falls at right distances to be coordinated by
the carboxylate side-chains of D89 and E102. NL1 was crystallized
without metal ions and a water molecule is found close to the
position that should be occupied by the divalent metal.
Interestingly, no close structural match is found neither for H41
nor K134 of the influenza virus PAN. This points to differences
between the two active sites since His41 was proposed to play a
catalytic role in the influenza PAN. However, we note that another
possible contributor could be NL1 C103 main-chain carbonyl as it
superimposes quite well with PAN I120 main-chain carbonyl
(Figure 2B). The triad made of K115, D119, and K122 in NL1 is
spatially equivalent to K134 in PAN. In summary, despite no aa
sequence homology, the active site structures of the influenza PAN
and LCMV NL1 domains are clearly related but not identical
(Figure 1C, 2), strongly suggesting that these two domains exhibit
closely related enzymatic activities (see below).
The NL1 Endonuclease Fold is Conserved Amongst
Bunyaviridae
In addition to Arenaviridae and Orthomyxoviridae, Bunyaviridae is the
other family of virus to possess a segmented negative-strand RNA
genome. It contains four genera of animal viruses (Orthobunyavirus,
Phlebovirus, Nairovirus, Hantavirus) and one genus of plant virus
(Tospovirus) [23]. Although the genomic organisation differs
between these three virus families, Bunyaviridae are also thought
to use a cap-snatching mechanism to prime mRNA synthesis [24].
Arenaviruses, and Bunyaviridae share a conserved RdRp motif
within their large L protein, as well as a conserved N-terminus
domain [18]. Amino-acid sequence alignments, assisted by
secondary structured prediction, of the N-terminal part of LCMV
and Bunyaviridae L protein reveal that the latter also possesses the
conserved active site motifs characteristic of type II endonucleases
(Figure S2A). However, we could identify the catalytic motif within
the L protein N-terminal end for only four out of the five
bunyavirus genera: Orthobunyavirus, Phlebovirus, Hantavirus and
Tospovirus. The L protein of Nairovirus is much larger (,4000 aa)
than the L protein of other members of the Bunyaviridae family
(,2200 aa). The putative endonuclease catalytic motif was located
after aa ,700, the N-terminal of Nairovirus L protein being
assigned as a so-called OTU-like domain [25].
Secondary structure predictions were used to draw the topology
diagram of the NL1-like domain for each genera (Figure S2B). As
expected from the sequence alignment, each genus seems to share
a b-sheet with a variable number of b-strands. Furthermore, the
PD catalytic motifs are in each case located in a loop before a b-
strand, as expected. The PUMV, HLCV and RVFV NL1-like
domains are more closely related to LCMV NL1 than are the
TOMV and CCGV. The TOMV NL1-like domain contains 6 b-
strands and shares the PD motif just upstream the first b-strand,
Figure 2. The endonuclease active site. A, Structure-based superimposition of the endonuclease active site from the influenza PAN protein and
the arenavirus NL1 domain. Putative active site residues of NL1 are shown as grey sticks and the active site of PAN (PDB code 2W69) in cyan. The two
Mn2+ ions present in the PAN structure (but not in the present NL1 domain crystal structure) are shown as light green spheres with their closest ligand
indicated by a dashed line. B, C-alpha trace ribbon-representation of the superimposition of the endonuclease active site from the influenza PAN
(cyan) protein and the arenavirus NL1 domain (grey). The carbonyl main-chain of PAN I120 and NL1 C103 are shown in sticks. The metal ions are
shown as light green spheres.
doi:10.1371/journal.ppat.1001038.g002
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whereas it is just upstream the second b-strand in the case of NL1
and PAN. Finally, the structural organization of the putative
CCGV endonuclease domain seems to diverge even further from
the others. Indeed, whereas the conserved lysine is shared by the
same helix for all the domains, that of Nairovirus may be located at
the end of the b4 strand (Figure S2B). Thus we conclude that the
endonuclease motif is conserved across four animal virus genera
Orthobunyavirus, Phlebovirus, Nairovirus and Hantavirus.
NL1 is a Mn2+-Dependent RNA Endonuclease
Recent crystal structures of complexes of PAN with three
different nucleoside monophosphates show that PAN binds
nucleotides [26]. The ability of NL1 to bind nucleotides was
investigated using UV-crosslink experiments. We observe that
NL1 binds NTPs, preferably UTP and GTP, whereas ATP and
CTP show a weaker association (Figure 3A). The PAN structures
were determined in complex with ATP, CTP and UTP but not
GTP [26] whereas NL1 bind GTP in a stronger fashion than ATP
or CTP. The crystal structure relatedness to the endonuclease fold
would suggest that the NL1 domain is able to bind RNA rather
than nucleotides. We tested RNA binding by NL1, and found that
indeed, NL1 binds RNA (Figure 3B). The band shift assay is also
suggestive that the RNA substrate is cleaved under the assay
conditions, as judged by degradation products at the bottom of the
gel under the labeled RNA oligo (Figure 3B). Therefore, we
surmise that nucleotide binding properties observed here reflect
the ability of NL1 to bind RNA with some sequence specificity in
the cap-snatching pathway (see below).
Several synthetic RNA oligonucleotides were used to charac-
terize the endonuclease activity (Figure 4). NL1 is able to cleave
ssRNA having no stable secondary structure at specific sites
indicating a preference for the presence of uracil (Figure 4A, B),
and adenosine to a lesser extent. Likewise, a moderately stable
RNA hairpin containing uracil (DG=23.4 kcal/mole) is cleaved
down to a 14/15-mer product whereas a stable (DG=214.7 kcal/
mole) RNA hairpin devoid of uracil remains unattacked even in its
single stranded regions (Figure 4A, B). PolyU RNA is cleaved
randomly down to a 8-mer product with a better efficiency than
polyA, whereas polyC is not a substrate for NL1 (not shown). A 59-
terminal nucleoside uracil or adenosine 59-monophosphate is also
cleaved and the 59-monophosphate RNA end apparently com-
petes for internal cleavage. A 59-capped RNA of 264 nucleotides
in length also acts as a substrate. It is cleaved at several specific
positions indicated by the sequential appearance of band products
over time (Figure 4B). This indicates that the cap structure does
not seem to be a direct RNA binding determinant. A Phlebovirus
(Toscana) virus endonuclease domain was prepared according to
bio-informatic predictions described above. Its endonuclease
activity was compared to both that of arenavirus NL1 and the
influenza H5N1 endonuclease [16]. The enzymes were equally
active using short RNA substrates, although it is apparent that
sequence-specific cleavage is different for each enzyme: the
influenza enzymes prefers cleavage at puric sites, Toscana virus
and LCMV enzymes prefer adenosine- and uracil-containing sites
(Figure 4B). NL1 is ,90-fold more active in the presence of Mn2+
than Mg2+, and shows background activity with Ca2+ and
Zn2+(Figure 4C and not shown). The Mn2+ ion has also a
significant stabilizing effect as judged by thermostability studies,
whereas Zn2+ has a deleterious effect.
Mutagenesis analysis of most residues identified as part of the
active site (Figure 2A) impaired the endonuclease activity. The
most drastic effect was observed for D119, but residual activity was
scored for E51, D89, and less for E102 (Figure 4D). As these three
residues might coordinate metal ions as proposed above, defective
Figure 3. Nucleotide and RNA binding assays of LCMV NL1
domain. A, Cross-linking assay. 7 mg of purified protein were incubated
in the absence (2) or presence of each indicated radiolabelled NTP. The
mixture was then UV-irradiated and loaded onto a denaturing
polyacrylamide gel. The latter was analyzed by autoradiography (top)
and Coomassie blue staining (bottom). B, Band shift assay. Radiolabelled
RNA was incubated with increasing quantities (1.4 mg (+), 4.2 mg (++) and
7 mg (+++)) of NL1 protein. Reaction mixture was then analyzed by PAGE,
and the gel was visualized by autoradiography (left) and Coomassie blue
staining (right). Apparent degradation products are indicated by arrows
under the RNA input arrow.
doi:10.1371/journal.ppat.1001038.g003
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metal-binding due to a point mutation might be compensated by
the presence of the remaining two adjacent acidic residues. A
double mutant D89A/E102A shows further reduced but not
abolished activity. Mutations K115A and K122A generated
strongly altered activity, but the similar level of residual activity
does not allow the identification of which lysine is predominant in
catalysis.
The Endonuclease Activity is Essential for RNA
Transcription, not Replication
The effect of 33 mutations in L1 on virus RNA and protein
expression was studied in a cell-based mini-replicon system. The
LCMV L protein mediates the synthesis of two RNA species: first,
capped mRNA terminating within the intergenic region, and
second, antigenomic RNA being a full-length copy of the genomic
RNA template [9,27]. This dual role in RNA synthesis is
recapitulated in the mini-replicon system. It contains all trans-
acting factors (L protein and NP) required for transcription and
replication of a genome analogue containing Renilla luciferase as a
reporter gene (mini-genome). Reporter gene expression was
measured in luciferase assay (Table 2), while RNA synthesis was
measured in Northern blot (Figure 5), in which luciferase mRNA
and antigenome can easily be distinguished due to their size
difference. Wild-type (WT) L protein led to expression of high
levels of Renilla luciferase (2–3 log units signal-to-noise ratio) as
well as Renilla luciferase mRNA and antigenome in a ratio of
about 1:1. Expression of mutant L protein was verified by
immunoblotting (Figure S3).
The phenotype of mutants E41A, E41Q, K44A, S54A, C60A,
T108S, F116A, D142N, and W155A is similar to that of wild-type.
Figure 4. Endonuclease activity of NL1. A, Nucleotide sequence of the radiolabelled RNA used for the activity assays. The * indicates the
radiolabelled nucleotide. Big and small triangles indicates the primary and secondary cleavage site by wild-type (WT) NL1, respectively. B, Kinetics of
endonuclease activity of WT NL1 on different substrates (left), and for Influenza and Toscana virus (INFV, TOSV) endonuclease domain (right). Activity
assays were performed as described in Materials and Methods, using 3.3 mM of RNA and 1 mM of protein. Reactions were quenched by the addition of
EDTA/formamide, and analyzed using 20% polyacrylamide/7M urea gel. Substrate and degradation product sizes are indicated. C, Divalent cations
effect on the NL1 activity. The reaction was allowed to proceed during 45 min as described in Materials and Methods. The divalent cation assay (left)
was run during 45 min without intermediate points. Titration of divalent ions on NL1 by thermal shift assay (right). Tm is the melting temperature of
NL1 with the divalent ions ; To is the melting temperature of the protein alone. D, Mutational analysis of NL1 domain on the endonuclease activity.
Kinetics were performed as described above, with WT, D89A and D119A mutants (Left). Graph showing the % of endonuclease activity determined
using FujiImager normalized quantitation for the different mutants (right).
doi:10.1371/journal.ppat.1001038.g004
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Mutants E179A, E179Q, E182A, E182Q, and Y183A also express
luciferase and RNA at high level, but the steady-state level of
mRNA relative to that of antigenome is reduced by about 50%.
Mutants F104A, R106A, F112A, K115A, D142A, R144A,
R161A, R185A neither express Renilla luciferase nor any RNA
species, indicating that global functions of L protein are affected.
The most interesting phenotype is observed with mutants
D89A, D89N, E102A, E102N, D119A, D119N, K122A, D129A,
and D129N. They synthesize antigenome close or equal to wild-
type level, but are defective in mRNA and, thus, reporter gene
expression (Figure 5 and Table 2, shown in boldface). A similar
phenotype is seen with mutants E51A and E51Q, though
associated with reduced antigenome level. These data indicate
that residues E51, D89, E102, D119, K122, and D129A are
essential for viral mRNA synthesis, but not required for expression
of uncapped RNA species. With the exception of the D129 residue
located at the surface of the protein remote from the endonuclease
active site, it is remarkable that these transcription-null mutants
form the catalytic site (Figure 2) and match precisely those of the
PD…(D/E)XK endonuclease type II signature sequence.
Table 2. Functional Analysis of L Protein Mutants in LCMV Mini-Replicon System.
Mutant1 Renilla luciferase activity (sRLU) RNA expression level (Northern blot signal)
% of wild-type2 Signal-to-noise ratio3
Antigenome level,
% of wild-type4
mRNA-to-antigenome ratio,
relative to wild-type5
E41A 44.3 243.2 21.9 2.01
E41Q 42.4 310.7 25.5 1.95
K44A 30.2 215.8 23.6 0.93
E51A 1.3 8.5 28.5 0.39
E51Q 0.5 3.6 32.9 0.26
S54A 23.5 175.6 28.3 0.80
C60A 47.9 357.7 62.4 1.13
D89A 0.5 3.5 107.6 0.20
D89N 0.5 3.8 138.5 0.19
E102A 0.9 3.5 119.3 0.22
E102N 3.3 13.6 78.2 0.26
F104A 0.6 3.8 — —
R106A 4.4 32.5 — —
T108S 29.7 212.7 48.0 0.89
F112A 0.3 1.8 — —
K115A 0.9 6.8 — —
F116A 27.4 209.4 39.1 1.79
D119A 2.0 12.5 47.5 0.06
D119N 8.0 43.0 46.4 0.07
K122A 1.6 9.3 55.3 0.04
D129A 1.3 6.5 56.5 0.04
D129N 1.3 7.4 54.1 0.05
D142A 2.8 17.6 — —
D142N 42.8 270.6 66.1 0.93
R144A 2.3 10.2 — —
W155A 34.7 203.3 91.0 0.91
R161A 3.4 17.6 — —
E179A 40.0 239.4 109.9 0.46
E179Q 25.4 174.6 105.0 0.44
E182A 32.6 201.3 154.9 0.40
E182Q 29.3 184.9 103.1 0.42
Y183A 16.9 98.8 82.3 0.48
R185A 0.3 1.4 — —
1Mutants with selective defect in mRNA synthesis are shown in boldface.
2Standardized relative light unit (sRLU) value (wild-type = 100%). Mean of $2 independent transfection experiments.
3sRLU value of mutant divided by sRLU value of negative control mutant containing a mutation in the catalytic site of the RNA-dependent RNA polymerase. Mean of$2
independent transfection experiments.
4Antigenome signals in Northern blots were quantified via intensity profiles (wild-type = 100%).
5RNA signals in Northern blots were quantified and the mRNA-to-antigenome signal ratio was calculated. The wild-type ratio was set at 1 for each experiment (i.e. the
signal ratio of a mutant was normalized with the wild-type ratio) to render independent blots comparable.
doi:10.1371/journal.ppat.1001038.t002
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Discussion
The structural and functional results presented here show that the
LCMV NL1 domain is an RNA endonuclease. The uncoupling of
RNA replication from transcription and selective disappearance of
mRNA when NL1 active site residues are mutated strongly suggests
that this activity is involved in cap-snatching.
The identification of the arenavirus endonuclease is in line with
the recent discovery of the PAN endonuclease domain of influenza
virus. Whereas the active site of influenza virus features a cluster of
three acidic residues, the active site of arenavirus contains four
acidic residues (E51, D89, E102 and D119), as well as two
important lysine residues K115 and K122 neighboring D119
(Figure 2A). The NL1 active site resembles but is clearly distinct
from that of influenza PAN. Indeed, there is no histidine in the
catalytic center, and the arenavirus NL1 nuclease has some specific
features both upstream and downstream of the PD signature
sequence. We define the arenavirus endonuclease motif as E-X38-P-
D-X(11,13)-E-X12-K-X3-D-X2-K. The most obvious difference with
the only known related RNA endonuclease, that of influenza virus
PAN, is a divergence upstream the PD motif in structural elements
carrying the E51 residue (Figure 1C), and the presence of a triad
K…D…K at the distal side of the latter signature sequence
(Figure 2A). Contrary to PAN which shares a conserved and
essential histidine involved in the binding of both the metal ion and
a nucleotide onto helix a3 [15,16,26], NL1 does not possess this
conserved histidine residue. Instead, NL1 has a glutamic acid
residue E51, which might reflect a different nucleobase specificity as
detected in our nuclease assays (Figure 4). Likewise, residues
downstream the PD motifs are distinct from the consensus
sequence, and differently organized into a triad including two
lysines. The presence of water molecules and previous structural
models for influenza PAN allows to propose putative positions of
metal ions, coordinated by D89 and E102.
The first step in the general mechanism for phosphodiester
hydrolysis is the preparation of the attacking nucleophile by
deprotonation, usually involving a general base deprotonating a
water molecule. Lysine is often considered as this general base
candidate in endonucleases but is not strictly conserved [28,29].
Here, there are no indications against D119 being this general base.
Alternately, it could well be either lysine K115 or K122. Both are
oriented towards the active site, and they could well have their pKa
lowered by D119 in order to initiate the reaction. Reverse genetic
studies provide evidence for K122, not K115. Indeed, mRNA
production is selectively abolished and clearly uncoupled from RNA
synthesis in the case of K122A mutant, while the K115A mutant was
completely defective preventing interpretation of its role in the
endonuclease catalytic site. Although it is not known if uncapped
mRNAs are synthesized and degraded for the transcription-null
mutants, the most plausible scenario is that primer shortage prevents
significant capped mRNA synthesis. Overall, the replicon data
presented here closely match those obtained on the closely related
Lassa arenavirus using a similar replicon system [30]. Arenaviruses
may thus use two clearly independent and distinct RNA synthesis
priming mechanisms: one is dependent on an active endonuclease
carried by the N-terminus of the L protein, and the other might be
linked to the observation that an extra G residue is found at the 59-
end of arenavirus genomes and antigenomes. The latter G bases
would thus reflect a yet-uncharacterized priming mechanism
unrelated to the U/A cleavage sequence preference of NL1.
NL1 also binds nucleotides, but the NTP binding site should differ
from that of PAN. Indeed, the influenza PAN histidine 41 is involved
in binding the nucleobase of the presumed incoming RNA substrate.
The NL1 endonuclease does not share the same sequence specificity,
and E51 is positioned at a spatially equivalent position.
The cap structure does not seem to be a direct RNA binding
determinant (Figure 4B), as endonucleolytic cleavage is not
directed to cleavage sites preferentially in the vicinity of the cap.
We thus infer that an independent cap-binding site way exist
elsewhere in viral proteins to bind and select cellular mRNAs, a
possibility reminiscent of influenza for which PA carries the
endonuclease activity and PB2 the cap binding site [15,16,31].
Structure and sequence alignment studies show that the N-
terminal endonuclease domain of the L protein is also conserved in
the Bunyaviridae family, although the Nairovirus endonuclease
domain is not located into the N-terminal end of the protein.
These findings were confirmed by the endonuclease activity of the
N-terminal end of the L protein of TOSV (Figure 4B). Thus, we
provide evidence that all three segmented negative single-strand
RNA virus species share an endonuclease domain probably
involved in the cap-snatching process during the viral life cycle.
These data raise the question of a possible common ancestor for
these viruses. Indeed, these three virus families use a cap-snatching
mechanism involving binding and cleavage of cellular mRNA caps
subsequently used by a large primer-dependent RNA-dependent
RNA polymerase. It seems more plausible that the L gene has
evolved by divergence over time, rather than by multiple
Figure 5. Mutational analysis of the L protein in the context of the LCMV replicon system. Synthesis of antigenomic RNA and Renilla
luciferase mRNA was analyzed by Northern blotting. Negative control cells (neg. ctrl.) expressed mini-genome, NP, and an L protein mutant with a
mutation in the catalytic site of the RNA-dependent RNA polymerase. The methylene blue-stained 28S rRNA is shown below the blots as a marker for
gel loading and RNA transfer. Each panel represents an independent experiment with separate controls. Careful examination of the blots revealed
residual signals at the mRNA position for some mutants negative in Renilla luciferase assay. Thus, these signals do not correspond to functional
mRNA, but may be prematurely terminated antigenome.
doi:10.1371/journal.ppat.1001038.g005
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acquisitions of several activities converging into a common
structure, at least in the case of the endonuclease. Furthermore,
our study raises the interesting possibility that other activities
involved in RNA replication/transcrition might be discovered by
comparative analysis of Orthomyxoviridae PB1, PB2, PA and
Arenaviridae/Bunyaviridae L proteins.
To our knowledge, a single crystal structure of a functional
arenavirus protein is currently available, that of the Machupo virus
glycoprotein GP1 in complex with its human receptor, TfR1 [32].
Our results provide an arenavirus L domain structure, with a role
consistent with the hypothesis of a cap-snatching mechanism
suggested for arenaviruses [9,10]. The strategy used here to
produce individually active domains might be useful to further
characterize the Arenaviridae/Bunyaviridae large L protein which had
so far resisted all biochemical characterization attempts.
The influenza, Arenaviridae and Bunyaviridae endonucleases are so
far the only three examples of RNA endonucleases similar to type
II DNA restriction endonucleases. The presence of such an
endonuclease suggests that it could serve as a fruitful target for
antiviral strategies against these two families, since such kind of
inhibitors have been reported in the case of the influenza virus
[33,34,35].
Materials and Methods
Cloning, Expression and Purification of LCMV NL1
Domain
The LCMV NL1 cDNA (Armstrong strain, aa 1 to 196) was
cloned into pDest14 with a N-terminus hexa-histidine tag and
expressed in E.coli Rosetta (DE3) pLysS (Novagen), at 17uC in
2YT medium overnight after induction with 500 mM IPTG. Cell
pellets from harvested cultures were resuspended in 50 mM Tris
buffer, pH 8.0, 300 mM NaCl, 10 mM imidazole, 0.1% Triton,
5% Glycerol. Lysozyme (0.25 mg/ml), PMSF (1 mM), DNase I
(2 mg/ml), and EDTA free protease cocktail (Roche) were added
before sonication. IMAC chromatography of clarified lysates was
performed on a 5 ml His prep column (Akta Xpress FPLC system,
GE Healthcare) eluted with imidazole. Size exclusion chromatog-
raphy was performed on preparative Superdex 200 column (GE
Healthcare) pre-equilibrated in 10 mM Imidazole, pH 8.0,
50 mM NaCl, 2 mM DTT. Protein was concentrated (28 mg/
ml) using a centrifugal concentrator. For enzymatic studies, WT
and mutants were express in the E.coli BL21 star strain (Invitrogen)
and further purified on HiTrap Q sepharose 1 ml column (GE
Healthcare) to remove E. coli RNase contaminants. Proteins eluted
in a linear gradient from 50 mM to 1 M NaCl in 10 mM Hepes
buffer, pH 7.5, 2 mM DTT. A synthetic gene of the H5N1 PAN
endonuclease was designed as described [16]. The Toscana virus
(strain France AR_2005, aa 2 to 233) cDNA was obtained from
infected cell cultures. Both ORFs were cloned as a N-terminal
Thioredoxin-Hexahistidine fusion in pETG20A. The tag was
cleaved using TEV protease before a final gel filtration.
Crystallization
Crystals grew in LiSO4 250 mM, citrate 50 mM, isopropanol
5.5%, using the hanging drop vapor diffusion method in Linbro plates
by mixing 1 ml of protein solution with 1 ml of reservoir solution.
Crystals were cryoprotected by dipping in a solution containing 65%
of crystallization buffer and 35% of a buffer made of size exclusion
chromatography buffer/glycerol (50/50). Crystals were cryo-cooled in
liquid N2. The crystals belong to space group C2221 and have two
molecules per asymmetric unit. Despite repeated attempts, crystal
soaked into the above buffer supplemented with various concentra-
tions of MnCl2 yielded crystals diffracting to .4 A˚.
Data Collection and Structure Determination
Diffraction intensities were recorded on the ID14-4 beamline at
the European Synchrotron Radiation facility, Grenoble, France.
Data were processed and integrated with MOSFLM [36]. Scaling
and merging of the intensities was performed with SCALA and
programs from the Collaborative Computational Project, No. 4
(CCP4) suite [37]. The structure was determined using SAD data
from one selenomethionylated protein crystal diffracting to 3.4 A˚
resolution with SHARP/autoSHARP, followed by density modifi-
cation with SOLOMON and DM. An initial model was built using
BUCCANEER and completed in COOT, followed by refinement
using BUSTER (see Text S1). Details of structure determination are
given as supplemental material. Data from a native crystals
diffracting to a 2.13-A˚ resolution were collected on an ADSC
QUANTUM 315r at a wavelength of 0.9835 A˚. The structure was
refined with BUSTER andCOOTusing this data set (Table 1) [38].
The atomic coordinates have been deposited at the PDB (3JSB).
Sequence Retrieval
A PHI-BLAST search using the sequence corresponding to the
L1 domain and the signature of the Arenaviridae endonuclease motif
i.e. P-D-x(11,13)-E-x(12)-K-x(3)-D-x(2)-K ; was performed against non-
redundant databases [39]. After 3 iterations, Batai and Kairi
viruses both belonging to Orthomyxoviridae, appears in the section
with an E-Value below threshold. A fourth iteration including
these two sequences allows retrieving the entire family of
orthomyxoviruses, with E-value comprised between 3e218 and
2e24.
A standard CDD search from the sequence of Tensaw virus
allows retrieving all the L of the Bunyaviridae family hitting the pfam
04196 [40].
Sequence Comparison
A multiple sequence alignment of the N-terminal end of the L
protein from LCMV, HLCV, BUNV, HANV, PUMV, RVFV,
TOSV, TOMV,WTMV, CCGV, DUGV, was first performed with
the T-coffee algorithm (http://tcoffee.vital-it.ch/cgi-bin/Tcoffee/
tcoffee_cgi/index.cgi). Using the secondary structure prediction of
the endonuclease domain of L proteins, the putative conserved active
site residues were identified and placed correctly in the alignment.
UV-Crosslink Experiments
7 mg of purified protein were incubated for 15 min at 25uC,
with 0.5 ml of the various a-32P NTP (0.4 mCi/ml) in 10 ml of
reaction buffer containing 10 mM Imidazole, pH 8.0, 50 mM
NaCl, 2 mM DTT. The reaction mixtures were then exposed to
UV light (254 nm) for 6 min at 5 mm distance. The crosslinked
species were separated in a 15% polyacrylamide denaturing gel
and visualized by autoradiography using photo-stimulated plates
and a Fujilmager (Fuji).
RNA Binding Experiments
The RNA 59-AUUUUGUUUUUAAUAUUUC-39 (Ambion)
was [32P] 59-end labeled, and 0.4 mM of radiolabelled RNA was
incubated 20 min at 25uC without and with 1.4 mg, 4.2 mg and
7 mg of protein in 10 ml of 10 mM Imidazole, pH 8.0, 50 mM
NaCl, 2 mM DTT. Reaction mixtures was analyzed by PAGE
and visualized by autoradiography.
Ion Binding Assays
Titration curves with CaCl2, MnCl2, MgCl2 and ZnCl2 were
performed at 1 mg/ml protein in gel filtration buffer using thermal
shift assay. Technical details can be be found in [41].
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Endonuclease Assays
Endonuclease activity was assayed using 4 different heteromeric
RNA substrates: an unstructured 19 mer as described above, a 21
mer stable hairpin (59-UGAGGCCCGGAAACCGGGGCC-39
(Ambion), DG=214.7 Kcal/mole), a 22 mer moderately stable
hairpin (59- CGCAGUUAGCUCCUAAUCGCCC-39 (Ambion),
DG=23.4 Kcal/mole), and a long 264 mer RNA corresponding
to the SARS-CoV 59-genome sequence. The latter was radiola-
belled with a cap structure at its 59-end using the ScriptCap m7G
Capping System (Epicentre Biotechnologies) with [a32P]GTP.
Endonuclease assays were carried out using 3.3 mM of radio-
labeled RNA in a buffer containing 40 mM Tris-base, pH 7.5,
100 mM NaCl, 10 mM b-Mercaptoethanol and 2 mM MnCl2.
Reactions were initiated by the addition of 1 mM of protein and
incubated at 37uC, and stopped by the addition of EDTA/
formamide. Reactions products were analyzed using denaturing
polyacrylamide gel electrophoresis (20% polyacrylamide, 7 M
urea in TTE buffer (89 mM Tris, 28 mM taurine, 0.5 mM
EDTA) and analyzed by autoradiography.
Mutagenesis and Reverse Genetics Assays Using a LCMV
Mini-Replicon System
The LCMV replicon system is based on strain Armstrong clone
13 and has been established in analogy to the Lassa virus replicon
described previously [42]. BSR T7/5 cells constitutively express-
ing T7 RNA polymerase [43] were transiently transfected with T7
promoter-driven expression constructs for L protein, nucleopro-
tein (NP), mini-genome (MG) containing Renilla luciferase
reporter gene, and firefly luciferase as a transfection control. L
protein mutants were generated as described [44]. One day after
transfection, total RNA was prepared for Northern blotting and
cell lysate was assayed for firefly and Renilla luciferase activity.
Renilla luciferase levels were normalised with firefly luciferase
levels resulting in standardized relative light units (sRLU).
Northern blot was performed using an antisense 32P-labeled
riboprobe targeting the Renilla luciferase gene. Autoradiography
was quantified on a PhosphorImager (Amersham Biosciences). To
verify protein expression, hemagglutinin (HA)-tagged L protein
was expressed in BSR T7/5 cells inoculated with modified
vaccinia virus Ankara expressing T7 RNA polymerase (MVA- T7)
[45] and detected in immunoblot using anti-HA antibody.
Supporting Information
Figure S1 Sequence Alignment of Viral Endonuclease Domains.
A, Structure-based sequence alignment of NL1 with the two
influenza PAN (3EBJ, 2W69), Tt1808 (1WDJ) and SdaI (2IXS),
showing the structurally-conserved endonuclease motif (Highlight-
ed in red). B, Sequence alignment of arenavirus NL1: Lympho-
cytic choriomeningitis virus (LCMV), Dandenong virus (DANV),
Mopeia virus (MOPV), Morogoro virus (MORV), Mobala virus
(MOBV), Ippy virus (IPPV), Lassa virus (LASV), Lujo Virus
(LUJV), Parana virus (PARV), Pichinde virus (PICV), Allpahuayo
virus (ALLV), Chapare virus (CHAV), Tamiami virus (TAMV),
Whitewater Arroyo virus (WWAV), Bear Canyon virus (BCNV),
Flexal virus (FLEV), Pirital virus (PIRV), Amapari virus (AMAV),
Guanarito virus (GTOV), Cupixi virus (CPXV), Machupo virus
(MACV), Junin virus (JUNV), Tacaribe virus (TCRV), Sabia virus
(SABV), Oliveros virus (OLVV), Latino virus (LATV). Residues in
a solid red background are strictly conserved. The blue point
indicates the key active site residues.
Found at: doi:10.1371/journal.ppat.1001038.s001 (4.29 MB TIF)
Figure S2 Conservation of NL1 Between Arenaviruses and
Bunyaviruses. A, Sequence alignment showing endonuclease motif
(highlighted in red) of the NL1 domain from LCMV and the five
genus of the Bunyaviridae families. Each genera is represented by
two viruses: Orthobunyavirus: Human La Cross Virus (HLCV) and
Bunyamwera virus (BUNV), Hantavirus: Hantaan virus (HANV)
and Puumala virus (PUMV), Phlebovirus: Rift valley fever virus
(RVFV) and Toscana virus (TOSV), Tospovirus: Tomato virus
(TOMV) and Watermelon silver mottle virus (WTMV), Nairovirus:
Crimean-Congo hemorrhagic fever virus (CCGV) and Dugbe
virus (DUGV). Position of the start of the motif is labelled in blue
for each virus. B, Based on secondary structure predictions
topology diagrams were drawn for the NL1 domains from PUMV,
RVFV, TOMV, HANV, CCGV. Colours are the same as in
Figure 1D. N-terminal and C-terminal position are labelled with
the aa position. The two red dots, the black dot and the green dot
indicate the PD, E/D, and K residues, respectively, from the key
active site. Principal conserved secondary structures are labelled as
for LCMV NL1 domain.
Found at: doi:10.1371/journal.ppat.1001038.s002 (8.97 MB TIF)
Figure S3 Verification of L protein expression by immunoblot-
ting. L protein used for analysis in replicon assay was tagged with
HA tag, expressed under T7 promoter control in cells inoculated
with modified vaccinia virus Ankara expressing T7 RNA
polymerase (MVA-T7), and detected in immunoblot using anti-
HA antibody. MVA, cells inoculated with MVA-T7 but not
transfected; neg. ctrl., L mutant containing a mutation in the
catalytic site of the RdRp.
Found at: doi:10.1371/journal.ppat.1001038.s003 (1.13 MB TIF)
Text S1 Supplementary Methods.
Found at: doi:10.1371/journal.ppat.1001038.s004 (0.08 MB
DOC)
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The cap structure found at the 5′ end of eukaryotic 
mRNAs consists of a 7-methylguanosine (m7G) moi-
ety linked to the first nucleotide of the transcript via a 
5′–5′ triphosphate bridge1 (FIG. 1a). The cap has several 
important biological roles, such as protecting mRNA 
from degradation by 5′ exoribonucleases and directing `  
pre-mRNA splicing and mRNA export from the nucleus2. 
In addition, the cap confers stability to mRNAs and 
ensures their efficient recognition by eukaryotic trans-
lation initiation factor 4E (eIF4E) for translation3,4. 
Conversely, RNA molecules with unprotected 5′ ends 
are degraded in cytoplasmic granular compartments 
called processing bodies (P-bodies)5. Uncapped RNAs, 
such as nascent viral transcripts, may also be detected 
as ‘non-self ’ by the host cell, triggering (in mammalian 
cells) an antiviral innate immune response through the 
production of interferons6,7.
During virus–host co-evolution, viral RNA-capping 
pathways that lead to the same cap structure as that of 
host mRNAs have been selected for as efficient mecha-
nisms to ensure both escape from detection by the innate 
immune system and efficient production of viral pro-
teins. Compared with canonical eukaryotic mRNA cap-
ping, viral mRNA capping is highly diverse in terms of 
its genetic components, protein domain organization, 
enzyme structures and reaction mechanisms. Here, we 
review what is known about the various mRNA-capping 
pathways used by viruses that infect eukaryotes, paying 
particular attention to human pathogens. We also attempt 
to connect the pathways, machineries, structures and 
reactions involved in the viral RNA-capping process, 
and the specific cellular factors that trigger a response 
from the innate immune system.
Capping, decapping and turnover of host RNA
Nascent cellular mRNAs are generally produced in the 
nucleus in a 5′-triphosphate form and are modified co-
transcriptionally by a set of cap-synthesizing enzymes. 
These enzymes are recruited by the DNA-dependent 
RNA polymerase RNA pol II on pausing, once the 
transcript is approximately 20–25 nucleotides long. 
Interestingly, two viruses — vaccinia virus (from the 
Poxviridae family of double-stranded DNA (dsDNA) 
viruses) and mammalian orthoreovirus (from  the 
dsRNA Reoviridae family) — played a major part in 
the discovery of the RNA cap1,8–11, because they produce 
high levels of capped viral mRNAs and encode their 
own capping machinery, allowing bona fide RNA cap 
synthesis in vitro. Mammalian orthoreovirus mRNAs 
and dsRNA genomes were first shown to be blocked 
at the 5′ end, preventing phosphorylation by poly-
nucleotide kinase9,10. Purified mammalian orthoreo-
virus preparations were then demonstrated to be able 
to methylate mRNA 5′ ends, and the full mRNA cap 
structures were deciphered for both dsRNA ortho-
reoviruses9,10,12 (those targeting humans and insects) 
and the dsDNA species vaccinia virus11, followed by 
many other viral species1,13,14.
The three canonical capping reactions responsible 
for the synthesis of the cap structure are outlined in 
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Pre-mRNA splicing 
A post-transcriptional 
modification of pre-mRNA, in 
which introns are excised and 
exons are joined in order to 
form a translationally 
functional, mature mRNA.
Conventional and unconventional 
mechanisms for capping viral mRNA
Etienne Decroly1, François Ferron1, Julien Lescar1,2 and Bruno Canard1
Abstract | In the eukaryotic cell, capping of mRNA 5′ ends is an essential structural 
modification that allows efficient mRNA translation, directs pre-mRNA splicing and mRNA 
export from the nucleus, limits mRNA degradation by cellular 5′–3′ exonucleases and allows 
recognition of foreign RNAs (including viral transcripts) as ‘non-self’. However, viruses have 
evolved mechanisms to protect their RNA 5′ ends with either a covalently attached peptide 
or a cap moiety (7-methyl-Gppp, in which p is a phosphate group) that is indistinguishable 
from cellular mRNA cap structures. Viral RNA caps can be stolen from cellular mRNAs or 
synthesized using either a host- or virus-encoded capping apparatus, and these capping 
assemblies exhibit a wide diversity in organization, structure and mechanism. Here, we 
review the strategies used by viruses of eukaryotic cells to produce functional mRNA  
5′-caps and escape innate immunity.
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The third phosphate attached 
at the 5′ end of the ribose 
moiety of a nucleotide.
‘Ping-pong’ mechanism 
A two-step mechanism in  
which a substrate molecule 
first forms a (covalent) link  
with the enzyme and is then 
transferred to an acceptor 
molecule to yield a product.
Poly(A) tail 
A string of AMP that is added 
to the 3′ end of mRNA.
NUDIX hydrolase superfamily 
A family of proteins that 
hydrolyse a wide range of 
organic pyrophosphates, 
including NDPs, NTPs, 
dinucleoside and 
diphosphoinositol 
polyphosphates, nucleotide 
sugars and RNA caps, with 
varying degrees of substrate 
specificity.
FIG. 1b. This pathway is found in all eukaryotic species, 
as well as in most DNA viruses and members of the 
family Reoviridae, and consists of the following 
reactions: hydrolysis of the γ-phosphate of the primary 
transcript by an RNA 5′-triphosphatase (RTPase); 
transfer of GMP to the 5 ′-diphosphate RNA 
(ppNp-RNA; in which N is the first transcribed 
nucleotide and p is a phosphate group) by a guanylyl-
transferase (GTase) through a ‘ping-pong’ mechanism, 
leading to the formation of GpppNp-RNA; and 
methyl ation of the guanosine moiety by a cap- 
specific S-adenosyl-l-methionine (AdoMet)-dependent 
(guanine-N7)-methyltransferase (N7MTase), pro-
viding the minimal RNA cap chemical structure, 
named cap-0 (m7GpppNp), which is recognized by the 
translation factor eIF4E15. Further methylation reac-
tions catalysed by (nucleoside-2′-O)-methyltransferases 
(2′OMTases) can occur on the first and second nucleo-
tides 3′ to the triphosphate bridge, yielding cap-1 
(m7GpppNm2′-O), and cap-2 (m7GpppNm2′-OpNm2′-Op) 
structures, respectively (FIG.  1). Cap-4 structures 
(m7GpppNm2′-OpNm2′-OpNm2′-OpNm2′-Op) were also 
identified on parasite mRNAs16.
Following translation, the lifespan of an mRNA 
molecule is controlled by two main processes in 
eukary otic cells: first, the removal of its poly(A) tail and 
subsequent 3′-to-5′ exonucleolytic degradation, 
and second, an mRNA-decapping step that allows 
5′-to-3′ exo nucleolytic degradation (see REFS 17,18 for 
a review). Interestingly, decapped RNA may apparently 
be re-capped by the combined action of an as-yet-
unknown 5′-monophosphate kinase19 interacting with 
a host cell GTase that is also present in minor amounts 
in the cytoplasm (see REF. 20 for a review). Cytoplasmic 
decapping is catalysed by DCPS, a member of the 
NUDIX hydrolase superfamily, and stimulated by decap-
ping enhancer proteins. Following RNA decapping in 
P-bodies, transcripts are quickly degraded by 5′-to-3′ 
exonucleases such as XRN1. Thus, 5′-triphosphate 
mRNAs are almost completely absent in the cyto-
plasm. The eukaryotic cell has consequently evolved 
mechanisms to sense triphosphate RNA as non-self 
and uses these RNA species to trigger an innate 
immune response6,7. Viruses are the most common 
cell invaders to produce cytoplasmic mRNAs and have 
therefore been under a selective pressure to evolve 
Figure 1 | RNA cap structure and canonical capping 
mechanisms. a | The mRNA cap consists of a 
7-methylguanosine linked to the 5′ nucleoside of the 
mRNA chain through a 5′–5′ triphosphate bridge. The 
methyl group at the N7 position of the guanosine is 
shaded green, and the 2′-O-methyl groups of the first  
and second nucleotide residues, forming the cap-1 and  
the cap-2 structures, respectively, are shaded red. b | The 
cap-0 structure is formed on nascent RNA chains by the 
sequential action of three enzymes. First, the RNA 
triphosphatase (RTPase) hydrolyses the γ-phosphate of  
the nascent RNA (pppNp-RNA, in which N denotes the 
first transcribed nucleotide and p denotes a phosphate 
group) to yield a diphosphate RNA (ppNp-RNA) and 
inorganic phosphate (P
i
) . Then, guanylyltransferase 
(GTase) reacts with the α-phosphate of GTP (Gppp), 
releasing pyrophosphate (PP
i
) and forming a covalent 
enzyme–guanylate intermediate (Gp–GTase). The GTase 
then transfers the GMP molecule (Gp) to the 5′-diphosphate 
RNA to create GpppNp-RNA. In the final step,  (guanine-N7)- 
methyltransferase (N7MTase) transfers the methyl group 
from S-adenosyl-ƃ-methionine (AdoMet) to the cap 
guanine to form the cap-0 structure, 7-methyl-GpppNp 
(m7GpppNp), and releases S-adenosyl-ƃ-homocysteine 
(AdoHcy) as a by-product. The capping reaction is 
completed by methylation of the ribose-2′-O position  
of the first nucleotide by the AdoMet-dependent 
(nucleoside-2′-O)-methyltransferase (2′OMTase), 
generating the cap-1 structure (m7GpppNm
2′-Op). The  
box contains examples of viruses that acquire their cap 
structures using the cellular capping machinery or encode 
their own viral capping machineries that adopt the 
canonical pathway. Question marks indicate viruses that 
are likely to follow this conventional pathway. The RNAs 
capped by viral enzymes are indistinguishable from 
cellular mRNA and can thus be translated into proteins  
by the cellular ribosomal machinery. BTV, bluetongue 
virus; HBV, hepatitis B virus; HSV, herpes simplex viruses;  
SARS CoV, severe acute respiratory syndrome coronavirus.
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Single-stranded 
positive-sense RNA viruses
(ss(+)RNA viruses). Viruses 
that have or produce mRNAs 
that are co-linear to their 
genomic RNA.
43S pre-initiation complex 
A multiprotein complex 
composed of eukaryotic 
translation initiation factor 3 
(eIF3), eIF4A, eIF4E and eIF4G 
associated with the small 
ribosomal subunit. This 
pre-initiation complex scans 
the mRNA towards the ‘start’ 
codon (typically AUG), where 
translation is initiated.
counteracting mechanisms to conceal their RNA 
5′ ends from the innate immunity machineries of the 
host cell.
Some viruses, such as those in the family Picornaviridae 
(single-stranded positive-sense RNA viruses (ss(+)RNA 
viruses); for example, polioviruses and encephalomyo-
carditis virus (EMCV)) recruit the 43S pre-initiation 
complex in a 5′-cap-independent manner (BOX 1). Other 
viruses (for example, viruses of the family Caliciviridae, 
which are also ss(+)RNA viruses) covalently attach 
their RNA 5′ end to a VPg-like protein, which directly 
interacts with the cap-binding protein eIF4E and 
initiates translation of viral mRNAs21. In members of the 
Picornaviridae, VPg may be lost before translation22,23.
However, by far the most common viral mecha-
nism for ensuring efficient translation of viral proteins 
and avoiding immune surveillance mechanisms is 
through the acquisition of a cap structure. The remark-
able diversity of mechanisms that lead to an RNA cap 
structure identical to that of the host cell mRNAs is 
described below.
Conventional capping of viral RNA
Even when the viral replication cycle includes a nuclear 
phase, any virus entering a host cell must express 
its genes in the cytoplasm using the host translation 
machinery. Viral genomes can be made of single-
stranded or double-stranded nucleic acids, either RNA 
or DNA, and the corresponding strategies used for 
protecting their RNA transcripts are outlined in FIG. 2.
Cap structures can be added to viral RNAs by one 
of the three following mechanisms. In the first mecha-
nism, most viruses that synthesize their mRNA using 
cellular RNA pol II use the cellular capping machinery 
(FIGs 1b,2), as exemplified by most DNA viruses (except 
for those from the dsDNA virus family Poxviridae) and 
by RNA viruses such as those of the family Retroviridae 
(ss(+)RNA viruses) and the family Bornaviridae 
Box 1 | Getting around the lack of capping
Some viruses (such as single-stranded positive-sense RNA (ss(+)RNA) viruses from the 
families Picornaviridae, Caliciviridae and Astroviridae) do not have a cap structure at  
the 5′ end of their mRNAs or genomic RNAs. Rather, they covalently attach to the 5′ RNA 
end a protein termed VPg21 and/or carry an internal ribosome entry site (IRES) structure 
in the 5′ untranslated region154. IRESs have now been found in many different cellular 
and viral RNAs, including those of ss(+)RNA viruses from the families Picornaviridae and 
Dicistroviridae, the genus Lentivirus and the Flaviviridae genera Hepacivirus and 
Pestivirus. In pestiviruses, genomic RNA remains in a 5′-triphosphate form and thus 
promotes high levels of expression of host interferon-stimulated genes. However, these 
viruses also trigger several pathways that limit the antiviral response155,156, resulting in a 
competitive advantage for IRES-dependent translation of viral genes157.
Figure 2 | RNA 5′ ends in the mammalian-virus world. Mammalian viruses, with the exception of those from the 
single-stranded positive-sense RNA (ss(+)RNA) virus genera Pestivirus and Hepacivirus, use strategies to chemically  
modify their mRNA 5′ ends through either covalent attachment of a protein (VPg for ss(+)RNA viruses from the families 
Picornaviridae, Caliciviridae and Astroviridae) or covalent attachment of an RNA cap structure (all other viruses). Arrows 
indicate the type of RNA 5′ end protection that is used by these viral groups, and the enzymes and mechanisms involved 
are indicated. Dashed arrows indicate a likely but incompletely demonstrated pathway. Viral and cellular proteins are 
distinguished with the prefixes v and c, respectively. Yellow shading highlights viral groups for which the life cycle includes 
a nuclear phase in the host cell. This list of viral taxa is non exhaustive and used as an example only. ds, double-stranded;  
E, enzyme; EndoN, endonuclease; GTase, guanylyltransferase; IRES, internal ribosome entry site; m7, 7-methyl; MTase, 
methyltransferase; NTPase, nucleotide 5′-triphosphatase; p, phosphate group; PRNTase, polyribonucleotidyl transferase; 
RTPase, RNA triphosphatase; ss(–)RNA, single-stranded negative-sense RNA.
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(single-stranded negative-sense RNA viruses (ss(–)RNA 
viruses)). A second strategy consists of acquiring cap 
structures from cellular mRNAs by ‘cap snatching’ 
(FIGS 2,3). RNA viruses such as members of the fami-
lies Orthomyxoviridae, Arenaviridae and Bunyaviridae 
— which are ss(–)RNA viruses, with the latter two fam-
ilies also referred to as ambisense RNA viruses — steal 
short, capped cellular mRNAs through endonucleolytic 
cleavage. The stolen short, capped mRNAs are then used 
by the viral polymerase to prime synthesis of viral RNA. 
Figure 3 | Unconventional capping pathways. a | The RNA-capping mechanism of negative-sense RNA ((–)RNA) viruses 
such as those of the family Rhabdoviridae. The NTPase hydrolyses the γ-phosphate of GTP (Gppp) to yield a GDP (Gpp) and 
inorganic phosphate (P
i
). Polyribonucleotidyl transferase (PRNTase) reacts with the nascent viral RNA (pppNp-RNA; in which 
N denotes the first transcribed nucleotide), releasing pyrophosphate (PP
i
) and forming a covalent PRNTase–pNp-RNA 
intermediate. The PRNTase then transfers the RNA molecule to the GDP to create GpppNp-RNA.  (Nucleoside-2′-O)-
methyltransferase (2′OMTase) transfers the methyl group from S-adenosyl-ƃ-methionine (AdoMet) to the first nucleotide  
of the RNA. The capping reaction is then completed by methylation of the cap by the AdoMet-dependent (guanine-N7)- 
methyltransferase (N7MTase). The box lists examples of viruses that acquire their cap structures using such a capping 
pathway. Question marks indicate viruses that are likely to follow this conventional pathway. b|^ 6JG40#ECRRKPI
mechanism of positive-sense RNA ((+)RNA) viruses such as those of the family Alphaviridae. The RNA triphosphatase 
(RTPase) hydrolyses the γ-phosphate of the viral RNA to yield a diphosphate RNA (ppNp-RNA) and P
i
. A GTP molecule is 
methylated at its N7 position by the AdoMet-dependent N7MTase. Guanylyltransferase (GTase) then binds the N7-methyl-GTP  
(m7Gppp), forming a covalent link with a catalytic histidine (m7Gp–GTase) and releasing PP
i
. The GTase then transfers the 
m7GMP molecule (m7Gp) to the 5′-diphosphate RNA to create m7GpppNp-RNA. The box indicates viruses that acquire their 
cap structures using such a capping pathway. c | the RNA-capping mechanism of (–)RNA viruses such as those of the family 
Orthomyxoviridae; this mechanism is referred to as cap snatching. The PB2 subunit of the viral RNA-dependent RNA 
polymerase (RdRp) binds to the 5′ end of cellular capped mRNAs (which are enriched in the processing (P)-bodies), and the 
PA subunit then releases short capped RNAs by using its endonuclease (EndoN) activity. These capped RNAs are used as 
primers by the viral RdRp in viral transcription to generate viral mRNA using the viral (–)RNA as a template. The RdRp then 
synthesizes the complementary negative-sense strand. The box provides example of viruses that acquire their cap 
structures using a similar capping pathway. Note that most of the mRNAs that are capped by viral enzymes are 
indistinguishable from cellular mRNAs and can be translated into proteins by the cellular ribosomal machinery.  
AdoHcy, S-adenosyl-ƃ-homocysteine; HEV, hepatitis E virus; RVFV, Rift Valley fever virus; VSV, vesicular stomatitis virus.
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attached at the 5′ end of the 
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GXXXGK(T/S), and the  
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(R/K)XXXXGXXXXLhhhhD  
(in which h refers to any 
hydrophobic residue). 
Nucleophilic attack 
Generally, a starting point for a 
chemical reaction; a doublet of 
electrons selectively attacks 
the positive or partially positive 
charge of the atomic nucleus in 
order to create a new chemical 
bond.
For the third method, many viruses encode their own 
capping machinery and have evolved a diverse set of 
dedicated enzymes and mechanisms to carry out cap-
ping. Accordingly, most viruses with an ssRNA genome 
synthesize or acquire the RNA cap using their own set 
of enzymes (FIG. 2). Within this diversity, the capping of 
viral mRNA can be classified as either ‘conventional’, 
when it follows the mRNA-capping pathways used by 
eukaryotes and DNA viruses (that is, the sequential 
action of RTPase, GTase and MTases) (FIGS 1b,2), or 
‘unconventional’, when it does not (see below and FIG. 3).
The best characterized conventional RNA-capping 
system is that exemplified by the dsDNA virus vaccinia 
virus, which expresses a multifunctional mRNA cap-
synthesizing enzyme (D1) containing RTPase, GTase 
and N7MTase domains24. The 5′-triphosphate of the 
nascent mRNA is first hydrolysed by the RTPase to yield 
5′-diphosphate RNA, which is then sequentially trans-
ferred to other internal domains25,26 to be capped and 
methylated, the latter reaction with allosteric stimulation 
through direct association with viral D12 protein25,26. 
Cap assembly is completed by the viral VP39, a bifunc-
tional protein that catalyses the 2′-O-methylation of the 
cap-0 structure and also acts as an elongation factor for 
poly(A) polymerase27. Viruses from the dsRNA virus 
family Reoviridae share the same pathway as vaccinia 
virus. The enzymes remain physically associated in an 
inner capsid (or ‘transcriptionally active core’), which 
constitutes a molecular machine or ‘assembly line’ that 
is able to transcribe the genome, synthesize the cap and 
inject the resulting mRNA into the cytoplasm of the host 
cell for translation. In addition, further assignment and 
characterization of the GTase activity in viruses of the 
genus Flavivirus and those of the family Coronaviridae 
may join these viruses, which are ss(+)RNA viruses, to 
the conventional RNA-capping pathway group.
Conventional viral RNA-cap-synthesizing enzymes 
RNA triphosphatases. RTPases catalyse the cleavage 
of the interphosphate bond between the β-phosphate and 
the γ-phosphate of 5′-triphosphorylated mRNA (FIG. 1b). 
A range of enzyme structures exist (FIG. 4a), indicating 
that during evolution several independent solutions 
evolved for this initial step of the capping reaction, 
which is often found in association with RNA-binding 
and strand separation activities. Most RTPases are also 
able to hydrolyse NTPs28–30.
RTPases can be categorized into four groups, further 
defined by the metal dependency of the hydrolytic reac-
tion mechanism that they use to cleave the interphos-
phate bond. Metal-dependent RTPases can be organized 
into three structural groups: the histidine triad (HIT)-
like fold (α–β complex), the triphosphate tunnel metallo-
enzyme (TTM) and the viral RNA helicase-like fold 
(FIG. 4a).
The HIT-like fold is found in NSP2, from the dsRNA 
rotaviruses, and so far it is the only RTPase identified 
with such a fold. It has an amino-terminal helical domain 
and a carboxyl terminus with an α–β fold that resembles 
the ubiquitous cellular HIT group of nucleotidyl hydro-
lases31. The nucleotide-binding site is located in the cleft 
between the two domains, which contains a histidine 
residue involved in binding and in Mg2+-dependent 
hydrolysis of both NTP and RNA substrates. NSP2 self-
assembles into a doughnut-shaped octamer, a quaternary 
structural organization that creates several RNA-binding 
sites, which are presumably needed to destabilize RNA 
duplexes during genome replication and packaging30,32,33.
TTM enzymes hydrolyse NTPs in the presence of 
Mn2+ or Co2+ and are found in fungi and protozoa, and 
in most DNA viruses that encode an RTPase, including 
poxviruses, chlorella virus, baculoviruses and mimi-
viruses34–37. The RTPase Cet1 from Saccharomyces cerevi-
siae is nearly identical to that of mimiviruses and serves 
as a paradigm for the TTM group. Its structure features a 
characteristic tunnel lined by eight antiparallel β strands 
(FIG. 4a) and a double glutamate motif 36,38. The mRNA 
supposedly sits in the tunnel, which harbours several 
charged and hydrophilic side chains that coordinate 
Mn2+ and SO2– in the crystal structure. SO2– is thought 
to indicate the position of the γ-phosphate of mRNA.
The third group comprises proteins with NTPase and 
helicase activity, belonging to the large helicase super-
families SF1 and SF2 (REFS 39–41). Such NTPase–helicase 
family members are found in flaviviruses (for example, 
NS3 proteins of dengue virus, yellow fever virus, West 
Nile virus and Japanese encephalitis virus), corona-
viruses (for example, nsp13 of severe acute respiratory 
syndrome coronavirus (SARS CoV), although for this 
member of the SF1 helicases the crystal structure is not 
known), alphaviruses (for example, the protein nsP2) 
and potexviruses (for example, protein 1A of bamboo 
mosaic virus), all of which are ss(+)RNA viruses, and 
also in viruses of the family Reoviridae (for example, the 
protein λ1), which are dsRNA viruses. The fold adopted 
by SF2 helicases features two RecA-like subdomains 
between which a cleft accommodates the nucleotide or 
5′-triphosphate RNA substrate42. The RecA sub domains 
I and II carry the Walker A and B motifs. Residues belong-
ing to the Walker A motif (also named motif I) form 
the P-loop, which stabilizes the terminal phosphate 
moiety of the substrate, whereas acidic residues from 
the Walker B motif (also named motif II or DEXD box) 
coordinate the Mg2+ needed for hydrolysis42. Structural 
and biochemical studies revealed that the RTPase and 
NTPase activities of helicase enzymes from flaviviruses 
(ss(+)RNA) have a common catalytic site28,42–47. Similar 
biochemical studies have mapped an associated heli-
case–RTPase activity in other viral families, including 
alphaviruses (ss(+)RNA)48. However, structural data are 
needed to better understand how these multifunctional 
viral proteins coordinate their various activities.
Metal-independent RTPases are found in plants, 
metazoa and viruses such as baculoviruses (dsDNA)49,50. 
They belong to the cysteine phosphatases superfamily. 
The RTPase reaction proceeds in two steps, starting 
with entry of the 5′-triphosphate RNA into the active-
site tunnel and formation of a covalent cysteinyl- 
S-phosphoester adduct. The catalytic cysteine responsible 
for the nucleophilic attack on the γ-phosphate of the RNA 
5′ end belongs to a P-loop motif (HCXXXXXR(T/S)). 
The second step releases inorganic phosphate. Cysteine 
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phosphatases adopt a characteristic α–β fold with a 
central twisted, five-stranded parallel β-sheet flanked 
by six α-helices49. The catalytic cysteine that specifically 
recognizes the γ-phosphate of the RNA 5′ end resides 
at the bottom of the substrate-binding pocket, whereas 
other conserved residues from the P-loop, together 
with surrounding residues, form a positively charged 
channel that can accommodate the α-phosphate and the 
β-phosphate of the RNA 5′ end. The shape of the bind-
ing pocket dictates the selectivity for triphosphate RNA 
and seems too deep to grant diphosphate RNA access 
to the active site.
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pKa value 
The acid dissociation constant, 
a quantitative measurement  
of the strength of a chemical 
group as an acid in solution. It 
corresponds to the pH value  
at which half of the ionizable 
group is either protonated or 
deprotonated.
ε-amino group 
A positively charged group 
found at the extremity of a 
lysine side chain. The ε-amino 
group is a primary amine and, 
owing to its high pKa value, it is 
reactive and often participates 
in reactions at the active site of 
enzymes.
Guanylyltransferases. GTases of DNA viruses contain 
two domains: a nucleotidyltransferase (NTase) domain 
that is conserved in capping enzymes, RNA ligases and 
DNA ligases51, and a C-terminal oligonucleotide-binding 
domain that is observed in capping enzymes and several 
DNA ligases. Sequence alignments aided by structural 
information for several family members identified con-
served residues and motifs both in the nucleotide-binding 
site and in the NTase site51,52. A lysine-containing motif, 
KXDG(I/L), is conserved among the GTases encoded by 
several DNA viruses (vaccinia virus, Shope fibroma virus 
and African swine fever virus) and the yeasts S. cerevi-
siae and Schizosaccharomyces pombe. The lysine in this 
motif was shown to be the catalytic residue in the GTase 
of vaccinia virus53–55 and in the yeast capping enzyme56. 
Moreover, this motif is conserved in the active site of poly-
nucleotide ligases, which, like capping enzymes, catalyse 
an enzymatic reaction via the formation of a covalent 
Lys–NMP intermediate57. 
The structure of the GTases from Paramecium bur-
saria chlorella virus 1 (dsDNA), humans58 and the yeast 
Candida albicans (the protein Cgt1) have been solved 
individually and, for the chlorella virus GTase and Ctg1, 
in complexes with cap analogues, GTP or as a covalent 
GTase–GMP intermediate59–61. These structures sug-
gest the following reaction scheme, during which the 
oligonucleotide-binding and NTase domains, acting as a 
clamp, undergo a series of large conformational changes. 
These domains open up to load GTP, close to catalyse the 
formation of a covalent enzyme–GMP complex through 
the action of the catalytic lysine, open again to release 
pyrophosphate and bind the pre-mRNA substrate, close 
again to catalyse nucleotidyl transfer to the RNA and 
finally re-open to release the GpppNp-RNA product51,60 
(FIG. 4b).
The dsRNA viruses of the family Reoviridae use one 
multifunctional capsid protein for the capping reaction. 
λ2 of the dsRNA virus mammalian orthoreovirus62, 
VP4 of bluetongue virus (in the genus Orbivirus63) and 
VP3 from cytoplasmic polyhedrosis virus (in the genus 
Cypovirus64) act as assembly lines, such that the RNA 
substrate is shuttled from one domain to the next (see 
below). The GTase domains of these proteins feature 
different folds (see below and FIG. 4c) to DNA virus 
GTases. Despite these structural differences, viruses 
from the genera Orthoreovirus and Aquareovirus use a 
conserved lysine residue (although not part of the signa-
ture sequence found in DNA viruses) to form a covalent 
intermediate with GMP65,66. In flaviviruses (ss(+)RNA), 
the 2′OMTase domain has been proposed to act as a 
GTase67,68. However, the proposed catalytic lysine is not 
conserved in flaviviruses69.
Methyltransferases. Despite the limited overall amino 
acid sequence identity in the large family of AdoMet-
dependent MTases, most of these enzymes share a 
common structural core made of seven β-strands 
flanked by three α-helices on each side of the sheet, 
similar to the core found in the catechol-O-MTase (a 
class I AdoMet-dependent MTase70,71). This core cata-
lytic domain has evolved extensions that consist of 
structurally non-conserved domains and allow these 
MTases to accommodate a range of methyl accep-
tors70. The MTases exist either as isolated proteins 
(for example, nsp16 viruses from the Coronaviridae; 
ss(+)RNA72), or as domains of larger proteins (such 
as NS5 of viruses from the ss(+)RNA virus genus 
Flavivirus69,73 or the multidomain cap assembly lines 
of dsRNA viruses from the Reoviridae62). In some 
instances the same protein domain can have dual 
N7MTase and 2′OMTase activities (for example, the 
MTase domain in NS5 from flaviviruses74,75), sharing 
the same cofactor-binding site. When this is the case, 
repositioning of the RNA substrate must occur.
Both N7MTases and 2′OMTases share the class I 
family fold (FIG. 4d). N7-methyl transfer is thought to be 
promoted by optimal positioning of the reacting groups, 
mediated by several aromatic residues, and by an electro-
static environment that is favourable for the reaction25,76. 
By contrast, 2′OMTases rely on a conserved catalytic 
tetrad, Lys-Asp-Lys-Glu69,77,78. The catalytic reaction was 
deciphered by several structural studies of the 2′OMTase 
VP39 of vaccinia virus79,80. It was suggested that 
residues in the vicinity of the catalytic Lys175 (the 
second lysine in the Lys-Asp-Lys-Glu motif) decrease 
the pKa value of its ε-amino group. This orientates the 
2′-hydroxyl group of the ribose for a nucleophilic 
in-line sn-2 attack on the AdoMet methyl group81.
Figure 4 | Structural constituents of viral capping machineries, folds and 
mechanisms. a | Different RNA triphosphatase (RTPase) folds. For the metal-dependent 
mechanism, the triphosphate tunnel metalloenzyme (TTM) fold is exemplified by the 
structure of the RTPase (Protein Data Bank (PDB) accession code 2QZE) from the genus 
Mimivirus, which consists of double-stranded DNA (dsDNA) viruses; the histidine triad 
(HIT)-like fold of the RTPase from dsRNA rotaviruses (PDB accession code 1L9V) and the 
helicase fold of the RTPase from the single-stranded positive-sense RNA (ss(+)RNA) virus 
dengue virus (PDB accession code 2BHR) are also shown. For the metal-independent 
OGEJCPKUO|VJGHQNFQHVJG462CUGHTQOVJGFU&0#DCEWNQXKTWUGU
2&$CEEGUUKQPEQFG
1YN9) is the only viral structure available so far. Structures are coloured cyan for 
α-helices and pink for β-strands. b | Structure-based model of a guanylyl transfer 
mediated by the dsDNA virus Paramecium bursaria chlorella virus 1 guanylyltransferase 
(GTase). Presented are the five stages of the reaction: loading of GTP onto the active site, 
with the GTase in an open conformation (PDB accession code 1CKO); the GTase in a 
closed conformation and the creation of covalent intermediate GTase–GMP through  
a lysine residue (model derived from the structure in PDB accession code 1CKN); the 
intermediate GTase–GMP reopening to bind a pre-mRNA molecule (model derived from 
the structure in PDB accession code 1CKO); the GTase closing again to complete the 
transfer (model derived from the structure in PDB accession code 1CKN); and, transfer 
completed, the GTase opening to release the GpppNp-RNA (in which p is a phosphate 
group and N is the first transcribed nucleotide) (PDB accession code 1CKM). Structures 
are coloured cyan for α-helices and pink for β-strands. c | Assembly line structures. 
Protein VP4 (PDB accession code 2JHC) of bluetongue virus (a dsRNA virus from the 
genus Orbivirus) and protein λ2 of mammalian orthoreovirus (a dsRNA virus) (PDB 
accession code 1EJ6). The colour code correlates with the colour of each domain as 
represented in the assembly sequence arrow to the left. Domains in green are extra 
domains that do not take part directly in the capping mechanism. d | Methyltransferase 
structures. Left: the (guanine-N7)-methyltransferase (N7MTase) domain of protein D1 
from the dsDNA virus vaccinia virus (PDB accession code 2VDW) in complex with a 
molecule of S-adenosyl-ƃ-homocysteine (AdoHcy). Middle: the N7MTase–(nucleoside- 
2′-O)-methyltransferase (2OMTase) domain of NS5 from  dengue virus (ss(+)RNA) in 
complex with the cap analogue 7-methyl-G (m7G)-pppGm
2′-O and AdoHcy (PDB 
accession code 2P41). Right: VP39, the 2′OMTase  of the dsDNA virus vaccinia virus, in 
complex with a capped RNA and AdoHcy (PDB accession code 1AV6). All figures were 
prepared using PyMOL.
◀
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Stem loop 
A hairpin structure in 
single-stranded RNA or DNA, 
resulting from intramolecular 
base-pairing when two  
regions of the same strand 
contain partial or perfect  
anti-complementary  
nucleotide sequences.
Using cap analogues, the molecular basis for recogni-
tion of GpppNp-RNA versus cap-0-RNA has also been 
characterized for VP39 (REFS 80,82). The m7G is stacked 
between two aromatic residues, and electron delocali-
zation and electrostatically enhanced stacking owing to 
N7 methylation favours the recognition of the cap over 
GTP (FIG. 4d).
One interesting aspect of MTase activity relates to 
its regulation: in three cases, interfacial activation is 
achieved either by a cofactor protein (such as the vac-
cinia virus D12 subunit, which enhances the N7MTase 
activity of D1 through an allosteric mechanism25,26, and 
the SARS CoV (ss(+)RNA) metalloprotein nsp10, which 
acts as a cofactor to activate the 2′OMTase nsp16 but 
not the N7MTase nsp14 (REF. 83)) or by binding to lipid 
membranes (as is the case for nsP1 of the ss(+)RNA 
alphaviruses).
What determines the sequence of the two methyl-
ation steps? For flaviviruses74,75 or coronaviruses83,84, 
which are ss(+)RNA viruses, the order in which methyl-
ations are performed is not encoded in the global protein 
architecture. Rather, variations in kinetics and affinity 
may dictate the order in which reactions occur83,85. In 
the case of flaviviruses, RNA secondary structures also 
seem to be important: whereas the N7MTase activity of 
the bifunctional NS5 MTase domain requires a long sub-
strate encompassing a specific stem loop RNA structure, 
christened stem loop A (SLA), the 2′OMTase activity is 
able to transfer a methyl group to short RNA acceptors75.
Cap assembly lines. Several dsRNA viruses encode 
structural proteins that are packaged with their genome 
in the viral particle and are able to perform the four 
reactions needed to synthesize a cap-1 structure, much 
like an assembly line (FIG. 4c). The key molecular compo-
nents of the RNA-capping machinery in members of the 
dsRNA virus family Reoviridae are RNA-directed RNA 
polymerase (named VP1 in orbiviruses and rota viruses, 
and λ3 in orthoreoviruses) and a multifunctional 
cap-synthesizing enzyme (named VP4 in orbiviruses, 
VP3 in rotaviruses and λ2 in orthoreoviruses). Both 
λ2 and VP4 are composed of four domains that were 
identified as RTPase, GTase, N7MTase and 2′OMTase, 
respectively62,63. The spatial arrangement of the differ-
ent protein domains reflects the time sequence of the 
enzymatic reactions that are required for mRNA cap-
ping following synthesis by the viral polymerase (FIG. 4c). 
Although it is unclear how and when RTPase activity 
occurs, a complete pathway has been proposed in which 
guanylyl transfer occurs near the base of the pentameric 
‘turret’ (formed by λ2 in orthoreoviruses), followed by 
N7-methylation and 2′-O-methylation of the mRNA62. 
Therefore, in dsRNA viruses, the sequence of steps in 
the cap synthesis pathway should remain identical to the 
sequence in the capping pathway for cellular mRNAs 
and for DNA viruses such as vaccinia virus, for which 
the capping machinery is embedded in a multidomain 
protein complex.
The GTase domain and both MTase domains of blue-
tongue virus (a dsRNA virus in the genus Orbivirus) 
were unambiguously mapped on the VP4 structure, but 
the position of the RTPase domain remains uncertain63. 
However, it is believed that both the RTPase and GTase 
activities reside in the same C-terminal domain of VP4, 
a unique architecture that is reminiscent of, but distinct 
from, double-domain RTPase–GTase proteins found in 
metazoans and plants. The enzymatic activity requires 
Mg2+ (REFS 63,86,87). However, VP4 does not adopt a 
typical metal-dependent RTPase fold. A cysteine residue 
is found in a deep cavity similar to that harbouring the 
catalytic motif of the cysteine phosphatase superfam-
ily63. Thus, these assembly line enzymes seem to have 
incorporated features from various phylogenetic origins.
Unconventional cap synthesis pathways
The first indication that there are deviations from the 
conventional RNA-capping pathway for viral mRNAs 
came in the early 1970s, around the time of the discov-
ery of the RNA cap structure. Since then, is has been 
demonstrated that the ss(–)RNA virus vesicular sto-
matitis virus (VSV) and ss(+)RNA alphaviruses (from 
the family Togaviridae) can synthesize a viral RNA cap 
that is identical to a cellular RNA cap, albeit constructed 
through a completely different mechanism. Although 
alphaviruses do not proceed further than synthesizing 
a cap-0 structure, the fact that divergent biosynthetic 
pathways converge to the consensus cap structure indi-
cates that the selective pressure to maintain this structure 
must be high.
The Mononegavirales RNA-capping pathway. 
Mononegavirales is a viral order of ss(–)RNA viruses 
with unsegmented genomes, such as VSV and rabies 
virus (in the family Rhabdoviridae), measles virus (from 
the family Paramyxoviridae), bornavirus (from the fam-
ily Bornaviridae), and Ebola viruses and Marburg viruses 
(from the family Filoviridae). These viruses encode a 
multifunctional L protein that carries RNA-dependent 
RNA polymerase (RdRp) and RNA cap synthesis acti-
vities. These enzymes have evolved independ ently 
from other known eukaryotic cap-synthesizing 
enzymes, and the L proteins of VSV88,89, spring viraemia 
of carp virus90, human respiratory syncytial virus91 and 
Chandipura virus92 transfer GDP rather than GMP 
to the RNA 5′ end. Part of a domain in the conserved 
region V of L protein contains the GDP polyribo-
nucleotidyl transferase (PRNTase) activity, and forms a 
covalent enzyme–pNp–RNA intermediate (FIG. 3a) with 
the nascent viral RNA. The covalent bond with RNA 
involves a conserved histidine residue present in an ‘HR’ 
motif instead of the lysine residue used by conventional 
GTases92. The 5′-monophosphorylated viral mRNA start 
sequence then receives GDP generated from GTP93 by 
an as-yet-unknown NTPase. The VSV MTase, present 
in domain VI of L protein78,94, subsequently methyl-
ates the core cap structure at the ribose-2′-O position 
of the first nucleotide, followed by methylation at the 
guanine-N7 position, generating GpppAm2′-O-RNA and 
m7GpppAm2′-O-RNA, respectively95–97. The capping reac-
tion seems to be dependent on RNA length, indicating a 
possible spatial rearrangement in L protein98. Although 
no crystal structure is available yet, the MTase activities 
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Cell-based replicon assays 
Assays that allow one to follow 
the replication of a ‘minimal 
viral genome’ encoding the 
viral replication complex but 
no structural or envelope 
proteins, which are usually 
replaced by reporter genes 
(such as luciferase or 
chloramphenicol acetyl 
transferase genes).
share the AdoMet-binding and active site, which com-
prises a conserved Lys-Asp-Lys-Glu catalytic tetrad, 
typical of 2′OMTases.
The RNA-capping pathway of the alphavirus-like 
togaviruses. Alphaviruses (ss(+)RNA viruses, such as 
Semliki Forest virus, sindbis virus and chikungunya 
virus) synthesize a cap-0 structure through a non- 
conventional mechanism (FIG. 3b). The Semliki Forest 
virus replicase protein nsP1 has N7MTase and GTase 
activities, the latter still incompletely characterized, and 
is presumably involved in the capping of viral mRNA 
after nsP2-mediated cleavage of the β–γ phosphate 
bond at the 5′ end99,100. Although the GTase activity of 
nsP1 has not been fully demonstrated, GTP leads to 
the formation of a covalent enzyme–GMP complex, 
albeit only in the presence of AdoMet99,101. Accordingly, 
mutagenesis and in vitro assays have also revealed that 
the MTase catalyses the transfer of a methyl group from 
AdoMet to the N7 position of GTP before the formation 
of the covalent m7GMP–enzyme complex. The covalent 
link involves a conserved catalytic histidine residue that 
is required for the GTase reaction but not for MTase 
activity. Interestingly, brome mosaic virus replicase pro-
tein 1A, bamboo mosaic virus nsp102, tobacco mosaic 
virus P126 (REF. 103) and hepatitis E virus p110 (REF. 
104) have properties similar to the N7MTase and GTase 
of alphaviruses, pointing to a common evolutionary 
origin for these distantly related viruses of plants and 
animals. Crystal structures are not yet available for any 
of these enzymes.
Virus-mediated RNA cap snatching
Among the ss(–)RNA viruses, those of the families 
Arenaviridae, Bunyaviridae and Orthomyxoviridae have 
a segmented RNA genome and form the order tenta-
tively named Multinegavirales (FIG. 2). These viruses do 
not have a cap-synthesizing machinery. However, they 
have evolved to steal caps from host mRNAs in order to 
prime their own viral replication, in a process known 
as cap snatching (REFS 105–107). Cap snatching involves 
three steps (FIG. 3c). First, the 5′-methylated cap-1 or 
cap-2 structure of a host mRNA is bound by a specific 
site in the viral RdRp (or possibly the N protein108). 
Then, endonucleolytic cleavage of the cellular mRNA 
occurs several nucleotides downstream from the cap 
structure. Finally, this short, capped RNA is used as a 
primer for the synthesis of viral mRNA by the RdRp. The 
sequence, length and structure of the mRNA 5′ end that 
comes with the cap varies from one virus to the other. 
Most sequences are 15–20 nucleotides long106,109–112, but 
arenaviruses, nairoviruses and thogotoviruses use shorter 
primers113–116. Following endonucleolytic cleavage, the 
‘decapped’ cellular mRNAs (BOX 2) are targeted to the deg-
radation machinery, resulting in the downregulation of 
cellular mRNAs.
Enzymes from the cap-snatching pathway. Cap snatch-
ing was found initially in influenza viruses (ss(–)RNA 
viruses of the family Orthomyxoviridae), which serve as 
a model system for the other two viral families known 
to use snatching (ss(–)RNA viruses of the families 
Bunyaviridae and Arenaviridae), although differences 
in the proteins involved and the lengths of snatched 
sequences are expected, as shown for Thogoto virus117. 
The influenza virus polymerase is made of three sub-
units: PA, PB1 and PB2. A cap-binding domain was 
found in the central region of the PB2 subunit118, and 
an endonuclease domain at the N terminus of the PA 
subunit119,120. The structures of both domains shed light 
on the molecular mechanisms leading to cap snatching 
(see below). The cap-binding domain has a novel fold, 
although the mode of m7G binding by aromatic stack-
ing is similar to that used in other cap-binding pro-
teins. By contrast, the endonuclease domain of PA has 
a fold that is characteristic of the two-metal-dependent 
PD(D/E)XK nuclease superfamily but has the peculiar-
ity of a metal-ligating histidine residue in the active site, 
conferring Mn2+ specificity121 (FIG. 5).
In contrast to orthomyxoviruses, both arenaviruses 
and bunyaviruses have a single protein (L) carrying the 
polymerase and cap-snatching activities. Recent stud-
ies showed that a Mn2+-dependent endonuclease that is 
homologous to that of orthomyxoviruses exists at the 
N terminus of arenaviral and bunyaviral L protein122,123 
(FIG. 5a). Mutational analysis and cell-based replicon assays 
demonstrated that viral nuclease activities are essential 
for cap-dependent transcription of viral mRNA124. These 
domains have a conserved architecture and mechanism, 
which suggests an evolutionary link between them 
despite their low sequence identity (FIG. 5b).
A preliminary electron microscopy study of L protein 
from Machupo virus (an arenavirus) showed a central 
Box 2 | The RNA-decapping pathway of viruses
Viruses cap and decap RNA, and many viruses regulate the decapping pathway in order 
to control the ratio of viral and cellular mRNAs.
Decapping of cellular mRNA by 5CEEJCTQO[EGU|EGTGXKUKCGL-A virus (from the 
Totiviridae family of double-stranded RNA viruses) proceeds through a decapping 
enzyme carried by the Gag subunit of the capsid; this Gag subunit is responsible for 
covalently binding cap structures (7-methyl-GpppG (m7GpppG), in which p is a 
phosphate group) of cellular mRNA158. The decapping activity of Gag aids in the 
expression of viral RNA, apparently by producing large amounts of cellular RNA decoys 
that inhibit the 5|EGTGXKUKCG enzyme 5′–3′ exoribonuclease 1 (Xrn1)159 and compete 
with degradation of viral RNA. How the viral mRNA is recruited by the eukaryotic 
VTCPUNCVKQPKPKVKCVKQPHCEVQT|'
G+('EQORNGZTGOCKPUVQDGGNWEKFCVGF+PVJGECUGQH
the family Poxviridae (double-stranded DNA viruses), the decapping enzyme (D10) 
increases the turnover of host mRNAs and contributes to the shutdown of host protein 
expression160. Moreover, D10 seems to preferentially degrade m7GpppGm
2′-O rather 
than m7GpppAm
2′-O and thereby hydrolyses early-phase viral RNA carrying 
predominantly m7GpppGm
2′-O cap structures
161. In other words, this viral pathway 
benefits from having mRNAs (produced by the capping apparatus) that will be recruited 
D[VJGG+('EQORNGZCPFUKOWNVCPGQWUN[TGOQXGUVJGRQVGPVKCNEQORGVKVKQPHTQO
cellular mRNAs for ribosome binding. Viral ‘cap-snatching’ (see main text) also results  
KPVJKUKODCNCPEGHCXQWTKPIGZRTGUUKQPQHXKTCNIGPGU(KPCNN[UGXGTCNXKTWUGUJCXGDGGP
TGRQTVGFVQKPVGTHGTGYKVJVJGEGNNWNCT40#VTCHHKEMKPICPFFGEQ[OCEJKPGT[(KTUVC
single-stranded positive-sense RNA (ss(+)RNA) enterovirus was shown to inhibit the 
ability of cells to form stress granules by cleaving RAS·GAP-binding protein (G3BP) 
family members. The kinetics of poliovirus-induced processing (P)-body disruption 
correlates with production of viral proteases that induce the degradation of P-body 
proteins, such as DCP1A and the 3′-deadenylase complex component PAN3. Recently, 
VJGUU
40#XKTWUGUJGRCVKVKU|%XKTWUCPF*+8YGTGCNUQTGRQTVGFVQDGEQPPGEVGF 
to the cellular decapping machinery and to regulate it (reviewed in REF. 162).
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ring similar to the RdRp of dsRNA viruses but decorated 
with additional, non-conserved accessory domains. The 
authors speculate that these extra domains are involved 
in cap snatching, and that arenaviral and bunyaviral 
L proteins contain independently folded and functional 
domains, as does the influenza virus RdRp125,126.
The recent nucleoprotein (NP) structure and enzy-
matic assay of Lassa virus (ss(–)RNA; Arenaviridae) 
revealed a second nuclease108, which is probably involved 
in damping the interferon response127, and a dTTP-
binding site, which is proposed to be a cap-binding site 
involved in cap snatching. The idea that the cap-binding 
site for cap snatching may be in the nucleoprotein rather 
than the L protein had already been suggested for hanta-
viruses (ss(–)RNA; Bunyaviridae)128. In this model, L and 
N (as the NP protein is called in hantaviruses) cooperate 
in the process. Meanwhile, the structure of N from Rift 
Valley fever virus (also a bunyavirus)129 does not present 
any of these features. These data call for caution before 
extending the assignation of such a function to related 
nucleoproteins.
Innate immunity and RNA capping
Mammalian cells have co-evolved with viruses and have 
developed several mechanisms to detect a viral infec-
tion (such as detecting uncapped or partially capped 
RNA, VPg–RNA, and so on) and induce an antiviral 
response in neighbouring cells130–132. This innate immu-
nity is based on a small number of receptors called pat-
tern recognition receptors (PRRs), which discriminate 
self from non-self components. Non-self detection 
depends on the recognition of a limited set of pathogen- 
associated molecular patterns (PAMPs), which are mol-
ecules or components that are characteristic of infec-
tious agents, such as viral nucleic acids133. The presence 
of non-self nucleic acids is detected through sensors 
such as Toll-like receptors (TLRs), which recognize 
DNA or RNA in intracellular compartments that do 
not usually contain these molecules. Moreover, sev-
eral PRRs sense the presence of foreign nucleic acids 
directly in the cytoplasm — namely, the NOD-like 
receptors (NLRs) and the retinoic acid-inducible gene 
(RIG)-like receptors (RLRs)134. As host cell RNA  is 
present in the cytosol, PRRs sense uncommon RNA 
structures that are present in infected cells, such as 
dsRNA, RNA presenting a 5′-triphosphate, RNA with an 
incompletely methylated cap structure (cap-0, for mam-
malian standards) or RNA bearing a protein co valently 
attached to the 5′ end (such as VPg). The detection of 
PAMPs by PRRs triggers intracellular signalling events 
that mainly induce the production of type I interferon 
(IFN), interleukin-1 (IL-1) and pro-inflammatory 
cytokines, as well as the establishment of a cellular 
antiviral state in order to limit viral propagation135,136 
(FIG. 6).
Among the PRRs, the TLR family is the best studied 
innate immunity sensor family. TLRs are transmembrane 
proteins that are mainly expressed in immune cells, such 
as macrophages and dendritic cells. They are local-
ized in endosomal compartments or at the cell surface. 
TLRs contain a leucine-rich repeat motif that recog-
nizes PAMPs, and a Toll–IL-1 receptor (TIR) domain is 
present in the cytoplasmic part of the protein, ensuring 
signal transduction through TIR domain interaction with 
the TIR domains of cytoplasmic adaptor proteins such 
as MYD88 and TRIF (also known as TICAM1). TLR3, 
TLR7 and TLR8 are activated by different kinds of RNAs. 
TLR3 detects dsRNA, whereas TLR7 and TLR8 recognize 
ssRNA carrying a 5′-triphosphate or a cap-0 structure137.
In contrast to TLRs, the NLRs and RLRs are localized 
in the cell cytoplasm132 and detect the presence of intra-
cellular invaders. Among the RLRs, RIG-I (also known 
as DDX58) and MDA5 (also known as IFIH1) seem to 
discriminate non-self RNA from self RNA on the basis 
of the RNA 5′ end134. Metazoan self RNA presents a 
5′ cap-1 or cap-2 structure. RIG-I protein is special-
ized in the detection of 5′-triphosphate RNA, whereas 
MDA5 senses the presence of RNA with a cap-0 struc-
ture or linked to a protein such as VPg138. RIG-I and 
MDA5 consist of two N-terminal caspase-recruitment 
domains (CARDs), a central DEXH box-containing 
RNA helicase–ATPase domain and a C-terminal regu-
latory domain (CTD)139. It is likely that, in the absence 
Figure 5 | Unconventional capping machineries. Endonucleases and cap-binding 
PB2. C|| Domains involved in the ‘cap-snatching’ mechanism. The organization of 
cap-snatching domains of influenza viruses (single-stranded negative-sense RNA (ss(–)
RNA) viruses of the family Orthomyxoviridae), and corresponding domains of distantly 
related viruses of the families Arenaviridae and Bunyaviridae (also ss(–)RNA viruses). 
Influenza virus polymerase is composed of three proteins of multiple domains: PA, PB1 
and PB2. PA and PB2 are involved in cap snatching. PA carries the endonuclease domain 
in its amino terminus, whereas PB2 has an inner domain responsible for cap binding. 
Mapping of the domain organization for arenaviruses and bunyaviruses is less advanced; 
only the endonuclease domain is mapped to the amino terminus of L protein. The 
cap-binding domain is not clearly identified, as it is thought to be in either L protein or 
nucleocapsid (N or NP) protein, depending on the virus. b|^ |5VTWEVWTGUQHVJGFKHHGTGPV
endonuclease domains of viruses from the families Orthomyxoviridae (influenza viruses), 
Arenaviridae (lymphocytic choriomeningitis virus (LCMV)) and Bunyaviridae (La Crosse 
virus) (Protein Data Bank (PDB) accession codes 3HW4, 3JSB and 2XI5, respectively), and 
of the cap-binding domain from an influenza virus (PDB accession code 2VQZ). Despite 
having no sequence similarities, the folds of these endonuclease domains are conserved, 
suggesting a convergent evolution. Structures are coloured cyan for α-helices and pink 
for β-strands. 
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of ligands, the CARDs of RIG-I are auto-inhibited by 
other domains of the protein. For RIG-like proteins, 
nucleic acid binding to the RNA-binding site of the CTD 
induces a conformational change resulting in interaction 
of the CARD with the signalling adaptor molecule IFNβ 
promoter stimulator 1 (IPS1; also known as CARDIF, 
MAVS or VISA). IPS1 recruits a signalling complex 
in order to activate transcription factors such as inter-
feron regulatory factor 3 (IRF3) and nuclear factor-κB 
(NF-κB), leading to the expression of IFNβ and other 
proteins that drive the antiviral response (FIG. 6).
The molecular basis for RNA recognition with 
and without 5′ end modification and/or overhang-
ing nucleotides was analysed for RIG-I and MDA5. 
Initial studies indicated that RIG-I specifically recog-
nizes 5′-triphosphate-containing ssRNA140. It was later 
found that RIG-I requires base-paired structures in 
conjunction with a 5′-triphosphate to trigger an anti-
viral response141. The molecular basis of the specific 
interaction between the RIG-I CTD and 5′-triphosphate 
dsRNA was deciphered by a crystallographical study of 
the CTD in complex with RNA142. This study revealed 
Figure 6 | Sensing of viral RNA by the innate immune system. A virus that infects a cell releases viral RNA into the 
host cytoplasm or endosomes in one of four forms: RNA protected by a 5′ cap-1 structure (7-methyl-Gppp-2′-O-methyl-
NP-RNA, depicted here as m7GpppNmp-RNA, in which N is the first transcribed nucleotide and p is a phosphate group), 
5′-triphosphate RNA (pppNp-RNA), RNA linked to VPg or RNA carrying a 5′ cap-0 structure (m7GpppNp-RNA). Cap-1 
RNA is recognized by pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs), retinoic acid-inducible gene 
(RIG)-like receptors (RLRs) and NOD-like receptors (NLRs), which in this case recognize, for example, double-stranded 
RNA (dsRNA). In absence of a cap structure, the 5′-triphosphate of RNA is sensed by the RLR RIG-I, and the VPg–RNA and 
cap-0 RNA are recognized by another RLR, MDA5. Both RIG-I and MDA5 recruit the mitochondrial-anchored protein 
interferon-β (IFNβRTQOQVGTUVKOWNCVQT|
+25YJKEJKPVWTPTGETWKVUCRRTQRTKCVGKPJKDKVQTQH0(κB kinase (IKK) 
proteins to activate nuclear factor-κB (NF-κ$CPF+(0TGIWNCVQT[HCEVQTU
+4(U6JKUTGUWNVUKPVJGKPFWEVKQPQHV[RG|++(0U
and the production of pro-inflammatory cytokines such as interleukin-1 (IL-1). The endosomal receptor TLR7 can 
recognize cap-0 RNA and 5′-triphosphate RNA, whereas TLR8 recognizes only 5′VTKRJQURJCVG40#|6.4TGETWKVUVJG
adaptor protein MYD88 through a Toll–IL-1 receptor (TIR)–TIR domain interaction, leading to the activation of NF-κB and 
+4(QT+4(VJKUTGUWNVUKPVJGKPFWEVKQPQHV[RG|++(0UCPFVJGRTQFWEVKQPQH+.CPFQVJGTRTQKPHNCOOCVQT[E[VQMKPGU
#PVKXKTCNTGUVTKEVKQPHCEVQTUCTGCNUQUVKOWNCVGFD[V[RG|++(0TGEGRVQT
+(04CPFCTGMPQYPVQKPJKDKVVJGTGRNKECVKQPQH
RNA viruses carrying non-capped genomes. Autocrine and paracrine IFN binds IFNR and initiates the JAK–STAT (Janus 
kinase–signal transducer and activator of transcription) signalling cascade. Among hundreds of proteins encoded by 
IFN-stimulated genes (ISGs), some antiviral proteins specifically target uncapped viral RNA. The IFIT (IFN-induced 
protein with tetratricopeptide repeats) proteins specifically sequester 5′-triphosphate RNA (IFIT1) or cap-0 RNA 

+(+6|2TQVGKPMKPCUG40#CEVKXCVGF
2-4TGEQIPK\GU′-triphosphate RNA through an amino-terminal dsRNA-binding 
FQOCKPEQORQUGFQHVYQDKPFKPIOQVKHU#EVKXCVGF2-4RJQURJQT[NCVGUGWMCT[QVKEVTCPUNCVKQPKPKVKCVKQPHCEVQT|α 
(eIF2αVJTQWIJKVUMKPCUGFQOCKPCPFDNQEMURTQVGKPVTCPUNCVKQP|40CUG.KUUVKOWNCVGFD[′,5′oligo(A) oligonucleotides 
synthesized by oligoadenylyl synthases (OASs) and is also involved in the degradation of capped and non-capped viral RNA.
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Viral antigenomes 
Viral RNAs that are 
complementary strands to  
the genome. The antigenome 
strand is used as a matrix for 
the synthesis of new viral 
genomes, and of viral mRNAs 
in the case of positive-sense 
RNA viruses. 
that 5′-triphosphate dsRNA binds to the CTD of RIG-I 
more tightly than its single-stranded counterpart. The 
5′-triphosphate is sequestered in a lysine-rich cleft 
of the CTD, with a phenylalanine residue stacked to 
the terminal base pair. Interestingly, 5′-triphosphate 
dsRNA methylated at the 2′-O position of its first or 
second nucleotide is expected to create a steric conflict 
with the CTD of RIG-I. Accordingly, it does not stimulate 
the RIG-I pathway.
In contrast to RIG-I, MDA5 is thought to recognize 
either a viral RNA 5′ end carrying structures that are 
distinct from a 5′-triphosphate or longer, structured 
(mesh) RNA that would be generated during the viral 
life cycle. Indeed, MDA5 was reported to sense both 
dsRNA and ssRNA bearing a 5′ cap-0 (REFS 138,143) 
or linked to VPg. Structural analysis of the MDA5 
CTD indicated that its global fold is similar to that 
of the RIG-I CTD144, with amino acid differences in 
the domains involved in the recognition of the RNA 
5′ end.
The involvement of MDA5 and TLR7 in the detec-
tion of cap-0-containing RNA was recently character-
ized in the antiviral response observed for a coronavirus 
mutant lacking 2′OMTase activity138. The replication of 
this mutant virus was dramatically impaired in infected 
mice. However, the replication of this virus was restored 
in MDA5-, TLR7- or type I IFN receptor (IFNR)-
deficient mice. It has also been suggested that other 
interferon-stimulated genes (ISGs) restrict the repli-
cation of 2′OMTase-deficient viruses145. Accordingly, 
IFIT1 (IFN-induced protein with tetratricopeptide 
repeats 1; also known as IFI56) and IFIT2 (also known as 
IFI54) were reported to limit the replication of West Nile 
virus (an ss(+)RNA virus of the genus Flavivirus), vac-
cinia virus (a dsDNA virus of the family Poxviridae) and 
murine hepatitis virus (an ss(+)RNA virus of the family 
Coronaviridae) lacking 2′OMTase activity145. IFIT1 was 
recently shown to bind and sequester 5′-triphosphate 
RNA into a multiprotein complex containing IFIT2 and 
IFIT3 (also known as IFI60) in order to exert its anti-
viral effect146. Therefore, it is likely that 2′-O-methylation 
of the RNA cap promotes escape from the host innate 
antiviral response through avoidance of IFIT-mediated 
suppression.
Conclusions
Since the discovery of ‘blocked and methylated’ mRNA 
ends nearly 40 years ago, viruses have played an essen-
tial part in deciphering the process of mRNA capping, 
as well as its relationship with various cellular processes 
such as transcription, translation and innate immu-
nity. Viral RNA capping is a field that still has a lot of 
uncharted territory: whether the RNA 5′ ends are pro-
tected or not is still unknown for many neglected viral 
families, and the GTase resists identification even for 
some studied human pathogens (for example, the ss(+)
RNA viruses of the order Nidovirales).
It is likely that, during their co-evolution with 
their hosts, viruses evolved different adaptation strat-
egies to protect their RNA transcripts. The diversity 
of mechanisms expressed in nature to add a cap to an 
RNA 5′ end is larger than that described here. Future 
research will also aim to elucidate how the fine-tuning 
between host-mediated decapping of viral RNA, virus-
mediated capping of viral RNA and host innate immu-
nity is performed. Moreover, it has been shown that viral 
antigenomes are not capped147, an observation that has 
now been extended to many different viruses. Thus, ‘no 
capping’ signals probably exist. In addition, the abun dance 
of template RNAs must certainly need to be finely regu-
lated for optimal viral replication. The corresponding 
signals and regulations are largely unknown.
Finally, owing to its spectacular mechanistic diversity, 
RNA capping is an attractive field for the design of anti-
viral drugs. Several molecules have been proposed to act 
directly or indirectly on viral RNA capping. Ribavirin is a 
broad-spectrum antiviral agent that is active against sev-
eral viruses that add or snatch RNA caps, and its pleio-
tropic mechanism includes targeting the RNA-capping 
machinery148,149. So far, efforts to design MTase inhibi-
tors have used the AdoMet and AdoHcy (S-adenosyl-l-
homocysteine) backbone to synthesize analogues that 
are specific to viral enzymes150. The increasing knowledge 
about active-site differences between cellular and viral 
MTases is expected to provide antiviral selectivity. Last, 
inhibitors of cap-snatching endonuclease have long 
been known119,151–153. Recently published crystal struc-
tures119,122,123 of their targets should inform antiviral-drug 
design projects.
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ABSTRACT In the past few years there has
been a growing awareness that a large number of
proteins contain long disordered (unstructured) re-
gions that often play a functional role. However,
these disordered regions are still poorly detected.
Recognition of disordered regions in a protein is
important for two main reasons: reducing bias in
sequence similarity analysis by avoiding alignment
of disordered regions against ordered ones, and
helping to delineate boundaries of protein domains
to guide structural and functional studies. As none
of the available method for disorder prediction can
be taken as fully reliable on its own, we present an
overview of the methods currently employed high-
lighting their advantages and drawbacks. We show
a few practical examples of how they can be com-
bined to avoid pitfalls and to achieve more reliable
predictions. Proteins 2006;65:1–14.
© 2006Wiley-Liss, Inc.
Key words: protein disorder; predictionmethods
INTRODUCTION
Intrinsically unstructured/disordered or natively un-
folded proteins have a broad occurrence in living organ-
isms. They are characterized by the lack of stable second-
ary and tertiary structure under physiological conditions
and in the absence of a binding partner/ligand. Intrinsi-
cally disordered proteins fulfil essential functions, which
are often linked with their disordered structural state.
A protein region is defined as disordered if it is devoid of
stable secondary structure and if it has a large number of
conformations as seen usingmethods such as X-ray crystal-
lography (lack of electron density), nuclear magnetic reso-
nance (NMR), circular dichroism (CD), small-angle X-ray
scattering, and various hydrodynamic measurements.1,2
However, this definition embraces several categories of
disorder: molten globules, partially unstructured proteins
(premolten globules), and random coils (by increasing
mobility and decreasing residual secondary structure con-
tent (see Uversky3).
What is the practical interest of identifying disordered
regions? Disorder prediction is an essential prerequisite to
protein sequence analysis. Disordered regions often have a
biased amino acid composition that can lead to spurious
sequence similarity with unrelated proteins. The recogni-
tion of regions of disorder is thus crucial to avoid spurious
sequence alignments with sequences of globular proteins
(for examples, see Iyer et al.4). Moreover, the recognition of
disordered regions facilitates the identification of Eukary-
otic Linear Motifs (ELMs), which are short functional
motifs occurring mainly (!70%) within disordered regions
(e.g., SH3, PDZ, phosphorylation sites5–7).
Second, disordered regions often prevent crystallization
of proteins, or the generation of interpretable NMR data.
Therefore, structural biologists use disorder predictions to
delineate compact domains to solve their 3D structure, or
to dissect target sequences into a set of independently
folded domains in order to facilitate tertiary structure and
threading predictions.8
Although the identification of disordered regions of less
than 20 residues in length is generally thought to be less
accurate,9 recent results suggest that progress has been
made in predicting short disordered regions.10,11 Accord-
ingly, we herein consider also short (i.e., less than 20
residues) regions of disorder.
As in other areas of bioinformatics, the reliability of
disorder prediction benefits from the use of several meth-
ods based on different concepts, different physicochemical
parameters, or different implementations. Using a single
disorder predictor is not sufficient to achieve predictions
good enough to decipher the modular organization of a
protein (for examples, see refs. 12–16). Herein, we briefly
review the sequence features of disordered proteins. Disor-
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der prediction methods are described in Table I, with tips
and caveats concerning each predictor listed in Table II.
We present a general scheme for disorder prediction in
Figure 1, while Figure 2 illustrates a possible pitfall in
disorder prediction. We applied the general scheme de-
scribed in Figure 1 to an in-depth analysis of two well-
characterized proteins, the nucleoprotein of measles virus
(Figs. 3 and 4) and the Ubiquitin-like protein domain of
hPLIC-2 (Fig. 5), and show how prediction methods need
to be combined to achieve accurate disorder predictions.
SEQUENCE FEATURES OF DISORDERED
PROTEINS
Sequence Composition
Intrinsically disordered proteins generally have a biased
amino acid composition. A consensus of two independent
studies, focusing respectively on the amino acids preferred
at the surface of globular proteins or on those found less
frequently in secondary structures17,18 established the
following empirical rule: G, S, and P are disorder-
promoting amino acids, W, F, I, Y, V, and L are order-
TABLE I.MainFeatures of SoftwareTools forDisorderPrediction
Predictor What is predicted Based on
Generates and
usesmultiple
sequence
alignment?
PONDR23,68,69 All regions that are not rigid including random
coils, partially unstructured regions, and
molten globules
Local aa composition, flexibility,
hydropathy, etc
No
http://www.pondr.com
SEG24 Low-complexity segments that is, “simple
sequences” or “compositionally biased
regions”
Locally optimized low-
complexity segments are
produced at defined levels of
stringency and then refined
according to the equations of
Wootton andFederhen24
No
http://mendel.imp.univie.ac.at/
METHODS/seg.server.html
http://www.ncbi.nlm.nih.gov/BLAST
(simplified versionwith default
settings)
ftp://ftp.ncbi.nih.gov/pub/seg/seg
(to download program)
Disopred211 Regions devoid of ordered regular secondary
structure
Cascaded support vector
machine classifiers trained
onPSI-BLASTprofiles
Yes
http://bioinf.cs.ucl.ac.uk/disopred
Globplot18 http://globplot.embl.de Regionswith high propensity for globularity
on theRussell/Linding scale (see next)
Russell/Linding scale of
disorder (propensities for
secondary structures and
random coils)
No
Disembl70 http://dis.embl.de LOOPS (regions devoid of regular secondary
structure); HOTLOOPS (highlymobile
loops); REMARK465 (regions lacking
electron density in crystal structure)
Neural networks trained on
X-ray structure data
No
NORSp71 RegionswithNoOrderedRegular Secondary
Structure (NORS).Most, but not all, are
highly flexible
Secondary structure and
solvent accessibility
Yes
http://cubic.bioc.columbia.edu/
services/NORSp
FoldIndex72 Regions that have a lowhydrophobicity and
high net charge (either loops or
unstructured regions)
Charge/hydropathy analyzed
locally using a sliding
window
No
http://bip.weizmann.ac.il/fldbin/
findex
Charge/hydropathymethod58 Fully unstructured domains (random coils) Global sequence composition
(hydrophobicity versus net
charge)
No
http://www.pondr.com
HCA (Hydrophobic Cluster
Analysis)73
Hydrophobic clusters, which tend to form
secondary structure elements
Helical visualization of amino
acid sequence
No
http://smi.snv.jussieu.fr/hca/hca-
seq.html
PreLink74 http://genomics.eu.org Regions that are expected to be unstructured
in all conditions, regardless of the presence
of a binding partner.
Compositional bias and low
hydrophobic cluster content.
No
IUPred43 http://iupred.enzim.hu Regions that lack awell-defined 3D structure
under native conditions
Energy resulting from
interresidue interactions,
estimated from local amino
acid composition
No
RONN44 http://www.strubi.ox.ac.uk/
RONN
Regions that lack awell-defined 3D structure
under native conditions.
Bio-basis function neural
network trained on
disordered proteins
No
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TABLE II. Tips andCaveats ofDisorderPredictionMethods
Tips Caveats
PONDR PONDR comes in several versions:
VL-XTmay be used to look for binding sites,
indicated by sharp drops in themiddle of
long disordered regions.
VSL1 performs better to identify short
regions of disorder.
VL3 should be preferred to delineate
domains as it gives smoother predictions.
SEG The stringency of the search for low-
complexity segments is determined by three
user-defined parameters: triggerwindow
length [W], trigger complexity [K(1)] and
extension complexity [K(2)]
Parameters for disorder prediction:
for long nonglobular domains, use long
window lengths, typically: seg sequence 45
3.4 3.75
for shorter nonglobular domains, typically
use: seg sequence 25 3.0 3.3
Disopred2 Prediction accuracy is lower if there are fewhomologues
Globplot Gives easy overview ofmodular organization
of large proteins thanks to user-friendly,
built-in SMART, PFAM, and low-
complexity predictions.
Changes of slope often correspond to domain
boundaries
Disembl Gives predictions of low complexity regions
and of aggregation propensity
Use the Loop predictor only as a filter to remove false disorder
predictions ofHot Loops andRemark465, i.e., if Loop predicts
that a region is orderedwhereasHot Loops or Remark 465
predict the opposite, Loop should be trusted
NORSp Beware: someNORSare rigid, whereas somehighlymobile
regions have predicted secondary structure
Prediction accuracy is lower if there are fewhomologs available
FoldIndex Highlights some regions that are probably
short loops better than a simple
hydrophobicity plot
Foldindex does not provide results on theN- andC-termini.
Therefore, it is not convenient to use it on small proteins (!100
aa).
Charge/hydropathy
method
Thismethod has not been trained on
disordered proteins. Therefore, it is
expected to recognize types of disordered
proteins that are underrepresented in the
disordered protein databases.
Requires prior knowledge ofmodular organization of protein.
Applicable only to domainswithout disulfide bonds and
withoutmetal-binding regions.
HCA Highlights coiled coils and regionswith a
biased composition
User’s interpretation required
Highlights regionswith potential for induced
folding
Highlights very short potential globular
domains
Allowsmeaningful comparisonwith related
proteins
Allows a better definition of the boundaries of
disordered regions
Prelink Prelink generally predicts as ordered unstructured regions that
have the potential to be ordered in the presence of a partner
(i.e., to undergo induced folding)
IUPred IUPREDuses a novel algorithm thatwas not
trained on disordered proteins. Therefore, it
is expected to recognize types of disordered
proteins that are underrepresented in the
disordered protein databases.
Applicable only to proteinswithout disulfide bonds andwithout
metal-binding regions.
RONN If RONN is being used to search for short regions of disorder it is
advisable to inspect the plot for regions close to, but below, the
threshold.
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promoting amino acids, while H and T are considered
neutral with respect to disorder. Using sequence composi-
tion as the sole predictive parameter of disorder is not
reliable. For instance, the RNA cap 2!-O-methyltrans-
ferase domain of dengue virus polymerase is structured19
and yet is heavily depleted in some order-promoting
residues and markedly enriched in some disorder-promot-
ing residues (data not shown). However, Weathres et al.20
recently reported that amino acid composition alone could
allow recognition of intrinsically disordered proteins with
a good accuracy. In any case, it is recommended to always
analyze the sequence composition of proteins prior to
further sequence analysis.21
Low Predicted Secondary Structure Content
Secondary structure prediction is based on the propen-
sity of each amino acid to belong to each type of secondary
structure element, computed along sliding windows. Long
("70 aa) regions devoid of predicted secondary structure
elements (as judged by using a combination of methods)
are generally disordered. There are a few exceptions,
called “loopy proteins,” which have no regular secondary
structure and yet are ordered, like the Kringle domain, a
triple-looped, disulphide-linked domain, found in some
serine proteases and in some plasma proteins.22
Low-Sequence Complexity
Low Complexity Regions (LCRs) are regions with a
biased composition (homopolymeric runs, short-period re-
peats, and more subtle overrepresentation of a few resi-
dues), making use of fewer types of amino acids. Intrinsi-
cally disordered proteins tend to have a low sequence
complexity, although it is not a general rule.23,24 It has
been shown recently that the more low-complexity regions
an eukaryotic protein has, the less it is likely to be solubly
expressed in bacteria. This might be related to the fact
that low-complexity regions, which are more frequent in
eukaryotic proteins than in bacterial proteins, are more
sensitive to proteolytic degradation.25 Given the tendency
of IDPs to have low complexity, one could expect that they
are less soluble than globular proteins. However, this is
not a general rule. For instance, the intrinsically disor-
deredN-terminal domain of themeasles virus phosphopro-
tein is even more soluble than the structured C-terminal
domain (see Karlin et al.26 and Longhi et al.27). Likewise,
the intrinsically disordered C-terminal domain of the
measles virus nucleoprotein has a solubility comparable to
that of its structured domain (see Longhi et al.27). Further-
more, intrinsically disordered proteins are less prone to
aggregation compared to globular proteins,28,29 which
facilitates their purification and conservation.
Fig. 1. General scheme for prediction of disordered and ordered regions in a protein.
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Fig. 2. Analysis of the human heat shock factor-binding protein 1 (Genbank accession number: AF068754) using different predictors. The graphical
output of each method and the corresponding interpretation is shown. The precise boundaries of ordered and disordered regions were derived from the
corresponding text output (not shown). Bottom, structural model of the protein reproduced from ref. 59 with permission of Richard Morimoto and the
American Society for Biochemistry and Molecular Biology. The N- and C-termini (thin lines) are disordered, whereas the central region forms a triple
coiled-coil (cylinders). Numbers correspond to the amino acid boundaries of these regions. SEG parameters are explained in Table II.
PROTEINS: Structure, Function, and Bioinformatics DOI 10.1002/prot
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Fig. 3. Measles virus (MV) nucleoprotein (N) (accession number: P35972) analyzed with different predictors. The graphical output of each method
and the corresponding interpretation is shown. The precise boundaries of ordered and disordered regions were derived from the corresponding text
output (not shown). [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]C
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Some special cases of low-complexity sequences are
found in proteins with a certain amino acid periodicity
(such as coiled-coils) and other nonglobular, yet ordered
proteins (collagen, for example). It is recommended to
always look for LCRs, coiled-coils, and repeats in a protein
prior to further sequence analysis (using programs such as
Paircoil30 and Multicoil31). More subtle parameters to
discriminate between globular and nonglobular proteins
using the program SEG are discussed in refs. 21 and 24
(see also Table I).
High-Sequence Variability
Disordered regions are on average much more variable
than ordered ones.32 The reason why they evolve faster is
not clear at present. The relationship between sequence
variability and flexibility is well known by crystallogra-
phers: when a protein does not crystallize despite repeated
attempts, crystallographers are used to removing hyper-
variable regions, presumed to be flexible linkers. High-
sequence variability is not by itself an evidence of disorder,
but only an indicator. A simple method to appreciate
sequence variability is visual inspection of a multiple
sequence alignment.However, it can sometimes bemislead-
ing. Programs that rely on nucleotide substitution rate (as
described by Brown et al.32) can be very informative and
should be used for a more rigorous analysis.33
PREDICTORS OF DISORDER
Several programs have been developed to predict disor-
dered regions using the sequence features reviewed above.
They are presented with their philosophy in Table I, and
their salient points are briefly discussed below. A detailed
description of each predictor is outside the scope of this
review, and the reader interested in more details on a
specific predictor is invited to refer to the relevant article,
indicated in Table I.
Fig. 5. Analysis of the Ubiquitin-like protein domain of hPLIC-2 (accession number: Q9UHD9) using different predictors. The protein sequence, with
the secondary structure elements derived from the structure (PDB code 1J8C), is shown. The solvent accessibility of each residue is plotted below the
sequence. The ribbon representation of the structure is shown; the globular domain is colored in gold while the disordered region is in blue. The picture
was obtained using Pymol. The graphical output of various prediction methods and the corresponding interpretation are shown. The precise boundaries
of ordered and disordered regions were derived from the corresponding text output (not shown). A blue bar highlights the disordered region for each
graphical output, except for VSL1 for which the disordered region is highlighted with a black line. [Color figure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
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Predictors of Disorder
Different predictors rely on different physicochemical
parameters. Therefore, a given predictor can be more
performant in detecting a given feature of a disordered
protein. Thus, predictors are complementary, a point
illustrated in the section focused on practical examples
(see below). As there is no consensus on what disorder
means, it is necessary to know precisely what is predicted
by each method. For instance, “long disordered regions”
predicted by PONDR correspond to regions that are not
rigid including random coils, partially unstructured re-
gions, and molten globules (Table I). On the contrary, if a
protein is predicted to be unstructured by the charge/
hydropathy method, it means that it is probably fully
unstructured (random coil) (Table I). This issue has been
stressed recently by a systematic comparison between
these two prediction methods.34
Most predictors rely on training against a dataset of
disordered protein regions. These datasets are either
entirely built up by the authors or represent improve-
ments of existing datasets. Despite continuous efforts,
these datasets retain some inconsistencies and are neces-
sarily biased, because large regions of disorder can prevent
crystallization. Furthermore, these datasets contain rela-
tively few disordered proteins. Indeed, Disprot (http://
www.disprot.org/),35 which is the largest publicly avail-
able database of disordered proteins whose disorder has
been experimentally assessed, contains only about 400
entries. For these reasons, it is useful to distinguish two
kinds of predictors: those that have been trained on
datasets of disordered proteins (PONDR, Globplot, Dis-
embl, Disopred2, RONN, PreLink), and those that have
not, namely the charge/hydropathymethod (and its deriva-
tive Foldindex), NORSp, and IUPred. The latter avoid the
shortcomings and biases associated to the disordered
datasets. Therefore, they are expected to perform better
than the former methods on disordered proteins presently
under-represented in training datasets.
PONDR, a neural network based on local amino acid
composition, flexibility, and other sequence features, was
the first predictor to be developed (Table I). It is now
available in various versions, each having its own specifici-
ties (e.g., VL-XT allows highlighting of potential protein-
binding regions), and Table II suggests which version
should be chosen according to the user’s goal. Noteworthy,
PONDR has found an application in the study of struc-
tured proteins. Indeed, there is a strong inverse correla-
tion between the VL-XT score within ordered regions and
the presence of dehydrons, which are underwrapped back-
bone hydrogen bonds, recently identified as a major deter-
minant of protein–protein interactions.36,37
Globplot uses a new scale called “Russell/Linding,”
specially developed to express the propensity for a given
amino acid to be in “random coil” or in “regular secondary
structure” (Table I). In Globplot, changes of slope often
correspond to domain boundaries (Table II).
Disembl consists of three separate predictors, trained on
separate datasets, that respectively comprise residues
within “loops/coils” (as defined by DSSP38), “hot loops”
(loops with high B-factors, i.e., very mobile from X-ray
crystal structure), or that are missing from the PDB X-ray
structures (called “Remark 465”) (Table I). The partition-
ing of residues into different flexibility groups is very
useful depending upon the user’s goals (i.e., “hot loop” may
be used to correlate certain functional aspects of proteins
with mobile loops, while “Remark 465” may be used to
detect linkers likely to affect crystallization).
Disopred2 (Table I) is also based on a neural network,
but incorporates information frommultiple sequence align-
ments because its inputs are derived from sequence pro-
files generated by PSI-BLAST.
RONN (Table I) uses a novel approach, a bio-basis
function neural network. It relies on the calculation of
“distances,” as determined by sequence alignment, from
well-characterized prototype sequences (ordered, disor-
dered, or a mixture of both). Its key feature is that amino
acid side chain properties are not considered at any stage.
Prelink (Table I) relies on amino acid composition and on
low hydrophobic cluster content. In this respect, it is a
derivative of HCA, a powerful approach that is discussed
below. PreLink is the first predictor that statistically
proved the ability of HCA to detect linkers, an ability that
had long been noticed before but never previously demon-
strated.
The charge/hydropathy analysis is based on the elegant
reasoning that folding of a protein is governed by a balance
between attractive forces (of hydrophobic nature) and
repulsive forces (electrostatic, between similarly charged
residues), Thus, globular proteins can be distinguished
from unstructured ones based on the ratio of their net
charge versus their hydropathy (Table I). A drawback of
this approach is that it gives only a global indication, not
valid if the protein is composed of both ordered and
disordered regions (Table II). A derivative of that method,
Foldindex, solves this problem by computing the charge/
hydropathy ratio along the protein (Table I).
NORSp (Table I) relies on the principle that long regions
predicted to be devoid of secondary structure and acces-
sible to the solvent are generally unstructured. However,
this is not always true, as in the case of the Kringle domain
mentioned above.
IUPred uses a novel algorithm that evaluates the energy
resulting from interresidues interactions. Although it was
derived from the analysis of the sequences of globular
proteins only, it allows the recognition of disordered
proteins based on their lower interaction energy. This
provides a new way to look at the lack of a well-defined
structure, which can be viewed as a consequence of a
significantly lower capacity to form favorable contacts,
correlating results of another study.39
The program SEG (Table I), which computes sequence
complexity, has not been developed to detect disordered
regions but has been used successfully in that aim by the
group of Koonin.21 Typical SEG parameters for disorder
prediction are found in Table II.
Table I also includes a nonautomated method that is
very useful for unveiling unstructured regions: Hydropho-
bic Cluster Analysis (HCA).40 HCA makes use of a two-
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dimensional helical representation of protein sequences in
which hydrophobic clusters are plotted along the sequence
(the reader is invited to refer to the excellent review by
Callebaut et al.40). HCA stands aside from other predic-
tors, because they only give insights on the extent of
disorder/order, but do not correlate this information with
the sequence by itself. Furthermore, there is little one can
actually learn from comparing the output of these predic-
tors for homologous proteins. In contrast, HCA provides a
representation of the short-range environment of each
amino acid, thus giving information not only on order/
disorder but also on the folding potential (see paragraph
on induced folding below). Although HCA does not provide
a quantitative prediction of disorder and rather presently
requires human interpretation, it provides additional,
qualitative information compared to automated predic-
tors, a point illustrated in the section focused on practical
examples (see below).
Error Rate of Predictors
A general error rate is difficult to evaluate, because it
depends of the definition of disorder used, on the evalua-
tion set, and on the criteria of evaluation. These points are
well illustrated by the evaluation of disorder predictors
within the recent Critical Assessment of Protein Structure
Prediction, CASP6, where very different rankings were
obtained as a function of the criteria used.41 Moreover, the
accuracy of a given predictor can be limited when predict-
ing a type of disorder different from that against which it
was trained.
Another reason that prevents the meaningful calcula-
tion of a precise error rate is the fact that a protein can be
disordered by itself, and yet adopt a structure either in a
cellular context (when binding to a partner, a phenomenon
called “induced folding”) or because of artefacts [crystal
contacts during crystallization, for instance, or structure
solved in a nonaqueous medium such as trifluoroethanol
(TFE)]. Many prediction “errors” fall, in fact, in these
categories, as discussed in two recent articles by the
groups of Poupon and of Dunker (see references therein
cited, and Figs. 4–5 in reference42 and Figure 6 in ref. 34).
Because of all the reasons stated above, error rates are
not given in Table I. In general, predictors are more
reliable in predicting order than in predicting disorder, as
(1) ordered sequences comprise only a very narrow portion
of sequence space, that is, their sequence properties are
much more recognizable; and (2) because of the limited
number of disordered protein sequences available for
predictor training. From the authors’ personal communica-
tions, a conservative accuracy for ab initio methods, such
as Disopred2, Disembl, and PONDR, is around 60–70% for
predicting disorder, and about 80% for predicting order.
Reportedly, the charge/hydropathy method has the best
overall accuracy (83%39). However, this method requires
prior knowledge of the domain boundaries (see Table I).
Despite the inherent difficulty of estimating meaningful
error rates, recent studies have pointed out that disorder
predictors can been grossly classified into three catego-
ries.43,44 These categories are by no means absolute, and
are presented only for convenience, to allow a better
interpretation of the results provided by the predictors and
to optimize their use in combination.
Some predictors perform better on short disordered
regions in the context of globally ordered proteins: Diso-
pred2, Prelink, and Disembl (Remark465). Actually, they
were specifically developed with that aim. These predic-
tors also have a good specificity (i.e., they predict relatively
few ordered residues to be disordered), but a moderate
sensitivity (i.e., they miss a significant number of disor-
dered residues). IUPred performs comparatively well for
predicting long disordered segments, and has a good
sensitivity. Finally, although no method has both a very
high specificity and a very high sensitivity, some predic-
tors are “polyvalent” (RONN, PONDR VSL1, Disembl “hot
loops,” FoldIndex and Globplot).
However, we would like to point out once again that
these observations are only aimed at guiding the user, and
in no way they are intended to provide a quantitative
comparison. The section focused on practical examples (see
below) will also give a qualitative idea of the respective
sensitivities and specificities of these methods.
PREDICTING INDUCED FOLDING
The analysis of hydrophobic clusters and of secondary
structures is of major interest for studying induced folding,
because burial of hydrophobic residues provides the major
driving force in protein folding. This force is, in turn,
regulated by secondary structures that play a role in
guiding the folding pathway. In some cases, hydrophobic
clusters are found within secondary structure elements
that are unstable in the native protein, but can stably fold
upon binding a partner. Therefore, HCA can be very
informative in highlighting potential induced folding. As
an example, we suspected that the isolated hydrophobic
cluster with a predicted !-helix within the disordered
NTAIL domain (Fig. 4) could correspond to a binding region
for one of the partners of N, the viral phosphoprotein P,
and thatNwould undergo induced folding upon binding P.
Later, this hypothesis was proven experimentally27,45–47
(see region highlighted by a bar in Fig. 4).
Molecular Recognition Elements (MoREs) are regions
within an intrinsically disordered protein that have a
propensity to bind to a partner and thereby to undergo
induced folding. It has long been noticed that PONDR can
highlight potential MoREs48 (Table II). For instance, a fine
analysis of PONDR plots led to the identification of
segments of increased structural propensity (i.e., prone to
induced folding) in the RNA degradosome-organizing do-
main of the Escherichia coli ribonuclease RNase E.49 The
group of Dunker recently developed a program to identify
!-helix-forming MoREs (called !-MoREs) from the amino
acid sequence.50 For instance, the above-mentioned region
within NTAIL that undergoes an !-helical transition upon
binding to P, was successfully identified. Linding also
showed how neural network predictions of disorder can
indicate the propensity of ELMs to undergo induced
folding.6
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PRACTICAL EXAMPLES SHOWING HOW
COMBINING DIFFERENT METHODS IMPROVES
DISORDER PREDICTION
Figure 1 illustrates a general sequence analysis scheme
that integrates the peculiarities of each method to predict
globular and disordered regions. As a first step, one should
perform an analysis of sequence composition51 and com-
plexity,24 a search for signal peptides, transmembrane
regions,52 leucine zippers,53 and coiled-coil regions,54–56 to
premark regions of biased composition. This step is crucial
in that it can avoid pitfalls that can lead to miss-
predictions, as exemplified in the next section.
It is also recommended to use DIpro57 to identify pos-
sible disulfide bridges and to search for possible metal-
binding regions by looking for conserved Cys3–His or
Cys2–His2 motifs in multiple sequence alignments. In-
deed, the presence of conserved cysteines and/or of metal-
binding motifs prevents meaningful local predictions of
disorder within these regions, as they may display fea-
tures typifying disorder while gaining structure upon
disulfide formation or upon binding to metal ions.58
Then, ab initio methods, such as Globplot, Disembl,
PONDR, Disopred2, IUPred, RONN, Prelink, Foldindex,
and NORSp (Table I) can be combined to define a consen-
sus on both globular and unstructured regions. Of course,
any supplemental information, as for instance sequence
similarity of a protein region to multidomain proteins, are
precious in terms of domain boundary definition. Once a
gross domain architecture for the protein of interest is
established, the case of domains whose structural state is
uncertain can be settled using the charge/hydropathy
method, which has a quite low error rate (see above).
An Example of a Pitfall: A Coiled-Coil
To illustrate a possible pitfall in disorder prediction, we
have chosen the Heat-Shock Factor binding Protein 1.
Biophysical and biochemical analyses have shown that it
consists of a long, trimeric coiled-coil, with the N- and
C-termini (respectively aa 1–8 and 58–76) being disor-
dered.59 Foldindex was not used, as it could not give
reliable predictions due the small size of the protein (Table
II). PONDR VSL1 predicts the whole protein as disordered
(Fig. 2). IUPred and RONN predict borderline disorder for
most of the protein (Fig. 2) and the C-terminus as disor-
dered. SEG does not detect any long, nonglobular region
(Fig. 2) (using the parameters shown in Table II). However
when using more sensitive parameters (Table II), it de-
tects a medium-length region of biased composition (aa
7–33). All other automated predictors predict the central
region as ordered and the N- and C-termini as disordered
(Fig. 2). A preliminary analysis using Multicoil31 and HCA
would have solved these discrepancies. Multicoil gives a
high probability of coiled-coil over aa 30–60 (not shown),
while the HCA plot is typical of a coiled-coil (a long and
horizontally extended hydrophobic cluster encompassing
aa 8–56) (Fig. 2). Furthermore, it is quite obvious from the
plot that the protein has a biased composition, being rich
in Q and D residues (noticeable thanks to their red color;
see Fig. 2). In particular, the Q-rich region roughly corre-
sponds to the low-complexity region detected by SEG (aa
7–33).
Thus, performing the preliminary analysis shown in
Figure 1 would have allowed detection of a coiled-coil
(which fooled some predictors into giving a wrong predic-
tion of borderline disorder) and would have overcome this
pitfall, while giving precious information on the protein
(biased composition). Once the structural status of the
region 8–60 has been established as a coiled-coil, the
comparative analysis of the ensemble of the results gives a
more accurate prediction. Indeed, almost all predictors
correctly predict disordered N- and C-termini with reason-
ably accurate boundaries (Fig. 2). This example also
illustrates the advantage of using predictors that rely on
different principles: for instance, because Prelink is based
on HCA, it is expected to correctly predicted coiled-coils as
ordered. As another example, PONDR VL-XT, gives a
correct prediction, whereas another version of PONDR,
VSL1, optimized to detect short disordered regions (Table
II), is completely fooled by the coiled-coil, and predicts it as
disordered.
Domain Identification
Figures 3 and 4 illustrate the approach used to study the
domain organization of the nucleoprotein (N) of measles
virus, a protein that encapsidates the viral RNA. Experi-
mental data available indicate thatN is organized into two
regions,NCORE (aa 1–399) andNTAIL (aa 400–525), respec-
tively ordered60 and disordered.46,61 As shown in Figure 3,
most ab initio methods converge to show the presence of a
disordered region at its C-terminus (consensus is aa
437–484), and of a globular core (aa 145–344). Interest-
ingly, Foldindex (Table I) highlights a very hydrophilic
region (aa 100–150) that is also visible as a short plateau
(aa 131–144) in the output of Disembl Remark 465 predic-
tor and that is predicted by Disopred2 too (aa 131–149).
Moreover, this region is hypervariable in sequence among
Morbillivirus members (not shown). Finally, because
changes in slope of Globplot often correspond to domain
boundaries (see Table I), from this analysis one would
suspect the following domain organization: a first domain
or subdomain encompassing residues 1–130, that is not
confidently predicted but might be ordered (cf. the nega-
tive slope of Globplot together with PONDR prediction); an
exposed loop spanning aa 131–149; a second, more com-
pact domain (aa 150–400, cf. steep negative slope), and a
disordered domain encompassing aa 401–525. Finally, the
charge/hydropathy method predicts that both suspected
subdomains are ordered and confirms that the C-terminal
domain is disordered (not shown).
HCA helps to refine these predictions. As shown in
Figure 4, the density of hydrophobic clusters indicates
without ambiguity that both subdomains identified by the
combination of previous methods are ordered, and the lack
of hydrophobic clusters within the 422–525 region indi-
cates that it cannot be ordered by itself (the hydrophobic
clusters in the 494–525 region are not long enough to lead
to the formation of a compact domain).
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Thus, no single method, nor even a combination of two
predictors, could successfully unveil the organization of
measles virus N, whereas the combined use of all predic-
tors proved to be much more powerful in terms of domain
boundary recognition. The hypervariable region (aa 131–
149) is indeed accessible to antibodies and thus exposed to
the solvent.62 However, a wealth of mutational data (see
Karlin et al.60 and references therein) indicates that
NCORE cannot be divided into independent modules, but
rather that the subdomains indicated above (aa 1–130 and
aa 145–400) probably fold cooperatively. Thus, the ex-
posed region (aa 131–149) is probably a loop and not a
linker that would connect two mobile domains. Whether it
is disordered or not is not known. However, as it is not
sensitive to proteolysis60 it is probably at least partially
ordered. These unsolved issues nicely illustrate the present
limits of disorder prediction.
Manual Refinement of Domain Boundaries using
HCA
Figure 5 illustrates a frequently encountered case in
disorder prediction, namely the occurrence of an extended
region of intermediate length (20 ! aa " 40) at one
extremity of the protein followed by a globular domain
(#70 aa). We have used the example of the Ubiquitin-like
domain of hPLIC-2, whose structure has been solved by
NMR.63 As shown in Figure 5 (top), the region encompass-
ing residues 1–31 is devoid of regular secondary structure
elements and is extended in solution. All predictors detect
a disordered region at the amino terminus (Fig. 5); how-
ever, the predicted boundaries of the disordered region
vary from one predictor to another, with a predicted length
ranging from 19 to 69 residues (see Fig. 5). Globplot
predicts disorder for the 1–20 region, four predictors
(Prelink, DisEMBL, VL-XT, and IUPred) define the C-
terminal boundary of the disordered region around residue
28, two predictors (Disopred and Foldindex) predict a
disordered region spanning residue 1–32, two predictors
(VSL1 and RONN) extend the prediction of disorder to the
region encompassing residues 1–60 (see Fig. 5), and SEG
predicts a potential nonglobular region within aa 2–69.
Based on these results, the user can be confident than
the N-terminal moiety of the protein is disordered, al-
though the exact C-terminal boundary of the unstructured
region remains uncertain (predictions vary from residue
19 to residue 69!) Use of HCA helps to reduce this
uncertainty. The HCA plot clearly allows the identification
of the 1–30 region as disordered, based on its almost total
depletion in hydrophobic residues, and of the 53–103
region as ordered, given its high density in hydrophobic
clusters. Thus, one can confidently predict that the protein
is organized into two moieties, with HCA having narrowed
the boundary between these two regions down to the
30–52 region. In the absence of functional or biochemical
clues (such as limited proteolysis studies), the production
of various truncated versions of each moiety is recom-
mended in view of functional or structural studies. Such
constructs should start or end at incremental positions
between residues 30 and 52 (i.e., at the ends of predicted
secondary structure elements; not shown). Indeed, the
experience that we gained in the context of past and
present structural genomics projects developed in our
laboratory (see SPINE and VIZIER projects at http://
www.afmb.univ-mrs.fr/-The-Spine-Program- and http://
www.afmb.univ-mrs.fr/-VIZIER-) has shown that a critical
factor in obtaining good-quality protein crystals is the
number of constructs generated around the predicted
boundary of the domain under study.
CONTRIBUTION OF DISORDER PREDICTIONS
TO BIOINFORMATICS ANALYSES
As already mentioned, the identification of disorder can
also avoid gross mistakes in protein sequence analysis. For
instance, Iyer et al.4 recently reported two examples in
which the SEG program (Table I), in combination with
multiple alignment and secondary structure prediction,
invalidates previous functional assignments for two pro-
teins, ATF-2 and PIF3, made on the basis of distant
sequence similarity to two domains (respectively histone
acetyltransferase (HAT) and PAS domain). The HAT and
PAS domains are globular, whereas the similar regions of
ATF-2 and PIF3 are confidently predicted to be unstruc-
tured, casting a strong doubt on their suspected homology.
Once regions of disorder have been identified, then
further bioinformatics analyses, aimed at identifying re-
lated proteins, can be carried out avoiding spurious se-
quence similarity. For instance, Rabitsch et al. illustrated
how to perform search for homologs of proteins composed
mostly of unstructured regions (Sgo1 and Sgo2). They
searched for candidate proteins having short stretches of
sequence or structural similarity (i.e., presence of a coiled-
coil) to Sgo1 and Sgo2, and distributed in a similar fashion
as compared to the candidate protein sequence.64
Disorder prediction can also greatly help to identify
short modules. For instance, it was instrumental in identi-
fying five novel groups of Lsm domain proteins.65 The
architecture of these proteins, which guided the research
for sequence similarities, was elucidated using the consen-
sus of Globplot, Disembl, NORSp, and PONDR analyses.
The authors identified conservedmotifs described as “stable
islands in a large sea of intrinsically unstructured se-
quence regions.” This is probably true of many large
human proteins for which very short conserved motifs in
the middle of long disordered regions remain to be discov-
ered.7 Another method that can be of great use in identify-
ing short (50–70 aa), globular domains located within
long, disordered regions (e.g., chromodomains) is HCA.40
CONCLUSION
As we have seen from two detailed examples, no single
predictor can reveal the structural organization of a pro-
tein. However, in combination they provide relatively
accurate results. Thus, there is obvious room for improve-
ment of predictors by combining features of several pro-
grams (i.e., by including information on predicted second-
ary structure elements, or information derived from
multiple sequence alignments). It would also be of major
interest to check whether known regions of induced folding
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correlate well with isolated hydrophobic clusters, corre-
sponding to predicted !-helices, within disordered re-
gions.45–47 Other improvements may arise from a better
understanding of the different types, or “flavors” of disor-
der.66
As a last, optimistic note, one should never give up
carrying out a crystallization experiment because of an
order/disorder prediction: recently, Mavrakis et al. submit-
ted the phosphoprotein of rabies virus to crystallization
trials, despite the fact that the N-terminal moiety, which
accounts for more than half of the protein, was predicted to
be disordered. Crystals formed in the drop. In fact the
N-terminus had been cleaved off by contaminating pro-
teases and the crystals were made of the C-terminal part
. . . whose structure was readily solved!67
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Abstract
!-Actinin belongs to the spectrin family of actin crosslinking and bundling proteins that function as key regulators of cell motility,
morphology and adhesion. The actin-binding domain (ABD) of these proteins consists of two consecutive calponin homology (CH)
domains. Electron microscopy studies on ABDs appear to support two competing actin-binding models, extended and compact, whereas
the crystal structures typically display a compact conformation. We have determined the 1.7 Å resolution structure of the ABD of !-
actinin 1, a ubiquitously expressed isoform. The structure displays the classical compact conformation. We evaluated the two binding
models by surface conservation analysis. The results show a conserved surface that spans both domains and corresponds to two previ-
ously identiWed actin-binding sites (ABS2 and ABS3). A third, and probably less important site, ABS1, is mostly buried in the compact
conformation. However, a thorough examination of existing structures suggests a weak and semi-polar binding interface between the two
CHs, leaving open the possibility of domain reorientation or opening. Our results are consistent with a two-step binding mechanism in
which the ABD interacts Wrst in the compact form observed in the structures, and then transitions toward a higher aYnity state, possibly
through minor rearrangement of the domains.
© 2006 Elsevier Inc. All rights reserved.
Keywords: Spectrin family; Surface conservation analysis; X-ray crystallography; Protein–protein interaction
1. Introduction
The dynamic assembly/disassembly of the actin cytoskel-
eton is regulated by a large number of actin-binding pro-
teins (ABPs). These proteins interact with monomeric (G-)
and Wlamentous (F-) actin through structurally conserved
motifs. One of the most abundant actin-binding motifs is
the calponin homology (CH) domain (»110 residues),
which can occur in single or multiple copies (Broderick and
Winder, 2005; Gimona et al., 2002). CH domains are pres-
ent in all members of the spectrin family such as "-spectrin,
dystrophin, utrophin, and !-actinin, which play key roles in
the regulation of cell motility, morphology and adhesion.
The actin-binding domain (ABD) of these proteins consists
of two N-terminal CH domains, CH1 and CH2, connected
by a Xexible linker. Although CH1 accounts for most of the
F-actin-binding aYnity, CH2 (which does not bind actin by
itself) contributes somewhat to the overall binding aYnity
of the ABD (Way et al., 1992).
In the cell !-actinin crosslinks actin Wlaments and
serves as a connection between the cytoskeleton and sig-
naling and membrane proteins (Broderick and Winder,
2005; Otey and Carpen, 2004). !-Actinins are a family of
four closely related isoforms. Isoforms 2 and 3 are
expressed exclusively in muscle, where they crosslink actin
Wlaments in the Z disc (Beggs et al., 1992). Of the two non-
muscle isoforms, !-actinin 1 is ubiquitously expressed and
located primarily in focal adhesions (Pavalko and
Burridge, 1991), whereas isoform 4 is present in mem-
brane ruZes (Honda et al., 1998). !-Actinin functions as
! PDB IDS: 1EYI, 1EYN.
* Corresponding author. Fax: +1 617 972 1753.
E-mail address: rdominguez@bbri.org (R. Dominguez).
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an antiparallel homodimer. Each monomer consists of an
N-terminal ABD, followed by four spectrin repeats, and a
C-terminal calmodulin-like (CaM) domain. The function
of !-actinin appears to be regulated by the binding of
phosphatidylinositol (4,5)-bisphosphate (PIP2) to the
ABD (Fukami et al., 1992, 1996) and the binding of Ca2+
to the CaM domain in non-muscle isoforms.
The crystal structures of several ABDs have been deter-
mined, including those of human, A. thaliana and S.
pombe Wmbrin (Goldsmith et al., 1997; Klein et al., 2004),
utrophin (Keep et al., 1999b), dystrophin (Norwood et al.,
2000), human and mouse plectin (Garcia-Alvarez et al.,
2003; Sevcik et al., 2004) and !-actinin 3 (Franzot et al.,
2005). With the exception of the Wrst ABD of A. thaliana
Wmbrin (Klein et al., 2004), which contains a unique muta-
tion at the CH1–CH2 interface (discussed below), all the
ABD structures display a similar compact conformation,
characterized by extensive interactions between the two
CH domains. In two of the structures, those of utrophin
(Keep et al., 1999b) and dystrophin, the compact confor-
mation results from domain swapping between two mole-
cules in the asymmetric unit, a relatively common artefact
of X-ray crystallography (Liu and Eisenberg, 2002). How-
ever, in solution the ABD of utrophin is monomeric
(Winder, 1996) and that of dystrophin exists in a mono-
mer–dimer equilibrium (Norwood et al., 2000). Moreover,
both proteins appear to function as monomers in the cell
(Broderick and Winder, 2005). There is therefore little
doubt that most ABDs assume a compact conformation
in the unbound state, similar to that observed in the
structures.
By contrast, the conformation of actin-bound ABDs
has yet to be clariWed (Galkin et al., 2003; Lehman et al.,
2004). EM studies of ABD-decorated actin Wlaments have
suggested two diVerent modes of binding, compact (Han-
ein et al., 1998; McGough et al., 1994; Sutherland-Smith
et al., 2003) and extended (Galkin et al., 2002; Moores
et al., 2000). The compact model holds that the ABD
binds actin with only minor changes relative to the crystal
structures, whereas the extended model maintains that
the two CHs become fully separated upon binding. The
latter model implies that CH1 and CH2 interact semi-
independently with actin. These results appear to suggest
that diVerent ABDs, while sharing a common fold, bind
actin in completely diVerent conformations. Further-
more, based on studies on utrophin (Galkin et al., 2002)
and plectin (Cherepanova et al., 2005), it has been pro-
posed that a single ABD can bind actin in multiple
conformations (polymorphic binding). The above scenar-
ios are uncommon, and possibly unlikely, since proteins
of the same family tend to share a similar mode of
interaction.
We have determined the crystal structure of the ABD
of !-actinin 1, a ubiquitously expressed isoform. The
structure displays a compact conformation similar to that
observed in most ABDs. To gain further insights into the
nature of the ABD-actin interaction, we have mapped a
conserved surface area on the compact structure, which
corresponds approximately to two previously identiWed
actin-binding sites (ABS2 and ABS3). This analysis was
then extended to the separated CH domains, so that the
merits of the two binding models could be evaluated. An
examination of the existing structures reveals a moder-
ately conserved and semi-polar CH1–CH2 interface. This
interface is unlikely to become fully exposed but could
accommodate limited structural changes. The results are
consistent with a two-step binding mechanism in which
the ABD interacts Wrst in the compact form observed in
most of the structures, and then transitions toward a
higher aYnity state, possibly through minor rearrange-
ment of the two domains.
2. Experimental
2.1. Cloning, expression, and puriWcation of ABD
The cDNA encoding the ABD of human !-actinin 1
(GenBank ID BC003576) was purchased from ATCC,
ampliWed by PCR, and inserted between the NdeI and
EcoRI sites of the vector pTYB12 (New England BioLabs).
A fusion protein, consisting of chitin-binding domain,
intein and the ABD, was expressed in the E. coli strain
BL21Star(DE3) (Invitrogen), and puriWed on a chitin
aYnity column. The Wnal protein contains, in addition to
!-actinin 1 residues 30–253, an N-terminal (Ala-Gly-His-
Met) and a C-terminal (Glu-Phe-Leu-Glu-Pro-Gly) exten-
sion derived from the expression plasmid.
2.2. Crystallization and data collection
Crystals were obtained in two closely related forms and
under similar conditions at 4 °C, using the hanging-drop
diVusion method (Table 1). Crystals of form I were grown
in 50 mM NaCl, 1 mM EDTA, 100 mM imidazole, pH 6.7,
and 24% PEG 5000 MME, and crystals of form II in
50 mM NaCl, 1 mM EDTA, 200 mM K2HPO4, 20% w/v
polyethylene glycol 3350, pH 9.2. Datasets were collected
at the IMCA-CAT facilities of the Advanced Photon
Source (APS, Argonne, IL). The diVraction data were
indexed and scaled with the program HKL2000 (HKL
Research, Inc.).
2.3. Structure determination
A molecular replacement solution for crystal form I
was obtained with the program AMoRE (Navaza and
Saludjian, 1997), using the Wrst CH domain of plectin
(Garcia-Alvarez et al., 2003) and the second CH domain
of "-spectrin (Carugo et al., 1997) as search models and
data from 9.0 to 3.3 Å resolution. The correlation coeY-
cient for this solution was 47.4% (Rfactor, 0.458). After sev-
eral rounds of manual rebuilding with the program O
(Jones et al., 1991) and reWnement with the program CNS
(Brunger et al., 1998), the Wnal Rfactor was 18.3%
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(RfreeD 20.5%) for all the data to 1.7 Å resolution (Table
1). This model was then used to determine the structure of
the more compact crystal form II (Wnal RfactorD 18.4%
and RfreeD 21.6% at 1.8 Å resolution).
2.4. Surface conservation analysis
A total of 18 representative ABD sequences were
selected for this study (Fig. 1) and aligned with the program
Muscle (Edgar, 2004). The alignment was manually
improved with the program SeaView (Galtier et al., 1996).
Per-residue conservation indices were then calculated with
the program JalView (Clamp et al., 2004). Residues of the
!-actinin 1 ABD (crystal form I) were gradient colored
according to the conservation indices, using the program
ProtSkin (http://www.mcgnmr.ca/ProtSkin/). Conserved
surface areas were then visualized with the program PyMol
(http://pymol.sourceforge.net/).
2.5. Surface electrostatic potential and CH1–CH2 contacts
The electrostatic potential was mapped onto the solvent
exposed surfaces of the ABD and the individual CH
domains (Fig. 3) using the program GRASP (Nicholls
et al., 1991). Atom-to-atom contacts between the two CH
domains were analyzed with CCP4 program CONTACT
(CCP4, 1994). The distance cut-oVs for van der Waal
interactions, hydrogen bonds, and salt bridges were set,
respectively, to 4.2, 3.2, and 3.2 Å (Fig. 4).
3. Results and discussions
3.1. Structure of the ABD of human !-actinin 1
We have determined the crystal structure of the actin-
binding domain (ABD) of human !-actinin 1, a ubiqui-
tously expressed isoform (Fig. 2A). Data have been col-
lected for two crystal forms (I and II, see Section 2 and
Table 1). Crystal form I diVracted to a higher resolution
(1.7 Å), and the atomic structure built from this form con-
tains all the residues of the ABD. By contrast, in crystal
form II (determined to 1.8 Å resolution), several residues
(81–83, 108–109) are disordered and thus not included in
the Wnal model. Therefore, subsequent structural analyses
were performed on the structure resulting from crystal
form I.
The ABD of !-actinin 1 displays a compact conforma-
tion with extensive contact between the two CH domains.
This conformation has been observed in almost all the
ABD structures thus far available (Goldsmith et al., 1997;
Keep et al., 1999b; Klein et al., 2004; Norwood et al., 2000),
(Franzot et al., 2005; Garcia-Alvarez et al., 2003; Sevcik
et al., 2004). Strong similarities are found between the cur-
rent structure and the recently published structure of the
ABD of !-actinin 3 (Franzot et al., 2005), with an RMS
deviation of only 0.67 Å for all the C! atoms. Unlike !-
actinin 1 whose actin-binding activity is regulated by Ca2+,
the binding of the muscle-speciWc !-actinin 3 is insensitive
to Ca2+ (Landon et al., 1985). Such disparity can be attrib-
uted to a dysfunctional CaM domain in !-actinin 1. The
ABDs of these two isoforms are rather similar (with 89.3%
sequence identity) and do not appear to contribute to the
functional diVerences mentioned above. However, there is
one clear diVerence between the two ABD structures in the
conformation of the loop connecting helices E and F of
CH1 (residues 102–110). In !-actinin 1, this loop is located
closer to helix G, shielding the latter more eVectively from
the solvent. This diVerence probably results from the intrin-
sic Xexibility of the E–F loop, since the two isoforms share
identical sequence in this area. Several studies have identi-
Wed helix G of CH1 as a major actin-binding site (ABS2, see
discussions below). Therefore, Xexibility of the E–F loop
might be important in allowing the solvent accessibility of
this site to change readily.
3.2. Surface conservation and actin binding
The conformation of an actin-bound ABD would most
likely depend on the nature of its binding interface: if this
interface consists of a continuous area, spanning both CH
domains, a compact conformation would be more likely.
On the other hand, two independent sites (one on each CH
domain) could result in an extended binding conformation.
Thus, a precise characterization of the actin-binding
Table 1
Data collection and reWnement statistics
Values in parentheses correspond to highest resolution shell.
RmergeD"hkl |I¡ < I > |/" I, where I and <I> are the observed and mean
intensity values of reXection hkl. Rfactor D"hkl !Fo| ¡ |Fc!/" |Fo|, where
Fo and Fc are the observed and calculated structure factors amplitudes of
reXection hkl. Rfree, Rfactor calculated for a randomly selected subset of the
reXections (5%) that were omitted during reWnement.
Crystal form I Crystal form II
DiVraction data statistics
Space group P21212 P21212
Unit cell parameters
a, b, c (Å) 56.76, 110.89, 34.91 53.01, 111.07, 31.55
!, #, $ (°) 90.0, 90.0, 90.0 90.0, 90.0, 90.0
Resolution range (Å) 50¡ 1.7 (1.76–1.70) 50¡ 1.8 (1.85–1.80)
Measured reXections 257,342 98,540
Unique reXections 23,591 17,130
I/" 53.5 (6.6) 32.7 (3.5)
Completeness (%) 94.1 (69.0) 99.7 (61.6)
Rmerge 0.077 (0.292) 0.067 (0.283)
ReWnement statistics
Resolution range (Å) 40¡ 1.7 (1.75–1.70) 40¡ 1.8 (1.87–1.80)
No. of reXections 23,546 16,457
"-CutoV None None
Rfactor 0.183 (0.232) 0.184 (0.214)
Rfree 0.205 (0.273) 0.216 (0.246)
No. of atoms
Protein 1866 1814
Solvent 322
RMS deviations 0.009 0.007
Bonds (Å) 0.009 0.007
Angles (°) 1.19 1.28
PDB accession code (2EYI) (2EYN)
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Fig. 1. Alignment of 18 representative sequences of ABD domains. Accession codes are (from top to bottom): human !-actinin 1, P12814; human !-actinin
3, Q08043; human plectin, G02520; mouse plectin, Q9QXS1; human utrophin, P46939; mouse utrophin (NP_035812), human dystrophin, P11532; mouse
dystrophin, P11531; human Wlamin, O75369; chicken Wlamin, NP_989905; human "-spectrin, O15020; rat "-spectrin, Q9QWN8; mouse dystonin,
NP_598594; human dystonin, Q03001; human calmin, Q96JQ2; mouse calmin, Q8C5W0; human Wmbrin (plastin 3, ABD1), BAD96521; and human
Wmbrin (plastin 1, ABD1), AAH31083. Invariant residues are highlighted in yellow, while residues with greater than 70% conservation are boxed. The heli-
ces of CH1 and CH2, deWned according to the structure of the ABD of !-actinin 1, are represented as blue and red cylinders. Residues numbers corre-
spond to human !-actinin 1. Conserved and exposed amino acids are indicated below the alignment by dark-green (100% conservation) and light-green
(>70% conservation) rectangles. Similarly, conserved amino acids at the interface of the two CHs are indicated by purple (>75% conservation) and
magenta (>50% conservation) rectangles.
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interface, based on structural and sequence analysis, might
give us key insights as to how ABDs interact with F-actin.
A simple and frequently attempted approach is to visu-
alize known actin-binding regions on the surfaces of high-
resolution structures. Previous mutagenesis and NMR
studies have suggested three major actin-binding sites
(ABSs) on various ABDs (Bresnick et al., 1991; Corrado
et al., 1994; Fabbrizio et al., 1993; Kuhlman et al., 1992;
Levine et al., 1990, 1992). These three sites, ABS1 (residues
34–43 of human !-actinin 1), ABS2 (114–133), and ABS3
(141–160), correspond respectively to the N- and C-termi-
nal helices of CH1 (helices A and G), and to the interdo-
main linker and the N-terminal helix A of CH2. When the
above information was applied to the structure of !-actinin
1, ABS1 appears as an isolated site, whereas ABS2 and
ABS3 are contiguous (Fig. 2A). Similar results have been
reported in a recent study on the ABD of !-actinin 3 (Fran-
zot et al., 2005). The outcomes of such analysis, however,
could be ambiguous for a number of reasons: Wrst, each of
these ABSs is likely to contain extra residues in addition to
the region minimally required for actin binding; second,
only a portion of each ABS is exposed, and thus would be
Fig. 2. Potential actin-binding interface of the ABD domain. (A) Ribbon representation of the structure of the ABD of human !-actinin 1 (CH1, blue;
CH2, red) and surface representation showing the location of three identiWed actin-binding sites (ABS1, brown; ABS2, purple; and ABS3, cyan). (B) Sur-
face representation of the ABD of !-actinin 1 showing the potential actin-binding region suggested by sequence conservation analysis (corresponding to
amino acids with >70% conservation, gradient colored in green). Notice the general agreement between this region and ABS2 and ABS3 shown in (A).
This region consists of a larger area on CH1 and a smaller area on CH2, which are connected by a salt bridge between Lys137 and Glu235 (orange, left
panel). (C) Surface conservation on the separated domains of the !-actinin ABD. Conserved residues at the CH1–CH2 interface are gradient colored in
pink according to their conservation indices.
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in direct contact with F-actin; Wnally, the designation of
ABS segments, particularly that of ABS1, is only tentative,
since it was made before any structural information was
available (Broderick and Winder, 2005).
Actin is one of the most conserved proteins in nature.
Therefore, we reasoned that the corresponding actin-bind-
ing interface of any given family of actin-binding proteins
(ABPs) would consist of highly conserved areas on other-
wise variable surfaces. (Based on the assumption that the
interaction is conserved among all the member of the
family.) To identify such binding sites on ABDs, we Wrst
calculated the per-residue conservation indices for 18 repre-
sentative ABDs with the program JalView (Clamp et al.,
2004), based on a careful alignment of their sequences
(Fig. 1). In the next step, all residues of the ABD of !-
actinin 1 were gradient colored according the conservation
indices, and surface residues were visualized using the pro-
gram PyMol (see Section 2). The above analysis reveals two
highly conserved regions on the surface of the ABD, con-
sisting of a larger area centered around Leu124, Gly125 and
Trp128 of ABS2 (helix G, CH1), and the E–F loop of CH1,
and a smaller area centered around Leu151 of ABS3 (helix
A, CH2) and Phe169 (A-B linker, CH2) (Fig. 2B). The two
conserved areas are connected by a salt bridge between
Lys147 (ABS3, helix A, CH2) and Glu235 (helix G, CH2),
which shields the side chain of Met239 (helix G, CH2) from
the solvent. A similar analysis has been performed on the
crystal structure of the Wrst ABD of human Wmbrin (Banue-
los et al., 1998). Interestingly, this ABD lacks such a salt
bridge due to the replacement of the Glu residue with a
proline. As a result, the conserved surface area spans both
domains, from Gly229 and Trp232 on CH1 to Leu367 and
Leu272 on CH2 (corresponding to residues Gly125,
Trp128, Met239, and Leu151 of !-actinin 3). However,
Wmbrin ABD1 appears to be an exception since the above-
mentioned ionic pair is present in the crystal structures of
"-spectrin (Banuelos et al., 1998), !-actinin 3 (Franzot et al.,
2005), mouse plectin (Garcia-Alvarez et al., 2003; Sevcik
et al., 2004), and human plectin (Garcia-Alvarez et al.,
2003; Sevcik et al., 2004). Moreover, based on sequence
comparison, we further suggest that Wlamin and dystonin
also contain this salt bridge (Fig. 1). Could Lys147 and
Glu235 be part of a continuous binding surface in these
ABDs? Given the conservation of this interaction, such a
scenario is likely. However, the polarity of this interaction
is reversed in both utrophin (Keep et al., 1999a) and dystro-
phin (Norwood et al., 2000), with Lys on helix A and Glu
on helix G. Although such reversals may have little eVect on
protein stability, it is unclear if they would be tolerated in a
speciWc binding interface.
Surprisingly, in a compact ABD, no conserved surface
area of considerable size is formed by the residues of ABS1,
which is partially buried at the CH1–CH2 interface. A rea-
sonable explanation is that ABS1 may become accessible to
F-actin upon separation or at least reorientation of the two
CH domains. Indeed, when the same surface conservation
analysis was performed on individual domains (corre-
sponding to CH domains in the extended conformation),
we identiWed one more highly conserved area on the surface
of CH1, dominated by ABS1 and ABS2 (helices A and G)
(Fig. 2C). By contrast, the additionally exposed area on the
separated CH2 is only moderately conserved (Fig. 2C).
3.3. CH1–CH2 interface and ABD conformation
Do the two CH domains separate upon F-actin binding?
Some important hints can be garnered from a thorough
analysis of the interface between CH1 and CH2. Indeed,
strong and highly conserved contacts between the two
domains would support a compact model, whereas weak or
less conserved interactions would be consistent with an
extended model. To better understand the nature of the
CH1–CH2 interaction, we performed and exhaustive analy-
sis of all the existing crystal structures of ABDs (corre-
sponding to 9 proteins, 11 ABDs, 12 crystal forms, 19
crystallographically independent molecules). As part of this
analysis, we tabulated and categorized all the atom-to-atom
contacts between CH1 and CH2 within the distance of
4.2 Å (a generous distance cut-oV for van der Waal con-
tacts). The most important results of our study are pre-
sented below.
The Wrst criterion examined was the hydrophobicity of
the CH1–CH2 interface. As observed in this and previous
studies, a substantial surface area on each domain (700–
800 Å2) becomes buried by the CH1–CH2 interaction.
However, the entropic gain from this interaction does not
depend on the size of the buried surface alone, but also on
the general hydrophobicity of the buried residues. Our
analysis of various ABDs indicates that there are relatively
few incidences in which two non-polar side chains from the
two CHs contact each other (Fig. 4A). For instance, at the
CH1–CH2 interface of !-actinin 1 we found only two such
contacts; between Trp128 and Met239, and between Ile136
and Met239. At least one salt bridge and several hydrogen
bonds are usually observed at the interface between
domains. However, their occurrence appears to be random
as their positions are poorly conserved (Fig. 4A). In addi-
tion, the interfaces of various ABDs display a number of
relatively less favorable contacts, including those between
polar and non-polar side chains, and between hydrophobic
side chains and backbone atoms. Electrostatic mapping of
the ABD and the individual CH domains appears to con-
Wrm the above analysis, with a partial positive charge on
CH1 and a partial negative charge on CH2 (Fig. 3). In sum-
mary, the interface between CH1 and CH2 can be best
described as semi-polar.
As noted in previous studies, the general architecture of
the CH1–CH2 interface remains the same for all ABDs,
and involves the packing of helices A and G of CH1 against
the C-terminal region of CH2 (helices F and G and the E–F
linker) (Figs. 2A and 4A). For a given pair of residues
involved in interdomain contacts in one ABD, an equiva-
lent pair can usually be found in another ABD. However,
the type of interaction is rarely conserved. For example, the
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interacting pair Ala39–Lys220 in !-actinin 1 is replaced
with Asn131–Gln151 in human Wmbrin. This observation is
not totally unexpected, in particular since the C-terminal
region of CH2 is only moderately conserved (Fig. 4A). Fur-
thermore, although there are several conserved residues in
helices A and G of CH1, they tend to forge intradomain
instead of interdomain contacts. One contact, however,
between the side chains of Trp128 (helix G, CH1 of !-
actinin 1) and Lys236 (helix G, CH2), is highly conserved.
This contact, which involves extensive hydrophobic inter-
action and occasionally a !-cation bond (Crowley and
Golovin, 2005) appears to dominate the interdomain inter-
face (Fig. 4B). Most members of the spectrin family display
a similar pair, with the occasional replacement of the Lys
residue by Arg or Gln (Fig. 1). An exception is found in the
Wrst ABD of A. thaliana, in which the corresponding posi-
tions are occupied by Ser and Thr. Interestingly, the crystal
structure of this ABD (Klein et al., 2004) displays two con-
formations within the asymmetric unit: one resembles the
compact form seen in other ABDs (albeit with altered inter-
domain interactions); the other displays a signiWcantly
diVerent conformation characterized by few interactions
between CHs (Fig. 4). Therefore, we suggest that the Trp-
Lys pair functions as a hinge, linking CH1 and CH2 while
allowing for some plasticity at the interface.
3.4. Implications for F-actin binding
Our analysis shows a highly conserved surface area
spanning both CH domains of the compact ABD. We sug-
gest that this area represents the initial actin recognition
site in the compact conformation. The existence of a com-
pact initial binding state is supported by a study on the
ABD of plectin (Garcia-Alvarez et al., 2003). In that work,
actin binding was demonstrated for a mutant ABD
trapped in a compact conformation by an inter-domain
disulWde bond. The above-mentioned site corresponds
largely to ABS2, and to a minor extent, ABS3. By con-
trast, the conserved portion of ABS1 is not exposed in the
compact ABD, possibly because this site contributes mini-
mally to actin binding. Indeed, only ABS2 is absolutely
required for binding, as shown in a study of N- and C-ter-
minally truncated !-actinin constructs (Hemmings et al.,
1992; Kuhlman et al., 1992). Alternatively, ABS1 may
become exposed as a result of an actin-induced conforma-
tional change. Consistent with this view, our analysis of
the separated CH1 shows an additional conserved area
(centered on ABS1), which is otherwise buried in the com-
pact ABD. The conservation of this area may indicate a
role in actin binding since the separated CH2 lacks such
an area.
A second binding step may result in minor rearrange-
ment of the two domains. Indeed, although our analysis
shows a poorly conserved and semi-polar interface between
the two domains, in most ABDs there exists a strongly
interacting Lys-Trp pair that seems to keep the domains
together. Therefore, relative rotation of the two domains
around the Lys-Trp hinge is a likely scenario. However,
based on currently available data, the total separation of
domains suggested by the extended model cannot be ruled
out. Further research is required to distinguish between the
two binding models.
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On starvation, Dictyostelium cells aggregate to form multicellular
fruiting bodies containing spores that germinate when transferred
to nutrient-rich medium. This developmental cycle correlates with
the extent of actin phosphorylation at Tyr-53 (pY53-actin), which
is low in vegetative cells but high in viable mature spores. Here we
describe high-resolution crystal structures of pY53-actin and un-
phosphorylated actin in complexes with gelsolin segment 1 and
profilin. In the structure of pY53-actin, the phosphate group on
Tyr-53 makes hydrogen-bonding interactions with residues of the
DNase I-binding loop (D-loop) of actin, resulting in a more stable
conformation of the D-loop than in the unphosphorylated struc-
tures. A more rigidly folded D-loop may explain some of the
previously described properties of pY53-actin, including its in-
creased critical concentration for polymerization, reduced rates of
nucleation and pointed end elongation, and weak affinity for
DNase I. We show here that phosphorylation of Tyr-53 inhibits
subtilisin cleavage of the D-loop and reduces the rate of nucleotide
exchange on actin. The structure of profilin–Dictyostelium-actin is
strikingly similar to previously determined structures of profilin–
!-actin and profilin–"-actin. By comparing this representative set
of profilin–actin structures with other structures of actin, we
highlight the effects of profilin on the actin conformation. In the
profilin–actin complexes, subdomains 1 and 3 of actin close around
profilin, producing a 4.7° rotation of the two major domains of
actin relative to each other. As a result, the nucleotide cleft
becomes moderately more open in the profilin–actin complex,
probably explaining the stimulation of nucleotide exchange on
actin by profilin.
actin phosphorylation ! profilin–actin structure ! pY53-actin structure !
Dictyostelium discoideum actin ! gelsolin–actin structure
Multiple cellular functions, including cell motility, cell divi-sion, and endocytosis, involve dynamic remodeling of the
actin cytoskeleton (1, 2). Various studies have established a
connection between actin phosphorylation and cytoskeleton
remodeling. For example, fibroblast stimulation with epidermal
growth factors induces actin phosphorylation on serine residues
and the formation of membrane ruffles (3). Actin is also one of
the proteins found to be tyrosine phosphorylated in fibroblasts
expressing constitutively active Src tyrosine kinase and display-
ing significant cytoskeleton rearrangement (4). In Mimosa pu-
dica, a plant that closes its leaves and droops its petioles when
touched, actin is heavily tyrosine phosphorylated, and a decrease
in actin phosphorylation correlates with petiole bending (5). In
none of these examples, however, is the precise connection
between actin phosphorylation and cytoskeleton remodeling
well understood. Such a connection is better established in
Dictyostelium cells, in which the developmental cycle correlates
closely with the extent of actin tyrosine phosphorylation (6–11).
Dictyostelium cells grow and divide as amoebae in nutrient
medium, but they aggregate and differentiate into multicellular
organisms on starvation, ultimately forming fruiting bodies that
contain spores that germinate when conditions become favor-
able for growth (12). The extent of actin phosphorylation, which
is very low in growing vegetative cells, begins to increase 12–24
h into the developmental cycle, reaching!50% of the total actin
at !36 h (9–11). At this high level of actin phosphorylation, the
spores of the mature fruiting bodies remain viable for !20 days,
at which time viability and actin phosphorylation levels both
decrease, disappearing entirely by !30 days. Increases in actin
phosphorylation also occur when vegetative cells are exposed to
heat stress, sodium azide, and the phosphotyrosine phosphatase
inhibitor phenylarsine oxide (6, 8, 11, 13).
The phosphorylation site on Dictyostelium actin has been
mapped to residue Tyr-53 (8, 11). This site is near the DNase
I-binding loop (D-loop) of actin (residues 40–50), which is
implicated in intersubunit contacts in the filament (14–17). The
D-loop is disordered in most crystal structures of actin, including
in the two structures of unphosphorylated Dictyostelium actin
described here in complexes with profilin and gelsolin segment
1 (G1). In contrast, the D-loop is partially stabilized by hydro-
gen-bonding contacts with the phosphate group on Tyr-53 in the
structure of Tyr-53-phosphorylated actin (pY53-actin), which is
also described here in complex with G1. The stabilization of the
D-loop is further supported by biochemical characterization of
pY53-actin in solution.
Profilin stimulates nucleotide exchange on actin (18, 19).
However, the structural bases for this activity are not well
understood. The crystal structure of profilin–Dictyostelium-actin
described here is strikingly similar to previously determined
structures of profilin–!-actin (20) and profilin–"-actin (21).
Based on this representative group of profilin–actin structures,
we analyze the effects of profilin on the conformation of actin
and its role in nucleotide exchange.
Results and Discussion
Structures of pY53-Actin and Unphosphorylated Actin Complexedwith
G1. The different biochemical properties of pY53-actin and
unphosphorylated actin suggested that their structures may be
different (11). To test this possibility, we set out to crystallize
pY53-actin and unphosphorylated Dictyostelium actin under
identical conditions, so that their structures could be compared
directly. Actin’s natural tendency to polymerize constitutes an
obstacle to crystallization. Different approaches have been used
to overcome this problem, including the crystallization of com-
plexes of actin with actin-binding proteins (ABPs) (20, 22–26)
and toxins (27), and blocking actin polymerization by mutagen-
esis (28) or chemical cross-linking (29). We chose to attempt
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crystallization with profilin, gelsolin, vitamin D-binding protein
(DBP), and toxofilin, all proteins that bind to actin on the
opposite side from subdomain 2, which is where Tyr-53 is located
and phophorylation-dependent structural changes are more
likely to occur. Unphosphorylated Dictyostelium actin had al-
ready been crystallized in complex with G1 (30), and we
obtained crystals under similar conditions of both the unphos-
phorylated and phosphorylated forms (see Materials and Meth-
ods). In addition, we obtained crystals of unphosphorylated actin
with profilin and the vasodilator-stimulated phosphoprotein
(VASP) polyproline peptide 198GAGGGPPPAPPLAAQ213,
which binds to profilin on the opposite side from actin (21).
pY53-actin failed to crystallize with profilin under similar con-
ditions (see Conclusions). Toxofilin (26) did not crystallize with
either form of actin, and although DBP-actin yielded large
crystals, they diffracted x-rays poorly.
The structures of complexes of G1 with unphosphorylated
actin and pY53-actin were determined to resolutions of 1.6 Å
and 1.7 Å, respectively (Table 1). The two structures are
strikingly similar to each other and to prior structures of
mammalian skeletal !-actin with G1 (23) and gelsolin segments
1 to 3 (31), and Saccharomyces cerevisiae, Caenorhabditis elegans,
and Dictyostelium discoideum actin with G1 (30). In particular,
the conformation of actin is nearly identical in all these com-
plexes, with the notable exception of the D-loop (supporting
information (SI) Fig. S1). The D-loop is one of the most flexible
parts of the actin molecule, and it is disordered in most of the
structures. Because of its intrinsic f lexibility, we cannot compare
the conformation of the D-loop among different structures.
Factors such as crystal packing, crystallization conditions, actin
isoform, and the identity of the ABP used in the crystallization
may influence the conformation of theD-loop. In contrast, in the
current study we crystallized unphosphorylated actin and pY53-
actin under identical conditions, allowing for a direct compar-
ison of the effect of phosphorylation on the conformation of the
D-loop.
The conformation of the side chain of Tyr-53 is essentially the
same in pY53-actin and unphosphorylated actin (Fig. 1 and
Movie S1) and similar to other structures of actin, except for the
phosphate group on Tyr-53, which is clearly defined in the
electron density map of pY53-actin, but absent in unphosphor-
ylated actin. To further validate this observation, we analyzed
crystals of the two forms of actin using tandem mass spectrom-
etry (Fig. S2). After separation bymetal affinity chromatography
of phospho-peptides from tryptic digestions of protein samples
from the crystals, peptides containing phosphorylated Tyr-53
were detected only in crystals of pY53-actin. This result con-
firmed that the crystals of unphosphorylated actin were free of
the phosphorylated form. Although we cannot exclude the
presence of trace amounts of unphosphorylated actin in crystals
of pY53-actin, crystallographic occupancies of the phosphate
atoms in this high-resolution structure indicate that phosphor-
ylation is !100%.
The phosphate oxygens on Tyr-53 make hydrogen-bonding
interactions with the side-chain nitrogen atoms of Lys-61 and
Gln-49 and with the main-chain nitrogen atoms of Gln-49 and
Gly-48 in the D-loop (Fig. 1B). As a result, the D-loop, which is
fully disordered in the unphosphorylated structure (residues
42–49 were not visualized), becomes partially ordered in pY53-
actin, where four additional residues of the loop were resolved
in the electron density map (Gly-42, Met-47, Gly-48, Gln-49).
Although additional density was present, residues 43–46 could
still not be unambiguously traced. The average temperature
factor for the four additional residues observed in the D-loop is
79.4 Å2, compared to!30 Å2 for the rest of the structure (Table
1), suggesting that although more constrained, the D-loop is still
quite dynamic in this structure. Other than the changes in the
D-loop, the structural differences due to phosphorylation appear
minor (Movie S1). However, a symmetry-related molecule in the
crystal is located near the D-loop (Fig. S3), and it is possible that
the proximity of this crystal contact limited the full extent of the
conformational change. Another factor that could have limited
the magnitude of the conformational change is the presence of
G1 in the structure.
Probing the Structures of pY53-Actin and Unphosphorylated Actin in
Solution. The crystal structures suggest that phosphorylation of
Tyr-53 affects the conformation of the D-loop. We used sub-
tilisin cleavage of the D-loop to test this observation in solution.
The susceptibility of the D-loop to subtilisin cleavage between
residues Met-47 and Gly-48 has been commonly used to monitor
conformational changes in the D-loop resulting from factors
such as the type of nucleotide and divalent cation bound to actin
(32, 33), and the binding of actin-depolymerizing factor (ADF)/
Table 1. Crystallographic data and refinement statistics
Profilin–actin–
VASP202–244 Gelsolin–actin Gelsolin–pY53–actin
Space group P212121 C2 C2
Unit cell a/b/c, Å 38.04/76.18/180.82 178.88/69.17/56.56 178.42/69.05/56.54
Unit cell !/"/#, ° 90/90/90 90/104.36/90 90/104.2/90
Resolution, Å 2.3–50 (2.3–2.38) 1.6–50 (1.6–1.66) 1.7–50 (1.7–1.76)
Completeness, % 89.7 (80.9) 96.8 (78.4) 94.9(57.9)
Multiplicity 11.0 (11.1) 7.3 (3.8) 8.0 (2.1)
Rsym, %* 11.7 (34.9) 7.1 (52.1) 8.4 (40.7)
I/$ 20.3 (15.8) 36.6 (2.1) 23.1 (2.2)
Rfactor, %† 15.7 15.0 14.1
Rfree, %‡ 22.7 19.7 19.1
rms bonds, Å 0.015 0.011 0.012
rms angles, ° 1.504 1.326 1.365
B-factor actin/ABP, Å2 22.54/20.40 24.88/23.21 29.40/30.32
B-factor solvent, Å2 22.89 38.60 44.71
Number of aa/waters 513/318 491/461 494/460
PDB code 3CHW 3CIP 3CI5
Values in parentheses correspond to highest resolution shell.
*Rsym " #(I $ %I&)/#sI; I and %I&, intensity and mean intensity of a reflection.
†Rfactor " #!Fo $ Fc!/#!Fo!; Fo and Fc, observed and calculated structure factors.
‡Rfree; Rfactor of 5% of the reflections that were not used in refinement.
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cofilin to the filament (34). We found that phosphorylation of
Tyr-53 protects the D-loop from subtilisin cleavage, as shown by
a!50% reduction in the initial rate of cleavage of the D-loop in
pY53-actin compared to unphosphorylated actin (Fig. 1C). The
protection of the D-loop from subtilisin cleavage is consistent
with the more stably folded conformation of the loop observed
in the structure of pY53-actin.
Because the exchange of ATP for ADP on actin is thought to
alter the conformation of the D-loop (32), we speculated that
changes in the conformation of the loop might reciprocally affect
nucleotide exchange on actin. Consistent with this prediction, we
found that phosphorylation of Tyr-53 reduces the initial rate of
nucleotide exchange on actin by !45% (as measured by the
increase in fluorescence as etheno-ATP replaces bound ATP),
doubles the half-time to reach equilibrium, and reduces the
fluorescence of etheno-ATP at equilibrium by !50% (Fig. 1 D
and E). Because the conformational change in the D-loop does
not seem to extend to the nucleotide cleft (Movie S1), the
structural reasons for the differences in the rate of nucleotide
exchange and etheno-ATP equilibrium fluorescence are unclear.
Probably, pY53-actin and unphosphorylated actin have different
affinities for ATP and etheno-ATP, and the fluorescence of
etheno-ATP bound in the nucleotide cleft of pY53-actin may be
masked by the conformational change in the D-loop. Finally, it
is known that profilin accelerates (18, 19) and G1 inhibits (35)
nucleotide exchange on actin. Consistent with these reports, we
found that profilin stimulates (Fig. 1D) and G1 inhibits (Fig. 1E)
nucleotide exchange on Dictyostelium actin. The effects of these
two ABPs are very similar for phosphorylated and unphosphor-
ylated actin.
Structure of Unphosphorylated Dictyostelium Actin Complexed with
Profilin. The structural bases for the stimulation of nucleotide
exchange by profilin (18, 19) (Fig. 1D) have remained unclear.
Although the original structure of profilin–!-actin revealed a
moderately open nucleotide cleft in actin (20), a subsequent
structural determination suggested a far more open structure
(36). Some biochemical observations have also been interpreted
as evidence of a more open cleft in actin than suggested by the
majority of the crystal structures (37). However, a wide-open
cleft appears to be structurally unstable (38). More important,
the wide-open structure of profilin–!-actin (36) was obtained in
an unconventional way, by transferring the original crystals (20)
into a high-phosphate solution. Thus, opening of the cleft was
obtained by crystal manipulation rather than a physiologically
relevant factor.
Fig. 1. Conformational change in actin subdomain 2 on phosphorylation of Tyr-53. (A and B) Close views of subdomain 2 in the structures of unphosphorylated
actinandpY53-actin, showingomit electrondensitymaps (contouredat 1") aroundTyr-53 (see Figs. S3andS5 for a full viewof theG1-actin structure). TheD-loop
was not visualized in the unphosphorylated structure. Hydrogen-bonding contacts (red dashed lines) between the oxygen atoms of the phosphate group on
Tyr-53 and residues of the D-loop stabilize the conformation of the D-loop in the structure of pY53-actin. This and other figures of the paper were generated
with the program PyMOL (http://pymol.sourceforge.net/). (C) Phosphorylation protects the D-loop from subtilisin cleavage, as shown by the!50% decrease in
the initial rate of digestion. (D and E) Based on the increase in fluorescence as etheno-ATP replaces actin-bound ATP, phosphorylation reduces the rate of
nucleotide exchange from 0.011 s"1 for unphosphorylated actin to 0.006 s"1 for pY53-actin, but profilin accelerates and gelsolin inhibits nucleotide exchange
to the same extents for both forms of actin. The increase in fluorescence at equilibrium for pY53-actin is only 50% of the increase for unphosphorylated actin.
Data were recorded every 10 s.
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We recently reported two structures of profilin–!-actin (21),
determined to resolutions of 1.8 Å and 1.5 Å in the presence of two
different fragments of human VASP. Here we describe the struc-
ture of profilin–Dictyostelium-actin to 2.3 Å resolution (Fig. 2A and
Table 1). The two structures of profilin–!-actin and that of profilin–
Dictyostelium-actin are strikingly similar to one another and to the
original 2.55 Å structure of profilin–"-actin (20) (Fig. S4A), but
different from thewide-open structure of profilin–"-actin (36) (Fig.
S4B). Therefore, we now have possession of a representative set of
four profilin–actin structures, determined under different crystal-
lization conditions and crystal packing environments, and corre-
sponding to different isoforms and sources of actin.
Can we identify structural features unique to the profilin–actin
complex that would explain the acceleration of nucleotide
exchange? To answer this question, we compared the profilin–
actin structures to all of the actin structures in the protein data
bank. The principal conclusion from this analysis is that com-
pared to any other structure of actin, the nucleotide cleft is
moderately more open in the profilin–actin complex (Fig. 2A).
The conformational change leading to cleft opening begins with
subdomains 1 and 3 of actin closing around the profilin molecule.
As a result, the two major domains of actin on each side of the
nucleotide cleft rotate by 4.7° relative to each other (Fig. 2A). By
using the classical view of actin as a reference (Fig. 1A Left), this
rotation can be described as two perpendicular rotations of
!3.3° (Fig. 2A), roughly corresponding to the propeller-like
twisting and scissor-like opening of the domains suggested by
normal-mode analysis (39). An important distinction, however,
is that rather than a scissor-like motion, we observe a clamp-like
motion, i.e., as the target-binding cleft of actin ‘‘clamps’’ on the
profilin molecule, the nucleotide cleft opens at the opposite side
of the molecule. To better illustrate this movement, we generated
a movie of the conformational change by linear interpolation
between the atomic coordinates of the profilin–Dictyostelium-
actin structure and the ATP-bound structure of uncomplexed
monomeric actin (28) (Movie S2). Note that the latter structure
was chosen for this comparison because it was obtained by
mutagenesis of two residues in subdomain 4 (which prevents
polymerization), and it is therefore free of perturbations result-
ing from the binding of an ABP or chemical cross-linking. To
further show that cleft opening is a general feature of the
profilin–actin complex, we generated a second interpolation,
using as a reference the structure of unphosphorylated Dictyo-
stelium actin in complex with gelsolin (Movie S3).
Although a rotation of the actin domains similar to that
described above had already been pointed out when the structure
of profilin–"-actin was first reported (20), this effect was attrib-
uted to differences between !- and "-actin. In contrast, we find
that the profilin-induced rotation is independent of the source of
the actin. Moreover, the earlier comparison was made to the only
other actin structure available at the time, that of the complex
with DNase I (22), which binds atop actin subdomains 2 and 4
and probably limits nucleotide cleft opening.
As mentioned above, we could not obtain crystals of pY53-
actin with profilin, which led us to suspect that Tyr-53 phos-
phorylation affects the interaction with profilin. The binding of
profilin to actin is accompanied by a large decrease in the
intensity of tryptophan fluorescence, which is thought to result
from shielding of actin Trp-356 by profilin in the complex (40).
Therefore, we measured the quenching of tryptophan fluores-
cence to estimate the binding affinities of profilin for pY53-actin
and unphosphorylated actin. We found that profilin binds pY53-
actin and unphosphorylated actin with similar affinities, al-
though the quenching of tryptophan fluorescence is significantly
less for profilin–pY53-actin (Fig. 2B). Because the structure of
profilin–pY53-actin could not be obtained, it is unclear what
structural differences are responsible for this observation. In-
terestingly, in the two gelsolin structures, the region around
Trp-356 is f lexible, with residues Phe-352 to Trp-356 displaying
alternative side-chain rotamers (Figs. S1 and S5). In all other
structures of actin, Trp-356 presents a single and unique side-
chain orientation (Fig. S1), which is also the orientation of
Trp-356 in the structure of profilin–Dictyostelium-actin (Fig. S5).
If the region around Trp-356 is intrinsically f lexible, as suggested
by the two gelsolin structures, quenching of tryptophan fluores-
cence during profilin binding might result from locking Trp-356
Fig. 2. Profilin binding causes a moderate opening of the nucleotide cleft in actin. (A) Superimposition of the structures of profilin–Dictyostelium-actin (blue
and cyan) and uncomplexed monomeric actin (28) (blue and magenta). Two orientations are shown, rotated by 90°. The latter structure was obtained by
mutagenesis in subdomain 4 and is thought to be free of perturbations resulting from the binding of an ABP or chemical cross-linking. For clarity, profilin is not
shown in this figure (see Figs. S5 and S6 for a full viewof the profilin–actin structure). Subdomains 3 and 4of the structureswere superimposed (blue) to highlight
the relative movement of subdomains 1 and 2 (magenta or cyan). Using the classical view of actin as a reference (left view), the 4.7° rotation (calculated with
the program DynDom, http://www.sys.uea.ac.uk/dyndom/) between the two major domains of actin can be visualized as two perpendicular rotations of!3.3°.
The center of this rotation approximately coincides with the junctions between domains, consisting of residue Lys-336 and the helix between residues Ile-136
and Gly-146. Comparison of the profilin–actin structures with any other structure of actin, except for the wide-open structure of profilin–"-actin (36), results in
a similarmotionof the twomajor domains (see alsoMovies S2 andS3). Thismovement appears less dramatic thanpreviously anticipated (36, 37), but it is probably
sufficient to explain the stimulationofnucleotide exchangebyprofilin. (B)Quenchingof tryptophanfluorescenceonprofilinbinding (the results of two identical
experiments, with different preparations of both actins, are shown). Profilin binds pY53-actin and unphosphorylated actinwith similar affinities (Kd" 0.090 and
0.057 #M, respectively), but the quenching of tryptophan fluorescence is significantly less for profilin–pY53-actin.
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into a single conformation that is less exposed to solvent, rather
than direct masking of Trp-356 by profilin. Finally, because the
binding affinity of profilin is not significantly affected by actin
phosphorylation (Fig. 2B), it is likely that our inability to obtain
crystals of profilin–pY53-actin resulted from a conflict between
the conformational change in the D-loop and crystal contacts.
Indeed, analysis of crystal packing contacts reveals a symmetry-
related molecule near the D-loop (Fig. S6).
Conclusions
The extent of actin phosphorylation at Tyr-53 varies dramatically
during the different stages of the developmental cycle of Dic-
tyostelium cells (9–11). Biochemically, actin Tyr-53 phosphory-
lation had been shown to increase the critical concentration for
polymerization, reduce the rates of nucleation and pointed end
elongation, and decrease the affinity for DNase I (11). The
proximity of Tyr-53 to the D-loop, which is implicated in
intersubunit contacts in the filament (14–17) and mediates the
interaction with DNase I (22), was believed to account for most
of the biochemical properties of pY53-actin (8, 11). The struc-
tures of pY53-actin and unphosphorylated actin seem to confirm
this hypothesis. The D-loop is f lexible and unresolved in most
actin structures. However, in the structure of pY53-actin, hy-
drogen-bonding contacts between the phosphate oxygens on
Tyr-53, and residues of the D-loop help stabilize its conforma-
tion (Fig. 1B). Phosphorylation of Tyr-53 protects the D-loop
from subtilisin cleavage (Fig. 1C), providing additional evidence
for a more stable conformation of the loop in solution. A more
stably folded D-loop would probably interfere with the binding
of DNase I, and with intersubunit contact in the filament.
Our biochemical analyses suggest that phosphorylation of
Tyr-53 also affects other regions of the actin molecule, including
the nucleotide cleft and the target-binding cleft between sub-
domains 1 and 3, where both profilin and gelsolin bind (Fig. S5).
Thus, phosphorylation reduces the quenching of tryptophan
fluorescence that accompanies the binding of profilin (Fig. 2B),
lowers the rate of nucleotide exchange on actin, and reduces the
fluorescence of etheno-ATP bound to actin (Fig. 1 D and E).
Probably connected with these observations, the hydrolysis of
ATP on polymerization was previously shown to be much slower
for pY53-actin than for unphosphorylated actin (11). The causes
of these biochemical differences are not apparent from analysis
of the structures, which show little difference between pY53-
actin and unphosphorylated actin other than the conformational
change in subdomain 2 (Movie S1). However, there are multiple
examples of long-range allosteric interactions in actin, including
intramolecular coupling between the target-binding cleft and
subdomain 2, which occur both in the monomer and in the
filament (41). The causes of these allosteric effects are not always
clear from comparisons of the structures. Phosphorylation of
Tyr-53 appears to be yet another example of a modification in
subdomain 2 that alters the dynamic equilibrium between dif-
ferent regions of the actin molecule, from the D-loop, through
the nucleotide cleft, and down to the target-binding cleft.
We find that profilin–actin complexes present a moderately
more open nucleotide cleft than other actin structures. Opening
of the nucleotide cleft results from a relatively small rotation of
4.7° of the two major domains of actin relative to each other (Fig.
2A and Movies S2 and S3). This movement is less dramatic than
previously anticipated (36, 37), but it is probably sufficient to
explain the stimulation of nucleotide exchange produced by
profilin. Indeed, the most important factor in determining
nucleotide exchange might not necessarily be the degree of cleft
opening, but rather changes in the intricate network of hydrogen
bonding interactions that coordinate the nucleotide in the
catalytic cleft. Opening of the cleft is accompanied by slight
changes in this network and a small twist of the nucleotide
(Movies S2 and S3). Whereas the moderately open cleft stabi-
lized by profilin may explain the stimulation of nucleotide
exchange on actin, the short-lived state when actin releases its
nucleotide may be characterized by an even more open cleft,
probably analogous to that of the wide-open structure of profilin–
!-actin (36) (Fig. S4B). Finally, in the actin filament, the
nucleotide cleft appears to be more closed than in any of the
existing structures of the monomer (17), suggesting that addition
of profilin–actin at the barbed end of growing filaments results
in closure of the nucleotide cleft, which might then lower the
affinity for profilin and stimulate its rapid release.
The conformational changes associated with Tyr-53 phos-
phorylation and profilin binding described here are less extensive
than previously anticipated, but are associated with long-range
allosteric effects throughout the actin molecule. Large motions
such as the acto-myosin power stroke are visually arresting, but
conformational changes in proteins are usually less dramatic and
result from changes in the equilibrium between different states
in a landscape of nearly isoenergetic conformations (42).
Materials and Methods
Preparation of Proteins and Peptide. Phosphorylated and unphosphorylated
Dictyostelium actin were purified as described (11). Human profilin-I and the
VASP peptide 198–213 (corresponding to the last polyPro region of human
VASP) were prepared as described (21). The cDNA encoding for human gel-
solin was purchased from ATCC (catalog number MGC-39262). Gelsolin seg-
ment 1 or G1 (residues Met-52-Phe-176) was amplified by PCR and cloned
between theNdeI andXhoI sitesof vectorpTYB12 (NewEnglandBioLabs). This
vector comprises a chitin-binding domain (for affinity purification) and an
intein (for self-cleavage after purification). BL21(DE3) competent cells (In-
vitrogen) were transformed with this constructs and grown in LB medium at
37°C until the OD600 reached a value of 0.5. Expression was induced by the
addition of 0.5 mM isopropyl-!-D-thiogalactopyranoside (IPTG) and carried
out overnight at 20°C. Cells were harvested by centrifugation, resuspended in
chitin-affinity-column equilibration buffer (20 mM Tris!HCl, pH 7.5; 0.5 M
NaCl; 0.1% Triton X-100; 1 mM EDTA) and lysed using a microfluidizer appa-
ratus (MicroFluidics). Affinity purification on the chitin column was done
according to the manufacturer’s protocol (New England Biolabs). G1 was
eluted from the column after self-cleavage of the intein, which was induced
with 50 mM DTT for 2 days at 4°C. The protein was then dialyzed against 10
mM Tris!HCl, pH 8.0; 40 mM NaCl; 0.2 mM EDTA; and 1 mM NaN3 and further
purified on a superose12 column (Amersham Pharmacia).
Crystallization. Phosphorylated and unphosphorylated actin at !20 "M con-
centration in G-buffer (2 mM Tris, pH 7.5; 0.2 mM CaCl2; 0.2 mM ATP; 1 mM
NaN3) were mixed with profilin and G1 at a 1:1.2 molar ratio. The complexes
were purified on a superose12 columnpreequilibratedwith 2mMTris!HCl, pH
8.0; 2mMATP; 4mMMgCl2; 0.5mMEDTA; and 1mMNaN3. The profilin–actin
and G1–actin complexes were concentrated to !5 mg/ml and !13 mg/ml,
respectively by using Vivaspin centrifugal devices (Sartorius). Crystals of G1–
actin were obtained under similar conditions for the unphosphorylated and
phosphorylated forms: 100 mMHepes, pH 7.5; 1.7 M Li2SO4; 2 mMATP; 1 mM
EDTA; and 10% glycerol at 20°C in 4-"l hanging drops. Except for the use of
glycerol in this crystallization, these conditions are similar to those published
before (30). The crystals were flash-frozen in liquid nitrogen by using 20%
glycerol as a cryoprotectant and stored for data collection. Crystals of the
profilin–actin complex were obtained only for the unphosphorylated form.
This complex was crystallized with a VASP polyproline peptide (VASP198–213),
which binds profilin and facilitates crystallization. The crystallization condi-
tions were similar to those described by us for profilin–#-actin (21): 0.1 M
Bis-Tris, pH 6.5; 25% (wt/vol) PEG 3350. The crystals were flash-frozen in liquid
nitrogen for data collection with Paratone-N as a cryoprotectant.
Data Collection and Structure Determination. An x-ray dataset was collected to
theresolutionof2.3Åfromaprofilin–actincrystalbyusingthebeamlineF2ofthe
Cornell High Energy Synchrotron Source (Ithaca, NY). Datasets were collected
from crystals of G1 complexeswith unphosphorylated and phosphorylated actin
to the resolutions of 1.6 Å and 1.7 Å, respectively, using the 17-BM beamline of
the IMCA-CAT facility at the Advance Photon Source (Argonne, IL). All of the
datasetswere indexedandscaledwiththeprogramHKL2000(HKLResearch).The
structures were determined by molecular replacement using the CCP4 (43) pro-
gram Phaser and the structures of profilin–#-actin (2PAV) or G1-actin (1NM1) as
search models. Model building and refinement were performed with the CCP4
programs Coot and Refmac (Table 1).
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Subtilisin Cleavage of the D-Loop. Actin, 13 !M in G-buffer, was cleaved with
subtilisin at a molar ratio of actin:subtilisin of 8,000:1. Similar results were
obtained at a ratio of 5,000:1. The percentage digestion for each reactionwas
determinedas the ratio of the intensities of thedigested fraction (lower band,
!38,000 Da, on SDS PAGE) to the sum of the intensities of the digested and
undigested actin fractions.
Etheno-ATP Exchange. The fluorescence of etheno-ATP increases when it
replaces the ATP bound to actin. ATP-exchange experiments were carried out
in 4 mM Tris, pH 7.5; 1 mM DTT; 0.1 mM CaCl2; 0.01% NaN3; and 10 !M ATP,
with addition of 50 !M etheno-ATP at time 0. The experiments were per-
formed with 1 !M actin in the presence of either 0.5 !M profilin, which acts
catalytically (19), or 1.2 !M gelsolin.
Quenching of Tryptophan Fluorescence.Quenching of tryptophanfluorescence
by profilin was donewith 0.6 !Mactin in 4mMTris pH 7.5, 1mMDTT, 0.1mM
CaCl2, 0.01%NaN3and0.2mMATP.Kaleidagraph softwarewasused tofit the
data and determine Kd values.
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The Crystal Structures of Chikungunya and Venezuelan Equine
Encephalitis Virus nsP3 Macro Domains Define a Conserved
Adenosine Binding Pocket!
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Macro domains (also called “X domains”) constitute a protein module family present in all kingdoms of life,
including viruses of the Coronaviridae and Togaviridae families. Crystal structures of the macro domain from
the Chikungunya virus (an “Old World” alphavirus) and the Venezuelan equine encephalitis virus (a “New
World” alphavirus) were determined at resolutions of 1.65 and 2.30 Å, respectively. These domains are active
as adenosine di-phosphoribose 1!-phosphate phosphatases. Both the Chikungunya and the Venezuelan equine
encephalitis virus macro domains are ADP-ribose binding modules, as revealed by structural and functional
analysis. A single aspartic acid conserved through all macro domains is responsible for the specific binding of
the adenine base. Sequence-unspecific binding to long, negatively charged polymers such as poly(ADP-ribose),
DNA, and RNA is observed and attributed to positively charged patches outside of the active site pocket, as
judged by mutagenesis and binding studies. The crystal structure of the Chikungunya virus macro domain with
an RNA trimer shows a binding mode utilizing the same adenine-binding pocket as ADP-ribose, but avoiding
the ADP-ribose 1!-phosphate phosphatase active site. This leaves the AMP binding site as the sole common
feature in all macro domains.
The Togaviridae virus family comprises two positive-sense
RNA virus genera, viz., Alphavirus and Rubivirus (52). The
genus Alphavirus contains at least 28 viruses and has a world-
wide distribution, even though each virus has a local distribu-
tion. Some alphaviruses are not known to cause illness, but
others can cause severe disease in higher eukaryotes, in particular,
humans and horses. Alphaviruses present in the “Old World”
principally cause arthritis and skin rashes, whereas alphaviruses of
the “New World” may cause severe and even fatal encephalitis.
Most have vertebrate hosts, principally mammals, birds, or fish,
and are transmitted by mosquitoes, although other hematopha-
gous arthropods such as lice or mites can be vectors of some
alphaviruses (37).
Although known for decades as a virus that produces
sporadic human outbreaks in Africa, India, Southeast Asia,
and the Philippines, Chikungunya virus (CHIKV) unexpect-
edly emerged as a major arbovirus pathogen in many islands of
the Indian Ocean in 2005, and, more recently (2007) in Singa-
pore and Australia. The virus was also introduced into north-
ern Italy in 2007, where it established localized outbreaks. In
urban areas, the virus is mainly transmitted by the mosquito
Aedes aegypti but an adaptive mutation facilitated transmission
by another urban mosquito, Aedes albopictus, in La Re´union
island in 2005 as well as other places (7). Epidemics are spo-
radic, but a large part of the population can be infected, as was
the case in La Re´union island in 2006, where one-third of the
population ("250,000 people) was infected, leading to 237
deaths. CHIKV symptoms in humans include fever, rash, and
severe arthritis, which usually disappear after 1 week, but, in
some cases, arthritis can persist for more than 1 year (18).
Venezuelan equine encephalitis virus (VEEV) is a New World
alphavirus, present in the United States and Central and South
America. Different subtypes of VEEV exist, some of which
cause epidemics while others are zoonotic. In a few cases,
VEEV causes encephalitis in humans, particularly children
(40). This virus is also pathogenic for horses, with an observed
case fatality rate of around 80 to 90%. No vaccine or drugs are
licensed for treatment against alphaviruses.
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The 5! region of the positive-stranded RNA [(") RNA]
genome encodes four nonstructural proteins (nsP1, nsP2, nsP3,
nsP4), and the 3! region encodes the three major structural
proteins (the capsid and two envelope proteins). The nsP1
protein is a membrane-associated protein that bears methyl-
transferase and guanylyltransferase activities. It is involved in
the capping of the (") RNA genome (1). The nsP2 protein is
made of three domains, the first containing helicase, RNA
triphosphatase, and nucleoside triphosphatase activities (39,
53), whereas the second and third domains are a papaine-like
protease and a nonfunctional methyltransferase, respectively
(47). Moreover, nsP2 contains a nuclear localization sequence
which allows 50% of the translated nsP2 to be translocated into
the nucleus (35). The nsP4 protein contains the RNA-depen-
dent RNA polymerase, involved in genome replication and
transcription (42). The functions, roles, and activities of the
nsP3 protein are less well understood. Although it is involved
in the transcription process at an early stage of the infection
(51), no precise function or activity has been attributed to this
protein. It is made of two domains, the first one being a unique
macro domain (described below) located in the conserved N-
terminal region. The C-terminal region is less conserved and is
phosphorylated in up to 16 positions on serines and threonines
(22, 25, 50). The role of phosphorylation is not well docu-
mented, but deletion of the phosphorylated residues decreases
the RNA synthesis level (49). Moreover, the absence of phos-
phorylation on nsP3 in variants of the alphavirus Semliki For-
est virus (SFV) decreases viral pathogenicity, and the absence
of the C terminus of nsP3 alters SFV neurovirulence (48). The
C terminus of nsP3 is thus thought to have a nonessential
regulatory role.
The first 160 residues of the N-terminal region of nsP3,
known as the macro domain, have been initially identified
based on sequence similarity analysis between alphavirus, ru-
bivirus, and coronavirus (15). The domain was named the “X
domain,” referring to a domain with an unknown function
conserved in these viruses. Subsequent sequence analysis revealed
that this domain is remarkably conserved in all kingdoms of life
(2): 1,081 domains showing similarity to X domains are currently
indexed in the SMART database (24). They may represent a
protein or a single domain in a larger protein, and the domain can
also exist in duplicate or triplicate in the same protein (21). In
particular, this domain is present in a variant of histoneH2A. This
variant is called macroH2A, and its difference from the conven-
tional histone H2A is the presence of an additional domain called
“macro,” which shows similarity to X domains. Consequently, all
X domains have also been called macro domains.
In viruses, macro domains exist in alphaviruses and in vi-
ruses related to the genus Alphavirus, such as rubella virus
(genus Rubivirus) and hepatitis E virus (HEV) (genus Hepevi-
rus). Coronavirus and Torovirus, which belong to the Corona-
viridae family, are the only other viral genera containing a
macro domain, located in their large multifunctional nsp3 pro-
tein, which is otherwise unrelated to alphavirus nsP3.
The crystal structures of several macro domains have been
determined in archaebacteria (Archaeoglobus fulgidus) (2), eu-
bacteria (Escherichia coli and Thermus thermophilus), and eu-
karyotes (Saccharomyces cerevisiae, Rattus norvegicus, and
Homo sapiens) (4, 19, 20). The crystal structure of the macro
domain of the coronavirus responsible for severe acute respi-
ratory syndrome (SARS-CoV) has also been determined (10,
27, 43). The structural conservation between these structures is
remarkable and they have been defined as a family in the
SCOP database (30). This structural conservation suggests an
important role in the biology of their host organism, but this
role remains elusive so far.
An enzymatic activity was first discovered for the yeast macro
domain, which acts as an ADP-ribose 1#-phosphate phos-
phatase with a somewhat low turnover constant of 1.7 min$1
(28). This activity is involved in the downstream processing of
ADP-ribose 1#-phosphate, a side product of cellular pre-tRNA
splicing, thus controlling the metabolism of ADP-ribose 1#-
phosphate or other ADP-ribose derivatives with known regu-
latory functions in the cell. This activity has also been reported
for A. fulgidus (17), SARS-CoV (10, 43), and human CoV
(HCoV) (38), but was at the limit of detection for the alpha-
virus SFV (10). The affinity of ADP-ribose for the SARS-CoV
enzyme was low (dissociation constant [Kd] of 52.7 %M) (43),
and the pathway in which ADP-ribose 1#-phosphate phos-
phatase is putatively involved remains elusive. A recent study
showed that ADP-ribose binding is not a common property to
all macro domains. Indeed, the group 3 CoV macro domain
does not bind ADP-ribose, whereas a group 1 CoV macro
domain binds it with a dissociation constant Kd of 29 %M (36).
In the case of A. fulgidus, poly(ADP-ribose) (PAR) binding
has been reported (17). Such a binding property has also been
identified in CoVs (10), showing that some macro domains, in
particular viral macro domains, are able to bind long, nega-
tively charged polymers. The role of PAR binding could be
related to a cellular response to viral infection. Indeed, in
response to inflammation or stress, the nuclear enzyme PAR
polymerase-1 (PARP-1) promotes PAR synthesis (5). Alpha-
virus infection can induce PARP-1 activation (31) which leads
to the depletion of ATP and NAD" present in the cell and
apoptosis-inducing factor (AIF)-induced apoptosis.
In this article, we present the biochemical, enzymatic, and
structural analysis of two alphavirus macro domains, one from
CHIKV, a representative of the Old World alphaviruses, the
other from VEEV, a New World alphavirus present in the
Americas. The crystal structures of the CHIKV and VEEV
macro domains in complex with ADP-ribose show essentially
the same positioning of the ligand as that seen in the SARS-
CoV macro domain structure. The crystal structure of the
CHIKV macro domain in complex with adenosine-containing
short RNAs shows that the adenosine binding site is generally
conserved in macro domains. Moreover, binding of the short
RNA is enhanced by the presence of positively charged patches
present at the surface of the protein. The latter patches, located
in the immediate vicinity of the ADP-ribose binding crevice, are
significantly more charged than that of the SARS-CoV macro
domain.
MATERIALS AND METHODS
Oligonucleotides. RNA (AAAAAAAAAGCUACC, AAA, UUU, GGGGGG,
UCGGGGGCUGGC) and DNA (AAAGCCAAAAA) oligonucleotides were pur-
chased from Dharmacon.
Expression and purification of alphavirus macro domains. The cDNAs cor-
responding to two alphavirus macro domains from the nsP3 protein of CHIKV
(strain Ross, amino acids [aa] 1 to 160 of nsP3) and VEEV (strain P676, aa 1 to
160) were cloned into the pDest14 plasmid using the “Gateway” cloning proce-
dure (Invitrogen). A hexa-histidine sequence tag was fused at either the N-
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terminal end (CHIKV) or the C-terminal-end (VEEV). An incomplete factorial
expression screening in E. coli was performed for each construct in order to
design the best expression conditions required for scale-up, as previously de-
scribed (3). The proteins (wild type and mutants) were then produced under the
following conditions: (i) with E. coli Rosetta (DE3)(pLysS) (Novagen) cells at
25°C in SB medium (Athena Enzymes) overnight after induction with 500 !M
isopropyl "-D-1-thiogalactopyranoside (IPTG) for the CHIKV macro domain
and (ii) with E. coli Rosetta (DE3)(pLysS) cells at 37°C in 2YT medium for 4 h
after induction with 500 !M IPTG for the VEEV macro domain. Cells were
harvested by centrifugation at 2,800 # g. Cell pellets were then resuspended in
50 mM Tris buffer, 300 mM NaCl, 10 mM imidazole, 0.1% Triton, and 5%
glycerol (pH 8.0). Lysozyme (0.25 mg/ml), phenylmethylsulfonyl fluoride (1
mM), DNase I (2 !g/ml), and EDTA-free protease cocktail (Roche) were added
before performing a sonication step. The lysates were centrifuged at 12,000 # g
for 45 min, and the supernatant was recovered. The recombinant proteins were
purified using the Akta Xpress fast protein liquid chromatography system (GE
Healthcare) as follows. The first purification step (immobilized metal affinity
chromatography) was performed on a 5-ml His prep column (GE Healthcare).
The proteins were eluted with 50 mM Tris buffer (pH 8.0) containing 300 mM
NaCl and 500 mM imidazole. The purification was then refined by a size exclu-
sion chromatography step on a preparative Superdex 200 column (GE Health-
care) preequilibrated in a buffer designed for its ability to keep the protein
soluble and stable (14): 10 mM Tris (pH 7.5) plus 300 mM NaCl for the CHIKV
macro domain and 10 mM Bicine (pH 8.5) plus 50 mM NaCl for the VEEV
macro domain. Proteins were then concentrated up to 14.5 mg/ml and 14 mg/ml
using a Vivaspin 10-kDa molecular-mass-cutoff centrifugal concentrator (Viva-
science) for the CHIKV and VEEV macro domains, respectively. The Eastern
equine encephalitis virus (EEEV) macro domain was obtained from EEEV
cDNA by the same procedure described above and purified to homogeneity
following the same protocol as that of the CHIKV macro domain. It was used in
phosphatase assays (see Fig. 4). Its crystal structure will be reported elsewhere.
A seleno-methionine-substituted protein was used to determine the CHIKV
macro domain structure. The protein was expressed according to standard con-
ditions of methionine biosynthesis pathway inhibition (9) and purified following
the same procedure as that of the native protein.
Crystallization. Initial crystallization trials were set up for CHIKV and VEEV
macro domains with a nano-drop dispenser (Honeybee; Genomic Solutions) in
96-well sitting drop plates (Greiner Bio One) using three commercial crystalli-
zation kits: Structure Screen combination, Stura footprints (Molecular Dimen-
sions Limited), and Nextal SM1 (Qiagen).
The initial crystallization conditions of the CHIKV protein were further op-
timized by the hanging drop vapor diffusion method in Linbro plates by mixing
3 !l of protein solution with 2 !l of reservoir solution. Crystals grew in a mixture
of 46% polyethylene glycol 600 (PEG 600) and 100 mM HEPES (pH 7.4). For
the VEEV macro domain, initial hits were optimized by mixing 100 nl of protein
and 100 nl of reservoir solution using the sitting drop vapor diffusion method.
Optimized crystallization conditions of VEEV macro domain were 18% PEG
3350 plus 11 mM sodium acetate. Diffraction intensities were recorded on dif-
ferent beamlines (Table 1) at the European Synchrotron Radiation Facility
(Grenoble, France) and at SOLEIL Synchrotron (Gif-sur-Yvette, France). Inte-
gration of the different datasets was performed using MOSFLM (23) or XDS
(16). Scaling and merging of the intensities were carried out using programs from
the CCP4 suite (6) or XSCALE (16), depending on the data sets. Statistics are
provided in Table 1.
Structure determination. The structure of the CHIKV macro domain was
determined using the single-wavelength anomalous dispersion method (SAD) on
a 1.80-Å data set collected at the peak of the selenium absorption edge from a
seleno-methionine derivative crystal. Location of all the 16 selenium atoms (4
selenium atoms in each of the 4 molecules of the asymmetric unit) was per-
formed using SHELXD (44). Phases and figures of merit were calculated using
SHELXE (45). The excellent quality of the map allowed the program
ARPWARP to build residues 2 to 160 for molecules A and B and to partially build
molecules C and D. Refinement was performed against a 1.65-Å resolution data
set using REFMAC (6), Buster-TNT (41), and COOT (11). Refinement statistics
are listed in Table 1. The VEEV macro domain was determined by molecular
replacement with the program PHASER (29) using the CHIKV macro domain
as a model. Crystals diffracted to a 2.30-Å resolution for the VEEV protein.
Refinement was performed using REFMAC, Buster-TNT, and COOT.
Crystal soaking and cocrystallization experiments. CHIKV and VEEV macro
domain crystals were soaked for 16 h with ADP-ribose (4 mM) (Sigma). The
TABLE 1. Crystallization analysis data for CHIKV and VEEV
Parameter
Result ford:
CHIKV VEEV
Native Selenomethio-nylated protein
Soaked with
ADP-ribose Soaked with RNA Native
Cocrystallized with
ADP-ribose
Beamline ESRF ID14-EH2 ESRF ID23-1 ESRF ID23-1 ESRF ID14-EH2 ESRF ID23-1 SOLEIL
PROXIMA1
Space group P31 P31 P31 P31 I4 P212121
Cell dimensions (A˚) a $ b $ 87.06,
c $ 84.49
a $ b $ 86.81,
c $ 84.70
a $ b $ 87.96,
c $ 84.17
a $ b $ 86.82,
c $ 81.32
a $ b $ 129.63,
c $ 42.49
a $ 74.00, b $ 87.0,
c $ 105.00
Wavelength (A˚) 0.9330 0.9792 0.8856 0.9330 0.974 0.980
Resolution range (A˚) 35.00–1.65
(1.74–1.65)
35.00–1.80
(1.90–1.80)
35.00–1.90
(2.00–1.90)
30.00–2.00
(2.11–2.00)
35.00–2.30
(2.42–2.30)
30.00–2.60
(2.70–2.60)
Total no. of reflections 493,231 (71,649) 2,000,862
(237,557)
310,123
(38,681)
213,703 (30,275) 108,812 (16,349) 109,136 (10,819)
No. of unique
reflections
86,209 (12,610) 64,424 (8,446) 57,403 (8,387) 46,206 (6,793) 15,851 (2,317) 20,549 (2,014)
Completeness (%) 100 (100) 97.3 (87.3) 99.9 (99.9) 99.6 (100.0) 99.2 (100.0) 99.2 (89.2)
I/%(I) 18.1 (3.2) 37.4 (6.1) 15.7 (2.4) 17.4 (2.8) 9.0 (5.4) 15.74 (4.72)
Rsym (%)a 5.2 (46.8) 8.8 (50.2) 7.2 (55.4) 5.2 (52.5) 13.9 (26.4) 10.4 (49.7)
Multiplicity 5.7 (5.7) 31.1 (28.1) 5.4 (4.6) 4.6 (4.5) 6.9 (7.1) 5.3 (5.4)
Anomalous
completeness (%)
97.1 (86.1)
Anomalous multiplicity 15.4 (14.0)
R (%)b 16.6 17.0 21.5 20.3 19.7
Rfree (%)c 19.6 20.1 26.0 26.1 27.5
rmsd bond length (A˚) 0.012 0.013 0.014 0.013 0.010
rmsd angle (°) 1.347 1.447 1.398 1.348 1.433
Protein Data Bank no. 3GPG 3GPO 3GPQ 3GQE 3GQO
a Rsym $ % !I& 'I( !/% I, where I is the observed intensity and 'I( is the average intensity. Values in parentheses refer to the highest-resolution shell.
b R $ % !Fo!& !Fc!/%!Fo!.
c Rfree is calculated as R, but on 5% of all reflections that are never used in crystallographic refinement.
d Values in parentheses refer to the highest-resolution shell. ESRF, European Synchrotron Radiation Facility.
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CHIKV macro domain was soaked for 16 h with PAR (1.3 mM in the ADP-
ribose monomer) (Biomol International LP.), short RNA oligonucleotides AAA
(2 to 10 mM) (Dharmacon) and UUUUUU (2 to 10 mM) (Dharmacon), and the
DNA oligonucleotide AAAGCCAAAAA (10 mM) (Dharmacon). Crystals were
transferred in drops containing the mother liquor solution and the ligand. Co-
crystallization of the VEEV macro domain with ADP-ribose (5 mM) was per-
formed in 0.2 M ammonium sulfate, 0.1 M sodium cacodylate (pH 6.5), and 30%
PEG 8000.
Site-directed mutagenesis. Based on the CHIKV macro domain structure,
four point mutations were made using Stratagene’s Quickchange site-directed
mutagenesis. Single-amino-acid substitutions to alanine were performed in the
CHIKV macro domain for D10, N24, H67, and Y114.
Thermal denaturation shift assay. Several potential ligands were tested at 2
mM each (ADP-ribose, ADP-glucose, ATP, ADP, AMP, S-adenosyl-homocys-
teine, manganese chloride [MnCl2], magnesium chloride [MgCl2], NAD!, and
GDP using the quantitative PCR machine ICycler IQ (Bio-Rad) according to the
previously described thermal shift assay (12). Briefly, the CHIKV macro domain
(final concentration of 3 mg/ml in the size exclusion chromatography buffer
described above) was mixed with the ligand and a SYPRO orange solution in
concentrations recommended by the manufacturer (Invitrogen) in a final volume
of 25 "l. Incremental steps of temperature from 20 to 90°C were applied to the
samples. The denaturation of the protein was monitored by following the in-
crease of the fluorescence emitted by the probe that binds the exposed hydro-
phobic regions of the denatured protein. A melting temperature (Tm) can be
calculated as the mid-log of the transition phase from the native to the denatured
protein using a Boltzmann model. ADP-ribose titration from 0 to 2.5 mM was
then assessed on the CHIKV (wild type and D10A single mutant), VEEV and
SARS-CoV macro domains at 1 mg/ml in 10 mM HEPES plus 150 mM NaCl
(pH 7.5).
ITC. For isothermal titration calorimetry (ITC), ADP-ribose binding to
CHIKV and VEEV macro domains was measured using a Microcal MCS iso-
thermal titration calorimeter. Experiments were carried out at 25°C in a buffer
containing 10 mM HEPES plus 150 mM NaCl (pH 7.5). The protein concentra-
tion in the cell was 20 "M, whereas the ADP-ribose concentration in the syringe
was 300 "M. Heats of dilution were measured by injecting the ligand into the
protein solution. The recorded heat curve was subtracted from the experimental
curves prior to data analysis. Titration curves were fitted using MicroCal Origin
software, assuming one set of sites and enthalpy changes (#H), equilibrium
constants (Kd), and stoichiometry were extracted.
PAR binding assay. The PAR (1$-2% branched polymer of ADP-ribose linked
by 1%-2& glycosidic bonds), was synthesized by auto-poly-ADP-ribosylation of
PARP-1 in a reaction volume of 400 "l using 4 U of human PARP-1 (Sigma), 150
"MNAD!, and 40 "Ci of [32P]NAD! (GE Healthcare). After 2 h of incubation
at 24°C, the reaction was stopped by dilution (30-fold) with the slot blot buffer
(10 mM Tris [pH 7.5], 300 mM NaCl, 0.05% Tween 20). PAR binding on the
macro domains of several alphaviruses (CHIKV, VEEV, Sindbis virus, and SFV)
as well as SARS-CoV was tested. Various amounts of each protein (2,000, 1,000,
500, 250, 125, 62.5, 31.25, 15.63, 7.813, 3.906, 1.953, and 0.9766 pmol) were
blotted on a nitrocellulose membrane (Schleicher & Schuell) using a slot blot
apparatus (Bio-Rad). Bovine serum albumin (BSA) was also included as a
negative control. The membrane was then incubated for 1 h in the PAR prep-
aration and then washed extensively in slot blot buffer (five times in 100 ml), and
the membrane-bound fraction of PAR was analyzed using photostimulated
plates and an FLA3000 fluorescent image analyzer (Fuji).
RNA binding assay. Fifty microliters of RNA (AAAAAAAAAGCUACC; 100
"M) was labeled using 25 U of T4 polynucleotide kinase (New England Biolabs),
100 "M ATP, and 50 "Ci ['-32P]ATP (GE Healthcare). After 30 min at 37°C,
the reaction was stopped by incubating the mixture for 10 min at 70°C. RNA
binding to the CHIKV macro domain native and mutants was tested as follows:
2,000, 1000, 500, 250, 125, 62.5, 31.25, 15.63, 7.813, 3.906, 1.953, and 0.9766 pmol
of protein were blotted onto a nitrocellulose membrane (Schleicher & Schuell)
using a slot blot apparatus (Bio-Rad). BSA and hepatitis C virus RNA-depen-
dent RNA polymerase (HCVpol) were also included as negative and positive
controls, respectively. The radiolabeled RNA was diluted (300() in blotting
buffer (10 mM Tris [pH 7.5], 150 mM NaCl, 0.05% Tween 20). The membrane
supporting the blotted proteins was incubated for 1 h in this preparation at room
temperature. The membrane was washed five times in 100 ml of blotting buffer,
and the membrane-bound fraction of RNA was analyzed using photostimulated
plates and an FLA3000 fluorescent image analyzer (Fuji).
ADP-ribose 1!-phosphate phosphatase assay. ADP-ribose-1%-phosphate phos-
phatase activity was detected with thin-layer chromatography (TLC) assays for
the CHIKV (wild type and mutants), EEEV, and VEEV macro domains. The
yeast protein Poa1p was used as a positive control. First, ADP-ribose 1%-phos-
phate was produced by incubating 7 mM ADP-ribose 1%-2%-cyclic phosphate with
cyclic phosphodiesterase (15 ng/ml) for 3 h at 28°C. Then, 1 "l of the reaction
was mixed with 1 "l of 45 "M of the macro domain tested and 1 "M of 60 mM
MES (morpholineethanesulfonic acid) (pH 5.0). The reaction mixture was incu-
bated for 1 h at 28°C. Two microliters of the reaction mixture was then spotted
onto a polyethyleneimine-F (PEI-F) cellulose TLC plate, and the plate was
developed at room temperature in 150 mM NaCl and 150 mM sodium formate
(pH 3.0). The spots were detected from the fluorescent background under a UV
lamp emitting at a 254-nm wavelength (10).
Protein structure accession number. The coordinates of CHIKV macro do-
main structure, apo form, in complex with ADP-ribose and with RNA AAA have
been deposited in the Protein Data Bank under accession no. 3GPG, 3GPO, and
3GPQ, respectively. Those of the VEEV macro domain structure apo form and
in complex with ADP-ribose have been deposited in the Protein Data Bank
under accession no. 3GQE and 3GQO.
RESULTS
Protein production and crystallization. A cDNA construct
encompassing aa 1 to 160 of the alphavirus nsP3 macro domain
was designed based on available macro domain crystal struc-
tures (2, 4, 19, 20, 43), secondary structures, and disorder
predictions. CHIKV and VEEV nsP3 macro domains were
selected in order to compare macro domains from New and
Old World alphaviruses. These constructs were expressed in E.
coli and purified, and crystals were obtained for these two
proteins. Molecular replacement techniques using the closest
structural homologue (E. coli macro domain, identity of 29.9%
in 1 to 160 aa for the CHIKV macro domain) were unsuccess-
ful. The crystal structure of the CHIKV macro domain was
determined using the SAD technique in conjunction with
seleno-methionylated protein crystals that diffracted to 1.80 Å. It
was then refined against a native data set at a 1.65-Å resolu-
tion. The CHIKV crystals belong to the space group P31, and
four molecules are present in the asymmetric unit. VEEV
macro domain structure in an apo form was then determined at
a 2.30-Å resolution using molecular replacement and the
CHIKV macro domain as a template. The VEEV crystals of
the apo form belong to the space group I4, with two molecules
in the asymmetric unit.
Overall structure of alphavirus macro domains and com-
parison with other macro domains. The structures of the alpha-
virus macro domain consist of a central twisted six-stranded )
sheet surrounded by three helices on one side and one on the
other (Fig. 1A). The core ) sheet is well conserved within the
existing structures of macro domains from all origins also.
Positions of * helices are also well conserved, even if a deletion
is present in alphavirus macro domains near residue 48 (in
CHIKV macro domain; the numbering of CHIKV will be used
throughout), leading thus to the absence of one helix present in
other macro domains (Fig. 1E, *3 in SARS-CoV). Moreover,
the * helix 2 (aa 78 to 100) is longer in alphavirus macro
domains than in other macro domains (Fig. 1B and E). The
loops connecting the secondary structure elements are variable
in sequence and structure when compared to non-alphavirus
macro domain structures available, in particular the loops be-
tween the )3-)4, )4-*2, and )5-*3 elements. The root mean
square deviations (rmsds) between the CHIKV macro domain
and other reported macro domain structures are comprised
between 2.01 Å and 2.97 Å on 160 aa (sequence identity be-
tween 21.9 and 30.0%). Remarkably, the closest structure is
the E. coli macro domain and not the SARS-CoV macro do-
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FIG. 1. Structures of the macro domains from the alphaviruses CHIKV and VEEV. (A) Representation of CHIKV and VEEV macro domains in
a purple-to-red gradient (from N terminus to C terminus). Secondary structure elements are labeled on the CHIKV macro domain. (B) Superposition
of representations of the CHIKV, VEEV, SARS-CoV, and E. coli macro domains, colored, respectively, in dark blue, cyan, purple, and white.
(C) Electrostatic surface potential presented between!4 and 4 kT/e for the CHIKV and VEEV macro domains. The potential was generated using the
PDB2PQR server (8) and Adaptative Poisson-Boltzmann Solver (APBS) plug-in in Pymol (http://www.pymol.org). (D) Representation of the superpo-
sition between the macro domains from CHIKV (apo form in dark blue), VEEV (apo form in cyan and complexed with ADP-ribose in light orange).
The two main divergences between the three structures are indicated and circled. (E) Sequence alignment of the macro domains studied. They belong
to the genus Alphavirus, except for SARS-CoV. Residues in red boxes are strictly conserved, while those in yellow boxes are conserved by at least four
out of seven viruses aligned. Secondary structure elements from the viral macro domain crystal structures obtained are represented above the alignment.
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main present in the nsp3 protein product of the SARS-CoV
orf1a replicase polyprotein (10, 46). The rmsds between the C!
of SARS-CoV and alphavirus macro domains are between 2.80
and 2.97 Å on 160 aa. Structural differences between SARS-
CoV and the alphavirus macro domain are consistent with the
differences observed in all of the known macro domain crystal
structures. Moreover, the SARS-CoV macro domain is longer
at the N terminus and the additional 13 residues allow the
formation of a seventh " strand in the central " sheet. There-
fore, from a structural point of view, there is no obvious cluster
of related viral macro domain structures.
Electrostatic surface analysis of alphavirus macro domains re-
veals a highly positively charged patch located both in the crevice,
previously defined as an ADP-ribose 1#-phosphate phosphatase
active site (17) and at its periphery. The other face of the protein,
located far from the active site, is negatively charged (not shown).
This bimodal charge distribution is much more pronounced in
alphavirus macro domains than in other macro domain struc-
tures.
Between the two alphavirus macro domain structures, the
sequence identity is 57% and the crystal structures are also
very similar, the rmsd between CHIKV and VEEV macro
domains being 0.91 Å on 160 aa (Fig. 1A and D). Interestingly,
the main structural divergence appears between residues 30 to
37 when comparing CHIKV and VEEV macro domains in the
apo form (Fig. 1D, divergence 1). Some of these residues,
located close to the active site, are involved in RNA and
ADP-ribose binding (see below). This structural difference
could thus impact substrate binding differentially within the
alphaviruses (see Discussion). Interestingly, the corresponding
loop in other available macro domain structures is very well
conserved and corresponds to the position of the CHIKV
macro domain loop. In addition, two loops located far from the
active site, from positions 48 to 52 and 62 to 65, are different
between the CHIKV and VEEV macro domains (Fig. 1D,
divergence 2). These loops are located far from the active site.
The divergence of these loops does not originate from crystal
packing. Indeed, a crystal form obtained for the VEEV macro
domain in complex with ADP-ribose (see below) shows a sim-
ilar position of these loops despite a different packing.
Biochemical and structural basis of ADP-ribose binding.
Since several macro domains were reported as ADP-ribose
binding proteins (17), the binding of ADP-ribose and other
putative substrates was tested on the CHIKV macro domain
using a thermal shift assay following the strategy developed
previously (33). The Tm of the protein is measured using
SYPRO orange fluorescence, which increases when this dye
binds to hydrophobic core of the protein upon thermal dena-
turation. The melting temperature with the ligand (Tm) is
compared to the Tm of the protein alone (To) in order to assess
ligand binding. The ligands tested on the CHIKV macro do-
main can be divided into two groups (Fig. 2A). First of all,
ADP-ribose, ADP, ATP, and NAD$ shift significantly the Tm
of the protein to higher values (between 2 and 6°C). This first
group contains an ADP moiety. A ribose at the distal position
contributes to stabilizing the macro domain, better than either
nothing (for ADP), a phosphate (for ATP), a nicotinamide
group (for NAD$), or a glucose (for ADP-glucose). The other
ligands have either a poor effect or no effect on the thermal
melting resistance, suggesting that they do not bind the pro-
tein. Altogether, these results indicate that the CHIKV macro
domain has a specificity for (i) an adenine rather than a gua-
nine, (ii) two phosphate groups rather than either one or three,
and (iii) a ribose at the distal position.
Both CHIKV and VEEV macro domains bind ADP-ribose,
although they exhibit a quite different thermal denaturation
shift profile (Fig. 2B). The large Tm-To observed for the VEEV
macro domain will find a structural explanation (see Fig. 1D
and Fig. 3B for details). When the D10 position is changed to
alanine, the CHIKV macro domain loses its ability to bind
ADP-ribose (Fig. 2B; see the structural rationale for the se-
lection of this mutant below).
The ADP-ribose binding efficacy was then assessed by ITC.
The Kds for CHIKV (Fig. 2C) and VEEV (Fig. 2D) macro
domains are 5 % 0.4 &M and 3.9 % 0.65 &M, respectively.
Compared to the existing data, the binding affinity of both
CHIKV and VEEV macro domains for ADP-ribose is almost
the same as that of the yeast protein Poa1p (32) and 5 and 10
times stronger than that of SARS-CoV and HEV (10). In
contrast, the macro domain of SFV, the only other virus ana-
lyzed in this way, does not appear to bind ADP-ribose, al-
though protein instability might have impaired precise mea-
surement (32).
The structural basis of ADP-ribose specificity was revealed
by soaking and cocrystallization with ADP-ribose for CHIKV
and VEEV macro domains, respectively. ADP-ribose binds to
a crevice, previously defined as the ADP-ribose 1#-phosphate
phosphatase active site (17, 28), in a similar manner to the two
alphaviruses’ macro domains. The crevice is located at the top
of the " strands 2, 4, and 5 and surrounded by the loops
connecting "2-!1 and "5-!3 (Fig. 1A and 3A). ADP-ribose lies
in a slightly bent conformation comparable to that seen in
other known macro domain–ADP-ribose complexes. The spec-
ificity for the adenosine base detected by the thermal shift
assay (Fig. 2) is at least in part provided by the D10 residue.
The adenine moiety is selectively hydrogen bonded via its N6
nitrogen to the D10 side chain (Fig. 3B). Interestingly, this
residue is conserved in most macro domain sequences but not
Sindbis virus (Fig. 1E). However, in the latter virus, the N10
residue could engage the carbonyl group of its side chain
amide into a similar hydrogen bond with a N6 adenine. The D
residue at this position was shown to be responsible for the
adenosine specificity in A. fulgidus (17). In the CHIKV macro
domain, the N6 nitrogen is also hydrogen bonded to R144. In
addition, G32 contributes to the binding of adenine. The
3'-OH of the ADP-ribose proximal ribose (the adenosine ri-
bose) provides a hydrogen bond to T111 (Fig. 3B). Several
water molecules also interact with the proximal ribose. The
phosphate binding site involves the main chain NH groups of
the residues G112, V113, and Y114 for the CHIKV macro
domain and G112, I113, and F114 for the VEEV macro do-
main (Fig. 3B). These residues define a positively charged
pocket which is likely to bind bulky negatively charged groups.
The distal ribose of ADP-ribose is coordinated by the Y/F114
side chain and also makes hydrogen bonds with residues N24
and D/G31 in the main chain in CHIKV and VEEV, respec-
tively. These residues interacting with ADP-ribose are moder-
ately conserved in alphavirus macro domains (Fig. 1E). A
noticeable amino acid polymorphism in the ADP-ribose bind-
ing pocket is the isoleucine and phenylalanine in some alpha-
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viruses, such as VEEV, in lieu of V113 and Y114 as in CHIKV
(Fig. 1E). Even if these changes do not modify the conforma-
tion of the ADP-ribose bound in the CHIKV and VEEV
macro domain (Fig. 3B), they are likely to promote differences
in ADP-ribose binding affinity between them (see Discussion).
This binary complex structure allowed the selection of mutants
in order to probe ligand-protein interactions. The CHIKV
macro domain mutant D10A expectedly showed a reduced
thermal shift compared to the same assay with the native pro-
tein (Fig. 2B).
No noticeable conformational change occurs in the CHIKV
macro domain between the apo and ADP-ribose bound forms.
On the contrary, in VEEV macro domain, the loop containing
residues 30 to 37 changes its conformation when it binds to
ADP-ribose, and adopts a conformation similar to the corre-
sponding loop the CHIKV macro domain (Fig. 1D and 3B).
Additionally, residue R114 adopts a different rotamer. These
rearrangements are necessary in order to allow coordination of
the adenine and the proximal ribose of the ADP-ribose. Fur-
thermore, the residue N24 adopts two different rotamers, de-
pending on the asymmetric unit of the molecule. These mod-
ifications are probably related to the differences in thermal
denaturation shifts yet lead to similar measured equilibrium
constants around 4 to 5 !M. Moreover, these observed rear-
FIG. 2. ADP-ribose binding. (A) Thermal denaturation shift at a given ligand concentration (2 mM) for the CHIKV macro domain. Tm is the
melting temperature of the protein in the presence of the ligand, and To is the melting temperature of the protein alone. (B) ADP-ribose titration
using the thermal denaturation shift assay on CHIKV (wild type and D10A mutant), VEEV, and SARS-CoV macro domains. (C) ITC assay of
ADP-ribose binding to the CHIKV macro domain. (Upper panel) ITC raw data of ADP-ribose binding to the CHIKV and VEEV macro domains.
(Lower panel) ADP-ribose binding isotherm derived from raw data. (D) Same experiment as in panel C but using the VEEV macro domain.
6540 MALET ET AL. J. VIROL.
 at INIST-CNRS DRD on February 16, 2010 
jvi.asm
.org
Downloaded from
 
CXXX
rangements could explain the absence of ADP-ribose binding
in VEEV crystals soaked with ADP-ribose despite the affinity
of this domain for ADP-ribose as seen using ITC. Further-
more, in the VEEV macro domain crystal, one molecule of the
asymmetric unit contains a Bicine molecule (Fig. 3B), likely
originating from the gel filtration buffer. This Bicine molecule
could have prevented ADP-ribose binding in the soaking ex-
periment but corroborates the proposition that this pocket is
able to accommodate negatively charged groups.
ADP-ribose 1!-phosphate phosphatase activity. ADP-ribose
1!-phosphate phosphatase was the first activity detected for the
yeast Poa1p macro domain based on a genome-wide search of
this specific activity (28). In viruses, this activity has already
been detected for SARS-CoV, SFV, and HEV macro domains
(10) but was associated with a poor turnover constant. In the
case of alphaviruses, the SFV ADP-ribose 1!-phosphate phos-
phatase activity is at the limit of detection (10). This observation,
together with our ADP-ribose complexes presented above,
prompted us to test this activity for the alphavirus macro domains
studied here. CHIKV and VEEV macro domains showed an
activity comparable to that of yeast Poa1p macro domain (Fig. 4).
To get insight into the characterization of the residues involved in
catalytic activities, we tested whether the residues involved in
ADP-ribose binding in the crystal structure were indeed able to
alter the ADP-ribose 1!-phosphate phosphatase activity. The
CHIKV macro domain N24A and Y114A mutants were inactive,
while the D10A mutant showed only a decreased activity under
the conditions used (Fig. 4). As pinpointed by our structural
model, N24 is vicinal to the electrophilic center, i.e., the 1!
phophosphorus of the ADP-ribose 1! phosphate. The decrease
but not annihilation, of activity promoted by D10A is indeed
consistent with a role in binding, and not catalysis, as D10 is
hydrogen bonded to the ADP-ribose adenine (Fig. 3B), far away
from the 1! phophosphorus of the ADP-ribose 1! phosphate. In
contrast, N24 could well be involved in the phosphatase reaction,
as in the case of the SARS-CoV macro domain (10). N24 is
FIG. 3. Structural basis for ADP-ribose binding. (A) ADP-ribose
binding site of the CHIKV macro domain. On the left side is a rep-
resentation of the CHIKV macro domain with helices, strands, and
loops colored, respectively, in red, yellow, and green. ADP-ribose is
displayed in sticks with carbons in yellow, oxygens in red, nitrogens in
blue, and phosphorus in orange. The Fo " Fc difference map, con-
toured at 3#, was calculated at a 1.80-Å resolution from a model in
which the ligand was omitted. On the right side is an electrostatic
surface representation of the CHIKV macro domain in complex with
ADP-ribose. The electrostatic potential is shown between "8 and 8
kT/e and has been generated as in Fig. 1C. The ADP-ribose molecule
is shown as on the left side of panel A. (B) The ADP-ribose binding
site presented with the same orientation as in panel A. The CHIKV
macro domain in complex with ADP-ribose is shown in the upper part,
the VEEV macro domain in complex with a Bicine molecule originat-
ing from the buffer is presented in the middle part, and the VEEV
macro domain in complex with ADP-ribose is shown in the lower part.
ADP-ribose and Bicine are shown in cyan. Residues interacting with
ADP-ribose in the CHIKV macro domain are shown in blue, and
mutated residues are indicated with an asterisk. Corresponding resi-
dues in VEEV are colored in blue. Hydrogen bonds between the
ligand and the protein are shown in black dotted lines. The loops
containing residues 30 to 37 are shown in yellow in CHIKV and VEEV
macro domains: their conformations diverged particularly between
residues 32 and 35.
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correctly positioned to activate a water molecule, which in turn
could promote a nucleophilic attack on the phosphorus of the
ADP-ribose 1! phosphate. The distance of 6 Å between N24 and
the 1! position of the ribose could be consistent with such a
reaction, leaving enough space for both a water molecule and the
phosphate.
PAR binding. Conserved positive patches on the electro-
static surface of the protein (Fig. 1C) suggest possible binding
of longer negatively charged chains such as PAR or RNA.
Macro domain binding to PAR has already been shown for A.
fulgidus and SARS-CoV macro domains (10, 17). The difficulty
of obtaining homogeneous PAR in sufficient quantities inhib-
ited our attempts to obtain a crystal structure of an alphavirus
macro domain in complex with PAR. However, we tested PAR
binding for several alphavirus macro domains in comparison
with SARS-CoV PAR binding using a slot-blot assay. All al-
phavirus macro domains tested (CHIKV, VEEV, Sindbis virus,
and SFV) showed stronger PAR binding than SARS-CoV
macro domain (Fig. 5) (10). The alanine single-amino-acid
mutants described above were assayed for PAR binding. The
mutants did not induce a significant decrease in PAR binding
either (not shown). This indicates that any such single muta-
tion is not sufficient to destabilize the interaction with a PAR
chain significantly.
RNA binding. Since alphavirus are single-stranded RNA
viruses and macro domains are able to bind long negatively
charged chains, it had been hypothesized that a viral macro
domain could also bind RNA (21, 34). Neuvonen and Ahola
(32) have recently shown that several viral macro domains are
able to bind PAR as well as RNA. The interaction between
RNA and the CHIKV macro domain was studied using a
slot blot assay in conjunction with the HCV RNA-depen-
dent RNA polymerase serving as a positive control. Single-
stranded RNA binding was indeed detected using a wide va-
riety of RNA oligonucleotides of unrelated sequences. It was
detected not only for the wild-type CHIKV macro domain but
also for the D10A, N24A, and Y114A mutants (Fig. 6A). No
clear difference in binding affinity appeared when compared to
wild type. This means that as in the case of PAR, either the
RNA binding site does not correspond to the ADP-ribose
binding site or a single-amino-acid change has no drastic im-
pact on RNA binding, as previously hypothesized in the case of
PAR binding.
Structural basis of RNA binding. The structural basis of
RNA binding was then assessed by soaking crystals of the
CHIKVmacro domain with several small RNAs (see Materials
and Methods) and one DNA (AAAGCCAAAAA). Only small
adenine-containing RNA or DNA gave a significant extra den-
sity upon analysis of the soaked crystals. In these cases, a
density was observed within the hydrophobic crevice that binds
ADP-ribose. The AMP was virtually superimposable to the
adenosine moiety observed in the binary complexes with ADP-
ribose. However, the visible density differs between the mole-
cules of the asymmetric unit (data not shown). In contrast, in
the case of the AAA RNA, two molecules of the asymmetric
unit show a clear density corresponding to the soaked ligand.
This density corresponds to a bent RNA that is partially bound
in the crevice corresponding to the ADP-ribose binding site
(Fig. 6B and C).
Interestingly, an adenine base of the RNA is bound in a
similar fashion to that of the ADP-ribose adenine. The RNA is
partly disordered at its extremities. Due to steric constraints, a
3" phosphate cannot be positioned near the loop linking #5 to
$3 (containing residues 111 to 113; Fig. 6B). Thus, the first
nucleotide (nt 1 [at the 5" end]) of the RNA is located near this
latter loop (Fig. 6B). Only the 3" phosphate of nt 1 is visible,
together with the entire nt 2 and nt 3.
The binding of nt 1 is promoted by coordination of its phos-
phate with the main chain nitrogen group of residues G32,
G112, and V113 (Fig. 6C). The 2"-O position of the nt 2 ribose
is coordinated by W148 and C143. As in the case of ADP-
ribose, specificity for adenosine of nt 2 is mediated by the same
hydrogen bond between D10 and the adenine N6. The adenine
of nt 2 is also coordinated by residues G32 and R144. The
phosphate of nt 3 makes hydrogen bonds with nitrogen groups
of residues R144 and D145, whereas the ribose of nt 3 interacts
with D145 and W148. The adenine of nt 3 does not make any
interaction with the protein. Therefore, we conclude that the
CHIKV macro domain exhibits an RNA binding pocket en-
compassing an AMP binding pocket identical to that used for
ADP-ribose binding.
FIG. 4. Detection by TLC of ADP-ribose 1!-P, the product of the
ADP-ribose phosphatase activity. Control lanes (ADP-ribose 1!-phos-
phate and ADP-ribose) and reaction lanes with corresponding en-
zymes and D10A, N24A, and Y114A mutants are indicated. The
EEEV lane corresponds to the purified EEEVmacro domain designed
and produced in the same manner as the CHIKV macro domain. The
yeast macro domain protein Poa1p serves as a positive control.
FIG. 5. Slot blot PAR binding assay of macro domains from
CHIKV, VEEV, Sindbis virus, SARS-CoV, and SFV. BSA was used as
a negative control. PAR was synthezised using PARP-1 and
[32P]NAD%, diluted, and used as a probe to label immobilized proteins
(2,000 to 0.98 pmol) blotted onto a nitrocellulose membrane as de-
scribed in Materials and Methods.
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DISCUSSION
We have determined two novel alphavirus macro domain
crystal structures and shown that these domains can bind ADP-
ribose, RNA, and PAR. The crystal structures of the alphavirus
macro domains show a high degree of conservation with other
available macro domain structures (2, 4, 10, 19, 20, 27, 43).
Surprisingly, the macro domain that shows the highest se-
quence and structural similarity to alphavirus macro domain is
that of E. coli and not coronavirus. A direct reflection of this
observation is that alphaviruses exhibit a much higher affinity
for both ADP-ribose and PAR than coronaviruses do. This
might suggest that the macro domain module has been ac-
quired twice during evolution for different purposes within the
viral world or that the difference of macro domain function
between alphavirus and coronavirus has promoted divergence.
This point attracts attention to the fact that one should not
automatically assume that these macro domains perform the
same role, still as elusive, in coronaviruses and alphaviruses.
Along these lines, Neuvonen and Ahola (32) have reported a
comparative study of viral and cellular macro domains and
concluded that the function of a given macro domain might not
directly illuminate the function of any other related macro
domain.
ADP-ribose binding and ADP-ribose 1!-phosphate phos-
phatase activity, shown in most of the macro domains studied,
are also detected in alphaviruses (10, 17, 28, 43). The level of
activity is comparable to that of other tested viral macro do-
mains (Fig. 4) (10, 32), except for that of SFV, which appears
to be lower, assuming that protein stability is not interfering
with activity measurements (32).
Using mutagenesis experiments, we have confirmed the
binding determinants of the ADP-ribose molecule. The D10
residue conserved in all but one macro domain plays a central
role in adenine specificity, but not in ADP-ribose 1!-phosphate
phosphatase activity that is dependent on N24 and Y114 res-
idues. We show here that the CHIKVmacro domain also binds
RNA. The crystal structure of the CHIKV macro domain in
complex with the AAA trimer RNA allows the identification of
residues involved in substrate binding. This D10 residue is also
involved in the specific recognition of adenines, in the same
manner as in the case of ADP-ribose. The RNA is only par-
tially bound in the ADP-ribose binding site. However, even if
the D10A substitution is able to suppress ADP-ribose binding,
the CHIKV D10A macro domain is still able to bind longer
adenine-containing polymers, such as RNA or PAR. This in-
dicates that either binding of PAR/RNA involves more than a
single AMP unit or RNA/PAR binds to another site rather
than the ADP-ribose binding cleft.
A notable structural characteristic of macro domains is the
presence of positively charged residues close to the ADP-
ribose binding site, these basic patches being particularly pro-
nounced in the alphavirus macro domain. Since macro do-
mains from different species bind PAR and RNA (10, 17, 32),
these characteristics suggest that residues of these patches
could be involved in the binding of such negatively charged
substrates longer than ADP-ribose. In agreement with this
localized enhanced basicity present in alphavirus macro do-
mains, our results reveal a higher binding affinity to these
substrates in alphaviruses than in coronaviruses. Also, since
random sequence RNAs bind quite well to the macro domains
of different alphaviruses, the basic surface (Fig. 1C) might
represent another unspecific, negatively charged polymer bind-
ing site distinct from the AMP binding crevice.
Although many RNA oligonucleotides of unrelated se-
quences bind to the macro domain, it is remarkable that a
single AMP remains well defined at all electronic densities,
remaining the sole ligand moiety common to all macro do-
mains so far. Together with the possible RNA or PAR binding
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FIG. 6. RNA binding assays. (A) Slot blot RNA binding assay with
wild-type and mutant CHIKV macro domains using the 5"-32P-labeled
RNA AAAAAAAAAGCUACC as a probe to label immobilized pro-
teins. The amount of proteins blotted onto the membrane ranges from
2,000 to 0.98 pmol, as indicated. (B) Surface representation of the
CHIKV macro domain in complex with the RNA AAA. Proposed nt
1, 2, and 3 (I, II, and III, respectively) are circled. The electrostatic
potential is shown between #6 and 6 kT/e and has been generated as
in Fig. 1C. (C) RNA binding site. RNA is shown in green and inter-
acting residues in blue, with oxygens in red. H-bonds are indicated with
dotted lines.
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site outside the ADP-ribose binding cleft on the basic patches,
it is tempting to speculate that the viral macro domains work
with another yet-to-be defined AMP-containing substrate. Re-
cent results have also proposed this possibility when CoV
macro domains were compared and found to bind ADP-ribose
very differently: although structurally very close, a group 3 CoV
macro domain does not bind ADP-ribose, whereas a group 1
CoV macro domain binds it with a Kd of 29 !M (36).
There are a number of investigational avenues regarding the
role of the viral macro domains. First, alphavirus infection can
induce synthesis of a large quantity of PAR upon PARP-1
activation (31). This leads to depletion of ATP and NAD"
present in the cell and induces activation of the AIF, which in
turn promotes apoptosis. The role of the viral macro domain
could thus be related to the binding of PAR and to the mod-
ification of the cellular response to viral infection. It remains to
be investigated if and how PAR, which is synthesized by the
PARP-1 in the nucleus, could interact directly with alphavirus
macro domain, the latter having been detected only in the
cytoplasm.
Second, the binding of RNA certainly requires further bio-
chemical studies using the replication complex of these viruses.
Indeed, the macro domain, being part of a large replicase,
could serve either as a non-sequence-specific RNA recruit-
ment factor or adenine-containing RNA recruitment factor in
order to provide the RNA template to the neighboring non-
structural proteins.
Third, there are other areas of investigation that have been
suggested to depend on the function of the macro domain,
such as inflammation (13). It is also possible that functions
described in the second and third points above might be com-
bined since the coronavirus macro domain is located in the
same nsp3 as the papain-like proteinase domain, which has
been shown to possess deubiquitinylating and interferon an-
tagonistic activity (26).
Our work provides a structural basis with which to begin to
address these questions in alphaviruses, for which replicons
and infectious recombinant clones exist and which might prove
less demanding than equivalent studies using much larger CoV
genomes.
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Abstract
Background: Ubiquitination plays a critical role in regulating many cellular processes, from DNA
repair and gene transcription to cell cycle and apoptosis. It is catalyzed by a specific enzymatic
cascade ultimately leading to the conjugation of ubiquitin to lysine residues of the target protein
that can be the ubiquitin molecule itself and to the formation of poly-ubiquitin chains.
Findings: We present the crystal structure at 3.0 Å resolution of bovine ubiquitin crystallized in
presence of cadmium ions. Two molecules of ubiquitin are present in the asymmetric unit.
Interestingly this non-covalent dimeric arrangement brings Lys-6 and Lys-63 of each
crystallographically-independent monomer in close contact with the C-terminal ends of the other
monomer. Residues Leu-8, Ile-44 and Val-70 that form a hydrophobic patch at the surface of the
Ub monomer are trapped at the dimer interface.
Conclusions: The structural basis for signalling by poly-Ub chains relies on a visualization of
conformations of alternatively linked poly-Ub chains. This arrangement of ubiquitin could illustrate
how linkages involving Lys-6 or Lys-63 of ubiquitin are produced in the cell. It also details how
ubiquitin molecules can specifically chelate cadmium ions.
Background
Ubiquitin (Ub) is an evolutionary conserved protein of 76
amino-acids found in all eukaryotes. Ub participates in
the regulation of various cellular processes through conju-
gation to other cellular proteins, which is catalyzed by an
enzymatic cascade that involves the sequential actions of
three enzymes known as Ub-activating (E1), Ub-conjugat-
ing (E2) and Ub-protein ligase (E3) enzymes. As a result,
the C terminal glycine residue of Ub is ligated to the target
protein through the formation of an isopeptide bond to
one of its lysine residues, by a complex formed by the E2
and E3 enzymes. Covalent attachment of the C-terminal
end of Ub to lysine residues of a protein substrate, a proc-
ess known as ubiquitination, targets the substrate for a
range of possible fates including protein degradation.
Conjugation of a single Ub molecule regulates transcrip-
tion, endocytosis and membrane trafficking. Since the
ubiquitin protein itself contains seven lysine residues: Lys-
6, Lys-11, Lys-27, Lys-29, Lys-33, Lys-48 and Lys-63, addi-
tional Ub molecules can be ligated to each of these seven
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sites, leading to the formation of poly-Ub chains with dis-
tinct linkages between individual Ub molecules. The most
common poly-Ub chain is linked through Lys-48 and
serves as a signal for rapid degradation of substrates by the
proteasome-dependent proteolysis pathway [1]. Poly-Ub
chains linked through Lys-63 trigger non-proteolytic sig-
nals, such as for DNA repair, ribosomal protein synthesis,
inflammatory signalling, endocytosis and vesicular traf-
ficking. However, a recent report suggested that in vivo,
Lys-63-linked ubiquitin chain may also serve as a target-
ing signal for the 26S proteaseome [2]. Lys-6-modified
ubiquitin is a potent and specific inhibitor of ubiquitin-
mediated protein degradation [3]. Lys-11- and Lys-29-
linked chains also target the substrate for proteasome-
dependent protein degradation. Lys-29- or Lys-33-linked
ubiquitin chains regulate the enzymatic activity of kinases
[4]. Thus, different poly-Ub chains, despite being assem-
bled from identical Ub units are recognized as distinct sig-
nals by the cell machinery. Therefore, a visualization of
conformations of alternatively linked poly-Ub chains
should help deciphering the molecular and structural
basis for their signalling activities.
In the present study, we crystallized bovine ubiquitin in
the presence of a high concentration of cadmium salt in a
form that comprises two independent molecules per
asymmetric unit and report this structure at 3Å resolution.
Methods
Crystallization
Bovine ubiquitin (Sigma) was subjected to gel filtration
chromatography on a HiLoad 16/60 Superdex 75 column
(GE Healthcare) using buffer A (50 mM HEPES pH 7.5,
150 mM NaCl and 5 mM dithiothreitol). Fractions were
pooled and concentrated to 10 mg/ml in buffer A using an
Amicon Ultra-5 filter (Millipore). Screening for crystalli-
zation conditions was performed using sitting-drop
vapour diffusion in 96-well plates by mixing a volume of
0.2 Pl of protein solution with 0.2 Pl of precipitant. Drops
were equilibrated against 0.1 ml of precipitant solution at
291 K. Crystallization screens tested included the sparse-
matrix Crystal Screens 1 and 2, Crystal screen Lite & Cryo,
Index, SaltRx, MembFac, PEG/Ions, grid screens for
sodium malonate and ammonium sulfate (Hampton
Research) using a CyBio crystallization robot. Crystals
Table 1: Data collection and refinement statistics
Data collection statistics
Space group P4(3)32
Unit cell a, b, c (Å) 105.23
No. of molecules per asymmetric unit 2
Resolution (Å) 30.0-3.0
No. of measured reflections 92197
No. of unique reflections 4367
Completeness 99.9 (100.0)
Redundancy 21.1 (22.9)
Rsym (%) 6.9 (56.7)
I/ (I) 35.7 (5.8)
Refinement statistics
No. of reflections (working set/test set) 3613/172
R factor (Rwork/Rfree) 0.222/0.257
No. of atoms
Protein 1196
Cadmium 5
Water 42
B mean (Å2) 87.88
B (Wilson Plot, Å2) 101.29
B Protein atoms (Å2) 72.37
B cadmium atoms (Å2) 69.76
B water atoms (Å2) 59.02
R.M.S. deviations
Bond lengths (Å) 0.006
Bond angles (°) 1.44
Ramachandran statistics (%)
Most favored 81.8
Additionally allowed 17.4
Generously allowed 0.8
Disallowed 0.0
*Values in parentheses refer to the corresponding values of the 
highest resolution shell (3.00-3.12)
Table 1: Data collection and refinement statistics (Continued)
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were observed using a reservoir solution containing 100
mM HEPES pH 7.5, 50 mM cadmium sulfate, 1 M sodium
citrate.
Data collection and structure determination
Crystals suitable for diffraction experiments grew within
one week to maximum dimensions of approximately 0.20
× 0.25 × 0.25 mm and diffracted to 3.0 Å resolution at
third generation synchrotron beamlines. The data set was
collected at beamline ID14-4, ESRF (Grenoble, France)
using crystals frozen in the reservoir solution supple-
mented with 30% glycerol. Reflection data were indexed,
integrated and scaled using MOSFLM and the CCP4 pro-
gram suite (Table 1). The structure was determined by
molecular replacement with the program MOLREP [5]
using the monomeric Ub structure (PDB ID code 1UBQ)
as a search probe. The model was refined using the pro-
gram CNS [6] and rebuilt with program O [7]. The geom-
etry of the final model was checked with PROCHECK [8]
and figures for molecular representation were prepared
using PyMOL http://www.pymol.org. Statistics for struc-
ture refinement and validation are given in Table 1. The
Overall StructureFigure 1
Overall Structure. A. Schematic representation of the intermolecular contacts established by Ub monomer A (blue) and B 
(pink). Non-crystallographic (yellow) or crystallographic (green) contacts are marked under the corresponding residue. A cap-
ital letter marks an interaction <3.2Å and a small letter a contact <4Å. B. Secondary structure elements are indicated above 
the respective sequence. The relative accessibility (acc) is calculated by DSSP and rendered as blue-colored boxes (from dark-
blue: fully accessible, to white: buried). The hydropathic character of a sequence is calculated according to the algorithm of 
Kyte and Doolittle with a window of 3 and is rendered as red (hydrophobic) to blue (hydrophilic) boxes. C. The Ub non-cova-
lent crystallographic dimer using the color scheme in A). Side-chains of residues involved in the association are represented as 
yellow sticks and labeled. N- and C-terminal ends of each Ub chain are indicated.
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coordinates are available from the Protein Data Bank with
accession number 3H1U.
Results and Discussion
Overall Structure
The asymmetric unit contains two non-covalently linked
Ub monomers (Figure. 1) hereafter named A and B that
can be superimposed with an r.m.s. deviation of 0.89 Å
for 75 equivalent D-carbon atoms. The absence of cova-
lent bond formation between the two Ub monomers was
confirmed both by SDS PAGE and mass spectrometry
using dissolved Ub crystals that only revealed the presence
of monomeric species. Structural differences with other
crystallized ubiquitins [9-11] are located in one loop
spanning residues Thr-7-Gly-10 and at the C-terminal
ends that are engaged in different crystal packing interac-
tions (Figure. 2). Compared to the Lys-63-linked diubiq-
uitin that was also crystallized in presence of cadmium
ions [[11], PDB code 2JF5], significant variations in con-
formation are observed for monomer A with a r.m.s.d. of
0.88 and a r.m.s.d of 1.34 Å for the B monomer: Of note,
the D-carbon atoms of residues Leu-8 and Thr-9 are dis-
placed by 3.6 and 3.3 Å respectively compared to the Lys-
63-linked diubiquitin structure. Residue Leu-8 is an
important recognition element for the binding of Lys-48-
linked tetraubiquitin to the 26S proteasome and the Leu-
8Ala mutation causes the largest defect in substrate degra-
dation as compared to other mutations targeting the
hydrophobic patch (e.g. Ile-44Ala and Val-70Ala) [12,13].
The ubiquitin molecule displays extensive acidic and basic
Comparison of Ub crystallographic dimersFigure 2
Comparison of Ub crystallographic dimers. Monomer A of Ub (in green, this work) was superimposed with one mono-
mer of either 1AAR, 2O6V, 1F09, 2JF5, 1TBE. Only the D-carbon traces are displayed. The monomer B of Ub is in cyan, while 
the A and B monomers of other ubiquitins are colored in red and magenta. When present, cadmium ions from the crystalliza-
tion media are shown as spheres.
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The hydrophobic patch and binding of cadmium ionsFigure 3
The hydrophobic patch and binding of cadmium ions. A. Mapping the locations of the residues that form the hydropho-
bic patch (Leu-8, Ile-44, and Val-70) with respect to the crystallographic dimer interface in four Ub crystal structures. Chain A 
are shown in green and chain B in cyan. Residues from the hydrophobic patch are shown as red sticks and labelled. When 
present, cadmium ions are shown as either green or cyan spheres, according to the Ub monomer they bind to. B. The five cad-
mium binding sites observed. Residues of chain A are in green while symmetry related molecules are shown in different col-
ours. Contacts between cadmium ions (red spheres) and water molecules (magenta spheres) are indicated by dashed lines, 
with the corresponding distances labelled in Å. Oxygen atoms are coloured in red and nitrogen atoms in blue.
CXL
BMC Research Notes 2009, 2:251 http://www.biomedcentral.com/1756-0500/2/251
Page 6 of 7
(page number not for citation purposes)
patches at opposite faces of the monomer. The hydropho-
bic patch at the surface of each ubiquitin molecule
includes Leu-8, Ile-44 and Val-70 and mediates interac-
tion between mono- and polyubiquitin and a variety of
ubiquitin-binding domains [14]. In the present crystal
structure these residues are trapped at the interface
between monomers A and B (Figure 3A). A list of the
interactions between the two crystallographically-inde-
pendent Ub monomers is given in Table 2. Interestingly,
the relative arrangement of the two Ub monomers brings
Lys-6 from monomer A in close proximity to the C-termi-
nal end of monomer B. Likewise, Lys-B63 is next to the C-
terminus of a symmetry-related molecule of chain A (Fig-
ure 3A). Recently, it was shown that formation of Lys6-
linked polyubiquitin chains was catalysed by a het-
erodimeric RING E3 ligase complex consisting of the
breast cancer-susceptibility protein BRCA1 and BARD1
[15]. As BRCA1/BARD1 are localized at sites of DNA dam-
age through binding of their adaptor protein RAP80 to
Lys6- and Lys63-linked ubiquitin chains [16], both of
these chain types might be involved in DNA repair.
The buried surface area between the two monomers
present in the asymmetric unit is 1082 Å2 indicating that
this dimeric arrangement will not be maintained in solu-
tion. This was confirmed by gel filtration experiments
(not shown). Interestingly, the mode of association in the
crystal between molecules A and B (Figure 3A) is grossly
related to the Lys-48-linked diubiquitin structure
observed by Cook et al [9] which also buries the hydro-
phobic residues (Leu-8, Ile-44 and Val-70) at the interface
but has a much more extensive dimerization interface of
1507 Å2 ([9] PDB code 1AAR]. However, no clear correla-
tion seems to exist between isopeptide bond formation,
the oligomerization state and the surface area buried at
the molecular interface: tetra-ubiquitin chains have been
observed in various crystal structures either with a surface
of 1492 Å2 for the Lys-48-linked tetra-ubiquitin ([17]
PDB code 2O6V] or with much smaller buried interface of
659 Å2 ([10] PDB code 1TBE], 435 Å2 ([18] PDB code
1F9J], or 209 Å2 ([11] PDB code 2JF5]. The Lys-63-linked
diubiquitin ([11] PDB code 2JF5] adopts an extended
conformation with no clear interface formation between
Ub domains and fully exposes both hydrophobic patch
residues of each Ub to the solvent. Thus, in the present
structure, the overall conformation of ubiquitin mole-
cules differs from those seen in previously reported poly-
Ub structures (Figure 3A), which probably accounts for
distinct roles in cell signalling. The analysis of crystal
packing shows that both molecules within the asymmetric
unit come in close contact with symmetry-related mole-
cules (Additional File 1: Fig. S1). An electron density omit
map after removing Gly-75 of both chains from the phas-
ing model, indicates that these residues are well ordered
in the crystal (Additional File 2: Fig. S2). Although all
known Ub structures are closely related but their modes of
association differs. Thus the identification of a new inter-
face may explain the formation of Lys-6 or Lys-63 linked
diubiquitin.
Metal binding
Molecule A interacts with three cadmium ions and mole-
cule B chelates two cadmium ions. Cadmium ions con-
tribute directly to lattice formation by bridging residues
from four neighbouring ubiquitin molecules. The first
cadmium ion (Cd1) completes its tetrahedral coordina-
tion sphere by binding the carboxylic group of Glu64,
atom NE2 of His68* (the star denotes a residue from a
symmetry-related protein) and one water molecule (Fig-
ure 3B). Cadmium ions Cd2 and Cd5 are bound to the
carboxylic group of Glu16, main chain amide and carbo-
nyl groups of residue Met1 and the carboxylic group of
Asp32* and a water molecule. Cd2 binds to a water mol-
ecule but Cd5 does not interact with any water molecule
(Figure 3B). Cadmium ions Cd3 and Cd4 are chelated by
the carboxylic groups of Glu18 and Asp21 and atom NZ
of Lys29. One water molecule completes their coordina-
tion shells (Figure 3B). Interestingly, residues that bind
cadmium ions, especially Glu16, Glu18 and Glu64 show
a remarkable displacement from their positions in native
Table 2: Non-covalent interactions between two ubiquitin 
monomers
Molecule A Molecule B
Residue Atom Residue Atom Distance (Å)
Leu8 CD1 Gln40 NE2 3.23
Leu8 CD2 Gln40 OE1 3.99
Gln40 N Leu8 O 2.70
Gln40 OE1 Thr9 CG2 3.73
Gln40 NE2 Thr9 CG2 2.91
Arg42 NH1 Glu34 O 2.69
Arg42 NH1 Ile36 N 3.17
Arg42 NH2 Pro37 CD 3.38
Ile44 CG2 Leu71 CD2 3.44
Glu51 OE2 Lys11 NZ 3.19
Val70 CG1 Gln40 OE1 3.20
Val70 CG2 Gln40 NE2 3.69
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ubiquitin; detailed views of the various cadmium binding
sites are shown in Additional File 3: Fig. S3. A comparison
of the crystal structure reported here with other ubiquitin
complexed to metal ions ([11] PDB code 2JF5) is shown
in Figure 2. In addition, three out of five cadmium ions
bind to ubiquitin in different ways: Positions of Cd3 and
Cd4 are analogous to that observed in structure 2JF5, but
positions of Cd2 and Cd5 are occupied by magnesium
and cobalt ions, respectively. No ligand is present in struc-
ture 2JF5 corresponding to the position occupied by Cd1.
These results support the findings by Dokmanic and co-
workers [19] stating that the most abundant amino-acid
residues in the tetrahedral or octahedral cadmium coordi-
nation spheres are Cys followed by Glu and Asp.
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Additional file 1
Figure S1: Packing of molecules in crystal of Ub. A) The non-crystallo-
graphic dimer using a ribbon representation. B) Nearest symmetry mole-
cules (at 4Å) in the same orientation as A). C, D, E) rotation of B) by 
90° around the horizontal axis, at 90° along Y, at 180° along X respec-
tively. F) rotation of C) at 180° along Y.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-2-251-S1.PNG]
Additional file 2
Figure S2: Omit electron density map around the C-terminal of Ub. 
Omit electron density map around the C-terminal of chain A (panel A) 
and chain B (panel B) after removing residue Gly75 from the phase cal-
culation. The Fo -Fc difference electron density map contoured at 3.0  level 
is coloured in green and 2Fo -Fc map contoured at 1.5  level (in blue). 
Density accounting for Gly-75 is visible for both chains.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-2-251-S2.PNG]
Additional file 3
Figure S3: Comparison between structures of native and cadmium 
bound Ub. Superposition of the structures of native ubiquitin (magenta) 
and bovine ubiquitin (green) in the region of the binding sites of cadmium 
(red). The interactions between cadmium ions and donor atoms are indi-
cated by dotted lines.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-2-251-S3.PNG]
CXLII
electronic reprint
Acta Crystallographica Section F
Structural Biology
and Crystallization
Communications
ISSN 1744-3091
Editors: H. M. Einspahr and M. S.Weiss
Crystallization and diffraction analysis of the SARS
coronavirus nsp10–nsp16 complex
Claire Debarnot, Isabelle Imbert, Franc¸ois Ferron, Laure Gluais, Isabelle
Varlet, Nicolas Papageorgiou, Mickae¨l Bouvet, Julien Lescar, Etienne
Decroly and Bruno Canard
Acta Cryst. (2011). F67, 404–408
Copyright c⃝ International Union of Crystallography
Author(s) of this paper may load this reprint on their own web site or institutional repository provided that
this cover page is retained. Republication of this article or its storage in electronic databases other than as
specified above is not permitted without prior permission in writing from the IUCr.
For further information see http://journals.iucr.org/services/authorrights.html
Acta Crystallographica Section F
Structural Biology
and Crystallization
Communications
Editors: H. M. Einspahr and M. S. Weiss
journals.iucr.org
International Union of Crystallography
Wiley-Blackwell
ISSN 1744-3091
Volume 67
Part 1
January 2011
Acta Crystallographica Section F: Structural Biology and Crystallization Communications
is a rapid all-electronic journal, which provides a home for short communications on
the crystallization and structure of biological macromolecules. It includes four categories
of publication: protein structure communications; nucleic acid structure communica-
tions; structural genomics communications; and crystallization communications. Struc-
tures determined through structural genomics initiatives or from iterative studies such
as those used in the pharmaceutical industry are particularly welcomed. Section F is
essential for all those interested in structural biology including molecular biologists, bio-
chemists, crystallization specialists, structural biologists, biophysicists, pharmacologists
and other life scientists.
Crystallography Journals Online is available from journals.iucr.org
Acta Cryst. (2011). F67, 404–408 Debarnot et al. · nsp10–nsp16 complexCXLIII
crystallization communications
404 doi:10.1107/S1744309111002867 Acta Cryst. (2011). F67, 404–408
Acta Crystallographica Section F
Structural Biology
and Crystallization
Communications
ISSN 1744-3091
Crystallization and diffraction analysis of the SARS
coronavirus nsp10–nsp16 complex
Claire Debarnot,a Isabelle
Imbert,a Franc¸ois Ferron,a Laure
Gluais,a Isabelle Varlet,a Nicolas
Papageorgiou,a Mickae¨l Bouvet,a
Julien Lescar,a,b Etienne
Decrolya* and Bruno Canarda*
aDe´partement de Virologie Structurale,
Architecture et Fonction des Macromole´cules
Biologiques, UMR 6098, 163 Avenue de
Luminy, 13288 Marseille CEDEX 09, France,
and bSchool of Biological Sciences, Nanyang
Technological University, 60 Nanyang Drive,
Singapore 637551, Singapore
Correspondence e-mail:
etienne.decroly@afmb.univ-mrs.fr,
bruno.canard@afmb.univ-mrs.fr
Received 19 November 2010
Accepted 21 January 2011
To date, the SARS coronavirus is the only known highly pathogenic human
coronavirus. In 2003, it was responsible for a large outbreak associated with a
10% fatality rate. This positive RNAvirus encodes a large replicase polyprotein
made up of 16 gene products (nsp1–16), amongst which two methyltransferases,
nsp14 and nsp16, are involved in viral mRNA cap formation. The crystal
structure of nsp16 is unknown. Nsp16 is an RNA-cap AdoMet-dependent
(nucleoside-20-O-)-methyltransferase that is only active in the presence of nsp10.
In this paper, the expression, purification and crystallization of nsp10 in complex
with nsp16 are reported. The crystals diffracted to a resolution of 1.9 A˚
resolution and crystal structure determination is in progress.
1. Introduction
In 2003, an outbreak of a novel virus occurred in China and spread
through several countries. The identified agent, a previously unknown
coronavirus, was named severe acute respiratory syndrome corona-
virus (SARS-CoV). Much like other coronaviruses, SARS-CoV has
an!30 kb RNA genome with a 50 cap and a 30 poly(A) tail (Snijder et
al., 2003). The genome of SARS-CoV codes for two large poly-
proteins 1a and 1ab, which are autoproteolytically processed by at
least two viral proteases, producing 16 nonstructural proteins (nsps).
These nsps are thought to form a huge protein complex that is
responsible for viral RNA replication and transcription. In addition, a
set of subgenomic mRNAs encoding structural and accessory
proteins is produced by a sophisticated mechanism involving nested
mRNA synthesis using the full-length genomic RNA as template.
These mRNAs are thought to be capped and polyadenylated (Lai &
Stohlman, 1981; van Vliet et al., 2002).
Since 2003, interest in SARS-CoV has greatly promoted structural
and functional studies of its nsps. In recent years, many three-
dimensional structures of replication proteins have appeared in the
literature, including those of nsp1 (Almeida et al., 2007); several
domains of nsp3 [including (i) an N-terminal Glu-rich acidic domain
(AD; Serrano et al., 2007), (ii) an X domain (XD; Egloff et al., 2006),
(iii) the SUD domain (SARS-CoV unique domain; Chatterjee et al.,
2009) and (iv) the papain-like protease PLP2 (Ratia et al., 2006)];
nsp5 (Anand et al., 2002); a complex consisting of nsp7–nsp8 (Zhai et
al., 2005); the RNA-binding protein nsp9 (Egloff et al., 2004); the
zinc-binding protein nsp10 (Joseph et al., 2006, Su et al., 2006); and the
hexameric RNA endonuclease nsp15 (Ricagno et al., 2006). In many
cases, the crystal structures allowed scientists to suggest or to ascer-
tain a biochemical function for the nsps, such as nsp7–nsp8, which acts
as an RNA-dependent RNA primase (Imbert et al., 2006), and the
nsp15 endonuclease, the active site of which has been found to share
structural homology to the active site of RNAse A (Ricagno et al.,
2006; Joseph et al., 2007). The process of RNA capping, however, has
not yet benefitted from this structural work. Structural data is lacking
for the enzymes that are putatively involved in mRNA capping.
# 2011 International Union of Crystallography
All rights reserved
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In eukaryotes, mRNA capping results from a series of three to four
canonical reactions acting on the 50-end of the mRNA. The nascent
mRNA transcript endures a limited dephosphorylation in which the
last 50-phosphate is removed by a 50-RNA triphosphatase. A
guanylyltransferase (also named capping enzyme) attaches a GMP
molecule onto the 50-diphosphate RNA in a 50-to-50 orientation. The
capped RNA is then methylated at the N7 position of the cap guanine
nucleotide by an N7-guanine methyltransferase. This yields a cap-0
structure (m7GpppNN . . . ) as found mainly in yeasts and lower
eukaryotes. In higher eukaryotes and plants, a second methyl-
transferase acts on the first transcribed nucleotide at its 20-O position
to yield a cap-1 structure (m7GpppN20OmN . . . ), such as that found on
coronavirus mRNAs (Lai & Stohlman, 1981; van Vliet et al., 2002).
We have recently identified the RNA cap 20-O-methyltransferase
of the SARS-CoV (Bouvet et al., 2010; Lugari et al., 2010). This
activity is harboured by nsp16 as predicted by signature-sequence
analysis; however, the enzyme is only active in the presence of nsp10.
The latter has been shown to interact strongly with nsp16 using the
yeast two-hydrid method, indicating that the enzymes associate into a
complex that is stable enough to withstand purification (Imbert et al.,
2008).
Here, we report the cloning of nsp10 and nsp16 in a prokaryotic
expression vector. Upon expression of both genes, a stable complex
consisting of nsp10 and nsp16 (nsp10–nsp16) can be purified and
crystallized. We present X-ray diffraction data from these SARS-
CoV nsp10–nsp16 crystals.
2. Materials and methods
2.1. Tandem cloning of the nsp10 and nsp16 SARS-CoV genes
The Frankfurt 1 isolate of SARS-CoV (GenBank accession No.
AY291315; Thiel et al., 2003) was amplified in Vero-E6 cells and used
for production of the nsp10–nsp16 complex as follows: genes coding
for SARS-CoV nsp10 (139 amino acids, 14.84 kDa) and nsp16 (298
amino acids, 33.5 kDa) were cloned into the pmCOX Escherichia coli
dual expression plasmid kindly provided by Dr Bruno Coutard
(AFMB, France) containing two separate promoters. In this back-
bone, SARS-CoV nsp10 is expressed under a tetA promoter and
encodes a protein fused with an N-terminal Strep-Tag (eight amino
acids; WSHPQFEK) and nsp16 is expressed under a T7lac promoter
and encodes a protein fused with an N-terminal hexahistidine tag
(Bouvet et al., 2010). This system allows independent regulation of
the expression levels of the two genes by the addition of different
concentrations of tetracycline and IPTG (isopropyl !-d-1-thio-
galactopyranoside).
2.2. Expression and purification of the nsp10–nsp16 complex
SARS-CoV nsp10–nsp16 co-expression was performed in E. coli
strain C41 (DE3) (Avidis SA, France) harbouring the pLysS plasmid
(Novagen). Cultures were grown at 310 K until the OD600 nm reached
0.6. Expression was induced by adding 50 mM IPTG and 200 mg l!1
anhydrotetracycline and the cells were incubated for 16 h at 297 K.
Bacterial cell pellets were collected by centrifugation at 6000g, frozen
and resuspended in lysis buffer (50 mM HEPES pH 7.5, 300 mM
NaCl, 5 mM MgSO4) supplemented with 10 mg ml!1 DNase I. After
cell disruption at 100 MPa and 277 K (Constant Cell, UK) and clar-
ification by centrifugation at 20 000g for 30 min, the soluble protein
fraction was incubated with Strep-Tactin Sepharose (IBA BioTAG-
nology). After three washes in buffer (50 mM HEPES pH 7.5,
500 mM NaCl, 1 mM TCEP, 5 mM MgCl2), bound proteins were
eluted in wash buffer supplemented with 2.5 mM d-desthiobiotin.
2.3. Crystallization and diffraction analysis
Stura Footprint Screen, JCSG+ Screen and Structure Screens I and
II (Molecular Dimensions) were tried in CrystalQuick plates with
three wells per reservoir (Greiner Bio-One) using 400, 300 and 200 nl
drops. The drops contained increasing volumes (100, 200 and 300 nl)
of protein solution at a concentration of 5.4 mg ml!1 in elution buffer
(50 mM HEPES pH 7.5, 500 mM NaCl, 1 mM TCEP, 5 mM MgCl2,
2.5 mM d-desthiobiotin) and constant volumes of precipitant. A hit
condition was observed in 0.1M bicine pH 9, 2M MgCl2 after one
week. Crystallization optimization was performed by vapour diffu-
sion using the hanging-drop method at 293 K in Linbro plates
(Hampton Research). 2 ml drops (consisting of 1.5 ml protein solution
and 0.5 ml precipitant solution) were equilibrated against 1 ml
reservoir solution. Optimization of crystal-growth conditions led to
the following condition: 0.1M CHES pH 9, 1.52M MgCl2. Crystals
appeared after 24 h and visible growth stopped after 48–72 h. Before
cooling the crystals to 100 K in a nitrogen-gas stream (Oxford
Cryosystems), the crystals were briefly soaked in a cryoprotectant
consisting of 15%(v/v) glycerol added to the mother liquor. Native
diffraction data were recorded using either an ADSC Quantum 315 3
" 3 array detector on beamline PROXIMA 1 at the SOLEIL
Synchrotron Radiation Facility or an ADSC Quantum 210 2 " 2
array detector on beamline ID14-EH1 at the European Synchrotron
Radiation Facility. Data were processed using XDS (Kabsch, 2010)
and scaled with SCALA (Collaborative Computational Project,
Number 4, 1994). Crystal parameters and data-collection statistics are
summarized in Table 1.
2.4. Cross-linking of the purified nsp10–nsp16 complex
Purified nsp10–nsp16 complex (4 mg) in 50 mM HEPES pH 7.5,
150 mM NaCl, 5 mM MgCl2, 1 mM TCEP and 5% glycerol was
incubated overnight at 277 K with a solution of suberic acid
bis(N-hydroxysuccinimide ester) (SAB; Sigma) at a concentration of
0.005%. Samples were then denatured with an equal volume of 2"
dissociation buffer [100 mM Tris–HCl pH 6.8, 20% glycerol and
200 mM DTT, 4% sodium dodecyl sulfate (SDS) and 0.2% bromo-
crystallization communications
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Table 1
Data-collection and processing statistics.
Values in parentheses are for the highest resolution shell.
No. of crystals 1
Beamline PROXIMA 1 (SOLEIL synchrotron)
Wavelength (A˚) 0.979
Detector ADSC Q315r
Crystal-to-detector distance (mm) 256.35
Rotation range per image ($) 1
Total rotation range ($) 90
Exposure time per image (s) 1
Resolution range (A˚) 37.52–2.00 (2.11–2.00)
Space group C2221
Unit-cell parameters (A˚, $) a = 68.1, b = 184.6, c = 128.8,
" = ! = # = 90.00
Mosaicity ($) 0.097
Total no. of measured intensities 273149
Unique reflections 54947 (7963)
Multiplicity 3.7 (3.7)
Mean I/$(I) 7.5 (3.2)
Completeness (%) 99.7 (100)
Rmerge† 0.114 (0.430)
Rmeas 0.136 (0.500)
Overall B factor from Wilson plot (A˚2) 37.3
† Rmerge =
P
hkl
P
i jIiðhklÞ ! hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith observa-
tion of reflection hkl and hI(hkl)i is the weighted average intensity for all observations of
reflection hkl.
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phenol blue]. After 5 min of heating at 368 K, the proteins were
separated and analyzed on an SDS NuPAGE 4–12% gel (Invitrogen).
3. Results and discussion
3.1. Expression, purification and crystallization of a stable
nsp10–nsp16 complex
Many attempts in the laboratory to crystallize nsp16 on its own
remained unsuccessful. Although significant amounts (on a milligram
scale) of nsp16 can be obtained when expressed alone, the protein is
unstable in a variety of buffers and precipitates under various storage
conditions. Moreover, although signature-sequence analyses unam-
biguously identified a SAM-dependent methyltransferase fold (von
Grotthuss et al., 2003; Decroly et al., 2008), SARS-CoV nsp16 alone
does not exhibit this enzymatic activity. In contrast, nsp10 is
expressed to high levels in E. coli and can readily be purified and
crystallized. Two structures of nsp10 crystal forms were published
in 2006: one revealed monomers and dimers (Joseph et al., 2006) at
1.8 A˚ resolution (PDB entry 2fyg), whereas a complex dodecameric
structure at 2.1 A˚ resolution (PDB entry 2g9t) was observed when
nsp10 was expressed and crystallized as a fusion with nsp11 (Su et
al., 2006). Nevertheless, no function has been either predicted or
demonstrated for nsp10, which is a zinc-binding protein.
We have reported that nsp10 and nsp16 interact in vitro when co-
expressed in yeast (Imbert et al., 2008) or bacteria (Bouvet et al.,
2010). This observation prompted us to co-express the two proteins in
the prokaryotic expression vector and to attempt purification of the
complex. Nsp10 was cloned under the control of the tetA promoter in
fusion with a Strep-Tag peptide at its N-terminus and nsp16 tagged
with a hexahistidine tag at its N-terminus was inserted into the
same plasmid under the T7lac promoter. After transformation into
bacterial strain C41, protein expression was induced by the addition
of IPTG and tetracycline for 16 h at 297 K. The bacterial lysate was
clarified and nsp10 was adsorbed onto Strep-Tactin Sepharose beads.
After several washes, the proteins bound to Strep-Tactin were eluted
with 2.5 mM of the biotin analogue desthiobiotin. Upon SDS–PAGE
analysis, we detected the presence of Strep-nsp10 and His6-nsp16
proteins migrating as expected at around 15 and 35 kDa, respectively,
indicating that the two proteins had co-purified (Fig. 1). The overall
yield of the purified complex was typically 1 mg per litre of E. coli
culture. Estimation of protein concentration and normalization with
regard to molecular mass indicated an approximate 1:1 ratio of the
proteins.
3.2. Characterization of the nsp10–nsp16 complex
The nsp10–nsp16 complex was further characterized before
attempting to identify crystallization conditions. We first confirmed
the identity of each recombinant protein by matrix-assisted laser-
crystallization communications
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Figure 1
Purification of SARS-CoV nsp10 in complex with nsp16. The purified SARS-CoV
nsp10–nsp16 complex was analyzed by 12% SDS–PAGE and stained using
Coomassie Blue. Lane MK, molecular-weight markers; lane 1, 2 mg nsp10–nsp16
protein complex eluted from the Strep-Tactin column.
Figure 2
Characterization of SARS-CoV nsp10 in complex with nsp16. (a) Gel-filtration chromatogram of the SARS-CoV nsp10–nsp16 complex. The nsp10–nsp16 complex eluted
from the Strep-Tactin column was analyzed on a 16/60 S200 gel-filtration column and the elution of protein and nucleic acid was followed by measuring the absorption at
280 nm (blue) and 260 nm (orange), respectively. The main peak eluting after 90 ml corresponds to elution of a 50 kDa protein. (b) Cross-linking experiment. The purified
SARS-CoV nsp10–nsp16 complex was loaded onto a 4–12% NuPAGE gel and stained using Coomassie Blue. Lane MK, molecular-weight markers; lane 1, 4 mg non-cross-
linked nsp10–nsp16 complex, lane 2, 4 mg of the nsp10–nsp16 complex incubated overnight at 277 K with 0.005% SAB cross-linker.
electronic reprint
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desorption ionization time-of-flight mass spectrometry after in-gel
trypsin digestion (data not shown). We also analyzed the proteins
eluted from the Strep-Tactin column by size-exclusion chromato-
graphy. Fig. 2(a) shows the gel-filtration elution profile. We observed
that the stable nsp10–nsp16 complex elutes as a single peak corre-
sponding to 50 kDa. The interaction between nsp10 and nsp16 was
also confirmed by a cross-linking experiment. For this purpose, the
nsp10–nsp16 complex was incubated with 0.005% SAB, a cross-
linking reagent that specifically reacts with lysine residues. After
SDS–PAGE separation, we detected the bands corresponding to
nsp10 and nsp16 monomers as well as an additional band corre-
sponding to a nsp10–nsp16 complex migrating around 50 kDa (lane
Xtal in Fig. 3b). The presence of nsp16 in the complex was also
demonstrated by a methyltransferase assay (Selisko et al., 2010)
which showed that the purified fraction containing the nsp10–nsp16
complex exhibited 20-O-methyltransferase activity on short N7-
methylated capped RNA substrates (Bouvet et al., 2010). Together,
these results indicate that we have developed a method allowing the
production and purification of an active nsp10–nsp16 complex by
a one-step procedure. This protein preparation was used without
additional treatment for crystal growth.
3.3. Crystal growth and data collection
The complex was initially crystallized using 0.1M bicine pH 9, 2 M
MgCl2 (condition E2 fom Structure Screens I and II). Crystal growth
was then optimized and the best condition was finally chosen as 0.1 M
CHES pH 9, 1.52 MMgCl2. Crystals typically appeared overnight and
visible growth stopped after 48–72 h (Fig. 3a). To confirm that the
crystal contained the nsp10–nsp16 complex, we collected ten crystals,
crystallization communications
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Figure 3
(a) Optimized crystal of the SARS-CoV nsp10–nsp16 complex. The scale bar is 100 mm in length. (b) NuPAGE analysis of the nsp10–nsp16 complex from optimized crystals.
Ten optimized crystals were loaded onto a 4–12% NuPAGE gel and stained using Coomassie blue. Lane MK, molecular-weight markers; lane Xtal, nsp10–nsp16 complex. (c)
X-ray diffraction pattern from a crystal of the SARS-CoV nsp16–nsp10 protein complex. Resolution arcs are shown. Reflections are observed to below 2 A˚ (an enlargement
is shown in the inset).
electronic reprint
CXLVII
which were analyzed by SDS–PAGE after two washes. Fig. 2(b) shows
that both proteins, nsp10 and nsp16, were detected on Coomassie
Blue staining. This confirms that the crystals consist of the nsp10–
nsp16 complex with a similar stoichiometry as observed prior to
crystallization.
Crystals were flash-cooled in the same buffer supplemented with
15%(v/v) glycerol before exposure to synchrotron X-ray radiation. A
typical diffraction image is shown in Fig. 3(c), in which reflections
are visible to 2 A˚ resolution. Data integration and reduction indi-
cated that the crystals belonged to space group C2221, with one
complex per asymmetric unit (Table 1). The crystals (space group
C2221, unit-cell parameters a = 68.1, b = 184.6, c = 128.8 A˚) contained
one nsp10–nsp16 complex per asymmetric unit, with a solvent content
of 70% and a VM value of 4.17 A˚
3 Da!1.
4. Conclusions
We have crystallized a complex of the SARS-CoV nsp10 and nsp16
proteins. The presence of nsp10 in the complex confers 20-O-
methyltransferase activity on nsp16. The crystal structure of nsp10 is
known, whereas that of nsp16 is not. Given the quality of the crystals
described here and the fact that nsp10 is a zinc-binding protein, it
should be possible to determine the crystal structure using molecular-
replacement techniques merged with phases obtained by SAD
studies, taking advantage of the phasing power of the Zn atoms.
This work was supported in its initial phase by the VIZIER inte-
grated project (LSHG-CT-2004-511960) of the European Union Sixth
Framework and then by the French National Research agency under
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Me´dicale (Programme e´quipe FRM) to BC and the Direction
Ge´ne´rale de l’Armement (contract 07co404). MB has a fellowship
from the Direction Ge´ne´rale de l’Armement.
References
Almeida, M. S., Johnson, M. A., Herrmann, T., Geralt, M. & Wu¨thrich, K.
(2007). J. Virol. 81, 3151–3161.
Anand, K., Palm, G. J., Mesters, J. R., Siddell, S. G., Ziebuhr, J. & Hilgenfeld,
R. (2002). EMBO J. 21, 3213–3224.
Bouvet, M., Debarnot, C., Imbert, I., Selisko, B., Snijder, E. J., Canard, B. &
Decroly, E. (2010). PLoS Pathog. 6, e1000863.
Chatterjee, A., Johnson, M. A., Serrano, P., Pedrini, B., Joseph, J. S., Neuman,
B. W., Saikatendu, K., Buchmeier, M. J., Kuhn, P. & Wu¨thrich, K. (2009). J.
Virol. 83, 1823–1836.
Collaborative Computational Project, Number 4 (1994). Acta Cryst. D50,
760–763.
Decroly, E., Imbert, I., Coutard, B., Bouvet, M., Selisko, B., Alvarez, K.,
Gorbalenya, A. E., Snijder, E. J. & Canard, B. (2008). J. Virol. 82, 8071–
8084.
Egloff, M. P., Ferron, F., Campanacci, V., Longhi, S., Rancurel, C., Dutartre, H.,
Snijder, E. J., Gorbalenya, A. E., Cambillau, C. & Canard, B. (2004). Proc.
Natl Acad. Sci. USA, 101, 3792–3796.
Egloff, M. P., Malet, H., Putics, A., Heinonen, M., Dutartre, H., Frangeul, A.,
Gruez, A., Campanacci, V., Cambillau, C., Ziebuhr, J., Ahola, T. & Canard,
B. (2006). J. Virol. 80, 8493–8502.
Grotthuss, M. von, Wyrwicz, L. S. & Rychlewski, L. (2003). Cell, 113, 701–702.
Imbert, I., Guillemot, J. C., Bourhis, J. M., Bussetta, C., Coutard, B., Egloff,
M. P., Ferron, F., Gorbalenya, A. E. & Canard, B. (2006). EMBO J. 25, 4933–
4942.
Imbert, I., Snijder, E. J., Dimitrova, M., Guillemot, J. C., Le´cine, P. & Canard,
B. (2008). Virus Res. 133, 136–148.
Joseph, J. S., Saikatendu, K. S., Subramanian, V., Neuman, B. W., Brooun, A.,
Griffith, M., Moy, K., Yadav, M. K., Velasquez, J., Buchmeier, M. J., Stevens,
R. C. & Kuhn, P. (2006). J. Virol. 80, 7894–7901.
Joseph, J. S., Saikatendu, K. S., Subramanian, V., Neuman, B. W., Buchmeier,
M. J., Stevens, R. C. & Kuhn, P. (2007). J. Virol. 81, 6700–6708.
Kabsch, W. (2010). Acta Cryst. D66, 125–132.
Lai, M. M. & Stohlman, S. A. (1981). J. Virol. 38, 661–670.
Lugari, A., Betzi, S., Decroly, E., Bonnaud, E., Hermant, A., Guillemot, J. C.,
Debarnot, C., Borg, J. P., Bouvet, M., Canard, B., Morelli, X. & Le´cine, P.
(2010). J. Biol. Chem. 285, 33230–33241.
Ratia, K., Saikatendu, K. S., Santarsiero, B. D., Barretto, N., Baker, S. C.,
Stevens, R. C. & Mesecar, A. D. (2006). Proc. Natl Acad. Sci. USA, 103,
5717–5722.
Ricagno, S., Egloff, M. P., Ulferts, R., Coutard, B., Nurizzo, D., Campanacci, V.,
Cambillau, C., Ziebuhr, J. & Canard, B. (2006). Proc. Natl Acad. Sci. USA,
103, 11892–11897.
Selisko, B., Peyrane, F. F., Canard, B., Alvarez, K. & Decroly, E. (2010). J. Gen.
Virol. 91, 112–121.
Serrano, P., Johnson, M. A., Almeida, M. S., Horst, R., Herrmann, T., Joseph,
J. S., Neuman, B. W., Subramanian, V., Saikatendu, K. S., Buchmeier, M. J.,
Stevens, R. C., Kuhn, P. & Wu¨thrich, K. (2007). J. Virol. 81, 12049–12060.
Snijder, E. J., Bredenbeek, P. J., Dobbe, J. C., Thiel, V., Ziebuhr, J., Poon, L. L.,
Guan, Y., Rozanov, M., Spaan, W. J. & Gorbalenya, A. E. (2003). J. Mol.
Biol. 331, 991–1004.
Su, D., Lou, Z., Sun, F., Zhai, Y., Yang, H., Zhang, R., Joachimiak, A., Zhang,
X. C., Bartlam, M. & Rao, Z. (2006). J. Virol. 80, 7902–7908.
Thiel, V., Ivanov, K. A., Putics, A., Hertzig, T., Schelle, B., Bayer, S.,
Weissbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., Gorbalenya, A. E.
& Ziebuhr, J. (2003). J. Gen. Virol. 84, 2305–2315.
Vliet, A. L. van, Smits, S. L., Rottier, P. J. & De Groot, R. J. (2002). EMBO J.
21, 6571–6580.
Zhai, Y., Sun, F., Li, X., Pang, H., Xu, X., Bartlam, M. & Rao, Z. (2005).Nature
Struct. Mol. Biol. 12, 980–986.
crystallization communications
408 Debarnot et al. " nsp10–nsp16 complex Acta Cryst. (2011). F67, 404–408
electronic reprint
CXLVIII
Antiviral Research 86 (2010) 296–305
Contents lists available at ScienceDirect
Antiviral Research
journa l homepage: www.e lsev ier .com/ locate /ant iv i ra l
Dengue virus replicons: Production of an interserotypic chimera and cell lines
from different species, and establishment of a cell-based fluorescent assay to
screen inhibitors, validated by the evaluation of ribavirin’s activity
Nicolas Masséa, Andrew Davidsonb, Franc¸ois Ferrona, Karine Alvareza, Mike Jacobsc,
Jean-Louis Romettea, Bruno Canarda, Jean-Claude Guillemota,∗
a Architecture et Fonction des Macromolécules Biologiques, CNRS and Universités d’Aix-Marseille I et II, UMR 6098, ESIL Case 925, 13288 Marseille, France
b Department of Cellular and Molecular Medicine, School of Medical Sciences, University of Bristol, Bristol, UK
c Department of Infection, University College London Medical School, London, UK
a r t i c l e i n f o
Article history:
Received 9 September 2009
Received in revised form 8 March 2010
Accepted 16 March 2010
Keywords:
Dengue virus
Replicon
HTS
NS5
Antiviral
a b s t r a c t
The prevention and treatment of flavivirus infections are public health priorities. Dengue fever is the
most prevalent mosquito-borne viral disease of humans, affectingmore than 50million people annually.
Despite the urgent need to control dengue infections, neither specific antiviral therapies nor licensed
vaccines exist and the molecular basis of dengue pathogenesis is not well understood. In this study
we produced a novel dengue virus type 2 (DV2) subgenomic replicon that expresses a fusion protein
comprised of Enhanced Green Fluorescent Protein (EGFP) and Puromycin N-Acetyltransferase (PAC). We
successfully established BHK, COS andHuh7 cell lines that stably expressed the DV2 replicon. Using EGFP
as a reporter of DV replication complex activity, we set up a new HTS assay. The assay was validated
using the inhibitor ribavirin, confirmed by flow cytometry analysis and the analysis of NS5 expression
by Western-blot analysis. In order to develop a system to test antivirals against the NS5 proteins of all
four DV serotypes in a similar cellular environment, the replicon was further modified, to allow easy
exchange of the NS5 gene between DV serotypes. As proof of principle, a chimeric replicon in which the
DV2 NS5 gene was substituted with that of DV type 3 was stably expressed in BHK cells and used in
ribavirin inhibition studies. The assays described in this studywill greatly facilitate DV drug discovery by
serving as primary or complementary screening. The approach should be applicable to the development
of fluorescent cell-based HTS assays for other flaviviruses, and useful for the study of many aspects of
DV, including viral replication and pathogenesis.
© 2010 Elsevier B.V. All rights reserved.
1. Introduction
Dengue fever is the most prevalent mosquito-borne viral dis-
ease of humans, affecting more than 50 million people annually.
Dengue virus (DV) is a member of the Flaviviridae family together
with other important pathogens such as yellow fever, West Nile,
and Japanese encephalitis viruses. The four genetically related but
serologically distinct serotypes of DV (types 1–4) cause dengue
fever (DF), dengue hemorrhagic fever (DHF) and dengue shock
syndrome (DSS). Despite the urgent need to control dengue infec-
tions, neither specific antiviral therapies nor licensed vaccines
Abbreviations: DV, dengue virus; DV2, DV serotype 2; DV3, DV serotype 3; EGFP,
EnhancedGreen Fluorescent Protein;HTS, high throughput screening; IRES, internal
ribosome entry site; MTase, methyltransferase; NS5, non-structural protein 5; PAC,
Puromycin N-Acetyltransferase; RdRp, RNA-dependent RNA polymerase.
∗ Corresponding author. Tel.: +33 4 9182 8630; fax: +33 4 9182 8646.
E-mail address: Jean-Claude.Guillemot@afmb.univ-mrs.fr (J.-C. Guillemot).
exist, and the molecular basis of dengue pathogenesis is not well
understood. DV has a capped positive-sense single stranded RNA
genome containing a single open reading frame (ORF), flanked by
5′ and 3′ untranslated regions (UTR). The ORF encodes a polypro-
tein precursor, which is subsequently cleaved by cellular and viral
proteases into three structural proteins (capsid (C), premembrane
(prM) and envelope (E)) as well as seven non-structural proteins
(NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5). The non-structural
proteins assemblewith cellular proteins to form a replication com-
plex, where the viral RNA is synthesized (Lindenbach et al., 2007).
Two of the 10 viral proteins have key enzymatic activities and are
thus potential targets of inhibitors. NS3 acts as a serine protease
(with NS2B as a cofactor), 5′RNA triphosphatase, nucleotide phos-
phatase, and helicase (Lescar et al., 2008). NS5 is a bifunctional
protein: its amino-terminal domain carries a methyltransferase
(MTase) involved in methylation of the 5′ cap structure of genomic
RNA (Dong et al., 2008), whereas its carboxy-terminal domain is
the RNA-dependent RNA polymerase (RdRp) responsible for the
synthesis of viral RNA (Malet et al., 2008).
0166-3542/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
doi:10.1016/j.antiviral.2010.03.010
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To control the spread of DV, new tools are required, both to
improve our understanding of the replication complex and pro-
vide a cost-effective means of screening antiviral compounds.
Subgenomic replicon constructs contain all of the genetic ele-
ments needed for genome amplification in permissive cells but lack
the major part of the genes encoding the structural proteins. The
RNAs consequently replicate but are not packaged into viral parti-
cles. Subgenomic replicon can also encode drug selectable markers
and/or reporter proteins, that may substitute for the structural
protein coding regions. As they are non-infectious, subgenomic
replicons are important tools for the study of viral replication, the
screening of antiviral compounds and the testing of their inhibitory
potential (Khromykh et al., 2001; Lo et al., 2003a,b; Tilgner and Shi,
2004; Alvarez et al., 2005, 2008; Liu et al., 2005; Rossi et al., 2005,
2007; Tilgner et al., 2005; Filomatori et al., 2006; Gu et al., 2006; Ng
et al., 2007; Noueiry et al., 2007). They avoid problems associated
with the use of infectious virus and are particularly important for
the study of BL-3 pathogens, like DV.
In this study, we established stable cell lines expressing a novel
DV type 2 (DV2) replicon. In place of the DV structural genes,
the replicon contained a gene construct encoding a fusion protein
(EGFF–PAC) comprised of the Enhanced Green Fluorescent Protein
(EGFP) and Puromycin N-Acetyltransferase (PAC). Cells containing
the replicon couldbe selectedbypuromycin treatment,whilst EGFP
could be used as a reporter to follow the replication level of the
subgenomic replicon. First, BHK cells expressing the DV2 replicon
were established. The replicon systemswere then extended for the
first time to the COS monkey cell line and a human hepatic cell
line (Huh7). Extension of the replicon system to COS cells is impor-
tant as these cells are not easily naturally infected (unpublished
observations (Rodrigo et al., 2006)). The DV2 replicon Huh7 sta-
ble cell line constitutes a suitable tool for studying the interactions
between viral proteins and hepatic proteins, some ofwhichmay be
responsible for the infection-induced liver damage (Ekkapongpisit
et al., 2007; Pattanakitsakul et al., 2007; Higa et al., 2008).
Second, we set up a screening assay of inhibitors, based on the
use of EGFP as a readout. To validate the assay, we used ribavirin,
a broad spectrum antiviral molecule, which inhibits DV replication
(Koff et al., 1982; Crance et al., 2003; Takhampunyaet al., 2006). The
inhibitory effect of ribavirin observed in the DV2 replicon cell lines,
was similar to thatdescribedusing infectedcells, establishinganew
fluorescent HTS assay in a BL-2 environment. Moreover, the estab-
lishment of multiple cell lines carrying the DV replicon enables
evaluation of the inhibitory potential of selected compounds in cell
lines from different organs and species.
Finally, with the aim to test antivirals against the NS5 proteins
of the four DV serotypes and potential NS5mutants in a similar cel-
lular environment, we designed an original method. We modified
the DV2 replicon to allow easy exchange of a NS5 gene cassette.
We validated the construct by introducing the DV type 3 (DV3)
NS5 gene into the DV2 replicon. The chimeric replicon construct
was shown to be viable as it was possible to establish a stable cell
line expressing the DV2/3-NS5 replicon. In addition to demonstrat-
ing that a replication complex containing the NS1 to NS4B proteins
fromDV2 and the NS5 protein fromDV3 is functional, the chimeric
replicon can be used as a tool to test the effectiveness of antivi-
rals specifically against theMTase and the RdRp of the different DV
serotypes in a cellular context.
2. Materials and methods
2.1. Cells, media and reagents
Cellswere grown inDulbecco’smodifiedeaglemedium(DMEM)
(PAA) supplemented with penicillin, streptomycin and 5% (BHK
cells) or 10% (COS and Huh7 cells) foetal calf serum (FCS). For BHK-
, COS- and Huh7-DV EGFP-replicon containing cells, puromycin
(Sigma) was added at 3.5, 2 and 1!g/ml, respectively. Replicon
replication inhibition testsweredoneusingamediumwithoutphe-
nol red (Invitrogen), supplemented with penicillin, streptomycin,
2mM l-glutamine, 1mM sodium pyruvate and 5% FCS, without
puromycin. Ribavirin (Sigma) was resuspended in 100% DMSO at
20mM and stored at −20 ◦C.
2.2. Replicon plasmid construction
2.2.1. DV2 (new Guinea C strain) EGFP-PAC replicon plasmid
A DV2 replicon expressing an EGFP-PAC fusion protein was
constructed using the replicon pDEN!CprME-PAC2A (Jones et al.,
2005) that was previously derived from the genome length DV2
(newGuinea C strain) cDNA clone pDVWS601 (Gualano et al., 1998;
Pryor et al., 2001). Initially, the EGFP gene was amplified from
pEGFP (Clontech) by PCR, using primers P1 and P2 (all primers
are listed in Table 1) and cloned into pCR-Blunt-II-TOPO (Invit-
rogen) resulting in the plasmid pCR-EGFP. The PAC-1D2A gene
cassette was then amplified from pDEN!CprME-PAC2A by PCR as
two overlapping fragments (in order to replace an internal XbaI
site with a BglII site) using primers P3, P4, P5 and P6 respectively.
The PAC and 1D2A gene fragments were then joined by overlap
PCR using primers P3 and P6 and the resulting fragment cloned
into pCR-Blunt-II-TOPO to produce the plasmid pCR-PAC-1D2A.
The PAC-1D2A gene fragment was excised from pCR-PAC-1D2A
with NdeI and BamHI and cloned into the corresponding sites
of pCR-EGFP resulting in the plasmid pCR-EGFP-PAC-1D2A. The
EGFP and PAC genes are separated by a 21 nt linker containing
the restriction enzyme sites BglII, SphI and NdeI. The EGFP-
Table 1
List and sequences of the primers used in this study.
Primer Complete name Sequence 5′-3′
P1 P1 Sbf 5-GFP TCGACTGTACAAACTCCTGCAGGTACGCGTACCATGGTGAGCAAGGGCGAGGAGCTG
P2 P2 GFP-3 2r GTCCATATGGCATGCAGATCTTCGGTACAGCTCG
P3 P3 PAC/G-3 GCATGCCATATGGACATGACCGAGTACAAGCCCACGGTGCGCCTC
P4 P4 PAC/B-2r CAGATCTGGCACCGGGCTTGCGGGTCATGCACCAG
P5 P5 1D2A/PAC CCGCAAGCCCGGTGCCAGATCTGTCACCGAGTTGCTTTACCGG
P6 P6 1D2A/Sna/Pme GTTTAAACGCTACGTACGGGCCCAGGGTTGGACTCGACGTC
P7 P7 F attBl DV2 largeNS5 GGGGACAAGTTTGTACAAAAAAGCAGGCTGCAAGTATAGCGGCTAGAGG
P8 P8 R attB2 DV2 largeNS5 GGGGACCACTTTGTACAAGAAAGCTGGGTGGTTGAAGGCTCTCAAGGGCATCG
P9 P9 F pDON-DV2-largeNS5+AgeI CGAGAAGGGGAACCGGTAACATAGGAGAGACG
P10 P10 R pDON-DV2-largeNS5+AgeI CGTCTCTCCTATGTTACCGGTTCCCCTTCTCG
P11 P11 F pDON-DV2-largeNS5+ScaI GGAAGAGGCAGGAGTaCTGTGGTAGAAGGC
P12 P12 R pDON-DV2-largeNS5+ScaI GCCTTCTACCACAGtACTCCTGCCTCTTCC
P13 P13 F attBl DV3 NS5 GGGGACAAGTTTGTACAAAAAAGCAGGCTATGGGAACCGGTTCACAAGGTGAAACCTTAGGAGA
P14 P14 R attB2 DV3 NS5 GGGGACCACTTTGTACAAGAAAGCTGGGTCCACAGTACTCCCTCTGACTCCTCCTCCTTCCTGA
P15 P15 F pDON-DV2/3-largeNS5 VLtoAI CAGAGGGAGCAATTTGGTAAAAGGCAAAACTAACATG
P16 P16 R pDON-DV2/3-largeNS5 VLtoAI CATGTTAGTTTTGCCTTTTACCAAATTGCTCCCTCTG
CL
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Fig. 1. Schematic representation of the subgenomic DV2 and DV2/3-NS5 EGFP-replicon plasmids. (a) From the full length DV2 NGC infectious cDNA clone pDVWS601, a
large part of the C-prM-E coding sequence was deleted, leaving sequence encoding the N-terminal 27 amino acids of the C protein (C27) and the C-terminal 24 amino acids of
the E protein (E24). The deleted sequence was replaced by an EGFP-PAC-1D2A gene fusion. This replicon is under the control of a T7 promoter. (b) The pDON-DV2-largeNS5
plasmid was obtained by recombination of the pDON201 vector with a PCR product obtained from the DV2 EGFP replicon plasmid. (c) The DV3 (H87 strain) NS5 sequence
was obtained by RT-PCR. (d) The pDON-DV2/3-largeNS5 plasmid was obtained by exchange of the NS5-containing AgeI/ScaI fragments between the DV3 PCR product and
the pDON-DV2-largeNS5. (e) The DV2/3-NS5 EGFP-replicon was obtained by exchange of the NS5-containing HpaI/XbaI fragments between the pDON-DV2/3-largeNS5 and
the DV2 EGFP replicon. For all plasmids, white and black stars indicate restriction enzyme sites initially present or added by PCR, respectively.
PAC-1D2A gene fusion was excised from pCR-EGFP-PAC-1D2A by
digestion with BsrGI and SnaBI and cloned into the correspond-
ing sites of pDEN!CprME-PAC2A resulting in the production of
the replicon plasmid pDEN!CprME-EGFP-PAC-1D2A (hereafter
termed DV2 EGFP-replicon). The replicon plasmid contains a T7
promoter upstream of the DV sequence (such that transcription
adds a single G nt at the 5′ end of the DV 5′UTR) and retains DV2
sequences coding for the first 27 amino acids of the C protein
(including the first methionine) and the last 24 amino acids of the
E protein. The remainder of the sequence coding for the viral struc-
tural proteins was replaced by the EGFP-PAC-1D2A gene fusion
(Fig. 1a).
2.3. Construction of a DV2/3-NS5 EGFP-replicon plasmid
Using the DV2 EGFP-replicon plasmid as a template, a sequence
including theNS5 gene (extending from themiddle of theNS3 gene
to the plasmid sequence downstream of the viral 3′UTR) and con-
taining two pre-existing unique enzyme restriction sites near the
5′ and 3′ termini of NS5 (HpaI and XbaI, respectively) was ampli-
fied by PCR with primers P7 and P8. They contained attB1 and
attB2 sequences, allowing recombination with the pDON201 vec-
tor using the Gateway® (Invitrogen) cloning technology. Unique
enzyme restriction sites were then added by site-directedmutage-
nesis at the exact 5′ (AgeI site,with primers P9 andP10) and exact 3′
(ScaI site,with primers P11 andP12) termini of theNS5 gene result-
ing in the production of the plasmid pDON-DV2-largeNS5 plasmid
(Fig. 1b).
TheNS5geneofDV3 (H87 strain)was amplifiedbyRT-PCRusing
RNA fromDV3-infected cells,withprimers P13andP14 introducing
the AgeI and ScaI sites at the exact 5′ and exact 3′ termini (Fig. 1c).
Primers P13 and P4 also contained the attB1 and attB2 sequences,
allowing recombination with a pDON201 vector. By restriction
(with AgeI and ScaI) and ligation (with T4 ligase), the DV2 NS5
sequencewas removed from the pDON-DV2-largeNS5 plasmid and
replacedwith theDV3NS5sequence, producing theplasmidpDON-
DV2/3-largeNS5 (Fig. 1d). The amino acid substitutions created by
the introduction of the ScaI site into the DV3 NS5 sequence was
restored (Val.Leu to Ala.Ile) by site-directed mutagenesis (primers
P15 and P16).
The HpaI-XbaI fragment from either the pDON-DV2-largeNS5
plasmid (control) or the pDON-DV2/3-largeNS5 plasmidwere then
used to replace the equivalent fragment in the DV2 EGFP-replicon
plasmid. The new EGFP-replicon plasmids were named DV2-NS5
andDV2/3-NS5, respectively (Fig. 1e).All plasmidswere sequenced.
pDON201-derived plasmids and replicon plasmids were amplified
in E. coli DH5! at 37 ◦C and Stbl2 at 30 ◦C, respectively.
2.4. In vitro RNA transcription and transfection
DV2, DV2-NS5 and DV2/3-NS5 EGFP-replicon plasmids were
linearized by XbaI, extracted with phenol/chloroform and precipi-
tatedwith ethanol. The linearized plasmidswere used as templates
(2.5"g in a total reaction volume of 50"l) for the production
of replicon RNAs in the presence of 6m m7GpppA cap analog
(NEBiolabs),with the T7-dependentMEGAscript® kit fromAmbion.
Replicon RNAwas purifiedwith the RNeasy® kit (Qiagen). Replicon
RNA (2"g) was transfected with the TransMessenger® kit (Qia-
gen) into BHK and COS cells previously plated in a 6-well plate.
Huh7 cells (8×106 cells resuspended in 800"l of cytomix buffer
(Liang et al., 2005) were electroporated with 3"g of replicon RNA
(1 pulse, 950"F, 270V). After 48h, transfected and electroporated
cellswere selected for 7dayswithpuromycin, at the concentrations
described above. Cells expressing high levels of EGFP were sorted
with a Becton-Dickinson FACSVantageTM and then propagated in
the presence of puromycin.
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2.5. Inhibition of the replication of the replicon by ribavirin
Two methods were developed to assess the effects of com-
pounds on the replication of the DV replicon based on either 24 or
96 well formats. Control cells, DV2 and DV2/3-NS5 EGFP-replicon
cells were seeded either in 24-well plates or in black 96-well plates
at densities of 5×104 or 1×104 cells per well, respectively, in
complete uncoloredmedium supplementedwith 0.5% DMSO (v/v).
After 24h, themediumwas removed and cellswere incubatedwith
400!l (24-well plate) or100!l (96-well plate) of the samemedium
containing a range of ribavirin concentrations (1!Mto 100!M). In
each 96-well plate, incubations were done in triplicate and 6 con-
trol wells were also included. The media were renewed after 24h,
as cells were incubated with ribavirin for a total of 48h.
For the 96-well plate assay, the inhibitory effect of ribavirin
was defined according to its cytotoxic effect as follows. In addition
to the ribavirin treated and control cells, a range of cell num-
bers, from 1×104 to 8×104 were freshly seeded, in triplicate, into
each 96 well plate and incubated for 5 to 6h. The media was then
removed from all wells and replaced by 100!l of PBS. The EGFP
fluorescence from each well was read with a Tecan SafireII® fluo-
rimeter at 490nm (excitation) and 510nm (emission). Then 20!l
of Celltiterblue® reagent (Promega) was added per well, the plates
incubated for a further 75min at 37 ◦C and 5% CO2 and the fluores-
cence read at 560nm (excitation) and 590nm (emission). A 590nm
fluorescence curve produced using the range of cell numbers was
then used to define an equation to calculate the number of cells
present in each well. The 510nm fluorescence values were divided
by the calculated cell number and mean values for each point of
concentration were reported as a percentage of the mean control
value.
For the 24 well based assay, the EGFP-fluorescence intensity of
the cells in each well was analyzed by flow cytometry as described
below. Values for each ribavirin concentration were reported as a
percentage of the control value.
2.6. Protein expression analysis
2.6.1. Flow cytometry
Cells were washed with PBS and trypsinized. Pelleted cells
were washed twice with PBS containing 2% FCS and the EGFP-
fluorescence intensity was analyzed by flow cytometry with a
Becton-Dickinson FACScanTM.
2.7. Western-blot
Total proteins were extracted with cell lysis buffer (50mM Tris
Cl pH 7.4, 150mMNaCl, 0.5% Na deoxycholate, 1% NP40, 100!g/ml
PMSF, protease inhibitor cocktail from Sigma®) and loaded on a
SDS-PAGE (10%) gel. Purified recombinantDV2NS5protein (Selisko
et al., 2006) was also loaded as a control. Proteins were trans-
ferred to a PVDF membrane (Millipore), which was then blocked
with PBS/0.1% Tween20/5%milk, and then incubated with primary
and secondary antibodies. The following antibodieswere used;
a mouse monoclonal anti-GAPDH coupled to peroxidase (clone
GAPDH-71.1, from Sigma®, diluted at 1/25,000), a mouse mon-
oclonal anti-EGFP (clone JL-8, from Clontech, diluted at 1/4000),
a rat monoclonal anti-NS3 helicase domain (culture supernatant
of the clone 31F9.11, diluted at 1/10, produced in house), a rat
monoclonal anti-NS5 RdRp domain (clone 19A8.2, diluted at 1/500,
produced in-house), a goat anti-rat IgG (Jackson Immunoresearch,
diluted at 1/10,000) and a goat anti-mouse IgG (from Sigma,
diluted at 1/4000), both coupled with horse-radish peroxidase.
Western-blots were detected by chemiluminescence with ECL
(AmershamTM) and Biomax Light Films (Kodak).
3. Results
3.1. Construction of the DV2- and chimeric DV2/3-NS5
EGFP-replicon plasmids
As an initial step towards the development of a cell-based flu-
orescent screening assay for DV inhibitors, a DV2 (New Guinea C
strain) replicon expressing the drug selectable marker puromycin
N-acetyl-transferase (PAC) gene (Jones et al., 2005) was modified
to express an EGFP-PAC gene fusion (Fig. 1a). Previous DV replicons
that express both a reporter gene andadrug selectablemarker gene
have used internal ribosome entry sites (IRES) to initiate transla-
tion of the DV non-structural proteins (Puig-Basagoiti et al., 2006;
Ng et al., 2007). However, translation from IRES sequences can
be much less efficient than cap-dependent translation (Mizuguchi
et al., 2000; Ibrahimi et al., 2009) and influenced by positional
(Hennecke et al., 2001) and cell type specific effects (Hellen and
Sarnow, 2001). Therefore, we expressed the Enhanced Green Flu-
orescent reporter Protein (EGFP) as a fusion with the PAC gene
product. The 1D2A peptide derived from foot-and-mouth disease
viruswas engineered after the PAC gene. The 1D2Apeptide induces
a translation ‘skip’ (Doronina et al., 2008) which served to sep-
arate the EGFP-PAC-1D2A fusion protein from the remainder of
the DV polyprotein. The EGFP-PAC-1D2A gene fusion replaced the
major part of the DV2 structural genes. The sequence coding for
the first 27 amino acids of the C protein was retained, as it con-
tains the 5′ cyclization sequence (5′CS) important for replication
(You andPadmanabhan, 1999;Khromykhet al., 2001;Alvarez et al.,
2005). In addition, the sequence coding for the last 24 amino acids
of the E protein were retained because the C-terminal uncharged
hydrophobic sequence of the E protein acts as a signal sequence for
translocation of NS1 across the endoplasmic reticulum (Rice et al.,
1985; Falgout et al., 1989).
With the aim to test inhibitors against theNS5 protein of the dif-
ferentDVserotypes in a cellular environment,weestablishedaDV2
replicon carrying an NS5 gene cassette. To produce chimeric DV
EGFP replicon plasmids, we optimised a method designed to avoid
the generation of recombination events, frequently observedwhen
workingwith long viral sequences.Weproduced a plasmid (pDON-
DV2-largeNS5) that can be used to reliably exchange the NS5
sequence in the DV2 EGFP-replicon plasmid in two cloning steps.
The DV3 (H87 strain) NS5 sequence was first amplified by RT-PCR
from total RNA extracted from infected cells. The NS5 gene cas-
sette in the DV2 repliconwas replacedwith the DV3NS5 sequence,
producing the DV2/3-NS5-EGFP-replicon plasmid. Details of these
constructions are described in Section 2 and in Fig. 1.
3.2. Production of hamster, simian and human cell lines
supporting the DV2 EGFP-replicon
The DV2 EGFP-replicon plasmid was used as a template to pro-
duce a m7GpppA-capped replicon RNA that was introduced into
hamster BHK, simian COS, and humanHuh7 cells. The replicon RNA
wouldbe translated as a uniquepolyprotein by the cellularmachin-
ery. The fusion protein EGFP-PAC-1D2A would be separated from
the remainder of the polyprotein by the ribosome skip induced
by the 1D2A peptide. The DV non-structural proteins would be
cleaved either by cellular proteases or by the NS2B/NS3 protease
complex (Lindenbach et al., 2007) and assemble into a replication
complex. The puromycin concentration used for selection of repli-
con containing cells was set according to the differential sensitivity
level of each cell line: BHK cells were less sensitive than COS cells,
which were less sensitive than Huh7 cells. BHK cells transfected
with the replicon RNA were resistant to puromycin at 3.5!g/ml,
whereas non-transfected BHK cells were highly sensitive and died
in 2 days at 1!g/ml of puromycin. COS- andHuh7- DV2 cells trans-
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Fig. 2. Analysis of the expression of EGFP, NS3, NS5 andGAPDHproteins in replicon containing cells. (a) Analysis by flow cytometry of the fluorescence level of nontransfected
(dotted line) or stable established EGFP-replicon containing (solid line) cells. (b) Analysis by Western-blot of the NS5 (higher panel), NS3 (middle panel) and GAPDH (lower
panel) expression in non-transfected cells (lanes ‘c’) and in EGFP-replicon containing cells. Recombinant NS5 (rNS5) was loaded as a control. DV2: DV2 EGFP-replicon; DV2/3:
DV2/3-NS5 EGFP-replicon.
fected with the DV EGFP-replicon were selected using 2!g/ml and
1!g/ml of puromycin, respectively.
Transfected puromycin-resistant cells, but not non-transfected
cells, also expressed EGFP, as verified by fluorescent microscopy
and flow cytometry (data not shown). Cells expressing high levels
of EGFP were sorted and amplified. Replicon RNA was extracted
and sequenced, and no mutations observed. EGFP expression was
maintained at the same level for at least a period of 2 months
in the presence of the respective puromycin concentration. BHK-
, COS- and Huh7-DV2 EGFP-replicon containing cells were shown
to express EGFP (Fig. 2a) and the NS5 protein (Fig. 2b, higher pan-
els). EGFP expressionwasmonitored byflowcytometry,whilst NS5
protein expressionwas revealed byWestern-blot with an in-house
produced and well-characterized monoclonal antibody directed to
the DV2 NS5 RdRp domain.
3.3. Production of a BHK cell line supporting a chimeric DV2
EGFP-replicon with full length NS5 from DV3
The DV2-NS5- and the DV2/3-NS5-EGFP-replicon plasmids
were linearized and in vitro transcribed. BHK cells, transfectedwith
one or the other replicon RNA, were resistant to puromycin at
3.5!g/ml and expressed EGFP. Cells expressing high levels of EGFP
were sorted and amplified. In order to detect any adaptive muta-
tions, replicon RNA was once again extracted and sequenced. No
mutations were observed. Besides the EGFP protein (Fig. 2a), BHK
DV2/3-NS5 EGFP-replicon containing cells expressed the NS5 pro-
tein (Fig. 2b, higher right panel). The NS5 signal, as revealed with
an anti-NS5 monoclonal antibody directed to the DV2 NS5 RdRp
domain, was greater in BHK DV2 cells than in the BHK DV2/3-NS5
cells. However, the levels of expression of the viral NS3 protein
Fig. 3. Localization of solvent-accessible aminoacids differing between DV serotypes 2 and 3 on the NS5 MTase and RdRp domains. On the 3D ribbon views, non-conserved,
similar and conserved amino acids are colored in orange, yellow and white, respectively. (a) MTase (left; PDB code: 2P41): the catalytic tetrad (K61-D146-K182-E218), the
cofactor S-adenosyl-homocysteine (AdoHcy), the RNA binding region, and the GMP in the cap-binding site are indicated. (b) RdRp (PDB code: 2J7U): fingers, palm, thumb
subdomains, tunnels of NTP entry, RNA entry, RNA exit, the catalytic residues (D533-D663), and the priming loop, are indicated. (a) and (b) Dotted circles represent active
sites. Amino acids side chains are shown as sticks with the following color code: grey: C, blue: N, red: O. AdoHcy and GMP are shown as sticks with the following color code:
magenta: C, blue: N, red: O, yellow: S, orange: P. Nt: amino-terminal, Ct: carboxy-terminal. (For interpretation of the references to color in this figure legend, the reader is
referred to the web version of this article.)
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(middle right panel) and the cellular protein GAPDH (Fig. 2b, lower
right panel) were similar between the BHK DV2 and BHK DV2/3-
NS5 EGFP-replicon containing cells, indicating that both replicons
replicated at similar levels. The lower NS5 signal in the BHKDV2/3-
NS5 EGFP-replicon containing cellsmay result from a lower affinity
of themonoclonal antibody for the DV3-NS5 protein than the DV2-
NS5 protein.
The exchange of the DV2 NS5 gene with that of DV3, allowed
the assembly of a functional replication complex, as evidenced by
the long term maintenance of EGFP and NS5 expression, indica-
tive of replicon replication. The DV2 (NGC strain) and DV3 (H87
strain) NS5 proteins have 79% identity and 91% homology. The 3D
structure of the NS5 MTase (Egloff et al., 2002) and RdRp (Yap et
al., 2007) domains are shown in Fig. 3. The catalytic tetrade Lys-
Asp-Lys-Glu, the Adenosyl-Homocysteine (AdoHcy) cofactor, the
cap binding site and the RNA binding region are indicated on the
MTase 3D view (Fig. 3a). The palm, thumb and fingers subdomains,
the tunnels of NTP entry, RNA entry, RNA exit, the catalytic Asp
residues, and the priming loop, are indicated on the RdRp 3D view
(Fig. 3b). The amino acids potentially involved in protein-protein
interactions are solvent-accessible. Based on an alignment of the
DV2 NS5 and DV3 NS5 amino acid sequences (see Supplementary
Fig. I), we distinguished three types of solvent-accessible amino
acids: identical residues are labeled in white, similar residues in
yellowandnon-conserved residues in orange. Surface residues that
differ between the DV2 and DV3 NS5 MTase domain are mainly
observed on the !6 and !7 helices. In the case of the RdRp domain,
the main differences are localized on six !-helices: !1 and !8 on
the thumb subdomain, and !5, !13, !16 and !17 on the palm sub-
domain. As shown in Fig. 3, these helices are outside of the catalytic
sites, and this suggests that they are not the major determinants of
interactions with viral or cellular proteins crucial for a functional
DV replication complex.
3.4. Set-up and validation of a DV inhibitor EGFP-based screening
assay
In stable cell lines supporting autonomously replicating sub-
genomic replicons, RNA replication involves multiple viral and
cellular proteins which form the replication complex. These cells
provide multiple targets whose functions could be inhibited or
interactions disrupted by small molecule inhibitors of viral repli-
cation. We therefore examined whether the replicon cell lines
described above could be used as the basis of an antiviral screening
assay. The EGFP protein is cotranslated from the replicon RNAwith
the DV non-structural proteins, its level of expression is depen-
dent on a functional replication complex. Thus, the inhibition of the
replication and/or the translation of the replicon RNAwould lead to
a decrease in the level of EGFP expression, that would reflect a sim-
ilar decrease in the expression of the viral non-structural proteins.
The decrease in EGFP expression is easily measurable in a high
throughput assay using a plate-carrying fluorimeter. Identification
of inhibitors requires quantification of an EGFP expressiondecrease
in the steady-state level of RNA replicon. The cytotoxicity and the
inhibitory potential of the compounds were tested on the same
plate. To do so, cells were maintained with the molecules for 48h,
the solution being renewed after 24h. The initial cell number per
well and the duration of the assay are thus critical since the cell
density could affect the replication efficiency of the RNA repli-
con. The cell monolayer may be close to the subconfluent state
at the end of the assay, 1×104 cells per well in 96-well plates
were initially seeded and the readout measurements were done
3 days later. Since phenol red could interfere with fluorescence
measurements, to varying degrees depending on the cell density,
we decided to use an uncolored culture medium without phenol
red during the experiment, and to replace media by PBS before
measuring EGFP fluorescence. As chemical compounds have to be
dissolved in DMSO, the effect of DMSO concentration on cell via-
bility was examined. Replicon containing cells were fully viable at
0.5% DMSO, but stopped dividing at 1% DMSO and died in less than
24h above 1% DMSO. The inhibition assays were therefore carried
out in 96-well plates, with media containing a final concentration
of 0.5% DMSO. Under these conditions, the signal-to-noise ratio
(EGFP fluorescence level from replicon-containing cells divided by
the background signal from naïve BHK cells) was around 20 to
25. At the end of a 2-day treatment with potential inhibitors, the
Celltiterblue® reagentwasused to calculate the cell number in each
well. Total EGFP fluorescence was then correlated to this cell num-
ber. With only these two fluorescence readouts, we could quantify
inhibitory activity and toxicity and measure the EC50 (the effec-
tive concentration that led to 50% of the control fluorescence per
replicon cell) and the CC50 (the concentration that led to 50% of the
control cell number) of selected compounds.
To validate our screening assay, we used ribavirin for two rea-
sons: its antiviral activities and itsmoderate cellular toxicity (Graci
and Cameron, 2006), which are the two characteristics quanti-
fied with our assay. Ribavirin, a structural analog of GTP, is an
inhibitor of the replication of a broad spectrum of viruses (Sidwell
et al., 1972; Streeter et al., 1973). Ribavirin has been shown to
inhibit the replication of DV in infection assays (Koff et al., 1982;
Crance et al., 2003; Takhampunya et al., 2006) and in a DV subge-
nomic replicon assay (Ng et al., 2007). Five distinct mechanisms
have been proposed to explain the antiviral properties of rib-
avirin (for a review, see Parker (2005), Graci and Cameron (2006)).
These include both indirect mechanisms (inosine monophosphate
dehydrogenase inhibition, immunomodulatory effects) and direct
mechanisms (interference with RNA capping, polymerase inhibi-
tion, lethal mutagenesis). At least one direct mechanism has been
reported for a DV protein: the in vitro inhibition of the 2′-O MTase
activity of the DV NS5 protein (Benarroch et al., 2004).
Experiments carried out in the 96-well plate format, with BHK
DV2EGFP-replicon containing cells, allowedus to calculate a repro-
ducible EC50 value of 15.5±1.1"M for ribavirin (Fig. 4a, solid line).
This value is representative of 4 experiments and is consistentwith
values published previously using other cellular systems (Koff et
al., 1982; Crance et al., 2003; Takhampunya et al., 2006; Ng et
al., 2007). We calculated a Z’ factor, according to the mean val-
ues and the standard deviations of the EGFP fluorescence levels
of BHK DV2 EGFP-replicon containing cells, either not treated or
treated with 100"M or 50"M of ribavirin. The Z’ factor was 0.76
and 0.73, respectively, indicating that the assay is reliable (Zhang
et al., 1999). Similar reproducible EC50 values were calculated with
the other DV2 EGFP-replicon cell lines (Table 2): 12.7±1.7"M for
the COS DV2 EGFP-replicon containing cells and 11.9±0.7"M for
the Huh7 DV2 EGFP-replicon containing cells. As for the BHK DV2
EGFP-replicon containing cells, we tested the effect of ribavirin on
BHK DV2/3-NS5 EGFP-replicon cells and measured a reproducible
EC50 value of 12±1.2"M (Table 2).
An alternate assay was developed to directly quantify the
fluorescence of EGFP in individual cells treated with ribavirin,
independently of the cell count number. Replicon containing cells
seeded in 24-well plates were treated with ribavirin following
the same protocol used for 96-well plates but analysed by flow
cytometry. Fluorescence of individual cells was measured for each
ribavirin concentration and the mean values of the fluorescence
intensities were directly compared to the control value. Using this
assay, the EC50 value calculated for BHK DV2 EGFP-replicon con-
taining cells was 18.4±1.8"M (Fig. 4a, dotted line, representative
of 3 individual experiments), which is similar to the EC50 value
obtained with the high throughput 96-well assay. With the 24-
well format method, EC50 values were 5.8±0.6"M, 19.2±1.8"M
and 20±1.5"M, for COS- and Huh7- DV2-, and BHK DV2/3-NS5-
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Fig. 4. Measurement of CC50 and EC50 values of ribavirin onDV EGFP-replicon cells. (a) Ribavirin EC50 valueswere calculated on BHKDV2 EGFP-replicon containing cells, from
plate-carrying fluorimeter measurements (o, solid line) or obtained from flow cytometry measurements (×, dotted line). (b) From plate-carrying fluorimeter measurements,
ribavirin CC50 values were calculated on BHK cells (solid line), COS cells (large dotted line) and Huh7 cells (thin dotted line).
Table 2
EC50, CC50 and SI values of ribavirin on DV EGFP-replicon containing cell lines.
EC50 (!M) CC50 (!M)c SId
BHK DV2 EGFP 15.5±1.1a 18.4±1.8b 57.2±5.6 3.7
BHK DV2/3-NS5 EGFP 12±1.2a 20±1.5b 4.7
COS DV2 EGFP 12.7±1.7a 5.8±0.6b >100 >7.9
Huh7 DV2 EGFP 11.9±0.7a 19.2±1.8b 91.9±7.6 7.7
a EC50 values determined with the 96-wells plate assay.
b EC50 values determined with the 24-well plate assay.
c CC50 values were calculated with non-transfected cells.
d SI: selectivity index.
EGFP-replicon containing cells, respectively (Table 2). The high
throughput fluorescence assay was validated as EC50 values are
similar to those obtained with the flow cytometry assay. These
results demonstrated unequivocally that combining the total EGFP
fluorescence intensity measurement and cell counting using a flu-
orescent reagent is an appropriate method to rapidly calculate
inhibitory activity and EC50 values of selected compounds.
Moreover, with the same assay, we could measure CC50 values
and calculate the selectivity index (SI =CC50/EC50). For BHK cells,
the ribavirin CC50 was 57.2±5.6!M (Fig. 4b, solid line). This gave
SI values of 3.7 and 4.7, for BHK DV2- and BHK DV2/3-NS5- EGFP-
replicon containing cells, respectively. Ribavirin CC50 values were
higher than 100!M for COS cells (Fig. 4b, large dotted line) and
91.9±7.6!M for Huh7 cells (Fig. 4b, thin dotted line), giving SI
values above 7.7. Even though the EC50/CC50 and SI values of rib-
avirin showed only minor variation between different cell types
(Table 2), the availability of a number of different DV replicon con-
taining cell lines should prove useful for screening inhibitors that
may have different cell type specific characteristics.
3.5. The decrease in ribavirin-induced EGFP expression correlates
with replicon NS5 protein expression
To confirm that the decrease in EGFP expression reflected
a decrease in the expression of the viral non-structural pro-
teins, we analyzed the amounts of DV NS5 protein following
ribavirin treatment. Equal quantities of total protein extracted from
ribavirin-treated cells were loaded on a SDS-PAGE gel and trans-
ferred to a PVDF membrane. The level of expression of the cellular
protein GAPDH was not significantly affected by ribavirin treat-
ment (Fig. 5, lowerpanel). As expected, the EGFPprotein expression
level decreased in BHK DV2 EGFP-replicon containing cells treated
with ribavirin (Fig. 5, middle panel). Furthermore, the DV2 NS5
protein expression level decreased with increasing ribavirin con-
Fig. 5. Analysis by Western-blot of the expression of DV-NS5, EGFP and GAPDH
proteins upon ribavirin treatment. Upper panel: NS5, middle panel: EGFP, lower
panel: GAPDH. From left to right: purified recombinant NS5 protein (NS5), BHK cells
extract (BHK), BHK DV2 EGFP-replicon containing cells extracts, untreated (DV2) or
treated with ribavirin, 5, 10, 25, 33, 50 and 100!M.
centrations (Fig. 5, upper panel). These results demonstrated that
ribavirin inhibited the DV replication complex in the replicon con-
taining cell lines and that its antiviral effect can be determined
by monitoring the EGFP expression level correlated to the cell
number. In conclusion, our Western-blot analysis confirmed that
the high-throughput fluorescence measurements on the DV EGFP
replicon-containing cells could be used to identify new inhibitory
compounds.
4. Discussion
The goal of this study was to extend current genetic systems for
the development of HTS assays for anti-flavivirus drug discovery.
Using DV2 as amodel, we describe the construction of subgenomic
DV EGFP-replicon plasmids and the production of several subge-
nomic replicon containing cell lines.
Self-replicating, non-infectious flavivirus subgenomic replicons
have been widely used in studies of adaptive mutations (Liu et
al., 2005; Rossi et al., 2005, 2007), viral assembly and packaging
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(Harvey et al., 2004; Fayzulin et al., 2006; Leung et al., 2008), cou-
pling between replication and packaging (Khromykh et al., 2001),
viral RNA sequence and/or structure requirements for translation
or replication (Lo et al., 2003a; Tilgner and Shi, 2004; Alvarez et
al., 2005, 2008; Tilgner et al., 2005; Filomatori et al., 2006) and the
antiviral immune response (Jones et al., 2005; Hershkovitz et al.,
2008). Among these replicons, WNV-derived replicons have also
been used for the screening of inhibitors, utilizing the luciferase
reporter protein (Lo et al., 2003b; Rossi et al., 2005; Gu et al., 2006;
Ng et al., 2007; Noueiry et al., 2007), resulting in several screen-
ing successes (Puig-Basagoiti et al., 2005; Goodell et al., 2006; Gu
et al., 2006; Noueiry et al., 2007; Puig-Basagoiti et al., 2009). Two
reports have described an HTS assay based on a DV replicon, both
in BHK cells, with a luciferase reporter detection (Puig-Basagoiti et
al., 2006;Ng et al., 2007). The assays described in this study demon-
strate the establishment of a new DV replicon system based on an
EGFP readout.
The establishment of replicon containing cell lines that can be
used for HTS assays requires the expression of genes coding for
a drug selectable marker and a reporter protein. A number of
approaches have been used to produce the two individual pro-
teins, including theuseof self cleavingprotein sequences toprocess
polyproteins containing the two proteins and the use of an IRES
element to either initiate translationof theviral non-structural pro-
teins or a heterologous protein encoded by a gene cassette inserted
in the viral 3′UTR. In the DV2 EGFP replicon, the EGFP and PAC
proteins were produced as fusion protein that was cleaved from
the DV2 non-structural proteins by the 1D2A peptide sequence
from foot-and-mouth-disease virus. Previous studies have shown
that translation initiated by an IRES sequence downstream from a
cap-dependent translation start site is often inefficient (Mizuguchi
et al., 2000; Ibrahimi et al., 2009) and can be subject to cell type
specific effects. By contrast, the separation of heterologous gene
product/s from the viral non-structural proteins by the 1D2A pep-
tide essentially results in equimolar amounts of products (de Felipe
et al., 2006). As the EGFP fluorescence from DV2 EGFP replicon
containing cells was taken as a measure of non-structural protein
expression, it may be beneficial to have the EGFP-PAC fusion pro-
tein separated from the non-structural proteins through the use of
the 1D2A sequence rather than an IRES sequence. Both the EGFP
and PAC proteins were active in the context of a fusion protein
with the EGFP-PAC protein giving similar resistance to puromycin
as the PAC gene product alone in previous studies (Jones et al.,
2005). Although a gene construct containing an IRES element and
a selectable marker gene have been successfully introduced into
the 3′ UTR of a number of flavivirus replicons (Khromykh et al.,
2001; Shi et al., 2002; Rossi et al., 2005; Gu et al., 2006), including
DV type 1 (Suzuki et al., 2007), we and others have found it diffi-
cult to reliably insert similar gene cassettes into the DV2 genome
(unpublished data (Ng et al., 2007)). The ability to insert a unique
gene cassette encoding an EGFP-PAC fusion protein in place of the
structural protein genes circumvents this potential difficulty in DV
replicon production.
The DV replicon containing cell lines produced in this studywill
serve as useful tools for high throughput screening of DV replica-
tion inhibitors. Our assay is robust as the Z’ factor is greater than
0.7 and the signal-to-noise ratio is 20 to 25, values well suited for a
HTS assay. The EC50 and CC50 values determined for ribavirin with
the new DV replicon containing cell lines are similar to the values
described using virus infected cell lines (Koff et al., 1982; Crance et
al., 2003; Takhampunya et al., 2006; Ng et al., 2007). The effective-
ness of the inhibition of the DV replication complex, based on the
EGFP readout, was confirmed by examining the DV NS5 expression
level with a specificmonoclonal antibody. Our results demonstrate
unequivocally that the determination of replicon replication levels
using a fluorescence-based method that correlates the total EGFP
fluorescencewith total cell numbers is appropriate for themeasur-
ing inhibitory activity and for calculating the EC50 and CC50 values
of selected compounds. In aHTS, in 96- or 384-wells plates, the pro-
cesswouldbedivided in twoparts. A single EGFP readoutwill select
compoundswith both antiviral activity and/or cytotoxic effect. The
selected compounds, decreasing the EGFP level, will be tested for
their cytotoxicity, thus allowing to keep the non-cytotoxic com-
pounds with antiviral activity.
Two types of approaches are routinely used for antiviral assay
development. One approach is biochemistry-based, in which the
enzymatic activity of purified viral protein is assayed. For fla-
viviruses, enzymatic HTS assays have been developed for the
multifunctionalNS3 (protease, helicase, nucleoside triphosphatase,
and 5′-RNA triphosphatase) and NS5 (MTase and RdRp) proteins
(Johnston et al., 2007; Lim et al., 2008). The principal advantage
of the biochemistry-based assay is that the targets of the identi-
fied inhibitors are known. The other approach is replicon-based,
a biosafe alternative to using infectious virus and involves mul-
tiple targets in the viral life cycle. The assays described in this
study provide additional means for DV drug discovery. For exam-
ple, inhibitors obtained from anti-MTase and anti-RdRp based
screens can now be tested using the DV2 EGFP replicon-containing
cells. In addition, with the use of the DV2 or DV2/3-NS5 replicon-
containing cells it will be possible to determine the potential of the
MTase/RdRp inhibitors in the context of different DV serotypes.
Moreover, with the replicon carrying the NS5 gene cassette, it
will be possible to characterize NS5 mutants derived from bio-
chemical/structural analysis or resistance studies, in a cellular
environment.
A range of cell typeswere used in this study to stably express the
DV replicons. As in a number of previous studies we initially estab-
lished the DV2 EGFP replicon in BHK cells which were then used to
optimize the assays for HTS. The DV inter-serotypic chimeric repli-
con, expressing the NS1 to NS4 genes from DV2, and the NS5 gene
from DV3 was also established in BHK cells. In addition to its use
for drug discovery, the chimeric replicon system provides an inter-
esting tool to study the determinants of interactions which occur
in the viral replication complex.
Once established in BHK cells, the replicon systems were then
extended to a human hepatic cell line (Huh7) and the COS monkey
cell line. DV can infect many cell types and causes diverse clinical
and pathological effects. Although the main target cells in humans
are believed to reside in the reticuloendothelial system, both clin-
ical and experimental observations suggest that there is also liver
damage during DV infection. Clinical evidence of liver involve-
ment in DV infections includes the presence of hepatomegaly and
increased levels of serum liver enzymes (Seneviratne et al., 2006).
DV is able to replicate in both hepatocytes andKupffer cells (Huerre
et al., 2001). Thus, the DV2 replicon Huh7 stable cell line consti-
tutes a suitable tool for studying the interactions between viral
proteins and hepatic proteins, some of which may be responsible
for the infection-induced liver damage (Ekkapongpisit et al., 2007;
Pattanakitsakul et al., 2007;Higaet al., 2008). Extensionof the repli-
con systemtoCOScells demonstrated that evencells that arepoorly
infected with DV in vitro (unpublished observations (Rodrigo et al.,
2006)) can be used for maintaining DV replicons if they are per-
missive for genome replication. Monkey kidney-derived cells have
been previously used for DV protein interaction studies in vitro
(Kapoor et al., 1995).We therefore produced aCOS cell line contain-
ing the DV replicon, allowing studies of the DV replication complex
with antibodies directed to viral or cellular proteins. Compared to
BHK cells, COS cells have the advantage that they are less likely
to be susceptible to cross reactivity with mouse or rat monoclonal
antibodies, commonlyused for immunoprecipitation studies.Over-
all the production of a range of DV replicon cell lines provides new
opportunities for the study ofDV replication in a cellular context. At
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the same time, the establishment of multiple cell lines carrying the
DV replicon demonstrates the feasibility of directly evaluating the
potential of selected compounds in cell lines from different organs
and species.
In summary, the assays described in this studywill greatly facil-
itate DV drug discovery by serving as primary or complementary
screening assays. The approach should be applicable to the devel-
opment of cell-based HTS assay for other flaviviruses, and should
also be useful for the study of DV replication and pathogenesis.
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a b s t r a c t
Most viruses modify their genomic and mRNA 50-ends with the addition of an RNA cap, allowing efficient
mRNA translation, limiting degradation by cellular 50–30 exonucleases, and avoiding its recognition as for-
eign RNA by the host cell. Viral RNA caps can be synthesized or acquired through the use of a capping
machinery which exhibits a significant diversity in organization, structure and mechanism relative to
that of their cellular host. Therefore, viral RNA capping has emerged as an interesting field for antiviral
drug design. Here, we review the different pathways and mechanisms used to produce viral mRNA 50-
caps, and present current structures, mechanisms, and inhibitors known to act on viral RNA capping.
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1. Introduction
In the eukaryotic cell, RNA capping is a co-transcriptional event
consisting of a chemical modification of the nascent mRNA 50-end.
Since the early 70s, viruses have played a pivotal role in the discov-
ery and structural characterization of the RNA cap (Fig. 1), as well
as in the mechanistic elucidation of the RNA capping pathway.
Incidentally, virus families for which these discoveries were made
(Reoviridae and Poxviridae) use an RNA capping pathway that
turned out to be the same as that of their eukaryotic hosts. Soon
after these discoveries, other virus families were found to deviate
substantially from this ‘conventional’ pathway (see below).
In the conventional pathway, a cap structure is added to the
nascent 50-triphosphate mRNA in a series of reactions (Fig. 2).
The 50-triphosphate is first hydrolysed by an RNA 50-triphospha-
tase (RTPase). A guanylyltransferase (GTase), also called ‘‘capping
enzyme’’, adds the cap structure under the form of a guanosine
50-monophosphate in a 50–50 orientation. The cap is then methyl-
ated onto the N-7 position of its guanine by an RNA cap guanine
N-7-methyltransferase (N-7 MTase). This generates the minimal
cap-0 (m7GpppN. . .), found in metazoan and lower eukaryotes.
In higher eukaryotes, further methylation by ribose 20-O-methyl-
transferases (20-O MTases) occurs at the 20-position of the riboses
of the original transcript to yield mainly cap-1 (m7GpppNmN. . .)
but also cap-2 (m7GpppNmNmN. . .) structures.
The presence of the cap ensures stability of the transcript
against a variety of cellular 50–30 exonucleases and recognition of
the mRNA by the ribosomal protein eIF4E for efficient translation.
The capping was also shown to be involved in other cellular pro-
cesses such as RNA splicing and export (Darnell, 1979; Filipowicz
et al., 1976; Schibler and Perry, 1977).
Because of its coupling to RNA transcription, RNA capping is
mainly a nuclear process, although some RNA re-capping events
are suspected to occur in the cytoplasm (reviewed in Schoenberg
and Maquat (2009)). Viruses generally replicate in the cytoplasm,
causing there to be a time-window during which viral RNAs are
synthesized but not yet capped. Virus and cell co-evolution has
generated a number of cellular pathways and proteins involved
in sensing the presence of viral RNAs. The absence of RNA cap as
well as the presence of double stranded RNA are strong tokens
for a viral infection. These RNA species, alone or together, are de-
tected as ‘‘non-self’’ RNA by cellular sensors triggering an innate
cellular immunity response (Koyama et al., 2008; Takeuchi and
Akira, 2007; Wilkins and Gale, 2010). Viruses have evolved numer-
ous strategies to escape detection, including rapid and efficient vir-
al RNA capping.
Few virus families and genera do not rely on RNA capping. Pic-
ornaviridae use a protein as an RNA synthesis primer and this pro-
tein replaces the RNA cap in its role for transcription promotion
and RNA protection. Viruses from Pestivirus and Hepacivirus genera
use unprotected 50-triphosphate RNA ends and other strategies to
defend their RNA from the cell immunity systems (Garaigorta
and Chisari, 2009; Guidotti and Chisari, 2001; Malmgaard, 2004).
However, the vast majority of viruses use RNA capping. With
the ongoing deciphering of viral RNA capping machineries, a true
diversity of mechanisms, partners, and pathway organizations
which invariably leads to the same RNA structure are progressively
being uncovered. This diversity and its differences from the cellular
RNA capping machineries are drawing a lot of attention for antivi-
ral drug design.
2. Is RNA capping an appropriate target for antiviral research?
There are factors to bear in mind before considering RNA cap-
ping as an interesting drug design target:
Specificity: a most often put forward requirement is the unique-
ness of the viral target, i.e., the non-existence of a similar cellular
target that could also be hit by any antiviral drug and cause serious
side-effects. Interestingly, even when viral enzymes remain close
in structure and mechanism to their cellular counterpart, there re-
main structural and functional differences potentially useful to
achieve differential inhibition, i.e., selectivity for the viral target.
In most cases, viral enzymes are profoundly original in folding,
organization, and mechanisms, providing a large chemical space
for drug design and drug selectivity.
Potency: another important parameter is the expected outcome
of viral target inhibition. The question of whether the in vitro inhi-
bition effectively leads to a significant block of viral growthmust be
answered. One has to consider the twomajor mechanisms of action
of the viral target. It can be an enzyme, and inhibition of its enzyme
Fig. 1. The RNA cap structure: the cap consists of a 7-methylguanosine (blue box) linked to the 50 nucleoside of the messenger RNA chain through a 50–50 triphosphate bridge
(pink box). The methyl group of the guanosine at its N-7 position is surrounded in green, and the 20-O methyl group of the first and second nucleotide residue forming the cap-
1 and the cap2 structures, respectively, are surrounded in light orange.
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activity may have exponential consequences. On the other hand,
the virus may develop alternative pathways in order to resist anti-
viral molecules. For example, Flavivirus capping inhibitors had to be
validated since dengue virus was also shown to perform cap-
independent translation of its RNA genome (Edgil et al., 2006).
Another possibility is that the target protein can be a binding part-
ner devoid of catalytic activity and part of a protein–protein binding
equilibrium. Its inhibition would shift the equilibrium according to
the law ofmass action. The protein dosagemust be fine tuned to ex-
ert a powerful antiviral effect. In both cases, a significant effect on
viral growthmust be observed to validate the target as appropriate.
Amplifying mechanism: lastly, one has to consider the number of
events that the protein or target is involved in during the virus life-
cycle. For example, RNA-dependent RNA polymerases (RdRp)
incorporate several thousand nucleotides to produce a single
RNA genome. Inhibition of the viral RdRp at each nucleotide incor-
poration should exhibit a powerful antiviral effect. In contrast, RNA
capping events can vary from a single capping event (e.g., the gen-
ome of ss(+)RNA viruses), to many RNA capping events (e.g., Nid-
ovirales, Mononegavirales, etc.). Nevertheless, the connection
between RNA capping and antiviral innate immunity pathways is
expected to amplify any drug action on RNA capping. Immature
or incomplete RNA caps may not only exhibit an altered expression
profile, but may also be detected by a variety of innate immunity
sensors that add another direct negative effect on viral growth.
In this context, it is noteworthy that the efficacy of RNA capping
inhibition has been demonstrated. The inhibition of Flavivirus
MTase, which catalyzes two methylations per synthesis of an en-
tire RNA genome, has been reported to be able to completely sup-
press viral replication (Dong et al., 2008a).
3. Conventional and unconventional viral RNA capping
mechanisms
Alongside the discovery of conventional cellular and viral RNA
capping (Fig. 2), few viruses provided remarkable exceptions to
the seemingly ubiquitous presence of capped mRNAs in Eukarya
(as mentioned above for picorna-, hepaci- and pestiviruses). It
was soon discovered that other viruses also used ‘unconventional’
RNA capping reactions deviating from the conventional RNA cap-
ping scheme (example in Fig. 3 and for complete review (Decroly
et al., 2012)). Nevertheless, it is truly remarkable that several of
these widely different RNA capping reactions and pathways con-
verge to the same RNA cap structure (Fig. 4). This observation indi-
cates that the evolutionary pressure to keep this structure
protecting RNA must be significant. Viral RNA capping is thus an
interesting target for drug design. In the following sections we
summarize our current knowledge on viral enzymes involved in
conventional and unconventional RNA capping (main reference
structures in Fig. 5) and reported inhibitors (Fig. 6).
4. Conventional viral RNA cap-synthesizing enzymes
4.1. RNA triphosphatases
RTPases (Fig. 5, RTPase) are the enzymes responsible for the first
step of cap formation, hydrolyzing the c–b phosphodiester bond of
Fig. 2. Canonical RNA capping mechanisms. The cap-0 structure is formed on nascent
RNA chains by the sequential action of three enzymes. (1) The RNA triphosphatase
(RTPase, pink) hydrolyses the c phosphate of the nascent RNA (pppN-RNA, where N
denotes the first transcribed nucleotide) to yield a diphosphate RNA (ppN-RNA) and
inorganic phosphate (Pi). (2) RNA guanylyltransferase (GTase, light blue) reacts with
the a phosphate of GTP releasing pyrophosphate (PPi) and forms a covalent
enzyme–guanylate intermediate (Gp-GTase). The GTase then transfers the GMP
molecule (Gp) to the 50 diphosphate RNA to create GpppN-RNA. (3) RNA (guanine-
N-7)-methyltransferase (N-7 MTase, green), recruited by the GTase, transfers the
methyl group from S-adenosyl-L-methionine (AdoMet) to the cap guanine to form
the cap-0 structure (m7GpppN) and releases S-adenosyl-L-homocysteine (AdoHcy)
as a by-product. The capping reaction is then completed by the methylation of
the ribose-20-O position of the first nucleotide by the AdoMet-dependant (nucle-
oside-20-O)-methyltransferase (20-O MTase, orange), generating cap-1 structure
(m7GpppNm20O). Below the schematic are listed examples of viruses that acquire
their cap structures using the cellular capping machinery (first four examples) or
encode their own viral capping machinery that adopt the canonic pathway.
Question marks indicate viruses likely to follow this conventional pathway.
Fig. 3. Cap-snatching mechanisms. The endonuclease captures the cellular mRNA
from the cell (blue) and snatches (cleaves and transfers) the cap structure followed
by seven to eleven bases to the polymerase to start the viral mRNA (green). The
residual cellular RNA serves as decoy for the innate immunity. The RNAs capped by
viral enzymes are undistinguishable from cellular mRNA and can thus be translated
into proteins by the host-cell ribosomal machinery. Below the schematic are listed
examples of viruses that acquire their cap structures using the cap snatching
mechanism.
F. Ferron et al. / Antiviral Research 96 (2012) 21–31 23
CLXI
50-triphosphorylated mRNA. There is no enzyme conservation
amongst different kingdoms of life, meaning that the activity can
be found within a domain or a single protein presenting structural
and mechanistic diversities (for detailed review Decroly et al.
(2012)). Theses diversities make the RTPase an attractive target
for the development of specific and selective inhibitors. RTPases
can indeed be separated into two classes sorted by mechanistic
criteria, i.e., either with a metal-independent and -dependent
mechanism (Gu and Lima, 2005; Shuman, 2002). This separation
also divides higher eucaryote RTPases (including human) from
the vast majority of viral RTPases.
The metal-independent RTPase is so far a lone structural family,
including human RTPase, higher eukaryotes (plants) and viruses
like baculovirus. The substrate binding and catalytic site of these
enzymes is located in a P-loop enriched with histidines and a cys-
teine that mediates a two-step reaction with a covalent phos-
phoenzyme intermediate (Changela et al., 2001; Denu and Dixon,
1998).
Alternatively, for viral metal-dependent RTPases a structural
and mechanistic variety was found over the years. Metal-depen-
dent RTPases can be organized into three superfamilies: the HIT-
like fold (a–b complex) (Jayaram et al., 2002), the ‘triphosphate
tunnel metalloenzyme’ (TTM) (Benarroch et al., 2008; Gu and Lima,
2005; Lima et al., 1999; Shuman, 2001), and the viral RNA helicase-
like fold that carries one or more of the so-called Walker motifs
(Benarroch et al., 2004b).
The HIT-like fold (Fig. 5, RTPase III) found in Rotavirus NSP2 pro-
tein has a magnesium dependent NTPase/RTPase hydrolysis activ-
ity capable of removing the c-phosphate of either NTP or RNA
(Jayaram et al., 2002). Both activities share the same catalytic site
and mechanism. Also, the switch from one activity to the other is
substrate dependent (NTP or pppRNA). NSP2 is a protein that
self-assembles into a doughnut-shape octamer, which binds to sin-
gle-stranded RNA after destabilizing RNA–RNA duplexes. Each
NSP2 monomer has two subdomains separated by a deep electro-
positive cleft containing histidine residues involved in the binding
and the hydrolysis of NTP as well as RNA (Vasquez-Del Carpio
et al., 2006). The cleft is oriented on the surface of the doughnut.
The N-terminal subdomain is mostly a-helical while the C-termi-
nal domain adopts an a/b fold with a central twisted and anti-par-
allel b-sheet made of 5 b-strands, which is flanked by 5 a-helices.
The protein is both a structural component of the RNA packaging
and part of the capping machinery. Due to its unique structural fea-
tures, it should be considered as a target of choice for the develop-
ment of antiviral compounds.
Enzymes from the TTM superfamily hydrolyze NTPs to NDP + Pi
in the presence of manganese or cobalt and are found in fungi, pro-
tozoa, and most of DNA viruses that encode a RTPase (Orthopoxvi-
rus, Chlorovirus, Baculoviridae and Mimivirus). The RTPase of
Saccharomyces cerevisiae Cet1 serves as a model (Fig. 5, RTPase I)
and presents a structural tunnel composed of eight antiparallel b
strands with a motif encompassing two glutamates (Lehman
et al., 1999; Lima et al., 1999). The tunnel harbors several charged
and hydrophilic side chains coordinating manganese and sulfate
ions. The sulfate is thought to indicate the position of the c-phos-
phate of the newly synthesized mRNA. In a docking/modeling-
based study, a series of nucleoside analogues (6-chloropurine-ribo-
side-50-triphosphate, 6-methylthioguanosine-50-triphosphate, or
8-iodo-guanosine-50-triphosphate) was identified with high affin-
ity for binding and resistant to hydrolysis (Despins et al., 2010; Is-
sur et al., 2009a).
The last identified superfamily is the viral RNA helicase-like fold
(Fig. 5, RTPase II), which carries NTPase-helicase activity. These
RTPases are found in the RNA virus genera or families Flavivirus
(NS3), Coronaviridae, Orthoreovirus, Alphavirus and Potexvirus.
Structurally, they can belong to either SF1 or SF2 helicase super-
family. No viral helicase crystal structure belonging to the SF1
superfamily has been determined to date, yet the fold is thought
to be divergent from the canonical SF1 (Cordin et al., 2006). On
the other hand, the SF2 fold is formed by two RecA-like sub-do-
Fig. 4. Viral RNA capping pathways. Mammalian viruses, with the exception of ssRNA(+) pestiviruses and ssRNA(+) hepaciviruses, use strategies to chemically modify their
mRNA 50-ends through either covalent attachment of a protein (Viral Protein genome-linked, VPg, for ssRNA(+) -Picornaviridae, -Caliciviridae, and -Astroviridae), or covalent
attachment of an RNA cap structure (all other viruses). When possible the viruses were divided by red dashed lines according to the nature of their viral genome (single
stranded, double stranded, DNA, or RNA), and virus families and genera are written in italics. Three virus orders (ssRNA(+) Nidovirales and ssRNA(!) Mononegavirales and
Multinegavirales (ssRNA(!) and ambisense RNA) are shown in bold and underlined. Enzymes and mechanisms are indicated along arrows leading to Cap-RNA. Small letters
‘‘v’’ ahead of the enzyme name indicate that the enzyme is of viral origin. The list of presented families is non exhaustive and used as an example.
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mains, separated by a cleft that can accommodate either a nucleo-
tide or 50-triphosphate RNA substrate. The two sub-domains carry
the Walker motifs: the A motif forms the P-loop stabilizing the ter-
minal phosphate moiety of the substrate, and the B motif is com-
posed of acidic residues (D-E-x-D) coordinating the divalent ion
needed for substrate hydrolysis.
All the catalytic sites described above, or clefts accommodating
the RNA substrate or nucleotides could be used as a target for drug
design. However, more efforts are needed to better understand the
fine mechanistics that would lead to rational drug design.
4.1.1. Inhibitors
Amongst the different families of viral RTPases, very few inhibi-
tion studies have identified potentially interesting compounds
(Fig. 6). In that respect, the least neglected RTPase is cvRTP1, from
the DNA Paramecium bursaria Chlorella virus 1. Not surprisingly,
phosphate analogues (see Fig. 6, RTPase inhibitor I and II, also van-
adate) are weak inhibitors, with no ‘‘drug-like’’ properties (Takagi
et al., 2003). The family of Flavivirus NS3-like enzymes may have
greater value, since in addition to the RTPase activity they habour
two other activities (helicase and NTPase). The RTPase active site is
super-imposable to the NTPase active site, which provides energy
to unwind dsRNA. Suppression of the RTPase/NTPase activity
abrogates helicase activity, therefore, it is likely that bi-functional
inhibitors will be discovered in the near future (Lescar et al., 2008).
One example for this approach has been a study of the inhibitory
potential of purine analogues (one structure in Fig. 6, RTPase inhib-
itors III) that are expected to inhibit all three activities (Despins
et al., 2010).
4.2. Guanylyltransferases
GTases (Fig. 5, GTase) are responsible for attaching a GMP mol-
ecule onto the pre-mRNA. Contrary to RTPases, fold and mecha-
nism seem to be very well conserved amongst all kingdoms of
life, making de facto the GTase a difficult target for specific inhibi-
tor development. Yet there is a possibility that in the viral king-
dom, GTases exhibit other mechanisms and new folds that would
make GTases good candidates for drug development. This assump-
tion comes from both the difficulty in identifying GTases in the vir-
al world and the presence of GTase domains embedded within
larger proteins such as protein L in Mononegavirales or the variant
GTase domain found in cypovirus (Cheng et al., 2011) (Fig. 5, GTase
II). Known GTase proteins so far adopt a modular organization con-
taining an N-terminal nucleotide transferase domain with an ATP-
grasp fold and a C-terminal domain with an oligonucleotide/oligo-
saccharide binding fold (OB-fold) that is positioned as a lid over the
base subdomain of the N-terminal domain (Fig. 5, GTase I). The
GTP-binding site is located between the base and the hinge, and
is highly conserved in GTases from dsDNA viruses to humans.
The catalytic site can be defined by the presence of six conserved
motifs, for which Motif I contains a lysine that covalently links
GMP by hydrolysis of ppi from GTP, before its transfer onto RNA.
Other conserved motifs form the binding pocket for the nucleotide.
GTases from the ds RNA viruses of the Orthoreovirus genus form
part of a multidomain protein (or assembly line) carrying all RNA
capping functions. The GTase domain probably exists transiently
and no fold can be clearly defined, whereas the methyltransferase
domains are identifiable. Nevertheless, the catalytic residue is also
a conserved lysine (Sutton et al., 2007).
4.2.1. Inhibitors
Very few compounds have been described that could provide a
useful start for drug design. In the case of DNA viruses, the enzyme
shares structural and functional similarities to the ligase protein
superfamily, raising potential difficulties in achieving selectivity
inside the host cell. The pyrophosphate analogue foscarnet (a phos-
phonic acid derivative (Fig. 6, GTase inhibitor I)) has been shown to
inhibit the reaction, not surprisingly since the reaction produces
pyrophosphate (Soulière et al., 2008). In the case of several viral
families the GTase is still unknown (coronaviruses, flaviviruses).
In the flaviviruses, the GTase activity might be expressed by the
N-terminal domain of protein NS5 carrying also other related
RNA capping activities (MTases, Issur et al., 2009b). Therefore,
structural and mechanistic studies may provide efficient drug leads
targeting several activities at once as it is the case for Ribavirin, a
guanine nucleotide analogue, targeting GTase and MTase (Benar-
roch et al., 2004a; Bougie and Bisaillon, 2004).
4.3. Methyltransferases
The last step of the cap formation consists in the methylation of
the cap by RNA cap methyltransferases (Fig. 5, MTase). The N-7 po-
sition of guanine is methylated by the N-7 MTase and the first
nucleotide of the RNA transcript is further methylated at the ribose
20-OH position by 20-O MTase (see Fig. 1). S-adenosyl-L-methionine
(SAM) is the methyl donor for both the N-7 and 20-O methylations,
generating S-adenosyl-L-homocysteine (SAH) as a by-product. The
two methylations are either done by specific proteins (or domains)
Fig. 5. Structural models of viral enzymes involved in RNA capping. RTPase folds: (I) the
triphosphate tunnel metalloenzyme (TTM) fold is examplified by the structure of
the RTPase (PDB code 2QZE) from the genus Mimivirus, which consists of double-
stranded DNA (dsDNA) viruses; (II) the helicase fold of the RTPase from the single-
stranded positive-sense RNA (ss(+)RNA) dengue virus (PDB code 2BHR); (III) the
histidine triad (HIT)-like fold of the RTPase from dsRNA rotaviruses (PDB code
1L9V). GTase folds: (I) Structure of the dsDNA virus Paramecium bursaria chlorella
virus 1 GTase, showing the loading reaction: GTP onto the active site, with
the GTase in an open conformation (PDB code 1CKO); (II) GTase domain of the
Cypovirus (PDB code 3IZ3, residues 1–366). MTases folds: (I) N-7-MTase: the
(guanine-N-7)-methyltransferase (N-7 MTase) domain of protein D1 from
the dsDNA virus vaccinia virus (PDB accession code 2VDW) in complex with a
molecule of S-adenosyl-L-homocysteine (AdoHcy). II) 20-O MTase: VP39, the 20-O
MTase of the dsDNA virus vaccinia virus, in complex with a capped RNA and
AdoHcy (PDB code 1AV6). III) N-7/20-O methyltransferase: the N-7 MTase-(nucle-
oside-20-O)-methyltransferase (2’-O MTase) domain of NS5 from dengue virus
(ss(+)RNA) in complex with the cap analogue 7-methyl-G (m7G)-pppGm20-O and
AdoHCY (PDB code 2P41). Endonuclease fold: (I) endonuclease (N-terminal) domain
of L protein of lymphocytic choriomeningitis virus (PDB code 3JSB). Structures are
colored cyan for a-helices and red for b-strands. All figures were prepared using
PyMOL.
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(Poxviridae, Coronaviridae, Reoviridae) or by one single protein (or
domain) (Flavivirus).
The canonical SAM-dependent MTase fold presents alternating
b strands and a helices, that form a seven-stranded b sheet with
at least three parallel a helices on each side (a/b fold). The struc-
ture is reminiscent of the Rossmann fold also found in the dinucle-
otide-binding domains of dinucleotide-binding proteins. The SAM-
binding region is located at the N-terminal part of the b sheet and
is formed in part by residues from loops following the central
strands of the sheet. The substrate-binding region that is responsi-
ble for selectively binding nucleic acids is located in the C-terminal
part of the b sheet. Depending on nature of the methylation (N-7 or
20-O or both) additional structural features can be found to help
accommodate or stabilize the substrate.
The N-7 MTase of vaccinia virus (VV) serves as structural and
reference model of N-7 MTases. The activity is carried by the com-
plex of the C-terminal domain of protein D1 and protein D12. Both
the domain of D1 and D12 present the characteristic core a/b fold of
the MTase family (Fig. 5, N-7 MTase I), but the D12 protein lacks a
proper SAM binding site and does not show any activity on its own.
In contrast, it stimulates the MTase activity of D1 by 30- to 50-fold.
D12 does not affect the extent of substrate binding to the catalytic
subunit. Rather, it has an allosteric role increasing the affinity for li-
gands as well as increasing the overall stability of the complex. Re-
cently, similar finding have shown that the SARS 20-O MTase
activity harbored in protein nsp16 is stimulated by a small regula-
tory protein nsp10 (Bouvet et al., 2010; Decroly et al., 2011).
VP39 protein of VV serves as reference for 20-O MTase struc-
tures. It is a single-domain protein with a typical a/b fold (Fig. 5
20-O MTase II). This structure has all the features of the canonical
core domain. The catalytic residues of 20-O MTases are defined by
a conserved tetrad motif K-D-K-E located at the interface of
SAM-binding cavity and the substrate-binding cleft (Fig. 5, 20-O
MTase II). VP39 exhibits a hydrophobic pocket, at the end of the
RNA binding cleft, which presents aromatic side chain residues in-
volved in stacking the capped RNA.
Single domain MTases are exemplified by the Flavivirus MTase
domain of protein NS5. The NS5 protein of flaviviruses is divided
into two domains, an MTase residing in the N-terminal (one-third
of NS5) and an RNA-dependent RNA polymerase domain in the C-
terminal (two-thirds of NS5). The NS5 MTase domain was first
unambiguously characterized as a 20-O MTase (Egloff et al., 2002)
and later it was shown that the same SAM-binding site is used
for N-7 MTase activity (Ray et al., 2006). The core structure of
the domain consists of the 7-stranded b-sheet surrounded by four
a-helices (Fig. 5, N-7/20-O MTase III) and its catalytic site is identi-
fied by the universal tetrad K-D-K-E (Fig. 5, N-7/2’-O MTase III). The
core of the structure is not supposed to rearrange, yet optimal N-7
and 20-O methylations of the flavivirus cap require distinct bio-
chemical conditions, suggesting that the two methylations occur
through different mechanisms. Mutagenesis of the tetrad has
shown that only the D of the K-D-K-E catalytic tetrad is essential
for the N-7 methylation, and structural studies are still investigat-
ing the determination of the complete catalytic site for the N-7
MTase. Ray and colleagues (Ray et al., 2006) have shown that the
two cap methylation events are sequential and that the reaction
is controlled by a steric constraint for the substrates. Indeed the
N-7 methylation requires wild-type nucleotides at the 2nd (G)
and 3rd (U) positions, with a 50-stem–loop structure, whilst the
subsequent 20-O methylation requires wild-type nucleotides at
the 1st (A) and 2nd (G) positions and a minimum of 20 nucleotides
of viral RNA.
Fig. 6. Capping enzymes inhibitors. Inhibitors structure examples. RTPase inhibitors: (I) PPi (II) PPPi (III) 6-chloropurine-ribose-50-triphosphate. GTase inhibitors: (I) foscarnet (II)
ribavirin triphosphate. MTase inhibitors: (I) sinefungin (II) dAPPMA 20-O MTase inhibitors: (III) aurintricaboxylic acid (IV) inhibitor 7. Endonuclease inhibitors: (I) DPBA (II)
Flutimide.
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4.3.1. Inhibitors
The exploration of MTases constitutes the most actively grow-
ing field amongst viral RNA capping targets. The last 10 years have
seen viral RNA cap MTases coming increasingly into focus as tar-
gets for the discovery and development of antivirals (Dong et al.,
2008b; Issur et al., 2011; Liu et al., 2010). The inhibition of N-7
MTase activity is expected to exert a deleterious effect on viral rep-
lication because it blocks viral RNA translation. The essentiality of
the N-7-methylation for viral replication has clearly been demon-
strated for several viral families (Almazan et al., 2006; Dong
et al., 2008a; Ray et al., 2006; Zhou et al., 2007). In contrast, muta-
tional analysis indicates that 20-O MTase inhibition has weak ef-
fects on virus replication in cell culture (Ray et al., 2006; Zhou
et al., 2007). Nevertheless, 20-O MTases are now also considered
as potential targets due to the demonstration that RNA, lacking
2’-O-methylation on their cap structure, induces antiviral response
through the MDA5 sensor (Züst et al., 2011). Viruses mutated in
their 20-O MTase gene accordingly show strongly reduced replica-
tion capacity in animal models (Daffis et al., 2010). This has led to a
re-evaluation of the importance of 20-O-methylation (reviewed in
(Decroly et al., 2012)).
The discovery of inhibitors of viral MTases started and the elu-
cidation of RNA capping started in the dsDNA Poxviridae field. A
SAM analogue, sinefungin (Fig. 6, MTase inhibitor I), was reported
as the first potent inhibitor of the VV N-7 MTase activity (Pugh
et al., 1978) with a potent antiviral effect shown in a plaque forma-
tion assay. Another early study described inhibition of N-7 MTase
and 20-O MTase activities of VV by 20,50-linked oligo(adenylic acid)
triphosphates (Sharma and Goswami, 1981). Interestingly, these
molecules are ‘‘natural’’ metabolites produced by the host cell as
part of the innate immune response against viral infection (re-
viewed in Decroly et al. (2012)). Later, multi substrate adducts
with inhibitory activity against VV N-7 MTase were reported
(Fig. 6, MTase inhibitor II) (Benghiat et al., 1986). SAH analogues
were shown to inhibit VV and herpes simplex virus (HSV) and their
respective MTases were proposed as potential molecular targets
(Balzarini et al., 1992).
Concerning RNA virus MTases being part of the conventional
capping machinery, Flavivirus and Coronavirus MTases have been
particularly explored. The dengue virus 20-O MTase activity was
shown to be inhibited by the GTP-analogue ribavirin triphosphate
(Benarroch et al., 2004a), sinefungin, and SAH (Selisko et al., 2010).
Based on known complex structures of the dengue virus NS5
MTase domain (Benarroch et al., 2004a; Egloff et al., 2007, 2002)
which define the RNA cap binding sites during 20-O-methylation
and N-7-methylation (the latter being the actual active site) as well
as the SAM-binding site, several groups have employed virtual
screening and docking procedures to identify potential ligands
and thus inhibitors (Lim et al., 2011; Luzhkov et al., 2007; Milani
et al., 2009; Podvinec et al., 2010). Some molecules were found
to present inhibitory activity in the micromolar range in in vitro
enzymatic assays (Luzhkov et al., 2007; Milani et al., 2009; Podvi-
nec et al., 2010), see example in Fig. 6, MTase inhibitor IV). A new
conserved hydrophobic binding pocket next to the SAM-binding
site was identified on Flavivirus MTases, which is critical for viral
replication and cap methylations (Dong et al., 2010). This invites
to the design of SAM analogues that also interact with this adjacent
hydrophobic site and should be thus more potent and specific in
comparison to SAM analogues as sinefungin. High-throughput
screens using MTase activity assays and GTP-binding assays were
set up and used to identify inhibitor molecules (Geiss et al.,
2011; Lim et al., 2008). Concerning Coronavirus MTases the search
for antivirals has been less active. Some SAM analogues have been
tested and found to inhibit the N-7 MTase activity of nsp14 and the
20-O MTase activity of nsp16 in the low micromolar range (Bouvet
et al., 2010). One of the identified molecules, aurintricarboxylic
acid (ATA, (Fig. 6, MTase inhibitor III)), also inhibits SARS-CoV rep-
lication in infected cells (He et al., 2004). An indirect approach to
inhibit viral MTases is being considered for Coronavirus 20-O MTase
nsp16, the activity of which depends on its interaction with the
nsp10 protein (Bouvet et al., 2010; Decroly et al., 2011; Lugari
et al., 2010). Molecules that disrupt the interaction are expected
to inhibit the MTase activity of nsp16 and thus viral replication.
This approach can also be considered for the N-7 MTase activity
of protein D1 of VV, which depends on the activation by the stim-
ulatory protein D12 (De la Peña et al., 2007).
4.4. Cap assembly lines
Cap-assembly lines are proteins found in several dsRNA viruses
(Reoviridae). They are multi-domain and function proteins that are
packaged with the genome in the viral particle and are able to per-
form the four reactions needed to synthesize a cap-1 structure. Do-
mains of the cap assembly line must be tightly regulated and
coordinated to accomplish the sequential steps of the cap synthesis
pathway as they can exhibit activity independent from or in syn-
ergy with the capping process. The individual domains correspond-
ing to GTase and MTase have been characterized and have similar
folds to those previously described, although it is unclear how and
when RTPase activity occurs. A complete pathway has been pro-
posed in which guanylyl transfer is followed by N-7-methylation
and 20-O-methylation of the mRNA.
Each domain/function could be targeted individually. The entire
protein is also to be considered, as there is room for specific devel-
opment to sterically impair the necessary dynamic movements of
the respective domains. So far, though, no specific inhibitors of
cap assembly lines or either of their associated enzyme activities
have been described.
5. Unconventional cap synthesis pathways
The first indication for the existence of deviations from the con-
ventional viral RNA capping pathway came in the early 1970s,
around the time of the discovery of the RNA cap structure. Since
then, it has been demonstrated that vesicular stomatitis virus
(VSV, Mononegavirales) and alphaviruses (Togaviridae) can synthe-
size a viral RNA cap that is identical to a cellular RNA cap, albeit
through two completely different mechanisms. Togaviridae do
not proceed further than synthesizing a cap-0 structure, which re-
mains an interesting enigma since many members of this family
productively infect both insects and mammals.
5.1. The Mononegavirales RNA capping pathway
The Mononegavirales order, also referred to as negative-strand
(!) non-segmented (NNS) RNA viruses comprises major human
pathogens such as rabies virus (Rhabdoviridae), measles virus
(Paramyxovirinae), bornavirus (Bornaviridae) and Ebola/Marburg
viruses (Filoviridae). RNA capping is achieved by themultifunctional
L protein, which carries both RNA-dependent RNA polymerase
(RdRp) and RNA cap synthesis activities. Shortly after the discovery
of the RNA cap and conventional capping pathway, it was observed
that the VSV L protein (Abraham et al., 1975a, b) transferred GDP
rather than GMP onto the nascent transcript. Subsequently, L
proteins from spring viremia of carp virus (Gupta and Roy, 1980),
human respiratory syncytial virus (Barik, 1993), and chandipura
virus (Ogino and Banerjee, 2010) were shown to perform a similar
reaction and presumably follow the same RNA capping pathway.
This discovery adds a novel enzyme to the process as the path-
way involves a unique L-encoded GDP polyribonucleotidyltransfer-
ase activity (PRNTase), which forms a covalent enzyme-p-RNA
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intermediate involving a phosphoamidate bond. A conserved cata-
lytic histidine is present in a ‘‘HR’’ motif instead of lysine used by
conventional GTases (Ogino and Banerjee, 2010). GDP generated
from GTP (Ogino and Banerjee, 2007) by a yet-unknown NTPase
is then transferred to the 50-monophophorylated viral mRNA
50-end covalently attached to the PRNTase. Interestingly, the meth-
ylation sequence also is different from the conventional pathway
sequence. The RNA cap is first methylated at the ribose 20-O posi-
tion of the first nucleotide followed by the guanine N-7 position,
generating an RNA cap-1 structure. No crystal structure is available
yet to guide drug design against these unique enzymes. The PRN-
Tase should be considered as a prime target, perhaps more amena-
ble to antiviral design than the more common MTase fold.
5.1.1. Inhibitors
Most effort for antiviral design has been made for RSV, for
which a sizeable market exists. Interestingly, two compound fam-
ilies having submicromolar activities (IC50 = 21–200 nM) have
been described (Liuzzi et al., 2005; Sudo et al., 2005) that target
the L protein. The most potent compounds of respective series have
been used to elicit resistance and the resistance mutation map to
an L region or domain consistent with the presence of the PRNTase.
Although the PRNTase was discovered after the publication of
these compounds, mechanistic studies clearly indicated that the
guanylylation step was the actual target of the compounds. For
RSV, only two products are approved for antiviral therapy or pre-
vention: a monoclonal antibody (Palivizumab, Synagis) and ribavi-
rin (Empey et al., 2010; Vigant and Lee, 2011). The latter served as
a control compound with moderate antiviral effect in the discovery
of PRNTase inhibitors, but the precise mechanism of action of riba-
virin (i.e., capping, error catastrophe, IMP dehydrogenase, or else
(Leyssen et al., 2006; Severson et al., 2003; Zhou et al., 2003))
against Mononegavirales remains to be investigated.
5.2. The ssRNA(+) Togaviridae (alpha-like) RNA capping pathway
The Togaviridae (ss(+)RNA viruses) as exemplified by some
alphaviruses (Semliki Forest virus, sindbis virus and chikungunya
virus) synthesize their cap-0 structure through another non-con-
ventional mechanism (Fig. 4). The enzymes presumably involved
in the capping pathway are poorly characterized and their crystal
structures are not yet available. Nevertheless, it is likely that cap-
ping begins with N-7-guanine methylation of a GTP molecule by
the nsp1 N-7 MTase. This methylation is seemingly followed by
the formation of a covalent m7GMP–enzyme complex involving a
conserved histidine catalytic residue (Ahola et al., 1997). The N-
7-methylation of GTP seems to precede the formation of the en-
zyme–GMP complex, since the guanylate intermediate is not ob-
served in the absence of AdoMet (Ahola and Kääriäinen, 1995;
Ahola et al., 1997). Whereas the m7GMP transfer onto the 50 end
of viral RNA was not yet formally demonstrated, it is expected that
the 50 end of viral RNA bears a diphosphate. The hydrolysis of the
b–c phosphate bond at the 50 end is mediated by the nsp2 RTPase
domain (Vasiljeva et al., 2000). Brome mosaic virus replicase pro-
tein 1A (Ahola and Ahlquist, 1999), bamboo mosaic virus ORF1
protein (Li et al., 2001), tobacco mosaic virus P126 (Merits et al.,
1999) and hepatitis E virus p110 (Magden et al., 2001) were re-
ported to share properties with alphavirus N-7 MTases and GTases.
Interestingly, Sindbis virus and Semliki Forest virus were reported
more than 30 year ago to contain additional methyl groups at-
tached to the exocyclic N2 of the cap structure (HsuChen and Du-
bin, 1976; van Duijn et al., 1986). The role of this methylation in
virus replication is still unknown, but it is reminiscent to 2,2,7-
trimethylguanosine (TMG) cap that is found on non-coding eukar-
yal RNAs such as small nuclear (sn), small nucleolar (sno) RNAs,
and telomerase RNA (Busch et al., 1982; Seto et al., 1999).
5.2.1. Inhibitors
Ribavirin shows broad spectrum in vitro inhibitory activity
against RNA viruses, through presumably different modes of action
(Leyssen et al., 2006; Severson et al., 2003; Zhou et al., 2003). In the
case of alphaviruses, resistance mutants to ribavirin were mapped
into the GTase domain of the nsP1 protein (Scheidel et al., 1987;
Scheidel and Stollar, 1991) suggesting ribavirin interferes with
the GTase activity. Nevertheless, the ribavirin action mode remains
controversial. Ribavirin also reduces the intracellular concentra-
tion of GTP (Leyssen et al., 2005) and/or stimulates the expression
of interferon-stimulated genes such as that of protein MDA5 (Tho-
mas et al., 2011), which is known to sense viral RNA devoid of 2’-O-
methylation (Decroly et al., 2012; Züst et al., 2011).
In addition some efforts have focused on the identification of
specific inhibitors targeting specifically the nsP1 capping activity.
Several GTP analogues have been reported to inhibit Semliki forest
virus MTase and GTase activities with Ki values below 100 lM
(Lampio et al., 1999).
6. Virus-mediated RNA cap ‘snatching’
6.1. Enzymes from the cap-snatching pathway
The cap snatching mechanism is a common and alternative viral
strategy for cap formation. Instead of making its own RNA cap, the
virus has a machinery to remove and transfer (snatch) the cap from
host mRNA onto its own pre-mRNA (Fig. 3). Three major human
pathogen families, Arenaviridae, Bunyaviridae and Orthomyxoviridae
(Fig. 4), all of them ss(!)RNA viruses, have developed this strategy
(Bouloy et al., 1978; Caton and Robertson, 1980; Plotch et al.,
1979). The Orthomyxoviridae serves as a paradigm for both mecha-
nistic and structural studies. In the case of the influenza virus, the
replication complex is made of three proteins forming the poly-
merase complex (PA, PB1, PB2). Host cell mRNAs present in the
cytoplasm are targeted and recruited by PB2 that presents the
cap from the mRNA to the endonuclease domain (PA) to snip the
cap off. Then the short capped RNA is used as primer to polymerize
the viral RNA. The first structural endonuclease domain potentially
involved in cap snatching was recently identified in both Arenavi-
ridae, and Bunyaviridae L protein (Morin et al., 2010; Reguera
et al., 2010) (ENDOase, Fig. 5). The endonuclease fold features four
mixed b-strands forming a twisted sheet surrounded by seven a-
helices (Fig. 5). The b sheet forms the bottom of a negatively
charged cavity creating a binding site for divalent cations. Above
it, a C-terminal helix with a positive patch creates another pocket
to accommodate the RNA where the typical conserved PD...(D/E)XK
nuclease motif defines the catalytic site.
A fourth example of cap snatching has recently been described
in Totiviridae for a fungal virus (Fujimura and Esteban, 2011).
However, in this case the Totivirus L-A transfers only m7GMP
snatched from cellular mRNA. Hence, this mechanism lies some-
where between alphaviruses, which transfer m7GMP acquired
from GTP, and ‘‘conventional’’ cap-snatching viruses described
above, which transfer longer capped RNA oligonucleotides. As
an additional similarity to alphaviruses, the Totivirus L-A cap-
snatching enzyme makes a covalent m7GMP-enzyme intermedi-
ate through a histidine residue (Fujimura and Esteban, 2011; Aho-
la et al., 1997).
6.1.1. Inhibitors
Ribavirin again is an effective inhibitor of Arenaviridae (Olsch-
lager et al., 2011) and Bunyaviridae (Livonesi et al., 2006; Severson
et al., 2003), but it has pleïotropic effects as discussed above and
thus there is no direct evidence that the RNA cap snatching process
is an actual target.
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The first discovery of inhibitors of the cap snatching pathway
was made in 1994, when Tomassini et al. reported that 2,4-dioxo-
butanoic acid compounds were able to inhibit Influenza A and B
viruses in infected cell cultures (Tomassini et al., 1994). Remark-
ably, the compounds exhibited IC50 values in the micromolar
range, comparable to IC50 values observed when purified polymer-
ase cores were used in an in vitro endonuclease assay. The follow-
ing chemical diversification of the parent compound could achieve
a high specificity for influenza. Indeed, the L-735,882 compound
reached an IC50 value of 1.1 lM for influenza in an in vitro endonu-
clease assay and an IC50 value of 2 lM in a viral titer assay using
influenza virus infected cells. The La Crosse virus, a Bunyaviridae
for which RNA capping and RNA polymerase priming rely also on
cap snatching, remained unaffected both at the enzyme and virus
level. Interestingly, the La Crosse virus replicates in the cytoplasm
exclusively, unlike the influenza virus. Therefore, RNA caps are
likely snatched in different cellular compartments or environments
by these two viruses and this should be considerated at early steps
of drug design for large spectrum inhibitors.
In 2009 and 2010, a structural basis for the inhibition mecha-
nisms was provided by the crystal structure of the La Crosse virus
endonuclease domains in complex with DPBA (Reguera et al.,
2010) (Fig. 6, ENDOase inhibitor I)). The structural homology be-
tween the three available crystal structures indicates that a com-
mon pharmacophore including Mn2+ chelating functional groups
might be active against all three viral families. Based on these crys-
tal structures, several compound families have been described and
their antiviral activities characterized using enzyme-based assays,
viral growth assays and protein structure data. The first com-
pounds benefiting from structure-based activity analysis are cate-
chins isolated from green tea. Although they seem to target both
neuraminidase (Song et al., 2005) and endonuclease, one active
pharmacophore was identified as 3,4-dihydroxyphenyl. The same
group extended the family of interesting compounds with thalido-
mide derivatives, active through their 3,4-dihydroxyphenethyl
moieties, and later with marchantin-like phytochemicals produced
in very high yield in liverworts (Iwai et al., 2011). Together with
enzyme and virus-infected cell assays, docking the latter com-
pounds into the PA endonuclease active site gave very interesting
perspectives for effective drugs targeting influenza RNA capping.
7. Conclusions
The viral RNA capping machinery is remarkably diverse in orga-
nization, structure, and mechanisms used by its enzymes. All RNA
viruses capping their own viral RNAs have evolved enzymes pro-
foundly different from those of their host cell. As the power of anti-
viral compound screening and design increases, there are no
doubts that viral RNA capping enzymes will be the target of novel
highly efficient and selective drugs. Despite few exceptions, the
identification and atomic resolution structure of target enzymes
from major families has made significant progress in the last ten
years. The recent connection of viral RNA capping to the host cell
innate immunity mechanisms is more than ever a promising anti-
viral research field.
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